uniprot	category	disease_name	cluster	position	WT	Mut
Q2M2I8	LB/B	-	E7F2L1	509	K	Q
Q2M2I8	LB/B	-	E7F2L1	59	I	V
Q2M2I8	LB/B	-	E7F2L1	533	Q	H
Q2M2I8	LB/B	-	E7F2L1	603	V	A
Q2M2I8	LB/B	-	E7F2L1	694	T	M
Q2M2I8	LB/B	-	E7F2L1	725	P	T
Q2M2I8	LB/B	-	E7F2L1	771	P	R
Q2M2I8	LB/B	-	E7F2L1	835	G	D
Q4LEZ3	LB/B	-	B2RU19	96	G	R
Q9BZC7	LB/B	-	A0A2K6RTV2	583	P	H
Q9BZC7	LB/B	-	A0A2K6RTV2	674	F	V
Q2M3G0	LB/B	-	F6XQU3	560	K	E
Q2M3G0	LB/B	-	F6XQU3	669	K	R
Q2M3G0	LB/B	-	F6XQU3	915	A	T
Q2M3G0	LB/B	-	F6XQU3	970	E	K
Q2M3G0	LB/B	-	F6XQU3	905	Q	H
Q92887	LP/P	Dubin-Johnson syndrome (DJS) [MIM:237500]	U3IJ99	768	R	W
Q92887	LP/P	Dubin-Johnson syndrome (DJS) [MIM:237500]	U3IJ99	1382	Q	R
Q92887	LB/B	-	U3IJ99	281	S	N
Q92887	LB/B	-	U3IJ99	417	V	I
Q92887	LB/B	-	U3IJ99	789	S	F
Q92887	LP/P	Dubin-Johnson syndrome (DJS) [MIM:237500]	U3IJ99	1150	R	H
Q92887	LP/P	Dubin-Johnson syndrome (DJS) [MIM:237500]	U3IJ99	1173	I	F
Q92887	LB/B	-	U3IJ99	1450	A	T
Q92887	LB/B	-	U3IJ99	333	D	G
Q92887	LB/B	-	U3IJ99	353	R	H
Q92887	LB/B	-	U3IJ99	670	I	T
Q92887	LB/B	-	U3IJ99	849	L	R
Q92887	LB/B	-	U3IJ99	1036	I	T
Q92887	LB/B	-	U3IJ99	1181	R	L
Q92887	LB/B	-	U3IJ99	1188	V	E
Q92887	LB/B	-	U3IJ99	1291	P	L
Q92887	LB/B	-	U3IJ99	1515	C	Y
Q92887	LB/B	-	U3IJ99	1273	T	A
Q92887	LB/B	-	U3IJ99	246	M	L
Q92887	LB/B	-	U3IJ99	495	K	E
Q92887	LB/B	-	U3IJ99	562	F	L
Q92887	LB/B	-	U3IJ99	982	I	V
Q92887	LB/B	-	U3IJ99	1063	N	S
Q92887	LB/B	-	U3IJ99	39	Y	F
Q92887	LB/B	-	U3IJ99	486	T	I
Q92887	LB/B	-	U3IJ99	921	G	S
Q92887	LB/B	-	U3IJ99	1174	R	H
Q92887	LB/B	-	U3IJ99	1244	N	K
O15438	LB/B	-	U3IJ99	346	S	F
O15438	LB/B	-	U3IJ99	1297	R	H
O15438	LB/B	-	U3IJ99	1365	Q	R
O15438	LB/B	-	U3IJ99	1381	R	S
O15438	LB/B	-	U3IJ99	11	G	D
O15438	LB/B	-	U3IJ99	1286	R	G
O15438	LB/B	-	U3IJ99	548	L	Q
P42684	LB/B	-	V9KEF7	930	K	R
P42684	LB/B	-	V9KEF7	946	V	M
P42684	LB/B	-	V9KEF7	996	P	R
P42684	LB/B	-	V9KEF7	1085	S	N
P42684	LB/B	-	V9KEF7	1101	T	A
P42684	LB/B	-	V9KEF7	78	R	H
P42684	LB/B	-	V9KEF7	769	T	S
P28330	LB/B	-	A0A0N8ANT6	303	S	T
P28330	LB/B	-	A0A0N8ANT6	333	K	Q
P49748	LB/B	-	F7EK35	43	G	D
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	158	T	N
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	159	Q	R
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	174	V	M
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	185	G	S
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	218	E	K
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	243	L	R
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	247	K	T
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	260	T	M
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	281	A	D
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	283	V	A
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	290	G	D
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	294	G	E
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	299	K	N
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	317	V	A
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	352	M	V
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	366	R	C
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	366	R	H
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	382	K	Q
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	405	D	H
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	441	G	D
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	450	R	H
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	453	R	Q
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	454	D	N
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	456	R	H
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	459	R	W
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	463	G	E
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	469	R	Q
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	469	R	W
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	502	L	P
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	602	L	I
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	613	R	W
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	213	A	P
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	247	K	E
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	458	F	L
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	490	A	P
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	615	R	Q
P49748	LB/B	-	F7EK35	359	A	S
P49748	LB/B	-	F7EK35	623	S	F
P49748	LB/B	-	F7EK35	17	L	F
P49748	LB/B	-	F7EK35	65	P	L
P49748	LP/P	Acyl-CoA dehydrogenase very long-chain deficiency (ACADVLD) [MIM:201475]	F7EK35	583	S	W
Q9BWD1	LB/B	-	H0ZMD1	211	K	R
Q8NC06	LB/B	-	A0A2K6FQN4	118	P	L
Q8NC06	LB/B	-	A0A2K6FQN4	242	R	G
Q9NUZ1	LB/B	-	F1N6R7	255	T	M
Q9NUZ1	LB/B	-	F1N6R7	535	P	L
Q96GR2	LB/B	-	A0A2G8KD10	194	E	V
Q96GR2	LB/B	-	A0A2G8KD10	633	M	V
Q96GR2	LB/B	-	A0A2G8KD10	673	A	V
Q5FVE4	LB/B	-	A0A2G8KD10	143	V	A
Q5FVE4	LB/B	-	A0A2G8KD10	152	K	R
Q5FVE4	LB/B	-	A0A2G8KD10	584	G	D
Q5FVE4	LB/B	-	A0A2G8KD10	586	G	D
Q5FVE4	LB/B	-	A0A2G8KD10	601	P	R
Q5FVE4	LB/B	-	A0A2G8KD10	624	R	K
Q5FVE4	LB/B	-	A0A2G8KD10	626	E	Q
Q5FVE4	LB/B	-	A0A2G8KD10	650	R	S
Q9ULC5	LB/B	-	F6SMD6	182	M	V
Q9ULC5	LB/B	-	F6SMD6	486	T	A
P63261	LP/P	Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]	G7E609	89	T	I
P63261	LP/P	Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]	G7E609	118	K	M
P63261	LP/P	Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]	G7E609	264	P	L
P63261	LP/P	Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]	G7E609	278	T	I
P63261	LP/P	Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]	G7E609	332	P	A
P63261	LP/P	Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]	G7E609	370	V	A
P63261	LB/B	-	G7E609	160	T	I
P63261	LP/P	Baraitser-Winter syndrome 2 (BRWS2) [MIM:614583]	G7E609	120	T	I
P63261	LP/P	Baraitser-Winter syndrome 2 (BRWS2) [MIM:614583]	G7E609	135	A	V
P63261	LP/P	Baraitser-Winter syndrome 2 (BRWS2) [MIM:614583]	G7E609	155	S	F
P63261	LP/P	Baraitser-Winter syndrome 2 (BRWS2) [MIM:614583]	G7E609	203	T	K
P63261	LP/P	Baraitser-Winter syndrome 2 (BRWS2) [MIM:614583]	G7E609	254	R	W
P63261	LP/P	Baraitser-Winter syndrome 2 (BRWS2) [MIM:614583]	G7E609	256	R	W
P63261	LP/P	Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]	G7E609	118	K	N
P63261	LP/P	Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]	G7E609	122	I	V
P63261	LP/P	Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]	G7E609	241	E	K
P63261	LP/P	Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]	G7E609	187	D	H
Q8TC94	LB/B	-	A0A0M3KB40	37	S	F
Q8TC94	LB/B	-	A0A0M3KB40	51	A	V
Q8TC94	LB/B	-	A0A0M3KB40	227	N	H
Q8WXS8	LB/B	-	M3VW93	179	R	C
Q8WXS8	LB/B	-	M3VW93	590	L	P
Q8WXS8	LB/B	-	M3VW93	937	L	M
Q8WXS8	LB/B	-	M3VW93	1017	S	N
Q8WXS8	LB/B	-	M3VW93	1049	E	G
Q8TE57	LB/B	-	A0A146ZVJ1	110	M	V
Q8TE57	LB/B	-	A0A146ZVJ1	486	A	T
Q8TE57	LB/B	-	A0A146ZVJ1	789	R	C
Q8TE57	LB/B	-	A0A146ZVJ1	859	R	L
Q8TE57	LB/B	-	A0A146ZVJ1	863	E	K
O95450	LB/B	-	A0A091I9K0	245	V	I
O95450	LB/B	-	A0A091I9K0	1177	P	S
O95450	LB/B	-	A0A091I9K0	74	V	M
O95450	LB/B	-	A0A091I9K0	241	R	H
O95450	LB/B	-	A0A091I9K0	331	E	K
O95450	LB/B	-	A0A091I9K0	665	G	R
O95450	LB/B	-	A0A091I9K0	827	R	Q
Q8N6G6	LB/B	-	F7G6E2	242	S	N
Q6UY14	LB/B	-	H3CRK1	193	A	P
Q6UY14	LB/B	-	H3CRK1	1028	R	H
Q96EY9	LP/P	Neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies (NEDBGF) [MIM:615286]	A0A0N8ETV7	128	V	M
Q7Z695	LB/B	-	A0A287BNE8	307	S	P
Q7Z695	LB/B	-	A0A287BNE8	418	V	M
Q7Z695	LB/B	-	A0A287BNE8	622	P	L
Q7Z695	LB/B	-	A0A287BNE8	418	V	L
Q7Z695	LB/B	-	A0A287BNE8	626	P	L
Q7Z695	LB/B	-	A0A287BNE8	66	S	G
O60266	LB/B	-	A0A1A8JA76	107	S	P
O60266	LB/B	-	A0A1A8JA76	64	N	I
P35612	LB/B	-	A0A069DZJ1	28	D	N
P35612	LB/B	-	A0A069DZJ1	335	E	D
P35612	LB/B	-	A0A069DZJ1	663	S	R
P35612	LB/B	-	A0A069DZJ1	439	T	A
P35612	LB/B	-	A0A069DZJ1	98	S	C
Q96PE1	LB/B	-	F1MYY2	375	T	K
Q9UHX3	LB/B	-	F1PZP9	605	T	I
Q9UHX3	LB/B	-	F1PZP9	614	L	F
Q9UHX3	LB/B	-	F1PZP9	665	S	F
Q9UHX3	LB/B	-	F1PZP9	314	A	V
Q9UHX3	LB/B	-	F1PZP9	720	E	D
Q9UHX3	LP/P	Vibratory urticaria (VBU) [MIM:125630]	F1PZP9	492	C	Y
P48960	LB/B	-	F1PZP9	367	R	Q
Q86Y34	LB/B	-	M3XZL7	430	A	T
Q8IZF6	LB/B	-	B7ZCD1	276	I	M
Q8IZF6	LB/B	-	B7ZCD1	368	P	H
Q8IZF6	LB/B	-	B7ZCD1	1213	T	N
Q8IZF6	LB/B	-	B7ZCD1	1540	S	P
Q8IZF6	LB/B	-	B7ZCD1	1791	F	L
Q86V24	LB/B	-	A0A212CCY1	39	Q	R
P35318	LB/B	-	P97297	50	S	R
P35318	LB/B	-	P97297	85	P	R
P30542	LB/B	-	A0A2D0QA40	43	A	S
P30542	LB/B	-	A0A2D0QA40	50	S	P
P30542	LB/B	-	A0A2D0QA40	105	R	H
P30542	LB/B	-	A0A2D0QA40	261	P	Q
Q9NX46	LB/B	-	A0A2Y9J0Q6	209	E	K
Q9NX46	LP/P	Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures (CONDSIAS) [MIM:618170]	A0A2Y9J0Q6	79	T	P
P07550	LB/B	-	V8PBY4	16	G	R
P07550	LB/B	-	V8PBY4	27	E	Q
P07550	LB/B	-	V8PBY4	34	V	M
P07550	LB/B	-	V8PBY4	164	T	I
P07550	LB/B	-	V8PBY4	159	I	L
P07550	LB/B	-	V8PBY4	159	I	F
P07550	LB/B	-	V8PBY4	375	K	R
P07550	LB/B	-	V8PBY4	220	S	C
P07550	LB/B	-	V8PBY4	15	N	S
Q8N142	LP/P	Myopathy, distal, 5 (MPD5) [MIM:617030]	U3JJY4	261	D	N
P30520	LB/B	-	H3AR52	179	L	F
Q8WTP8	LB/B	-	M3YWK3	15	P	L
Q8WTP8	LB/B	-	M3YWK3	88	S	C
Q8WTP8	LB/B	-	M3YWK3	140	N	D
P51825	LB/B	-	A0A218UEP2	209	P	A
P51826	LB/B	-	A0A218UEP2	358	N	S
P51826	LB/B	-	A0A218UEP2	494	N	S
P51826	LP/P	KINSSHIP syndrome (KINS) [MIM:619297]	A0A218UEP2	231	P	A
P51826	LP/P	KINSSHIP syndrome (KINS) [MIM:619297]	A0A218UEP2	231	P	L
P51826	LP/P	KINSSHIP syndrome (KINS) [MIM:619297]	A0A218UEP2	233	A	S
P51826	LP/P	KINSSHIP syndrome (KINS) [MIM:619297]	A0A218UEP2	233	A	T
P51826	LP/P	KINSSHIP syndrome (KINS) [MIM:619297]	A0A218UEP2	233	A	V
P51826	LP/P	KINSSHIP syndrome (KINS) [MIM:619297]	A0A218UEP2	235	V	G
Q9UHB7	LB/B	-	A0A218UEP2	136	T	P
Q9UHB7	LP/P	CHOPS syndrome (CHOPS) [MIM:616368]	A0A218UEP2	254	T	A
Q9UHB7	LP/P	CHOPS syndrome (CHOPS) [MIM:616368]	A0A218UEP2	254	T	S
Q9UHB7	LP/P	CHOPS syndrome (CHOPS) [MIM:616368]	A0A218UEP2	258	R	W
P20933	LP/P	Aspartylglucosaminuria (AGU) [MIM:208400]	M0XY93	60	G	D
P20933	LP/P	Aspartylglucosaminuria (AGU) [MIM:208400]	M0XY93	72	S	P
P20933	LP/P	Aspartylglucosaminuria (AGU) [MIM:208400]	M0XY93	101	A	V
P20933	LP/P	Aspartylglucosaminuria (AGU) [MIM:208400]	M0XY93	161	R	Q
P20933	LP/P	Aspartylglucosaminuria (AGU) [MIM:208400]	M0XY93	163	C	S
P20933	LP/P	Aspartylglucosaminuria (AGU) [MIM:208400]	M0XY93	302	G	R
P20933	LP/P	Aspartylglucosaminuria (AGU) [MIM:208400]	M0XY93	306	C	R
P20933	LP/P	Aspartylglucosaminuria (AGU) [MIM:208400]	M0XY93	100	G	E
P20933	LP/P	Aspartylglucosaminuria (AGU) [MIM:208400]	M0XY93	135	F	S
P20933	LP/P	Aspartylglucosaminuria (AGU) [MIM:208400]	M0XY93	252	G	E
P20933	LP/P	Aspartylglucosaminuria (AGU) [MIM:208400]	M0XY93	252	G	R
P20933	LP/P	Aspartylglucosaminuria (AGU) [MIM:208400]	M0XY93	257	T	I
P20933	LB/B	-	M0XY93	149	T	S
P20933	LB/B	-	M0XY93	322	T	I
Q96MI9	LB/B	-	A0A087QHE0	463	P	L
Q96MI9	LB/B	-	A0A087QHE0	481	S	P
Q96MI9	LB/B	-	A0A087QHE0	1056	Q	R
Q96MI9	LP/P	Corneal dystrophy, Fuchs endothelial, 8 (FECD8) [MIM:615523]	A0A087QHE0	1036	C	S
Q15109	LB/B	-	A0A2F0BKE3	100	Q	R
Q15109	LB/B	-	A0A2F0BKE3	82	G	S
Q53H12	LB/B	-	A0A146R211	3	V	M
Q9UL18	LP/P	-	A0A1Y3ECR5	199	G	S
Q9UPW5	LP/P	Neurodegeneration, childhood-onset, with cerebellar atrophy (CONDCA) [MIM:618276]	A0A2U9BSS4	694	Y	D
Q9UPW5	LP/P	Neurodegeneration, childhood-onset, with cerebellar atrophy (CONDCA) [MIM:618276]	A0A2U9BSS4	851	T	M
Q9UPW5	LP/P	Neurodegeneration, childhood-onset, with cerebellar atrophy (CONDCA) [MIM:618276]	A0A2U9BSS4	918	R	W
Q9UPW5	LP/P	Neurodegeneration, childhood-onset, with cerebellar atrophy (CONDCA) [MIM:618276]	A0A2U9BSS4	990	H	L
P02765	LB/B	-	A0A1U7R4L0	248	M	T
P02765	LB/B	-	A0A1U7R4L0	256	S	T
P02765	LB/B	-	A0A1U7R4L0	276	D	N
P02765	LB/B	-	A0A1U7R4L0	317	R	C
P02765	LB/B	-	A0A1U7R4L0	142	V	L
O95831	LP/P	Combined oxidative phosphorylation deficiency 6 (COXPD6) [MIM:300816]	L8YBZ5	308	G	E
O95831	LP/P	Charcot-Marie-Tooth disease, X-linked recessive, 4, with or without cerebellar ataxia (CMTX4) [MIM:310490]	L8YBZ5	493	E	V
O95831	LP/P	Combined oxidative phosphorylation deficiency 6 (COXPD6) [MIM:300816]	L8YBZ5	243	V	L
O95831	LP/P	Deafness, X-linked, 5, with peripheral neuropathy (DFNX5) [MIM:300614]	L8YBZ5	260	T	A
O95831	LP/P	Deafness, X-linked, 5, with peripheral neuropathy (DFNX5) [MIM:300614]	L8YBZ5	422	R	Q
O95831	LP/P	Deafness, X-linked, 5, with peripheral neuropathy (DFNX5) [MIM:300614]	L8YBZ5	422	R	W
O95831	LP/P	Deafness, X-linked, 5, with peripheral neuropathy (DFNX5) [MIM:300614]	L8YBZ5	451	R	Q
O95831	LP/P	-	L8YBZ5	262	G	S
O95831	LP/P	Combined oxidative phosphorylation deficiency 6 (COXPD6) [MIM:300816]	L8YBZ5	338	G	E
O95831	LP/P	Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy (SEMDHL) [MIM:300232]	L8YBZ5	235	Q	H
O95831	LP/P	Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy (SEMDHL) [MIM:300232]	L8YBZ5	237	D	G
O95831	LP/P	Spondyloepimetaphyseal dysplasia, X-linked, with hypomyelinating leukodystrophy (SEMDHL) [MIM:300232]	L8YBZ5	237	D	V
Q96MA6	LB/B	-	F6PLL4	5	I	T
Q96MA6	LB/B	-	F6PLL4	130	D	G
P14550	LB/B	-	G1SQ01	52	N	S
P14550	LB/B	-	G1SQ01	55	E	D
O60218	LB/B	-	A0A1W4WL13	313	N	D
O60218	LB/B	-	A0A1W4WL13	87	P	S
O60218	LB/B	-	A0A1W4WL13	286	M	T
P17516	LB/B	-	F7GAU9	145	S	C
P17516	LB/B	-	F7GAU9	311	L	V
P17516	LB/B	-	F7GAU9	135	G	E
P17516	LB/B	-	F7GAU9	170	C	Y
P17516	LB/B	-	F7GAU9	250	Q	R
Q96JD6	LB/B	-	A0A1W4WL13	52	C	G
Q96JD6	LB/B	-	A0A1W4WL13	86	K	R
O43488	LB/B	-	A0A146RD75	142	A	T
O43488	LB/B	-	A0A146RD75	157	Q	H
O43488	LB/B	-	A0A146RD75	214	C	Y
O43488	LB/B	-	A0A146RD75	135	V	M
O43488	LB/B	-	A0A146RD75	198	G	S
O43488	LB/B	-	A0A146RD75	255	S	N
O43488	LB/B	-	A0A146RD75	180	E	K
O95154	LB/B	-	A7XLW9	138	V	M
O95154	LB/B	-	A7XLW9	215	N	D
O95154	LB/B	-	A7XLW9	323	T	A
Q8NHP1	LB/B	-	A0A146RD75	255	A	T
Q8NHP1	LB/B	-	A0A146RD75	322	F	V
Q13740	LB/B	-	M7AMM1	258	N	S
Q13740	LB/B	-	M7AMM1	301	T	M
Q13740	LB/B	-	M7AMM1	229	G	D
Q13740	LB/B	-	M7AMM1	315	L	M
Q13740	LB/B	-	M7AMM1	352	V	M
Q13740	LB/B	-	M7AMM1	367	M	I
P48448	LB/B	-	F6Z7D1	50	A	T
P48448	LB/B	-	F6Z7D1	302	S	R
P48448	LB/B	-	F6Z7D1	52	S	N
P48448	LB/B	-	F6Z7D1	203	H	R
P48448	LB/B	-	F6Z7D1	220	S	G
P48448	LB/B	-	F6Z7D1	276	R	W
P48448	LB/B	-	F6Z7D1	361	H	R
Q02252	LP/P	Methylmalonate semialdehyde dehydrogenase deficiency (MMSDHD) [MIM:614105]	S9YB57	446	G	R
P49189	LB/B	-	A0A2U3WI13	116	C	S
Q8TCU4	LB/B	-	G5CBQ1	672	V	G
Q8TCU4	LB/B	-	G5CBQ1	2112	S	R
Q8TCU4	LB/B	-	G5CBQ1	2575	S	N
Q8TCU4	LB/B	-	G5CBQ1	2673	D	H
Q8TCU4	LB/B	-	G5CBQ1	1413	G	A
Q8TCU4	LB/B	-	G5CBQ1	1876	I	V
Q8TCU4	LB/B	-	G5CBQ1	2285	R	P
Q8TCU4	LB/B	-	G5CBQ1	2857	N	S
Q8TCU4	LB/B	-	G5CBQ1	3435	K	E
Q9NP70	LB/B	-	F6XZ62	354	L	P
Q9NP70	LB/B	-	F6XZ62	439	H	R
Q9NP70	LB/B	-	F6XZ62	255	A	V
Q96NU7	LB/B	-	A0A218VAR2	3	S	G
Q96NU7	LB/B	-	A0A218VAR2	360	P	H
Q9Y2J4	LB/B	-	A0A1S3WPV2	731	E	D
Q9Y2J4	LB/B	-	A0A1S3WPV2	227	T	I
Q9Y2J4	LB/B	-	A0A1S3WPV2	342	A	P
Q9Y2J4	LB/B	-	A0A1S3WPV2	415	G	S
P03950	LB/B	-	K7EY74	84	K	E
P03950	LP/P	Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895]	K7EY74	12	F	S
P03950	LP/P	Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895]	K7EY74	20	P	S
P03950	LP/P	Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895]	K7EY74	36	Q	L
P03950	LP/P	Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895]	K7EY74	41	K	E
P03950	LP/P	Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895]	K7EY74	41	K	I
P03950	LP/P	Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895]	K7EY74	52	S	N
P03950	LP/P	Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895]	K7EY74	55	R	K
P03950	LP/P	Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895]	K7EY74	63	C	W
P03950	LP/P	Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895]	K7EY74	64	K	I
P03950	LB/B	-	K7EY74	70	I	V
P03950	LP/P	Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895]	K7EY74	136	P	L
P03950	LP/P	Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895]	K7EY74	137	V	I
P03950	LP/P	Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895]	K7EY74	138	H	R
P03950	LP/P	Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895]	K7EY74	38	Y	H
P03950	LP/P	Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895]	K7EY74	46	D	G
O15123	LB/B	-	H2QWK4	333	V	I
O15123	LP/P	Lymphatic malformation 10 (LMPHM10) [MIM:619369]	H2QWK4	435	C	S
Q12955	LB/B	-	A0A1U8BQ36	4257	I	V
Q12955	LB/B	-	A0A1U8BQ36	2885	H	Q
Q12955	LB/B	-	A0A1U8BQ36	3117	I	V
Q12955	LB/B	-	A0A1U8BQ36	3123	K	R
Q12955	LB/B	-	A0A1U8BQ36	2318	K	R
Q12955	LB/B	-	A0A1U8BQ36	2996	Q	H
Q8NFD2	LB/B	-	A0A2Y9K7I7	713	E	K
Q8NFD2	LB/B	-	A0A2Y9K7I7	239	A	T
Q8NFD2	LB/B	-	A0A2Y9K7I7	318	G	R
Q8NFD2	LB/B	-	A0A2Y9K7I7	442	G	R
Q8NFD2	LB/B	-	A0A2Y9K7I7	490	H	R
Q8NFD2	LB/B	-	A0A2Y9K7I7	4	D	Y
Q8NFD2	LB/B	-	A0A2Y9K7I7	122	R	H
Q8NFD2	LB/B	-	A0A2Y9K7I7	276	P	L
Q8NFD2	LB/B	-	A0A2Y9K7I7	366	L	F
Q8NFD2	LB/B	-	A0A2Y9K7I7	367	H	Q
Q8NFD2	LB/B	-	A0A2Y9K7I7	376	E	K
Q8NFD2	LB/B	-	A0A2Y9K7I7	426	E	K
Q8NFD2	LB/B	-	A0A2Y9K7I7	451	G	R
Q8NFD2	LB/B	-	A0A2Y9K7I7	595	T	I
Q8NFD2	LB/B	-	A0A2Y9K7I7	596	P	L
Q8NFD2	LB/B	-	A0A2Y9K7I7	653	N	S
Q8NFD2	LB/B	-	A0A2Y9K7I7	670	S	G
Q9P2S6	LB/B	-	L8IAN9	89	D	N
Q9P2S6	LB/B	-	L8IAN9	424	I	M
Q9P2S6	LB/B	-	L8IAN9	451	D	V
Q9P2S6	LB/B	-	L8IAN9	472	V	L
Q9P2S6	LB/B	-	L8IAN9	649	T	M
Q9NXR5	LB/B	-	A0A2K6PWC9	320	P	L
Q8TF21	LB/B	-	G3HSI3	111	A	T
Q8TF21	LB/B	-	G3HSI3	349	R	Q
Q8TF21	LB/B	-	G3HSI3	585	E	K
Q8TF21	LB/B	-	G3HSI3	684	S	A
Q6NSI1	LB/B	-	H2NS14	265	K	T
Q8N7Z5	LB/B	-	A0A1S3FWC2	702	D	N
Q8N7Z5	LB/B	-	A0A1S3FWC2	758	R	G
Q8N7Z5	LB/B	-	A0A1S3FWC2	1609	D	E
Q8N7Z5	LB/B	-	A0A1S3FWC2	1777	R	K
Q92625	LB/B	-	W5MV62	694	L	S
Q92625	LB/B	-	W5MV62	355	A	D
Q6ZW76	LB/B	-	F6QU63	404	A	T
Q6ZW76	LB/B	-	F6QU63	593	A	T
Q9NQW6	LB/B	-	A0A151P2S9	65	S	W
Q9NQW6	LB/B	-	A0A151P2S9	185	R	K
Q9NQW6	LP/P	Focal segmental glomerulosclerosis 8 (FSGS8) [MIM:616032]	A0A151P2S9	431	R	C
Q9NQW6	LP/P	Focal segmental glomerulosclerosis 8 (FSGS8) [MIM:616032]	A0A151P2S9	618	G	C
P23352	LP/P	Hypogonadotropic hypogonadism 1 with or without anosmia (HH1) [MIM:308700]	H3A9M1	267	N	K
P23352	LB/B	-	H3A9M1	534	V	I
P23352	LP/P	Hypogonadotropic hypogonadism 1 with or without anosmia (HH1) [MIM:308700]	H3A9M1	514	E	K
P23352	LP/P	Hypogonadotropic hypogonadism 1 with or without anosmia (HH1) [MIM:308700]	H3A9M1	163	C	Y
P23352	LP/P	Hypogonadotropic hypogonadism 1 with or without anosmia (HH1) [MIM:308700]	H3A9M1	172	C	R
P23352	LP/P	Hypogonadotropic hypogonadism 1 with or without anosmia (HH1) [MIM:308700]	H3A9M1	262	R	P
P23352	LP/P	Hypogonadotropic hypogonadism 1 with or without anosmia (HH1) [MIM:308700]	H3A9M1	304	N	S
P23352	LP/P	Hypogonadotropic hypogonadism 1 with or without anosmia (HH1) [MIM:308700]	H3A9M1	396	S	L
P23352	LP/P	Hypogonadotropic hypogonadism 1 with or without anosmia (HH1) [MIM:308700]	H3A9M1	517	F	L
P23352	LP/P	Hypogonadotropic hypogonadism 1 with or without anosmia (HH1) [MIM:308700]	H3A9M1	571	W	R
P23352	LB/B	-	H3A9M1	666	K	M
P23352	LB/B	-	H3A9M1	668	R	H
P23352	LP/P	Hypogonadotropic hypogonadism 1 with or without anosmia (HH1) [MIM:308700]	H3A9M1	134	C	G
P23352	LP/P	Hypogonadotropic hypogonadism 1 with or without anosmia (HH1) [MIM:308700]	H3A9M1	163	C	R
P23352	LP/P	Hypogonadotropic hypogonadism 1 with or without anosmia (HH1) [MIM:308700]	H3A9M1	539	E	K
P23352	LP/P	-	H3A9M1	217	Y	D
P23352	LP/P	Hypogonadotropic hypogonadism 1 with or without anosmia (HH1) [MIM:308700]	H3A9M1	587	V	L
P23352	LP/P	Hypogonadotropic hypogonadism 1 with or without anosmia (HH1) [MIM:308700]	H3A9M1	672	H	R
P50995	LB/B	-	A0A0P7U0W6	230	R	C
P50995	LB/B	-	A0A0P7U0W6	457	I	V
P50995	LB/B	-	A0A0P7U0W6	191	R	Q
P50995	LP/P	Amyotrophic lateral sclerosis 23 (ALS23) [MIM:617839]	A0A0P7U0W6	40	D	G
P50995	LP/P	Inclusion body myopathy and brain white matter abnormalities (IBMWMA) [MIM:619733]	A0A0P7U0W6	40	D	Y
P07355	LB/B	-	L5K0Z3	98	V	L
P20073	LB/B	-	W5PCN2	441	R	Q
Q63HQ0	LB/B	-	E7F124	297	T	I
O14617	LB/B	-	E9J3Z3	541	G	R
O14617	LB/B	-	E9J3Z3	1072	I	V
Q9Y6B7	LB/B	-	F1PTH0	480	L	S
Q9UPM8	LB/B	-	A0A146ZLG6	163	C	R
Q9UPM8	LB/B	-	A0A146ZLG6	85	I	T
Q9UPM8	LB/B	-	A0A146ZLG6	145	T	S
Q9UPM8	LB/B	-	A0A146ZLG6	211	R	Q
Q9UPM8	LB/B	-	A0A146ZLG6	264	N	S
Q9UPM8	LB/B	-	A0A146ZLG6	426	I	L
Q9UPM8	LP/P	Stuttering, familial persistent 1 (STUT1) [MIM:184450]	A0A146ZLG6	517	V	I
Q9UPM8	LB/B	-	A0A146ZLG6	618	V	I
Q9UPM8	LB/B	-	A0A146ZLG6	706	I	K
Q9UPM8	LP/P	Stuttering, familial persistent 1 (STUT1) [MIM:184450]	A0A146ZLG6	801	E	K
Q9UPM8	LB/B	-	A0A146ZLG6	813	M	V
Q8NCL9	LB/B	-	A0A2U3WX55	30	C	R
Q8NCL9	LB/B	-	A0A2U3WX55	80	Y	H
Q8NCL9	LB/B	-	A0A2U3WX55	261	R	C
Q8NCL9	LB/B	-	A0A2U3WX55	83	R	Q
Q8WW43	LB/B	-	A0A0Q3MK84	217	F	L
Q9HDC9	LB/B	-	A0A2I4AKQ9	65	I	V
Q9HDC9	LB/B	-	A0A2I4AKQ9	282	R	Q
Q9HDC9	LB/B	-	A0A2I4AKQ9	374	R	W
P02655	LB/B	-	H9H2U1	41	K	T
P02655	LP/P	Hyperlipoproteinemia 1B (HLPP1B) [MIM:207750]	H9H2U1	48	W	R
P02655	LB/B	-	H9H2U1	60	E	K
P02655	LB/B	-	H9H2U1	77	K	Q
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	2	E	K
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	608	R	Q
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	609	R	K
P10275	LB/B	-	G5AV30	646	A	D
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	665	I	N
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	665	I	N
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	678	L	P
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	696	D	H
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	696	D	N
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	696	D	V
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	704	S	G
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	704	S	G
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	708	L	R
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	733	D	N
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	733	D	Y
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	743	M	I
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	744	G	V
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	744	G	V
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	750	M	V
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	750	M	V
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	751	G	D
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	753	R	Q
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	755	F	V
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	763	L	F
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	764	Y	C
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	766	A	T
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	775	R	H
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	775	R	H
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	775	R	C
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	780	R	W
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	781	M	I
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	781	M	I
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	785	C	Y
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	788	M	V
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	795	F	S
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	799	Q	E
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	799	Q	E
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	808	M	R
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	808	M	V
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	815	S	N
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	815	S	N
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	832	R	L
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	832	R	Q
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	841	R	C
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	841	R	G
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	841	R	H
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	843	I	T
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	856	R	C
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	856	R	H
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	865	D	N
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	867	V	E
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	867	V	L
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	867	V	M
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	870	I	M
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	893	P	L
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	896	M	T
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	908	L	F
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	914	P	S
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	196	Q	R
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	257	L	P
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	392	P	R
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	392	P	S
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	841	R	S
P10275	LB/B	-	G5AV30	207	S	R
P10275	LB/B	-	G5AV30	216	G	R
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	492	G	S
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	548	L	F
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	549	P	S
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	560	C	Y
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	569	G	W
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	572	Y	C
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	574	A	D
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	577	C	F
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	577	C	R
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	580	C	F
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	580	C	Y
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	582	V	F
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	583	F	S
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	583	F	Y
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	586	R	K
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	597	A	T
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	598	S	G
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	602	C	F
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	605	D	Y
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	611	N	T
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	612	C	Y
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	616	R	H
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	616	R	H
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	616	R	P
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	617	L	P
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	617	L	R
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	618	R	P
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	618	R	P
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	672	P	H
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	682	E	K
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	685	V	I
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	687	C	R
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	688	A	V
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	689	G	E
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	701	L	M
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	702	L	F
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	702	L	H
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	703	S	A
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	704	S	C
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	706	N	S
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	709	G	A
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	709	G	V
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	711	R	T
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	713	L	F
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	723	L	F
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	724	P	S
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	725	G	D
P10275	LB/B	-	G5AV30	726	F	L
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	728	N	K
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	729	L	S
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	734	Q	H
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	738	I	T
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	742	W	R
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	743	M	V
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	745	L	F
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	746	M	T
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	747	V	M
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	749	A	D
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	752	W	R
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	755	F	L
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	757	N	S
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	759	N	T
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	760	S	F
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	764	Y	H
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	765	F	L
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	766	A	V
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	767	P	S
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	768	D	E
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	769	L	P
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	772	N	H
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	773	E	A
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	773	E	G
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	789	R	S
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	791	L	F
P10275	LB/B	-	G5AV30	794	E	D
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	807	C	Y
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	808	M	T
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	813	L	F
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	821	G	A
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	822	L	V
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	835	Y	C
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	842	I	S
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	855	R	K
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	857	F	L
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	864	L	R
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	865	D	G
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	866	S	P
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	871	A	G
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	871	A	V
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	872	R	G
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	882	L	V
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	887	M	V
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	890	V	M
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	890	V	M
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	899	I	T
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	904	V	M
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	905	P	H
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	905	P	S
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	910	G	R
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	912	V	L
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	917	F	L
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	918	H	R
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	683	P	T
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	706	N	Y
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	712	Q	E
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	744	G	E
P10275	LP/P	Androgen insensitivity, partial (PAIS) [MIM:312300]	G5AV30	828	F	V
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	875	H	R
P10275	LP/P	Androgen insensitivity syndrome (AIS) [MIM:300068]	G5AV30	880	D	Y
P10398	LB/B	-	S9XKK3	98	M	T
P10398	LB/B	-	S9XKK3	578	E	D
A6NJG6	LB/B	-	A0A2K6LXR5	145	R	Q
Q8N392	LB/B	-	A0A093J650	23	T	A
Q8N392	LB/B	-	A0A093J650	91	N	S
Q8N392	LB/B	-	A0A093J650	165	Q	H
Q5TG30	LB/B	-	A0A093J650	133	G	R
Q5TG30	LB/B	-	A0A093J650	413	R	L
Q5TG30	LB/B	-	A0A093J650	463	H	N
Q9BRR9	LB/B	-	H2SN31	50	R	G
Q9BRR9	LB/B	-	H2SN31	137	R	C
Q9BRR9	LB/B	-	H2SN31	370	S	A
Q6ZSZ5	LB/B	-	F7CZN8	889	Q	R
Q6ZSZ5	LB/B	-	F7CZN8	940	R	Q
Q6ZSZ5	LB/B	-	F7CZN8	1207	N	S
Q6ZSZ5	LP/P	Retinitis pigmentosa 78 (RP78) [MIM:617433]	F7CZN8	458	T	A
Q8IW93	LB/B	-	F7EFQ7	163	G	R
Q8IW93	LB/B	-	F7EFQ7	238	E	Q
Q9NR81	LB/B	-	S9WY41	13	K	R
Q9NR81	LB/B	-	S9WY41	335	L	V
Q15052	LB/B	-	A0A2K6NK60	297	Q	H
Q8IVW1	LB/B	-	I3L3L1	170	L	I
Q5FYB0	LB/B	-	C3ZGR1	565	S	R
Q13508	LB/B	-	A0A2U3YK50	363	S	L
Q9H2C2	LB/B	-	A0A1U7T7X1	101	G	E
Q9H2C2	LP/P	Developmental and epileptic encephalopathy 38 (DEE38) [MIM:617020]	A0A1U7T7X1	189	G	R
Q96QS3	LP/P	Lissencephaly, X-linked 2 (LISX2) [MIM:300215]	F6XTT5	332	R	H
Q96QS3	LP/P	Lissencephaly, X-linked 2 (LISX2) [MIM:300215]	F6XTT5	343	L	Q
Q96QS3	LP/P	Developmental and epileptic encephalopathy 1 (DEE1) [MIM:308350]	F6XTT5	353	P	L
Q96QS3	LP/P	Intellectual developmental disorder, X-linked 29 (XLID29) [MIM:300419]	F6XTT5	33	L	P
Q96QS3	LP/P	Intellectual developmental disorder, X-linked 29 (XLID29) [MIM:300419]	F6XTT5	286	G	S
Q96QS3	LP/P	Lissencephaly, X-linked 2 (LISX2) [MIM:300215]	F6XTT5	332	R	P
Q96QS3	LP/P	Agenesis of the corpus callosum, with abnormal genitalia (ACCAG) [MIM:300004]	F6XTT5	333	T	N
Q96QS3	LP/P	Lissencephaly, X-linked 2 (LISX2) [MIM:300215]	F6XTT5	353	P	R
Q96QS3	LP/P	Lissencephaly, X-linked 2 (LISX2) [MIM:300215]	F6XTT5	521	A	T
Q9ULH1	LB/B	-	L9JL47	728	I	V
Q8TDY4	LB/B	-	A0A2K5DQ98	377	E	A
Q495Z4	LB/B	-	H2NTV2	32	S	R
Q495Z4	LB/B	-	H2NTV2	114	C	R
Q96Q27	LB/B	-	G7PBC8	208	P	S
Q9Y574	LB/B	-	A0A2Y9PHU0	17	V	L
Q8N9N2	LB/B	-	K1QD82	34	D	N
Q8N9N2	LB/B	-	K1QD82	318	N	S
Q9UHC3	LB/B	-	S7NIE0	228	N	S
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	95	R	C
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	111	R	W
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	193	R	Q
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	286	Q	R
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	178	V	M
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	379	R	C
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	385	R	C
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	31	D	N
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	113	R	Q
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	186	R	Q
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	236	R	W
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	335	V	L
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	382	M	R
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	456	R	W
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	70	V	A
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	94	R	C
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	94	R	H
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	95	R	H
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	104	A	V
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	120	D	E
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	121	L	H
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	126	R	W
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	146	R	W
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	156	P	R
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	160	H	N
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	166	P	H
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	168	R	H
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	170	S	N
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	180	L	R
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	182	R	Q
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	191	R	W
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	193	R	W
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	205	A	V
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	213	R	Q
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	227	L	P
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	229	S	R
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	229	S	T
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	231	D	E
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	237	D	N
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	256	M	T
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	262	L	P
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	295	L	P
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	301	G	R
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	306	R	W
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	324	D	A
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	326	Q	L
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	343	L	F
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	343	L	P
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	368	M	V
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	380	K	E
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	385	R	H
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	385	R	L
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	388	H	Q
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	433	S	R
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	434	V	L
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	447	S	N
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	456	R	Q
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	73	E	K
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	297	R	Q
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	12	R	Q
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	87	D	G
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	360	M	T
P04424	LP/P	Argininosuccinic aciduria (ARGINSA) [MIM:207900]	G1SWV6	398	A	D
O95671	LB/B	-	A0A226NFB3	458	V	M
O95671	LB/B	-	A0A226NFB3	541	R	K
Q53RT3	LB/B	-	H0XLM8	49	T	A
Q53RT3	LP/P	Ichthyosis, lamellar, autosomal dominant (ADLI) [MIM:146750]	H0XLM8	199	K	E
Q53RT3	LP/P	Ichthyosis, lamellar, autosomal dominant (ADLI) [MIM:146750]	H0XLM8	311	R	P
Q53RT3	LP/P	Ichthyosis, lamellar, autosomal dominant (ADLI) [MIM:146750]	H0XLM8	314	P	T
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	14	G	S
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	18	S	L
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	86	R	C
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	118	A	T
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	157	R	H
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	180	S	N
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	192	A	V
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	272	R	C
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	280	G	R
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	304	R	W
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	324	G	S
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	363	R	L
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	363	R	W
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	390	G	R
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	19	C	R
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	86	R	H
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	95	R	S
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	96	P	S
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	117	G	S
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	117	G	D
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	157	R	C
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	179	W	R
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	191	E	K
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	265	R	H
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	269	V	M
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	283	E	K
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	310	K	R
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	362	G	V
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	270	E	Q
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	279	R	Q
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	310	K	Q
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	363	R	G
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	363	R	Q
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	389	T	I
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	69	V	A
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	108	R	L
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	119	T	I
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	40	Q	L
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	79	S	P
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	96	P	H
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	124	D	N
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	127	R	Q
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	127	R	W
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	160	L	P
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	190	Y	D
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	191	E	Q
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	202	A	E
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	206	L	P
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	263	V	M
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	265	R	C
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	277	K	T
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	284	T	I
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	291	Y	S
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	296	D	G
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	302	M	V
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	307	R	C
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	324	G	V
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	341	S	F
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	345	V	G
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	347	G	R
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	359	Y	D
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	141	V	G
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	91	T	P
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	96	P	L
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	100	R	C
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	100	R	H
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	111	A	D
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	117	G	C
P00966	LB/B	-	A0A0D1ZIX2	127	R	L
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	157	R	S
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	164	A	P
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	180	S	I
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	184	N	K
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	230	G	R
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	237	N	I
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	258	A	P
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	258	A	V
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	272	R	H
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	272	R	L
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	290	L	P
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	299	A	D
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	306	V	G
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	321	V	M
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	335	R	H
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	337	C	R
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	356	G	V
P00966	LP/P	Citrullinemia 1 (CTLN1) [MIM:215700]	A0A0D1ZIX2	389	T	P
O14525	LB/B	-	A0A093PQ09	1270	G	R
O14525	LB/B	-	A0A093PQ09	1278	R	G
O14525	LB/B	-	A0A093PQ09	932	H	R
O14525	LB/B	-	A0A093PQ09	942	H	Q
O75129	LB/B	-	A0A093PQ09	70	V	I
O75129	LB/B	-	A0A093PQ09	865	R	H
O75129	LB/B	-	A0A093PQ09	1149	V	I
Q8WWH4	LB/B	-	G3N8J2	216	K	T
Q9NVI7	LB/B	-	U3D8L8	15	G	D
Q9NVI7	LB/B	-	U3D8L8	101	S	N
Q9NVI7	LP/P	Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal (PHRINL) [MIM:618810]	U3D8L8	77	L	R
Q9NVI7	LP/P	Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal (PHRINL) [MIM:618810]	U3D8L8	454	L	R
Q5T9A4	LB/B	-	U3D8L8	7	V	I
P18846	LB/B	-	A0A1S3FC07	191	P	A
Q5U623	LB/B	-	M3YTC3	537	T	I
Q5U623	LB/B	-	M3YTC3	543	A	T
Q5U623	LB/B	-	M3YTC3	527	S	L
Q6ZNE5	LB/B	-	A0A226MRR1	131	N	K
Q6ZNE5	LB/B	-	A0A226MRR1	59	V	I
Q2TAZ0	LB/B	-	A0A146NIC8	175	V	I
Q2TAZ0	LB/B	-	A0A146NIC8	627	A	V
Q2TAZ0	LB/B	-	A0A146NIC8	948	G	R
Q2TAZ0	LB/B	-	A0A146NIC8	394	R	C
Q2TAZ0	LB/B	-	A0A146NIC8	404	A	V
Q2TAZ0	LB/B	-	A0A146NIC8	656	P	R
Q96BY7	LB/B	-	A0A146NIC8	1383	Q	E
Q96BY7	LB/B	-	A0A146NIC8	1567	I	T
Q96BY7	LB/B	-	A0A146NIC8	1124	N	D
Q9Y4P1	LB/B	-	B4DZK0	354	L	Q
Q92858	LB/B	-	A0A2U9BSU7	237	H	Q
Q96SQ7	LB/B	-	A0A250XYP5	150	L	P
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	23	G	E
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	39	N	T
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	65	L	S
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	131	R	Q
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	160	P	L
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	186	S	P
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	211	G	D
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	223	V	M
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	268	C	F
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	310	G	V
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	318	C	R
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	348	I	T
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	412	E	G
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	495	S	F
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	560	C	R
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	675	F	S
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	683	K	E
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	702	D	N
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	745	A	D
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	765	S	L
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	767	N	S
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	769	G	R
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	803	A	T
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	838	A	P
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	843	V	F
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	875	C	G
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	920	S	Y
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	943	H	R
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	975	P	R
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	357	T	K
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	749	G	R
P16615	LP/P	Acrokeratosis verruciformis (AKV) [MIM:101900]	C3XVK9	602	P	L
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	101	N	S
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	590	L	P
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	625	G	A
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	626	D	E
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	672	A	P
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	691	Q	P
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	750	R	W
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	765	S	W
P16615	LP/P	Darier disease (DD) [MIM:124200]	C3XVK9	900	L	P
Q93084	LB/B	-	C3XVK9	869	Q	H
P30049	LP/P	Mitochondrial complex V deficiency, nuclear type 5 (MC5DN5) [MIM:618120]	A0A061I2Y3	82	P	L
P30049	LP/P	Mitochondrial complex V deficiency, nuclear type 5 (MC5DN5) [MIM:618120]	A0A061I2Y3	106	V	G
O75787	LB/B	-	A0A2Y9FGG6	90	P	A
O75787	LB/B	-	A0A2Y9FGG6	290	A	P
O75787	LP/P	Congenital disorder of glycosylation 2R (CDG2R) [MIM:301045]	A0A2Y9FGG6	71	R	H
O75787	LP/P	Congenital disorder of glycosylation 2R (CDG2R) [MIM:301045]	A0A2Y9FGG6	98	L	S
O60423	LB/B	-	A0A2J8J1S8	45	G	R
O60423	LB/B	-	A0A2J8J1S8	618	V	I
Q5TC12	LB/B	-	A0A2U4BJN4	62	S	G
Q13535	LB/B	-	A0A093H141	64	T	A
Q13535	LB/B	-	A0A093H141	90	H	Y
Q13535	LB/B	-	A0A093H141	297	K	N
Q13535	LB/B	-	A0A093H141	316	V	I
Q13535	LB/B	-	A0A093H141	959	V	M
Q13535	LB/B	-	A0A093H141	1087	Y	H
Q13535	LB/B	-	A0A093H141	1213	S	G
Q13535	LB/B	-	A0A093H141	1607	S	N
Q13535	LB/B	-	A0A093H141	1612	N	S
Q13535	LB/B	-	A0A093H141	2120	G	A
Q13535	LB/B	-	A0A093H141	2132	Y	D
Q13535	LB/B	-	A0A093H141	2425	R	Q
Q13535	LB/B	-	A0A093H141	2434	P	A
Q13535	LB/B	-	A0A093H141	211	M	T
Q13535	LB/B	-	A0A093H141	1526	I	V
Q13535	LP/P	Cutaneous telangiectasia and cancer syndrome, familial (FCTCS) [MIM:614564]	A0A093H141	2144	Q	R
Q8WXE1	LB/B	-	A0A2K6GQQ6	125	K	Q
Q8WXE1	LB/B	-	A0A2K6GQQ6	240	P	L
O75882	LB/B	-	I3IZA0	303	D	A
O75882	LB/B	-	I3IZA0	426	I	T
O75882	LB/B	-	I3IZA0	1152	R	K
O75882	LB/B	-	I3IZA0	1226	V	I
Q5VV63	LB/B	-	I3IZA0	989	S	N
Q9H3M9	LB/B	-	G3NZ75	266	L	F
Q9H3M9	LB/B	-	G3NZ75	332	G	D
O14965	LB/B	-	H0ZDQ2	11	G	R
O14965	LB/B	-	H0ZDQ2	31	F	I
O14965	LB/B	-	H0ZDQ2	57	I	V
O14965	LB/B	-	H0ZDQ2	50	P	L
O14965	LB/B	-	H0ZDQ2	373	M	V
O14965	LB/B	-	H0ZDQ2	104	S	L
Q9NQS1	LB/B	-	E1BMD5	228	Q	R
P37288	LB/B	-	G3N6M6	6	G	S
Q5T1B0	LB/B	-	E1BJH9	742	A	V
Q5T1B0	LB/B	-	E1BJH9	991	E	Q
Q5T1B0	LB/B	-	E1BJH9	522	I	L
Q5T1B0	LB/B	-	E1BJH9	993	Q	E
Q96A70	LB/B	-	L5JRE5	288	A	S
Q8NCR0	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A11 (MDDGA11) [MIM:615181]	W5UJC1	247	G	E
Q8NCR0	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A11 (MDDGA11) [MIM:615181]	W5UJC1	252	V	G
Q8NCR0	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A11 (MDDGA11) [MIM:615181]	W5UJC1	268	V	M
Q8NCR0	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A11 (MDDGA11) [MIM:615181]	W5UJC1	292	R	P
Q96L58	LB/B	-	I3MYP1	174	E	D
Q96L58	LP/P	Ehlers-Danlos syndrome, spondylodysplastic type, 2 (EDSSPD2) [MIM:615349]	I3MYP1	6	R	W
Q96L58	LP/P	Spondyloepimetaphyseal dysplasia with joint laxity, 1, with or without fractures (SEMDJL1) [MIM:271640]	I3MYP1	65	S	G
Q96L58	LP/P	Spondyloepimetaphyseal dysplasia with joint laxity, 1, with or without fractures (SEMDJL1) [MIM:271640]	I3MYP1	67	P	L
Q96L58	LP/P	Spondyloepimetaphyseal dysplasia with joint laxity, 1, with or without fractures (SEMDJL1) [MIM:271640]	I3MYP1	156	D	N
Q96L58	LP/P	Spondyloepimetaphyseal dysplasia with joint laxity, 1, with or without fractures (SEMDJL1) [MIM:271640]	I3MYP1	207	D	H
Q96L58	LP/P	Spondyloepimetaphyseal dysplasia with joint laxity, 1, with or without fractures (SEMDJL1) [MIM:271640]	I3MYP1	217	G	S
Q96L58	LP/P	Spondyloepimetaphyseal dysplasia with joint laxity, 1, with or without fractures (SEMDJL1) [MIM:271640]	I3MYP1	232	R	C
Q96L58	LP/P	Spondyloepimetaphyseal dysplasia with joint laxity, 1, with or without fractures (SEMDJL1) [MIM:271640]	I3MYP1	300	C	S
Q96L58	LP/P	Ehlers-Danlos syndrome, spondylodysplastic type, 2 (EDSSPD2) [MIM:615349]	I3MYP1	309	S	T
Q96L58	LP/P	Spondyloepimetaphyseal dysplasia with joint laxity, 1, with or without fractures (SEMDJL1) [MIM:271640]	I3MYP1	79	T	A
Q96L58	LP/P	Spondyloepimetaphyseal dysplasia with joint laxity, 1, with or without fractures (SEMDJL1) [MIM:271640]	I3MYP1	186	F	L
Q96L58	LP/P	Al-Gazali syndrome (ALGAZ) [MIM:609465]	I3MYP1	206	C	W
Q96L58	LP/P	Spondyloepimetaphyseal dysplasia with joint laxity, 1, with or without fractures (SEMDJL1) [MIM:271640]	I3MYP1	256	R	W
Q7Z7M8	LB/B	-	A0A2K6K0F0	137	S	G
Q67FW5	LB/B	-	A0A1S3QBX4	341	A	T
Q00973	LB/B	-	E2QYX4	35	L	V
Q00973	LB/B	-	E2QYX4	172	G	R
Q00973	LB/B	-	E2QYX4	516	A	V
Q00973	LP/P	Spastic paraplegia 26, autosomal recessive (SPG26) [MIM:609195]	E2QYX4	300	R	C
Q00973	LP/P	Spastic paraplegia 26, autosomal recessive (SPG26) [MIM:609195]	E2QYX4	433	D	A
Q8NHY0	LB/B	-	A0A2Y9EWP5	40	A	D
Q8NHY0	LB/B	-	A0A2Y9EWP5	466	C	R
Q8NHY0	LB/B	-	A0A2Y9EWP5	436	Q	R
Q8NHY0	LB/B	-	A0A2Y9EWP5	523	R	W
P46379	LB/B	-	A7X5R6	625	S	P
P46379	LB/B	-	A7X5R6	728	A	V
Q9P281	LB/B	-	F1PQM0	2510	R	C
Q9P281	LB/B	-	F1PQM0	1168	T	A
Q9P281	LB/B	-	F1PQM0	272	A	T
Q9P281	LB/B	-	F1PQM0	1434	R	Q
Q9P281	LB/B	-	F1PQM0	1678	T	A
Q9P281	LB/B	-	F1PQM0	2029	V	I
Q9UQB8	LB/B	-	A0A1S3Q8S6	519	Q	R
Q9UHR4	LB/B	-	W5MQ93	460	S	T
O75531	LP/P	Nestor-Guillermo progeria syndrome (NGPS) [MIM:614008]	T0NJF3	12	A	T
Q07812	LB/B	-	A0A061HYX3	11	G	E
Q07812	LB/B	-	A0A061HYX3	39	G	R
Q8N3I7	LB/B	-	F7CKZ1	184	N	S
Q8N3I7	LB/B	-	F7CKZ1	207	R	H
Q8N3I7	LP/P	Bardet-Biedl syndrome 5 (BBS5) [MIM:615983]	F7CKZ1	72	G	S
Q8N3I7	LB/B	-	F7CKZ1	251	N	D
Q8N3I7	LP/P	Bardet-Biedl syndrome 5 (BBS5) [MIM:615983]	F7CKZ1	183	T	A
Q8IWZ6	LP/P	Bardet-Biedl syndrome 7 (BBS7) [MIM:615984]	A0A288CFV9	211	T	I
Q8IWZ6	LP/P	Bardet-Biedl syndrome 7 (BBS7) [MIM:615984]	A0A288CFV9	323	H	R
Q8IWZ6	LP/P	Bardet-Biedl syndrome 7 (BBS7) [MIM:615984]	A0A288CFV9	66	I	F
Q8IWZ6	LB/B	-	A0A288CFV9	671	Y	C
Q8IWZ6	LP/P	Bardet-Biedl syndrome 7 (BBS7) [MIM:615984]	A0A288CFV9	63	G	R
Q8IWZ6	LB/B	-	A0A288CFV9	293	Q	P
Q3SYG4	LP/P	Bardet-Biedl syndrome 9 (BBS9) [MIM:615986]	A0A1S3GRQ5	141	G	R
Q3SYG4	LB/B	-	A0A1S3GRQ5	455	A	V
Q3SYG4	LB/B	-	A0A1S3GRQ5	12	T	A
Q3SYG4	LB/B	-	A0A1S3GRQ5	455	A	T
Q3SYG4	LB/B	-	A0A1S3GRQ5	521	R	Q
Q3SYG4	LB/B	-	A0A1S3GRQ5	549	T	I
Q3SYG4	LB/B	-	A0A1S3GRQ5	665	L	F
Q3SYG4	LB/B	-	A0A1S3GRQ5	779	L	Q
Q92843	LB/B	-	A0A2K5CX04	133	Q	R
Q8N1M1	LB/B	-	F7BVY7	43	Y	H
Q8N1M1	LB/B	-	F7BVY7	622	E	G
Q8NFU0	LB/B	-	A0A1U7RN10	62	Y	C
Q8NFU0	LB/B	-	A0A1U7RN10	217	Y	S
Q8NFU0	LB/B	-	A0A1U7RN10	331	Q	E
Q8NFU0	LB/B	-	A0A1U7RN10	402	R	L
Q12934	LB/B	-	M3XQJ9	345	G	S
Q12934	LB/B	-	M3XQJ9	656	D	E
Q12934	LP/P	Cataract 33, multiple types (CTRCT33) [MIM:611391]	M3XQJ9	348	D	N
Q9C0J9	LB/B	-	M0R3T6	384	P	R
Q9C0J9	LB/B	-	M0R3T6	362	Y	H
Q9C0J9	LB/B	-	M0R3T6	384	P	Q
P54132	LP/P	Bloom syndrome (BLM) [MIM:210900]	A0A1L8H1D5	672	Q	R
P54132	LP/P	Bloom syndrome (BLM) [MIM:210900]	A0A1L8H1D5	843	T	I
P54132	LP/P	Bloom syndrome (BLM) [MIM:210900]	A0A1L8H1D5	1055	C	S
P54132	LP/P	Bloom syndrome (BLM) [MIM:210900]	A0A1L8H1D5	891	G	E
P54132	LP/P	Bloom syndrome (BLM) [MIM:210900]	A0A1L8H1D5	901	C	Y
P54132	LP/P	Bloom syndrome (BLM) [MIM:210900]	A0A1L8H1D5	1036	C	F
P54132	LB/B	-	A0A1L8H1D5	1209	S	T
P54132	LP/P	Bloom syndrome (BLM) [MIM:210900]	A0A1L8H1D5	841	I	T
P54132	LP/P	Bloom syndrome (BLM) [MIM:210900]	A0A1L8H1D5	878	C	R
P54132	LB/B	-	A0A1L8H1D5	137	K	R
P54132	LB/B	-	A0A1L8H1D5	298	T	M
P54132	LB/B	-	A0A1L8H1D5	591	R	Q
P54132	LB/B	-	A0A1L8H1D5	868	P	L
P54132	LB/B	-	A0A1L8H1D5	1205	V	I
P54132	LB/B	-	A0A1L8H1D5	1213	E	K
P54132	LB/B	-	A0A1L8H1D5	1321	V	I
P54132	LB/B	-	A0A1L8H1D5	1043	A	D
Q6QNY1	LB/B	-	A0A0E9XFT8	13	S	R
Q14667	LB/B	-	A0A0L8HRE9	986	H	Q
Q14667	LB/B	-	A0A0L8HRE9	1516	V	G
Q14667	LB/B	-	A0A0L8HRE9	2060	R	G
O95972	LP/P	Ovarian dysgenesis 2 (ODG2) [MIM:300510]	H3AZV6	235	Y	C
O95972	LB/B	-	H3AZV6	5	S	R
O95972	LP/P	Premature ovarian failure 4 (POF4) [MIM:300510]	H3AZV6	61	R	Q
O95972	LP/P	Premature ovarian failure 4 (POF4) [MIM:300510]	H3AZV6	61	R	W
O95972	LP/P	Premature ovarian failure 4 (POF4) [MIM:300510]	H3AZV6	68	R	W
O95972	LP/P	Premature ovarian failure 4 (POF4) [MIM:300510]	H3AZV6	76	R	C
O95972	LP/P	Premature ovarian failure 4 (POF4) [MIM:300510]	H3AZV6	76	R	H
O95972	LB/B	-	H3AZV6	103	N	S
O95972	LP/P	Premature ovarian failure 4 (POF4) [MIM:300510]	H3AZV6	138	R	H
O95972	LP/P	Premature ovarian failure 4 (POF4) [MIM:300510]	H3AZV6	148	L	P
O95972	LP/P	Premature ovarian failure 4 (POF4) [MIM:300510]	H3AZV6	196	N	K
O95972	LP/P	Premature ovarian failure 4 (POF4) [MIM:300510]	H3AZV6	206	R	H
O95972	LP/P	Premature ovarian failure 4 (POF4) [MIM:300510]	H3AZV6	221	W	R
O95972	LP/P	Premature ovarian failure 4 (POF4) [MIM:300510]	H3AZV6	243	I	V
O95972	LB/B	-	H3AZV6	200	H	Y
O95972	LP/P	Premature ovarian failure 4 (POF4) [MIM:300510]	H3AZV6	329	R	C
P12645	LB/B	-	G3NAR0	192	R	Q
P12645	LB/B	-	G3NAR0	176	Q	K
P12645	LB/B	-	G3NAR0	176	Q	L
P12645	LB/B	-	G3NAR0	205	L	F
P12645	LB/B	-	G3NAR0	222	T	M
Q8N8U9	LB/B	-	A0A2U9CGZ4	555	R	W
Q8N8U9	LP/P	Diaphanospondylodysostosis (DSD) [MIM:608022]	A0A2U9CGZ4	370	P	L
Q14692	LB/B	-	E9PTV4	237	R	H
Q14692	LB/B	-	E9PTV4	552	S	P
Q14692	LB/B	-	E9PTV4	652	K	R
Q14692	LB/B	-	E9PTV4	884	M	V
Q14692	LB/B	-	E9PTV4	1141	V	I
Q14692	LP/P	Aplasia cutis congenita, non-syndromic (ACC) [MIM:107600]	E9PTV4	930	R	H
Q8NFC6	LB/B	-	A0A2Y9S2D4	429	T	M
Q8NFC6	LB/B	-	A0A2Y9S2D4	650	L	I
Q8NFC6	LB/B	-	A0A2Y9S2D4	1369	A	G
Q8NFC6	LB/B	-	A0A2Y9S2D4	1448	T	A
Q8NFC6	LB/B	-	A0A2Y9S2D4	1515	T	A
Q8NFC6	LB/B	-	A0A2Y9S2D4	1645	V	I
Q8NFC6	LB/B	-	A0A2Y9S2D4	2361	G	S
Q8NFC6	LB/B	-	A0A2Y9S2D4	2396	P	L
Q8NFC6	LB/B	-	A0A2Y9S2D4	2944	V	M
Q53S33	LP/P	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia (MMDS2) [MIM:614299]	Q6DC87	96	H	R
Q53S33	LP/P	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia (MMDS2) [MIM:614299]	Q6DC87	67	I	N
P15056	LP/P	Lung cancer (LNCR) [MIM:211980]	A0A1E1XC06	466	G	V
P15056	LP/P	Lung cancer (LNCR) [MIM:211980]	A0A1E1XC06	597	L	R
P15056	LP/P	Colorectal cancer (CRC) [MIM:114500]	A0A1E1XC06	462	R	I
P15056	LP/P	Colorectal cancer (CRC) [MIM:114500]	A0A1E1XC06	463	I	S
P15056	LP/P	Colorectal cancer (CRC) [MIM:114500]	A0A1E1XC06	464	G	E
P15056	LP/P	Familial non-Hodgkin lymphoma (NHL) [MIM:605027]	A0A1E1XC06	469	G	A
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	469	G	E
P15056	LP/P	Familial non-Hodgkin lymphoma (NHL) [MIM:605027]	A0A1E1XC06	469	G	R
P15056	LP/P	Familial non-Hodgkin lymphoma (NHL) [MIM:605027]	A0A1E1XC06	594	D	G
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	595	F	L
P15056	LP/P	Noonan syndrome 7 (NS7) [MIM:613706]	A0A1E1XC06	597	L	V
P15056	LP/P	Colorectal cancer (CRC) [MIM:114500]	A0A1E1XC06	600	V	E
P15056	LP/P	Colorectal cancer (CRC) [MIM:114500]	A0A1E1XC06	601	K	E
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	246	A	P
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	257	Q	R
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	485	L	F
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	499	K	E
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	501	E	G
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	501	E	K
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	581	N	D
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	467	S	A
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	468	F	S
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	596	G	V
P15056	LB/B	-	A0A1E1XC06	301	P	S
P15056	LP/P	Noonan syndrome 7 (NS7) [MIM:613706]	A0A1E1XC06	241	T	M
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	241	T	P
P15056	LP/P	LEOPARD syndrome 3 (LPRD3) [MIM:613707]	A0A1E1XC06	241	T	P
P15056	LP/P	Noonan syndrome 7 (NS7) [MIM:613706]	A0A1E1XC06	241	T	R
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	245	L	F
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	275	E	K
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	499	K	N
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	525	L	P
P15056	LP/P	Noonan syndrome 7 (NS7) [MIM:613706]	A0A1E1XC06	531	W	C
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	599	T	R
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	601	K	Q
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	638	D	E
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	709	Q	R
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	244	T	P
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	262	Q	K
P15056	LP/P	Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]	A0A1E1XC06	580	N	D
P25440	LB/B	-	A0A0K8RXH3	238	L	F
P25440	LB/B	-	A0A0K8RXH3	474	A	V
P25440	LB/B	-	A0A0K8RXH3	547	R	K
P25440	LB/B	-	A0A0K8RXH3	49	A	G
P25440	LB/B	-	A0A0K8RXH3	49	A	S
P25440	LB/B	-	A0A0K8RXH3	212	A	P
P25440	LB/B	-	A0A0K8RXH3	260	P	Q
P25440	LB/B	-	A0A0K8RXH3	569	A	T
P25440	LB/B	-	A0A0K8RXH3	599	A	P
Q15059	LB/B	-	A0A0K8RXH3	172	A	V
Q15059	LB/B	-	A0A0K8RXH3	435	K	Q
Q15059	LB/B	-	A0A0K8RXH3	441	R	H
Q15059	LB/B	-	A0A0K8RXH3	447	S	P
Q8TDC3	LB/B	-	A0A2K6TU71	531	T	N
Q8TDC3	LB/B	-	A0A2K6TU71	749	G	S
Q8TDC3	LB/B	-	A0A2K6TU71	764	P	A
P35613	LB/B	-	G5C5W1	269	G	V
P35613	LB/B	-	G5C5W1	208	E	K
P35613	LB/B	-	G5C5W1	152	K	N
P35613	LB/B	-	G5C5W1	176	V	L
P35613	LB/B	-	G5C5W1	206	L	P
P35613	LB/B	-	G5C5W1	13	L	V
P35613	LB/B	-	G5C5W1	16	T	A
P35613	LB/B	-	G5C5W1	26	V	F
Q10589	LB/B	-	K7ETD2	143	V	F
B2RXH4	LB/B	-	S9YRB4	302	S	T
B2RXH4	LB/B	-	S9YRB4	352	E	G
Q13895	LB/B	-	A0A2U4CIA1	103	E	K
Q13895	LB/B	-	A0A2U4CIA1	426	P	S
Q9NQ89	LP/P	Intellectual developmental disorder, autosomal recessive 66 (MRT66) [MIM:618221]	A0A1S3K0H4	328	L	P
Q96LP6	LB/B	-	E9Q9Q5	11	E	D
Q96LP6	LB/B	-	E9Q9Q5	182	P	R
A8MTZ7	LB/B	-	G3UD27	140	I	V
Q8N769	LB/B	-	A0A2I3T529	26	H	Y
Q8WTQ4	LB/B	-	G1SIL4	152	R	Q
Q96EU7	LB/B	-	A0A099ZUP5	131	D	E
Q96EU7	LP/P	Tn polyagglutination syndrome (TNPS) [MIM:300622]	A0A099ZUP5	152	E	K
Q96EU7	LB/B	-	A0A099ZUP5	143	A	V
Q96EU7	LP/P	Tn polyagglutination syndrome (TNPS) [MIM:300622]	A0A099ZUP5	193	S	P
Q96EU7	LB/B	-	A0A099ZUP5	222	Q	H
Q8NDD1	LB/B	-	A0A2J8UE52	28	L	V
P00736	LB/B	-	G3WLP9	152	S	L
P00736	LB/B	-	G3WLP9	131	Y	H
P00736	LB/B	-	G3WLP9	163	H	Y
P00736	LB/B	-	G3WLP9	184	E	K
P00736	LB/B	-	G3WLP9	261	G	R
P00736	LB/B	-	G3WLP9	186	T	R
P00736	LP/P	Ehlers-Danlos syndrome, periodontal type, 1 (EDSPD1) [MIM:130080]	G3WLP9	50	V	D
P00736	LP/P	Ehlers-Danlos syndrome, periodontal type, 1 (EDSPD1) [MIM:130080]	G3WLP9	302	Y	C
P00736	LP/P	Ehlers-Danlos syndrome, periodontal type, 1 (EDSPD1) [MIM:130080]	G3WLP9	309	C	W
P00736	LP/P	Ehlers-Danlos syndrome, periodontal type, 1 (EDSPD1) [MIM:130080]	G3WLP9	338	C	R
P00736	LP/P	Ehlers-Danlos syndrome, periodontal type, 1 (EDSPD1) [MIM:130080]	G3WLP9	358	C	F
P00736	LP/P	Ehlers-Danlos syndrome, periodontal type, 1 (EDSPD1) [MIM:130080]	G3WLP9	371	C	W
P09871	LB/B	-	G3WLP9	383	R	H
P09871	LB/B	-	G3WLP9	119	R	H
P09871	LB/B	-	G3WLP9	327	V	L
P09871	LP/P	Ehlers-Danlos syndrome, periodontal type, 2 (EDSPD2) [MIM:617174]	G3WLP9	294	C	R
O95567	LB/B	-	A0A2K5MRT8	46	C	R
O95567	LB/B	-	A0A2K5MRT8	210	T	R
Q53TS8	LB/B	-	A0A2K5HSJ0	376	H	Q
Q49AR2	LB/B	-	U3KEI5	235	T	P
Q49AR2	LB/B	-	U3KEI5	405	D	E
Q5SZD1	LB/B	-	A0A2Y9ED07	137	Q	E
Q5SZD1	LB/B	-	A0A2Y9ED07	235	P	L
O95873	LB/B	-	A0A061IJK2	68	G	R
O95873	LB/B	-	A0A061IJK2	92	K	N
P10643	LP/P	Complement component 7 deficiency (C7D) [MIM:610102]	A0A1S3W445	220	R	Q
P10643	LP/P	Complement component 7 deficiency (C7D) [MIM:610102]	A0A1S3W445	379	G	R
P10643	LP/P	Complement component 7 deficiency (C7D) [MIM:610102]	A0A1S3W445	521	R	S
P10643	LP/P	Complement component 7 deficiency (C7D) [MIM:610102]	A0A1S3W445	682	E	Q
P10643	LP/P	Complement component 7 deficiency (C7D) [MIM:610102]	A0A1S3W445	687	R	H
P10643	LB/B	-	A0A1S3W445	420	K	Q
P10643	LB/B	-	A0A1S3W445	389	S	T
P10643	LB/B	-	A0A1S3W445	587	T	P
P10643	LB/B	-	A0A1S3W445	128	C	R
P10643	LB/B	-	A0A1S3W445	222	R	H
Q8N865	LB/B	-	A0A2K5DC11	82	Y	C
Q8N865	LB/B	-	A0A2K5DC11	158	A	T
Q8N865	LB/B	-	A0A2K5DC11	187	T	S
Q8N865	LB/B	-	A0A2K5DC11	300	H	R
Q8N865	LB/B	-	A0A2K5DC11	13	E	K
Q8N865	LB/B	-	A0A2K5DC11	86	R	C
Q8N865	LB/B	-	A0A2K5DC11	238	P	Q
Q8N865	LB/B	-	A0A2K5DC11	249	A	T
Q8N865	LB/B	-	A0A2K5DC11	143	P	Q
Q8N865	LB/B	-	A0A2K5DC11	518	N	D
Q8NEG2	LB/B	-	J3KQX6	74	A	S
Q9NRJ1	LB/B	-	A0A2K5YG88	19	T	M
Q9NRJ1	LB/B	-	A0A2K5YG88	49	K	R
Q9NRJ1	LB/B	-	A0A2K5YG88	57	T	I
Q49A92	LB/B	-	B7ZN57	512	A	T
Q96LL4	LB/B	-	A0A1U7UJD9	28	S	F
Q96LL4	LB/B	-	A0A1U7UJD9	285	L	M
Q96LT7	LB/B	-	W5LDU6	207	N	S
Q96KC9	LB/B	-	A0A2Y9MJQ1	76	K	Q
Q96KC9	LB/B	-	A0A2Y9MJQ1	211	T	I
Q96KC9	LB/B	-	A0A2Y9MJQ1	298	W	G
O00555	LP/P	Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]	Q5RHB2	192	R	Q
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	665	T	M
O00555	LP/P	Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]	Q5RHB2	665	T	M
O00555	LP/P	Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]	Q5RHB2	713	V	A
O00555	LP/P	Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]	Q5RHB2	1809	I	L
O00555	LB/B	-	Q5RHB2	21	A	V
O00555	LB/B	-	Q5RHB2	913	P	S
O00555	LB/B	-	Q5RHB2	917	E	D
O00555	LB/B	-	Q5RHB2	1014	E	K
O00555	LB/B	-	Q5RHB2	1104	G	S
O00555	LB/B	-	Q5RHB2	2395	P	S
O00555	LP/P	Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]	Q5RHB2	195	R	K
O00555	LP/P	Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]	Q5RHB2	218	S	L
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	253	H	Y
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	256	C	R
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	287	C	Y
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	293	G	R
O00555	LP/P	Spinocerebellar ataxia 6 (SCA6) [MIM:183086]	Q5RHB2	293	G	R
O00555	LP/P	Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]	Q5RHB2	582	R	Q
O00555	LP/P	Spinocerebellar ataxia 6 (SCA6) [MIM:183086]	Q5RHB2	582	R	Q
O00555	LP/P	Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]	Q5RHB2	714	D	E
O00555	LB/B	-	Q5RHB2	992	E	V
O00555	LP/P	Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]	Q5RHB2	1334	K	E
O00555	LP/P	Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]	Q5RHB2	1345	R	Q
O00555	LP/P	Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]	Q5RHB2	1383	Y	C
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	1402	F	C
O00555	LP/P	Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]	Q5RHB2	1455	V	L
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	1481	G	R
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	1489	F	S
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	1492	V	I
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	1660	R	H
O00555	LP/P	Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]	Q5RHB2	1666	R	W
O00555	LP/P	Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]	Q5RHB2	1682	W	R
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	1735	H	L
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	1755	E	K
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	2134	R	C
O00555	LB/B	-	Q5RHB2	731	E	A
O00555	LB/B	-	Q5RHB2	1172	P	L
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	248	Y	C
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	389	L	F
O00555	LP/P	Spinocerebellar ataxia 6 (SCA6) [MIM:183086]	Q5RHB2	405	A	T
O00555	LB/B	-	Q5RHB2	453	A	T
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	500	T	M
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	637	G	D
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	797	M	T
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	896	P	R
O00555	LP/P	Spinocerebellar ataxia 6 (SCA6) [MIM:183086]	Q5RHB2	1663	R	Q
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	1678	R	C
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	1868	C	R
O00555	LP/P	Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]	Q5RHB2	1694	V	I
O00555	LP/P	Episodic ataxia 2 (EA2) [MIM:108500]	Q5RHB2	388	E	K
O00555	LP/P	Developmental and epileptic encephalopathy 42 (DEE42) [MIM:617106]	Q5RHB2	101	E	Q
O00555	LP/P	Developmental and epileptic encephalopathy 42 (DEE42) [MIM:617106]	Q5RHB2	712	A	T
O00555	LP/P	Developmental and epileptic encephalopathy 42 (DEE42) [MIM:617106]	Q5RHB2	1435	W	R
O00555	LP/P	Developmental and epileptic encephalopathy 42 (DEE42) [MIM:617106]	Q5RHB2	1507	A	S
O00555	LB/B	-	Q5RHB2	1672	R	P
O00555	LP/P	Spinocerebellar ataxia 6 (SCA6) [MIM:183086]	Q5RHB2	1337	D	Y
Q13936	LB/B	-	L5KAL7	752	A	T
Q13936	LB/B	-	L5KAL7	2169	A	T
Q13936	LP/P	Timothy syndrome (TS) [MIM:601005]	L5KAL7	402	G	S
Q13936	LP/P	Timothy syndrome (TS) [MIM:601005]	L5KAL7	406	G	R
Q13936	LB/B	-	L5KAL7	84	Q	R
Q13936	LB/B	-	L5KAL7	391	I	L
Q13936	LB/B	-	L5KAL7	1868	P	L
Q13936	LB/B	-	L5KAL7	1869	M	V
Q13936	LB/B	-	L5KAL7	1893	K	R
Q13936	LP/P	Long QT syndrome 8 (LQT8) [MIM:618447]	L5KAL7	1186	I	T
Q13936	LP/P	Timothy syndrome (TS) [MIM:601005]	L5KAL7	1186	I	T
Q13936	LB/B	-	L5KAL7	37	G	R
Q13936	LB/B	-	L5KAL7	304	I	T
Q13936	LP/P	Timothy syndrome (TS) [MIM:601005]	L5KAL7	518	R	C
Q13936	LP/P	Timothy syndrome (TS) [MIM:601005]	L5KAL7	518	R	H
Q13936	LP/P	Long QT syndrome 8 (LQT8) [MIM:618447]	L5KAL7	582	A	D
Q13936	LB/B	-	L5KAL7	817	P	S
Q13936	LP/P	Long QT syndrome 8 (LQT8) [MIM:618447]	L5KAL7	858	R	H
Q13936	LP/P	Long QT syndrome 8 (LQT8) [MIM:618447]	L5KAL7	860	R	G
Q13936	LP/P	Long QT syndrome 8 (LQT8) [MIM:618447]	L5KAL7	1186	I	V
Q13936	LP/P	Long QT syndrome 8 (LQT8) [MIM:618447]	L5KAL7	1523	I	M
Q13936	LP/P	Long QT syndrome 8 (LQT8) [MIM:618447]	L5KAL7	1544	E	K
Q13936	LB/B	-	L5KAL7	1755	V	I
Q13936	LB/B	-	L5KAL7	1765	A	G
Q13936	LB/B	-	L5KAL7	1835	T	M
Q13936	LB/B	-	L5KAL7	1843	G	R
Q13936	LB/B	-	L5KAL7	1972	R	C
Q13936	LB/B	-	L5KAL7	2056	R	Q
Q13936	LB/B	-	L5KAL7	2174	N	S
Q13936	LP/P	Long QT syndrome 8 (LQT8) [MIM:618447]	L5KAL7	857	P	L
Q13936	LP/P	Long QT syndrome 8 (LQT8) [MIM:618447]	L5KAL7	857	P	R
Q13936	LP/P	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures (NEDHLSS) [MIM:620029]	L5KAL7	166	F	L
Q13936	LP/P	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures (NEDHLSS) [MIM:620029]	L5KAL7	177	K	R
Q13936	LP/P	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures (NEDHLSS) [MIM:620029]	L5KAL7	324	R	W
Q13936	LP/P	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures (NEDHLSS) [MIM:620029]	L5KAL7	403	V	M
Q13936	LP/P	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures (NEDHLSS) [MIM:620029]	L5KAL7	601	L	R
Q13936	LP/P	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures (NEDHLSS) [MIM:620029]	L5KAL7	611	M	T
Q13936	LP/P	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures (NEDHLSS) [MIM:620029]	L5KAL7	614	L	P
Q13936	LP/P	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures (NEDHLSS) [MIM:620029]	L5KAL7	614	L	R
Q13936	LP/P	Timothy syndrome (TS) [MIM:601005]	L5KAL7	643	S	F
Q13936	LP/P	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures (NEDHLSS) [MIM:620029]	L5KAL7	657	L	F
Q13936	LP/P	Timothy syndrome (TS) [MIM:601005]	L5KAL7	1135	E	K
Q13936	LP/P	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures (NEDHLSS) [MIM:620029]	L5KAL7	1187	V	A
Q13936	LP/P	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures (NEDHLSS) [MIM:620029]	L5KAL7	1408	L	V
Q13936	LP/P	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures (NEDHLSS) [MIM:620029]	L5KAL7	1411	V	L
Q13936	LP/P	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures (NEDHLSS) [MIM:620029]	L5KAL7	1411	V	M
Q01668	LB/B	-	L5KAL7	2097	D	N
Q01668	LP/P	Primary aldosteronism, seizures, and neurologic abnormalities (PASNA) [MIM:615474]	L5KAL7	403	G	D
Q01668	LP/P	Primary aldosteronism, seizures, and neurologic abnormalities (PASNA) [MIM:615474]	L5KAL7	750	I	M
Q01668	LP/P	-	L5KAL7	401	V	L
Q01668	LP/P	-	L5KAL7	407	G	R
Q01668	LP/P	-	L5KAL7	749	A	G
O43497	LP/P	Spinocerebellar ataxia 42 (SCA42) [MIM:616795]	A0A151N2S7	1715	R	H
O43497	LP/P	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits (SCA42ND) [MIM:618087]	A0A151N2S7	961	A	T
O43497	LP/P	Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits (SCA42ND) [MIM:618087]	A0A151N2S7	1531	M	V
O95180	LB/B	-	G3HBW3	1974	E	G
O95180	LP/P	Epilepsy, childhood absence 6 (ECA6) [MIM:611942]	G3HBW3	161	F	L
O95180	LP/P	Epilepsy, childhood absence 6 (ECA6) [MIM:611942]	G3HBW3	282	E	K
O95180	LB/B	-	G3HBW3	313	M	V
O95180	LP/P	Epilepsy, childhood absence 6 (ECA6) [MIM:611942]	G3HBW3	456	C	S
O95180	LP/P	Epilepsy, childhood absence 6 (ECA6) [MIM:611942]	G3HBW3	499	G	S
O95180	LB/B	-	G3HBW3	640	P	L
O95180	LP/P	Epilepsy, childhood absence 6 (ECA6) [MIM:611942]	G3HBW3	648	P	L
O95180	LB/B	-	G3HBW3	664	V	A
O95180	LB/B	-	G3HBW3	684	P	S
O95180	LP/P	Epilepsy, childhood absence 6 (ECA6) [MIM:611942]	G3HBW3	744	R	Q
O95180	LP/P	Epilepsy, childhood absence 6 (ECA6) [MIM:611942]	G3HBW3	748	A	V
O95180	LP/P	Epilepsy, childhood absence 6 (ECA6) [MIM:611942]	G3HBW3	773	G	D
O95180	LP/P	Epilepsy, childhood absence 6 (ECA6) [MIM:611942]	G3HBW3	784	G	S
O95180	LB/B	-	G3HBW3	788	R	C
O95180	LB/B	-	G3HBW3	812	V	M
O95180	LP/P	Epilepsy, childhood absence 6 (ECA6) [MIM:611942]	G3HBW3	831	V	M
O95180	LP/P	Epilepsy, childhood absence 6 (ECA6) [MIM:611942]	G3HBW3	848	G	S
O95180	LP/P	Epilepsy, childhood absence 6 (ECA6) [MIM:611942]	G3HBW3	1463	D	N
O95180	LB/B	-	G3HBW3	2060	R	H
O95180	LB/B	-	G3HBW3	2077	R	H
O95180	LB/B	-	G3HBW3	2173	P	S
O95180	LB/B	-	G3HBW3	1871	R	Q
O95180	LP/P	Epilepsy, idiopathic generalized 6 (EIG6) [MIM:611942]	G3HBW3	618	P	L
O95180	LP/P	Epilepsy, idiopathic generalized 6 (EIG6) [MIM:611942]	G3HBW3	755	G	D
O95180	LP/P	Hyperaldosteronism, familial, 4 (HALD4) [MIM:617027]	G3HBW3	196	S	L
O95180	LP/P	Hyperaldosteronism, familial, 4 (HALD4) [MIM:617027]	G3HBW3	1549	M	I
O95180	LP/P	Hyperaldosteronism, familial, 4 (HALD4) [MIM:617027]	G3HBW3	1549	M	V
O95180	LP/P	-	G3HBW3	1951	V	E
O95180	LP/P	Hyperaldosteronism, familial, 4 (HALD4) [MIM:617027]	G3HBW3	2083	P	L
P54284	LB/B	-	A0A1W4XZV5	423	R	H
Q13137	LB/B	-	A0A212D9I8	140	G	E
Q13137	LB/B	-	A0A212D9I8	227	G	R
Q13137	LB/B	-	A0A212D9I8	248	V	A
Q13137	LB/B	-	A0A212D9I8	273	T	A
Q13137	LB/B	-	A0A212D9I8	389	P	A
Q9UQM7	LP/P	Intellectual developmental disorder, autosomal dominant 53 (MRD53) [MIM:617798]	A0A0F8AJZ9	98	F	S
Q9UQM7	LP/P	Intellectual developmental disorder, autosomal dominant 53 (MRD53) [MIM:617798]	A0A0F8AJZ9	109	E	D
Q9UQM7	LP/P	Intellectual developmental disorder, autosomal dominant 53 (MRD53) [MIM:617798]	A0A0F8AJZ9	183	E	V
Q9UQM7	LP/P	Intellectual developmental disorder, autosomal dominant 53 (MRD53) [MIM:617798]	A0A0F8AJZ9	282	H	R
Q9UQM7	LP/P	Intellectual developmental disorder, autosomal dominant 53 (MRD53) [MIM:617798]	A0A0F8AJZ9	286	T	P
Q9UQM7	LP/P	Intellectual developmental disorder, autosomal dominant 53 (MRD53) [MIM:617798]	A0A0F8AJZ9	212	P	Q
Q9UQM7	LP/P	Intellectual developmental disorder, autosomal recessive 63 (MRT63) [MIM:618095]	A0A0F8AJZ9	466	H	Y
Q9Y6Y1	LB/B	-	K7DY74	1177	N	K
Q9Y6Y1	LB/B	-	K7DY74	1218	N	T
Q9Y6Y1	LB/B	-	K7DY74	1336	T	I
Q14444	LB/B	-	A0A226N6R5	263	A	D
Q14444	LB/B	-	A0A226N6R5	588	Q	H
Q14444	LB/B	-	A0A226N6R5	616	R	H
Q9BXY5	LB/B	-	F6ZAD5	125	L	F
Q8WWF8	LB/B	-	B4R203	85	R	Q
Q8WWF8	LB/B	-	B4R203	201	M	V
P52907	LB/B	-	S7PV98	219	S	L
Q9BWT7	LB/B	-	H2RWZ1	289	R	Q
Q9BXL6	LB/B	-	S7NIU0	883	R	H
Q9BXL6	LB/B	-	S7NIU0	547	R	S
Q9BXL6	LB/B	-	S7NIU0	585	V	I
Q9BXL6	LB/B	-	S7NIU0	820	R	W
Q9BXL6	LB/B	-	S7NIU0	962	R	Q
Q9BXL6	LB/B	-	S7NIU0	38	R	C
Q9BXL6	LB/B	-	S7NIU0	62	R	Q
Q9BXL6	LP/P	Pityriasis rubra pilaris (PRP) [MIM:173200]	S7NIU0	117	G	S
Q9BXL6	LP/P	Psoriasis 2 (PSORS2) [MIM:602723]	S7NIU0	117	G	S
Q9BXL6	LP/P	Psoriasis 2 (PSORS2) [MIM:602723]	S7NIU0	138	E	A
Q9BXL6	LP/P	Psoriasis 2 (PSORS2) [MIM:602723]	S7NIU0	142	E	G
Q9BXL6	LP/P	Psoriasis 2 (PSORS2) [MIM:602723]	S7NIU0	142	E	K
Q9BXL6	LP/P	Psoriasis 2 (PSORS2) [MIM:602723]	S7NIU0	150	L	R
Q9BXL6	LB/B	-	S7NIU0	171	H	N
Q9BXL6	LB/B	-	S7NIU0	176	D	H
Q9BXL6	LB/B	-	S7NIU0	179	R	H
Q9BXL6	LB/B	-	S7NIU0	191	V	L
Q9BXL6	LB/B	-	S7NIU0	200	S	N
Q9BXL6	LB/B	-	S7NIU0	285	D	G
Q9BXL6	LB/B	-	S7NIU0	593	I	N
Q9BXL6	LB/B	-	S7NIU0	682	R	W
Q9BXL6	LB/B	-	S7NIU0	714	G	S
Q9BXL6	LB/B	-	S7NIU0	973	D	E
Q9BXL6	LP/P	Pityriasis rubra pilaris (PRP) [MIM:173200]	S7NIU0	156	L	P
Q9BXL6	LP/P	Psoriasis 2 (PSORS2) [MIM:602723]	S7NIU0	69	R	W
Q9BXL6	LP/P	Pityriasis rubra pilaris (PRP) [MIM:173200]	S7NIU0	127	C	S
Q9BXL6	LP/P	Pityriasis rubra pilaris (PRP) [MIM:173200]	S7NIU0	136	Q	L
Q9BXL6	LP/P	Psoriasis 2 (PSORS2) [MIM:602723]	S7NIU0	197	E	K
Q9BXL6	LB/B	-	S7NIU0	350	L	P
Q9BXL6	LB/B	-	S7NIU0	357	L	P
Q5VZK9	LB/B	-	I3MJV1	77	V	I
Q5VZK9	LB/B	-	I3MJV1	545	P	L
Q5VZK9	LB/B	-	I3MJV1	639	A	G
Q5VZK9	LB/B	-	I3MJV1	1117	N	S
Q16568	LB/B	-	W5NA06	61	L	F
Q16568	LB/B	-	W5NA06	66	S	T
Q16568	LB/B	-	W5NA06	113	L	M
Q9UKL3	LB/B	-	A0A091U5I4	1659	P	S
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	39	P	A
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	62	R	M
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	66	R	C
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	116	A	T
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	127	E	A
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	138	T	M
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	143	G	E
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	174	L	R
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	185	R	Q
P41180	LP/P	Hyperparathyroidism, neonatal severe (NSHPT) [MIM:239200]	H9GD24	227	R	L
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	227	R	Q
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	297	E	K
P41180	LP/P	Hyperparathyroidism, neonatal severe (NSHPT) [MIM:239200]	H9GD24	582	C	Y
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	582	C	Y
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	681	Q	H
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	795	R	W
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	806	F	S
P41180	LB/B	-	H9GD24	851	C	S
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	557	G	E
P41180	LB/B	-	H9GD24	986	A	S
P41180	LB/B	-	H9GD24	1011	E	Q
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	616	L	V
P41180	LB/B	-	H9GD24	951	P	T
P41180	LB/B	-	H9GD24	990	R	G
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	767	E	K
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	11	L	S
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	13	L	P
P41180	LB/B	-	H9GD24	14	T	A
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	21	G	R
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	47	K	N
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	118	N	K
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	125	L	P
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	128	F	L
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	131	C	W
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	151	T	M
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	171	S	N
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	180	F	C
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	191	E	K
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	221	P	Q
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	225	K	T
P41180	LB/B	-	H9GD24	250	E	K
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	271	S	F
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	397	G	R
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	465	R	Q
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	509	G	R
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	553	G	R
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	555	I	V
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	562	C	Y
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	582	C	F
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	604	E	K
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	612	F	S
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	623	G	D
P41180	LP/P	Hyperparathyroidism, neonatal severe (NSHPT) [MIM:239200]	H9GD24	670	G	E
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	670	G	R
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	727	L	Q
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	728	V	F
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	742	W	R
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	773	L	R
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	788	F	C
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	788	F	L
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	820	S	F
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	843	A	E
P41180	LP/P	-	H9GD24	881	F	L
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	886	R	W
P41180	LP/P	Epilepsy, idiopathic generalized 8 (EIG8) [MIM:612899]	H9GD24	354	E	A
P41180	LP/P	Epilepsy, idiopathic generalized 8 (EIG8) [MIM:612899]	H9GD24	686	I	V
P41180	LP/P	Epilepsy, idiopathic generalized 8 (EIG8) [MIM:612899]	H9GD24	898	R	Q
P41180	LP/P	Epilepsy, idiopathic generalized 8 (EIG8) [MIM:612899]	H9GD24	988	A	G
P41180	LP/P	Epilepsy, idiopathic generalized 8 (EIG8) [MIM:612899]	H9GD24	988	A	V
P41180	LP/P	Hyperparathyroidism, neonatal severe (NSHPT) [MIM:239200]	H9GD24	100	T	I
P41180	LP/P	Hyperparathyroidism, neonatal severe (NSHPT) [MIM:239200]	H9GD24	650	L	P
P41180	LP/P	Hyperparathyroidism, neonatal severe (NSHPT) [MIM:239200]	H9GD24	689	V	M
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	697	V	M
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	42	F	S
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	53	S	P
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	55	P	L
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	66	R	H
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	81	I	M
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	110	A	T
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	122	S	C
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	125	L	F
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	129	C	R
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	136	P	L
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	143	G	R
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	158	G	R
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	159	L	P
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	166	S	G
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	172	R	G
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	178	N	D
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	215	D	G
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	220	R	W
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	221	P	L
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	221	P	S
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	228	E	K
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	459	Q	R
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	549	G	R
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	550	T	I
P41180	LP/P	Hyperparathyroidism, neonatal severe (NSHPT) [MIM:239200]	H9GD24	551	R	K
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	565	C	G
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	569	P	H
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	571	G	W
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	657	S	Y
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	661	C	Y
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	680	R	H
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	681	Q	R
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	707	E	V
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	748	P	R
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	774	G	S
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	802	N	I
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	802	N	S
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	817	V	I
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	830	G	S
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	832	F	L
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	832	F	S
P41180	LP/P	Hypocalcemia, autosomal dominant 1 (HYPOC1) [MIM:601198]	H9GD24	839	I	T
P41180	LP/P	Hypocalciuric hypercalcemia, familial 1 (HHC1) [MIM:145980]	H9GD24	972	T	M
P20810	LB/B	-	A0A2R9CCA2	592	E	G
P20810	LB/B	-	A0A2R9CCA2	408	C	S
P20810	LB/B	-	A0A2R9CCA2	380	E	K
P20810	LB/B	-	A0A2R9CCA2	537	A	V
Q969G5	LB/B	-	A0A2K6NFX8	8	R	P
Q969G5	LB/B	-	A0A2K6NFX8	104	A	T
Q969G5	LB/B	-	A0A2K6NFX8	158	L	P
Q969G5	LB/B	-	A0A2K6NFX8	255	L	F
Q6DHV5	LB/B	-	A0A140LIW0	1100	N	D
Q6DHV5	LB/B	-	A0A140LIW0	1273	Y	H
Q6DHV5	LB/B	-	A0A140LIW0	1437	Q	L
Q8TBZ0	LB/B	-	Q95JS9	209	P	Q
Q8TBZ0	LB/B	-	Q95JS9	299	L	M
Q8TBZ0	LB/B	-	Q95JS9	382	L	M
Q8TBZ0	LB/B	-	Q95JS9	409	S	F
Q8TBZ0	LB/B	-	Q95JS9	614	I	M
Q8TBZ0	LB/B	-	Q95JS9	669	Q	R
Q8TBZ0	LB/B	-	Q95JS9	817	S	L
Q8TBZ0	LB/B	-	Q95JS9	819	L	M
Q8TBZ0	LB/B	-	Q95JS9	500	Y	D
Q96NT0	LP/P	Congenital disorder of glycosylation 2O (CDG2O) [MIM:616828]	G5B9W5	11	D	Y
Q96NT0	LP/P	Congenital disorder of glycosylation 2O (CDG2O) [MIM:616828]	G5B9W5	31	L	S
Q5T0U0	LB/B	-	A0A1U7RCA8	269	I	T
Q8IYE1	LB/B	-	M0R4S7	547	S	T
Q8IYE1	LB/B	-	M0R4S7	25	R	W
Q8IYE1	LB/B	-	M0R4S7	375	E	V
Q6NUI1	LB/B	-	A0A2J8J3E5	82	G	D
Q8NDH2	LB/B	-	A0A2J8M9F4	4659	P	S
Q8NDH2	LB/B	-	A0A2J8M9F4	4723	M	V
Q8NDH2	LB/B	-	A0A2J8M9F4	4893	G	S
Q8NDH2	LB/B	-	A0A2J8M9F4	4943	S	P
Q8NDH2	LB/B	-	A0A2J8M9F4	4976	L	P
Q8NDH2	LB/B	-	A0A2J8M9F4	5011	G	A
Q8NDH2	LB/B	-	A0A2J8M9F4	5644	R	T
Q8NDH2	LB/B	-	A0A2J8M9F4	5750	N	S
Q8NDH2	LB/B	-	A0A2J8M9F4	5838	R	Q
Q8NDH2	LB/B	-	A0A2J8M9F4	5916	F	L
Q8NDH2	LB/B	-	A0A2J8M9F4	6011	L	P
Q8NDH2	LB/B	-	A0A2J8M9F4	6075	R	C
Q8NDH2	LB/B	-	A0A2J8M9F4	6112	T	M
Q8NDH2	LB/B	-	A0A2J8M9F4	6508	E	A
Q8NDH2	LB/B	-	A0A2J8M9F4	6544	K	E
Q6TFL3	LB/B	-	H2ZUG0	17	I	N
Q6TFL3	LB/B	-	H2ZUG0	121	S	T
Q6TFL3	LB/B	-	H2ZUG0	1069	K	R
Q6TFL3	LB/B	-	H2ZUG0	495	N	I
Q6TFL3	LB/B	-	H2ZUG0	821	C	Y
Q9P1Z9	LB/B	-	A0A2Y9QNS2	162	P	H
Q9P1Z9	LB/B	-	A0A2Y9QNS2	183	S	R
Q9P1Z9	LB/B	-	A0A2Y9QNS2	234	L	H
Q9P1Z9	LB/B	-	A0A2Y9QNS2	778	E	K
Q9P1Z9	LB/B	-	A0A2Y9QNS2	856	S	C
Q9P1Z9	LB/B	-	A0A2Y9QNS2	1175	F	L
Q9P1Z9	LB/B	-	A0A2Y9QNS2	1573	D	N
Q9P1Z9	LB/B	-	A0A2Y9QNS2	409	P	R
O60826	LP/P	Ritscher-Schinzel syndrome 2 (RTSC2) [MIM:300963]	A0A1A7ZB57	17	T	A
O60826	LP/P	Ritscher-Schinzel syndrome 2 (RTSC2) [MIM:300963]	A0A1A7ZB57	557	Y	C
O60826	LB/B	-	A0A1A7ZB57	546	D	N
Q8IWP9	LB/B	-	A0A2K5JYT4	42	S	Y
Q8IWP9	LB/B	-	A0A2K5JYT4	82	P	L
Q5VVM6	LB/B	-	S7PHS5	772	H	N
Q4G0X9	LB/B	-	A0A2Y9PP92	8	A	P
Q96M95	LB/B	-	A0A2G8K8V5	144	A	T
Q96M95	LB/B	-	A0A2G8K8V5	51	T	P
Q96M95	LB/B	-	A0A2G8K8V5	75	R	C
Q96ER9	LB/B	-	A0A091MNX2	360	F	S
A6NI79	LB/B	-	A0A2Y9SQQ7	197	R	K
A2IDD5	LB/B	-	S9XHM5	252	W	R
Q8IWF9	LB/B	-	A0A1U7SK55	49	T	A
Q9GZT6	LB/B	-	A0A2Y9Q299	10	F	L
Q2M329	LB/B	-	A0A2Y9LLU3	96	E	K
P51671	LB/B	-	A0A2F0BNB6	7	L	P
P51671	LB/B	-	A0A2F0BNB6	23	A	T
P51671	LB/B	-	A0A2F0BNB6	51	R	S
P51671	LB/B	-	A0A2F0BNB6	79	K	R
P51671	LB/B	-	A0A2F0BNB6	86	K	T
Q99616	LB/B	-	A0A2F0BNB6	5	A	S
Q99616	LB/B	-	A0A2F0BNB6	29	N	S
Q16627	LB/B	-	E2RA85	61	K	E
P10147	LB/B	-	E2RA85	78	E	D
P13236	LB/B	-	E2RA85	12	M	V
P13236	LB/B	-	E2RA85	20	P	L
P13236	LB/B	-	E2RA85	80	S	T
P80075	LB/B	-	A0A2F0BNB6	69	K	Q
P80075	LB/B	-	A0A2F0BNB6	14	A	V
O95388	LB/B	-	G5C6Q6	205	A	S
P20248	LB/B	-	Q3KQ49	163	I	V
O95067	LB/B	-	S7QB58	100	M	T
O95067	LB/B	-	S7QB58	395	I	T
O95067	LB/B	-	S7QB58	135	V	I
P22674	LB/B	-	G1QKK9	161	L	M
P22674	LP/P	Ciliary dyskinesia, primary, 29 (CILD29) [MIM:615872]	G1QKK9	239	H	R
P22674	LP/P	Ciliary dyskinesia, primary, 29 (CILD29) [MIM:615872]	G1QKK9	213	L	P
Q9C0I3	LB/B	-	A0A2K5DRG1	382	G	S
P49368	LB/B	-	L9KAL0	391	L	F
P48643	LP/P	Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive (HSNSP) [MIM:256840]	L9L693	147	H	R
P48643	LB/B	-	L9L693	146	E	V
P48509	LB/B	-	L8YC00	132	K	R
P48509	LB/B	-	L8YC00	137	P	S
P48509	LB/B	-	L8YC00	178	R	H
P48509	LB/B	-	L8YC00	120	T	M
Q8TD46	LB/B	-	A0A2K6GW16	112	K	R
Q8TD46	LB/B	-	A0A2K6GW16	144	T	P
Q8TD46	LB/B	-	A0A2K6GW16	200	H	Q
Q8TD46	LB/B	-	A0A2K6GW16	335	E	Q
Q9UJ71	LB/B	-	A0A0D9RRP0	55	A	V
Q9UJ71	LB/B	-	A0A0D9RRP0	213	P	S
Q9UJ71	LB/B	-	A0A0D9RRP0	278	V	A
Q9UJ71	LB/B	-	A0A0D9RRP0	288	N	D
Q9UJ71	LB/B	-	A0A0D9RRP0	136	Q	E
Q9UJ71	LB/B	-	A0A0D9RRP0	300	A	P
Q9UJ71	LP/P	Birbeck granule deficiency (BIRGD) [MIM:613393]	A0A0D9RRP0	264	W	R
Q9Y5K6	LB/B	-	F6ZVE6	581	N	K
Q9Y5K6	LB/B	-	F6ZVE6	374	T	A
Q08708	LB/B	-	L7N1P8	71	T	I
Q496F6	LB/B	-	M3YRX1	19	K	T
Q496F6	LB/B	-	M3YRX1	158	G	R
Q8IX05	LB/B	-	A0A091CW92	200	R	S
Q9NPF0	LB/B	-	G3QF47	8	Q	R
Q9NPF0	LB/B	-	G3QF47	220	G	R
Q9NPF0	LB/B	-	G3QF47	142	S	G
P04234	LB/B	-	A0A093DGC5	147	Q	R
P01730	LB/B	-	A6MUU7	265	R	W
P01730	LB/B	-	A6MUU7	191	K	E
P01730	LB/B	-	A6MUU7	227	F	S
P09326	LB/B	-	M3YRU1	102	E	Q
P09326	LB/B	-	M3YRU1	241	L	S
P06127	LB/B	-	A0A1U8BGJ9	224	P	L
P06127	LB/B	-	A0A1U8BGJ9	461	H	R
P06127	LB/B	-	A0A1U8BGJ9	471	A	V
P31358	LB/B	-	M3X640	41	I	M
P31358	LB/B	-	M3X640	40	N	S
P21854	LB/B	-	A0A287DBB8	234	P	L
P40259	LP/P	Agammaglobulinemia 6, autosomal recessive (AGM6) [MIM:612692]	A0A2Y9L2X2	137	G	S
P40200	LB/B	-	M3X4H9	142	A	P
P40200	LP/P	C syndrome (CSYN) [MIM:211750]	M3X4H9	280	T	M
P14209	LB/B	-	M3XQ21	166	M	V
P14209	LB/B	-	M3XQ21	173	N	I
O60729	LB/B	-	I3LR09	302	I	T
O60729	LB/B	-	I3LR09	341	I	T
O14613	LB/B	-	A0A0P7UXP0	176	N	S
O14613	LB/B	-	A0A0P7UXP0	191	I	F
Q99459	LB/B	-	A0A1J1HIY8	459	Y	C
O00311	LB/B	-	D4A8S5	23	Q	P
O00311	LB/B	-	D4A8S5	99	I	V
O00311	LB/B	-	D4A8S5	112	G	W
O00311	LB/B	-	D4A8S5	162	F	L
O00311	LB/B	-	D4A8S5	441	K	R
O00311	LB/B	-	D4A8S5	208	I	M
O00311	LB/B	-	D4A8S5	209	E	D
O00311	LB/B	-	D4A8S5	472	T	I
O00311	LB/B	-	D4A8S5	498	S	A
Q69YH5	LB/B	-	F6Q296	717	V	I
Q69YH5	LB/B	-	F6Q296	884	R	S
Q96GN5	LB/B	-	A0A2U4AST5	187	R	S
Q96GN5	LB/B	-	A0A2U4AST5	45	D	N
Q9Y6N8	LB/B	-	A0A094N836	413	S	F
P55287	LB/B	-	A0A094N836	255	T	M
P55287	LB/B	-	A0A094N836	275	M	I
P55287	LB/B	-	A0A094N836	373	S	A
P55287	LP/P	Teebi hypertelorism syndrome 2 (TBHS2) [MIM:619736]	A0A094N836	55	W	S
P55287	LP/P	Teebi hypertelorism syndrome 2 (TBHS2) [MIM:619736]	A0A094N836	140	E	K
P55287	LP/P	Teebi hypertelorism syndrome 2 (TBHS2) [MIM:619736]	A0A094N836	260	D	E
P55287	LP/P	Teebi hypertelorism syndrome 2 (TBHS2) [MIM:619736]	A0A094N836	260	D	N
P55287	LP/P	Teebi hypertelorism syndrome 2 (TBHS2) [MIM:619736]	A0A094N836	262	N	I
P55287	LP/P	Teebi hypertelorism syndrome 2 (TBHS2) [MIM:619736]	A0A094N836	266	P	L
P55287	LP/P	Teebi hypertelorism syndrome 2 (TBHS2) [MIM:619736]	A0A094N836	279	E	Q
P55287	LP/P	Teebi hypertelorism syndrome 2 (TBHS2) [MIM:619736]	A0A094N836	327	G	W
P55287	LP/P	Teebi hypertelorism syndrome 2 (TBHS2) [MIM:619736]	A0A094N836	374	V	E
P55289	LB/B	-	A0A094N836	68	V	M
P55289	LB/B	-	A0A094N836	284	I	V
P55289	LB/B	-	A0A094N836	475	I	T
P55290	LB/B	-	A0A2K5DL38	121	L	S
P55290	LB/B	-	A0A2K5DL38	65	R	C
P55290	LB/B	-	A0A2K5DL38	103	A	V
P55290	LB/B	-	A0A2K5DL38	113	G	R
P55290	LB/B	-	A0A2K5DL38	246	R	W
P55290	LB/B	-	A0A2K5DL38	367	E	Q
P55290	LB/B	-	A0A2K5DL38	376	A	T
P55290	LB/B	-	A0A2K5DL38	643	L	R
Q9HBT6	LB/B	-	A0A094N836	328	P	H
Q9HBT6	LB/B	-	A0A094N836	371	Q	R
Q9HBT6	LB/B	-	A0A094N836	391	P	L
Q9ULB5	LB/B	-	A0A094N836	576	N	S
Q9ULB5	LB/B	-	A0A094N836	370	D	E
Q9ULB4	LB/B	-	A0A094N836	6	Y	C
Q9ULB4	LB/B	-	A0A094N836	38	A	V
Q6ZTQ4	LB/B	-	A0A2K5JUR1	55	V	M
Q6ZTQ4	LB/B	-	A0A2K5JUR1	61	Q	H
Q6ZTQ4	LB/B	-	A0A2K5JUR1	529	C	Y
Q9NYV4	LB/B	-	B5DE93	530	P	A
Q9NYV4	LB/B	-	B5DE93	1189	L	Q
Q9NYV4	LB/B	-	B5DE93	1275	P	L
P24941	LB/B	-	A0A151X125	15	Y	S
P24941	LB/B	-	A0A151X125	290	T	S
P24941	LB/B	-	A0A151X125	18	V	L
Q00526	LB/B	-	A0A151X125	226	T	I
Q00526	LB/B	-	A0A151X125	264	M	T
Q00526	LB/B	-	A0A151X125	124	I	T
Q00526	LB/B	-	A0A151X125	214	R	H
Q00532	LB/B	-	A0A2D0T6B3	67	L	P
Q00532	LB/B	-	A0A2D0T6B3	275	Q	E
Q00532	LB/B	-	A0A2D0T6B3	330	L	V
Q00532	LB/B	-	A0A2D0T6B3	342	K	N
P38936	LB/B	-	H2RFJ9	31	S	R
P38936	LB/B	-	H2RFJ9	4	P	L
P38936	LB/B	-	H2RFJ9	63	F	L
P42773	LB/B	-	G1MGH8	126	T	M
Q86X02	LB/B	-	G1PXM1	300	D	E
P06731	LB/B	-	E1BMH6	398	E	K
P06731	LB/B	-	E1BMH6	340	A	D
P06731	LB/B	-	E1BMH6	664	R	S
P06731	LB/B	-	E1BMH6	137	Q	P
P06731	LB/B	-	E1BMH6	678	G	R
P06731	LB/B	-	E1BMH6	80	I	V
P06731	LB/B	-	E1BMH6	83	V	A
P17676	LB/B	-	A0A2U3WT63	195	G	S
O95319	LB/B	-	A0A0S7LPN3	438	D	H
O95319	LP/P	Developmental and epileptic encephalopathy 97 (DEE97) [MIM:619561]	A0A0S7LPN3	507	P	S
Q8N6W0	LB/B	-	A0A1D5PTC3	65	F	L
Q8TEP8	LB/B	-	A0A1D5PSP1	1053	T	A
Q8TEP8	LB/B	-	A0A1D5PSP1	1365	V	M
Q8TEP8	LB/B	-	A0A1D5PSP1	1109	Q	P
Q8TEP8	LB/B	-	A0A1D5PSP1	1544	R	H
Q8TEP8	LB/B	-	A0A1D5PSP1	1552	S	P
Q8TEP8	LB/B	-	A0A1D5PSP1	1701	L	F
Q8TEP8	LB/B	-	A0A1D5PSP1	2051	S	N
Q8TEP8	LB/B	-	A0A1D5PSP1	2121	L	P
Q8TEP8	LB/B	-	A0A1D5PSP1	2271	K	E
Q8TEP8	LB/B	-	A0A1D5PSP1	2449	R	L
Q9BV73	LB/B	-	G1KEL1	995	Q	H
Q9BV73	LB/B	-	G1KEL1	1441	R	Q
Q9BV73	LB/B	-	G1KEL1	1072	Q	E
Q9Y592	LB/B	-	F7CPR3	78	Q	R
Q9Y592	LP/P	Nephronophthisis 18 (NPHP18) [MIM:615862]	F7CPR3	87	L	P
Q9Y592	LP/P	Nephronophthisis 18 (NPHP18) [MIM:615862]	F7CPR3	511	R	P
Q5SZL2	LB/B	-	W5LF74	137	S	G
Q5SZL2	LB/B	-	W5LF74	166	D	V
Q5SZL2	LB/B	-	W5LF74	251	P	T
Q5SZL2	LB/B	-	W5LF74	532	Q	H
Q5SZL2	LB/B	-	W5LF74	640	M	V
Q5SZL2	LP/P	Lissencephaly 10 (LIS10) [MIM:618873]	W5LF74	58	S	C
Q5SZL2	LP/P	Lissencephaly 10 (LIS10) [MIM:618873]	W5LF74	65	D	N
Q96GE4	LB/B	-	G3RZL9	165	M	I
Q96GE4	LB/B	-	G3RZL9	811	A	V
P11597	LP/P	Hyperalphalipoproteinemia 1 (HALP1) [MIM:143470]	Q9BG59	459	D	G
P11597	LB/B	-	Q9BG59	331	G	S
P11597	LB/B	-	Q9BG59	390	A	P
P11597	LB/B	-	Q9BG59	422	V	I
P11597	LB/B	-	Q9BG59	468	R	Q
P11597	LB/B	-	Q9BG59	486	V	M
P11597	LB/B	-	Q9BG59	15	A	G
P11597	LB/B	-	Q9BG59	385	V	M
P11597	LB/B	-	Q9BG59	455	V	M
P11597	LB/B	-	Q9BG59	154	R	W
P11597	LP/P	Hyperalphalipoproteinemia 1 (HALP1) [MIM:143470]	Q9BG59	168	L	P
P11597	LP/P	Hyperalphalipoproteinemia 1 (HALP1) [MIM:143470]	Q9BG59	299	R	C
Q4G0U5	LB/B	-	A0A1U7QE01	637	V	I
Q4G0U5	LB/B	-	A0A1U7QE01	795	M	I
Q96G28	LB/B	-	A0A2U3XXI3	243	D	G
Q96G28	LB/B	-	A0A2U3XXI3	246	I	F
Q96G28	LB/B	-	A0A2U3XXI3	6	E	D
Q96NL8	LB/B	-	A0A2C9K1J0	19	P	A
Q96NL8	LP/P	Bardet-Biedl syndrome 21 (BBS21) [MIM:617406]	A0A2C9K1J0	177	R	W
Q96NL8	LP/P	Cone-rod dystrophy 16 (CORD16) [MIM:614500]	A0A2C9K1J0	177	R	W
Q96NL8	LP/P	Retinitis pigmentosa 64 (RP64) [MIM:614500]	A0A2C9K1J0	182	Q	R
Q9UL16	LB/B	-	A0A095A3Y8	291	E	G
Q6ZTR5	LB/B	-	M3XPD1	236	V	M
Q6ZTR5	LB/B	-	M3XPD1	345	C	R
Q6ZTR5	LB/B	-	M3XPD1	561	A	T
Q6ZTR5	LB/B	-	M3XPD1	634	H	Y
Q5T0N1	LB/B	-	A0A2K6F0K1	849	W	L
Q5T0N1	LB/B	-	A0A2K6F0K1	944	N	D
Q9C0B2	LB/B	-	W5MG58	50	S	I
Q9C0B2	LB/B	-	W5MG58	363	I	V
Q9C0B2	LB/B	-	W5MG58	628	G	C
P0CG37	LB/B	-	A0A2K6TDW4	78	R	W
P0CG37	LP/P	Heterotaxy, visceral, 2, autosomal (HTX2) [MIM:605376]	A0A2K6TDW4	112	R	C
P0CG37	LB/B	-	A0A2K6TDW4	189	R	C
A6NKQ9	LB/B	-	H2NZJ7	185	P	S
Q8WUX2	LB/B	-	A0A1A6H6P1	82	R	G
O96017	LP/P	Li-Fraumeni syndrome 2 (LFS2) [MIM:609265]	A0A091UHR9	145	R	W
O96017	LB/B	-	A0A091UHR9	157	I	T
O96017	LP/P	Prostate cancer (PC) [MIM:176807]	A0A091UHR9	180	R	C
O96017	LP/P	Prostate cancer (PC) [MIM:176807]	A0A091UHR9	181	R	C
O96017	LP/P	Prostate cancer (PC) [MIM:176807]	A0A091UHR9	181	R	H
O96017	LP/P	Prostate cancer (PC) [MIM:176807]	A0A091UHR9	239	E	K
O96017	LP/P	Prostate cancer (PC) [MIM:176807]	A0A091UHR9	64	E	K
O96017	LP/P	Prostate cancer (PC) [MIM:176807]	A0A091UHR9	145	R	P
O96017	LP/P	Prostate cancer (PC) [MIM:176807]	A0A091UHR9	167	G	R
O96017	LP/P	Prostate cancer (PC) [MIM:176807]	A0A091UHR9	180	R	H
O96017	LP/P	Prostate cancer (PC) [MIM:176807]	A0A091UHR9	323	T	P
O96017	LP/P	Prostate cancer (PC) [MIM:176807]	A0A091UHR9	476	T	K
O96017	LB/B	-	A0A091UHR9	436	L	M
O96017	LB/B	-	A0A091UHR9	446	N	K
O96017	LB/B	-	A0A091UHR9	447	F	I
O96017	LB/B	-	A0A091UHR9	448	I	S
O96017	LB/B	-	A0A091UHR9	501	E	K
O96017	LB/B	-	A0A091UHR9	512	L	V
O96017	LP/P	Breast cancer (BC) [MIM:114480]	A0A091UHR9	117	R	G
O96017	LB/B	-	A0A091UHR9	137	R	Q
O96017	LB/B	-	A0A091UHR9	428	S	F
O96017	LB/B	-	A0A091UHR9	406	R	H
O96017	LB/B	-	A0A091UHR9	347	D	N
O96017	LB/B	-	A0A091UHR9	500	S	C
O96017	LB/B	-	A0A091UHR9	371	H	Y
O96017	LP/P	Breast cancer (BC) [MIM:114480]	A0A091UHR9	390	Y	C
P24386	LP/P	Choroideremia (CHM) [MIM:303100]	T1J4P5	471	Q	L
P24386	LP/P	Choroideremia (CHM) [MIM:303100]	T1J4P5	507	H	R
P24386	LP/P	Choroideremia (CHM) [MIM:303100]	T1J4P5	550	L	P
Q9H444	LP/P	Cataract 31, multiple types (CTRCT31) [MIM:605387]	A0A146ZQN2	129	D	V
Q9H444	LP/P	Cataract 31, multiple types (CTRCT31) [MIM:605387]	A0A146ZQN2	161	E	K
Q8WUD6	LB/B	-	L5KFJ5	162	F	S
Q6WN34	LB/B	-	G3W438	335	P	L
P02708	LP/P	Myasthenic syndrome, congenital, 1A, slow-channel (CMS1A) [MIM:601462]	G1STJ9	173	G	S
P02708	LP/P	Myasthenic syndrome, congenital, 1A, slow-channel (CMS1A) [MIM:601462]	G1STJ9	176	V	M
P02708	LP/P	Myasthenic syndrome, congenital, 1A, slow-channel (CMS1A) [MIM:601462]	G1STJ9	237	N	K
P02708	LP/P	Myasthenic syndrome, congenital, 1A, slow-channel (CMS1A) [MIM:601462]	G1STJ9	274	T	I
P02708	LP/P	Myasthenic syndrome, congenital, 1A, slow-channel (CMS1A) [MIM:601462]	G1STJ9	289	S	I
P02708	LP/P	Myasthenic syndrome, congenital, 1B, fast-channel (CMS1B) [MIM:608930]	G1STJ9	253	F	V
P02708	LP/P	Myasthenic syndrome, congenital, 1A, slow-channel (CMS1A) [MIM:601462]	G1STJ9	269	V	F
P02708	LP/P	Myasthenic syndrome, congenital, 1B, fast-channel (CMS1B) [MIM:608930]	G1STJ9	276	F	L
P02708	LP/P	Myasthenic syndrome, congenital, 1B, fast-channel (CMS1B) [MIM:608930]	G1STJ9	305	V	I
P02708	LP/P	Myasthenic syndrome, congenital, 1B, fast-channel (CMS1B) [MIM:608930]	G1STJ9	152	V	L
P02708	LB/B	-	G1STJ9	358	D	V
P02708	LP/P	Myasthenic syndrome, congenital, 1A, slow-channel (CMS1A) [MIM:601462]	G1STJ9	438	C	W
P02708	LP/P	Multiple pterygium syndrome, lethal type (LMPS) [MIM:253290]	G1STJ9	229	R	L
Q15822	LB/B	-	G1STJ9	22	T	I
Q15822	LB/B	-	G1STJ9	125	T	A
Q15822	LP/P	Epilepsy, nocturnal frontal lobe, 4 (ENFL4) [MIM:610353]	G1STJ9	279	I	N
P32297	LB/B	-	G1STJ9	37	R	H
Q15825	LB/B	-	G1STJ9	447	N	S
O43529	LB/B	-	W5KCK3	258	D	N
O43529	LB/B	-	W5KCK3	20	V	L
Q9NRB3	LB/B	-	A0A2K5U037	52	P	H
Q9NRB3	LB/B	-	A0A2K5U037	61	T	S
Q9NRB3	LB/B	-	A0A2K5U037	109	R	S
Q9NRB3	LB/B	-	A0A2K5U037	145	A	P
Q9NRB3	LB/B	-	A0A2K5U037	94	P	L
P33076	LB/B	-	F6ZCE4	500	G	A
P33076	LP/P	Bare lymphocyte syndrome 2 (BLS2) [MIM:209920]	F6ZCE4	469	L	P
P33076	LB/B	-	F6ZCE4	658	A	G
P33076	LP/P	Bare lymphocyte syndrome 2 (BLS2) [MIM:209920]	F6ZCE4	962	F	S
P33076	LB/B	-	F6ZCE4	45	L	V
P33076	LB/B	-	F6ZCE4	174	R	G
P33076	LB/B	-	F6ZCE4	900	Q	R
P33076	LB/B	-	F6ZCE4	782	V	A
P33076	LB/B	-	F6ZCE4	781	S	L
P12277	LB/B	-	A0A1V4KAB6	177	K	R
P12277	LB/B	-	A0A1V4KAB6	309	S	L
P12277	LB/B	-	A0A1V4KAB6	360	L	F
Q9Y6N3	LB/B	-	A0A287B4K4	84	Y	T
Q9Y6N3	LB/B	-	A0A287B4K4	104	I	T
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	127	G	V
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	270	L	R
P51795	LP/P	Hypophosphatemic rickets, X-linked recessive (XLRHR) [MIM:300554]	G1N0D7	314	S	L
P51795	LP/P	Low molecular weight proteinuria with hypercalciuria and nephrocalcinosis (LMWPHN) [MIM:308990]	G1N0D7	350	R	P
P51795	LP/P	Nephrolithiasis, X-linked recessive, with renal failure (XRN) [MIM:310468]	G1N0D7	576	G	E
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	582	G	R
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	590	S	P
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	597	E	D
P51795	LB/B	-	G1N0D7	212	M	I
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	249	G	D
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	273	S	L
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	282	G	A
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	289	C	R
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	291	C	R
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	295	L	P
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	330	G	V
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	337	E	A
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	340	S	G
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	340	S	R
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	342	Y	C
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	343	F	L
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	348	L	F
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	410	N	K
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	532	G	D
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	539	L	P
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	583	G	E
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	583	G	R
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	586	R	W
P51795	LP/P	Low molecular weight proteinuria with hypercalciuria and nephrocalcinosis (LMWPHN) [MIM:308990]	G1N0D7	594	I	K
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	615	S	N
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	616	K	E
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	617	W	G
P51795	LP/P	Dent disease 1 (DENT1) [MIM:300009]	G1N0D7	727	T	S
P51798	LP/P	Osteopetrosis, autosomal dominant 2 (OPTA2) [MIM:166600]	A0A2K5PP64	762	R	Q
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	762	R	Q
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	766	L	P
P51798	LP/P	Osteopetrosis, autosomal dominant 2 (OPTA2) [MIM:166600]	A0A2K5PP64	767	R	W
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	767	R	W
P51798	LP/P	Osteopetrosis, autosomal dominant 2 (OPTA2) [MIM:166600]	A0A2K5PP64	215	G	R
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	240	G	R
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	249	P	R
P51798	LP/P	Osteopetrosis, autosomal dominant 2 (OPTA2) [MIM:166600]	A0A2K5PP64	286	R	Q
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	332	M	V
P51798	LB/B	-	A0A2K5PP64	418	V	M
P51798	LP/P	Osteopetrosis, autosomal dominant 2 (OPTA2) [MIM:166600]	A0A2K5PP64	490	L	F
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	526	R	W
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	614	L	P
P51798	LP/P	Osteopetrosis, autosomal dominant 2 (OPTA2) [MIM:166600]	A0A2K5PP64	677	G	V
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	744	S	F
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	767	R	Q
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	261	I	F
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	132	L	P
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	214	N	S
P51798	LP/P	Osteopetrosis, autosomal dominant 2 (OPTA2) [MIM:166600]	A0A2K5PP64	318	F	L
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	403	R	Q
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	521	G	R
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	526	R	Q
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	549	L	P
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	651	L	P
P51798	LP/P	Osteopetrosis, autosomal dominant 2 (OPTA2) [MIM:166600]	A0A2K5PP64	758	F	L
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	762	R	W
P51798	LP/P	Osteopetrosis, autosomal recessive 4 (OPTB4) [MIM:611490]	A0A2K5PP64	767	R	P
P51798	LP/P	Hypopigmentation, organomegaly, and delayed myelination and development (HOD) [MIM:618541]	A0A2K5PP64	715	Y	C
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	169	G	R
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	97	L	P
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	121	G	R
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	128	G	D
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	162	F	C
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	163	G	D
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	165	S	F
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	71	H	D
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	75	L	P
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	79	R	L
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	81	L	F
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	81	L	P
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	81	L	W
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	128	G	A
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	139	A	T
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	146	R	T
Q9Y5I7	LP/P	Hypomagnesemia 3 (HOMG3) [MIM:248250]	W5QGY8	165	S	P
P56856	LB/B	-	S7P7F8	149	M	L
A6NM45	LB/B	-	L5LB21	18	L	F
C9JDP6	LB/B	-	A0A096MRD4	219	H	Y
A5D8T8	LB/B	-	A0A091CXV8	118	V	A
A5D8T8	LB/B	-	A0A091CXV8	151	T	M
A5D8T8	LB/B	-	A0A091CXV8	339	S	R
Q9P126	LB/B	-	A0A2Y9RPE8	20	I	V
Q9P126	LB/B	-	A0A2Y9RPE8	24	S	P
Q9P126	LB/B	-	A0A2Y9RPE8	28	S	F
Q9P126	LB/B	-	A0A2Y9RPE8	64	G	D
Q9UMR7	LB/B	-	A0A1U7UKN5	36	H	L
Q9BXN2	LB/B	-	A0A151MRC5	223	I	S
Q6UXN8	LB/B	-	A0A151MRC5	107	A	G
O14967	LB/B	-	A0A091CSW2	160	A	S
O14967	LB/B	-	A0A091CSW2	290	V	I
O14967	LB/B	-	A0A091CSW2	352	R	W
O15247	LP/P	Intellectual developmental disorder, X-linked, syndromic 32 (MRXS32) [MIM:300886]	A0A2U4BIX6	101	H	Q
O95833	LB/B	-	A0A2U4BIX6	38	P	H
Q9NZA1	LB/B	-	A0A2K6GCU6	257	P	H
Q9NZA1	LB/B	-	A0A2K6GCU6	114	T	A
P49761	LB/B	-	H0W2B7	486	R	C
P49761	LB/B	-	H0W2B7	607	Q	R
P49761	LB/B	-	H0W2B7	628	R	W
Q5K131	LB/B	-	A0A2J8XN89	9	S	F
Q96JQ2	LB/B	-	D4A626	963	P	L
O75503	LP/P	Ceroid lipofuscinosis, neuronal, 5 (CLN5) [MIM:256731]	B2RUP8	230	D	N
O75503	LB/B	-	B2RUP8	319	K	R
O75503	LP/P	Ceroid lipofuscinosis, neuronal, 5 (CLN5) [MIM:256731]	B2RUP8	63	R	H
O75503	LP/P	Ceroid lipofuscinosis, neuronal, 5 (CLN5) [MIM:256731]	B2RUP8	209	Y	D
O75503	LP/P	Ceroid lipofuscinosis, neuronal, 5 (CLN5) [MIM:256731]	B2RUP8	63	R	P
O75503	LB/B	-	B2RUP8	219	E	A
O75503	LP/P	Ceroid lipofuscinosis, neuronal, 5 (CLN5) [MIM:256731]	B2RUP8	330	W	C
O75503	LB/B	-	B2RUP8	26	W	R
O75503	LP/P	Ceroid lipofuscinosis, neuronal, 5 (CLN5) [MIM:256731]	B2RUP8	77	C	Y
O75503	LP/P	Ceroid lipofuscinosis, neuronal, 5 (CLN5) [MIM:256731]	B2RUP8	143	N	S
O75503	LP/P	Ceroid lipofuscinosis, neuronal, 5 (CLN5) [MIM:256731]	B2RUP8	149	L	P
O75503	LP/P	Ceroid lipofuscinosis, neuronal, 5 (CLN5) [MIM:256731]	B2RUP8	156	P	S
O75503	LP/P	Ceroid lipofuscinosis, neuronal, 5 (CLN5) [MIM:256731]	B2RUP8	158	W	R
O75503	LP/P	Ceroid lipofuscinosis, neuronal, 5 (CLN5) [MIM:256731]	B2RUP8	158	W	S
O75503	LB/B	-	B2RUP8	193	N	K
O75503	LP/P	Ceroid lipofuscinosis, neuronal, 5 (CLN5) [MIM:256731]	B2RUP8	325	Y	C
Q16740	LP/P	Perrault syndrome 3 (PRLTS3) [MIM:614129]	A0A2K5DX41	145	T	P
Q16740	LP/P	Perrault syndrome 3 (PRLTS3) [MIM:614129]	A0A2K5DX41	147	C	S
Q16740	LP/P	Perrault syndrome 3 (PRLTS3) [MIM:614129]	A0A2K5DX41	229	Y	D
A2RUU4	LB/B	-	A0A2K5IS47	15	F	S
Q96KA5	LB/B	-	W5M6Y6	537	T	M
Q9NRP2	LB/B	-	A0A226N587	11	T	S
P46091	LB/B	-	M7AH44	307	I	V
Q8IYT2	LB/B	-	F6YZK8	60	L	F
Q8IYT2	LB/B	-	F6YZK8	163	F	Y
Q8IYT2	LB/B	-	F6YZK8	416	N	S
Q8IYT2	LB/B	-	F6YZK8	608	T	K
Q8IYT2	LB/B	-	F6YZK8	753	F	L
Q9NZN8	LB/B	-	L9KZN3	460	A	T
O95628	LB/B	-	A0A2P4TCE9	7	A	G
Q92600	LB/B	-	A0A1V4K677	143	I	T
Q12860	LB/B	-	H3B1F1	798	V	L
Q12860	LB/B	-	H3B1F1	824	E	G
Q02246	LB/B	-	H3B1F1	145	A	T
Q02246	LB/B	-	H3B1F1	657	R	W
Q02246	LB/B	-	H3B1F1	366	P	L
Q02246	LB/B	-	H3B1F1	1024	V	I
Q9P232	LB/B	-	H3B1F1	630	S	N
Q9P232	LB/B	-	H3B1F1	708	N	S
O94779	LB/B	-	H3B1F1	23	S	A
O94779	LB/B	-	H3B1F1	70	L	R
O94779	LB/B	-	H3B1F1	81	N	S
O94779	LB/B	-	H3B1F1	530	I	V
O94779	LB/B	-	H3B1F1	1065	Y	F
O94779	LB/B	-	H3B1F1	1079	S	T
O94779	LB/B	-	H3B1F1	1094	M	V
Q9UQ52	LB/B	-	H3B1F1	440	A	S
Q9UQ52	LB/B	-	H3B1F1	150	F	S
Q9UQ52	LB/B	-	H3B1F1	303	R	Q
Q9UQ52	LB/B	-	H3B1F1	314	F	V
Q9UQ52	LB/B	-	H3B1F1	954	E	V
Q96IL0	LB/B	-	Q32Q90	27	P	A
Q96IL0	LB/B	-	Q32Q90	88	N	S
Q13057	LB/B	-	A0A0L8FKJ1	55	S	Y
Q13057	LP/P	Neurodegeneration with brain iron accumulation 6 (NBIA6) [MIM:615643]	A0A0L8FKJ1	499	R	C
O43405	LP/P	Deafness, autosomal dominant, 9 (DFNA9) [MIM:601369]	S7NK92	51	P	S
O43405	LP/P	Deafness, autosomal dominant, 9 (DFNA9) [MIM:601369]	S7NK92	66	V	G
O43405	LP/P	Deafness, autosomal dominant, 9 (DFNA9) [MIM:601369]	S7NK92	88	G	E
O43405	LP/P	Deafness, autosomal dominant, 9 (DFNA9) [MIM:601369]	S7NK92	109	I	N
O43405	LP/P	Deafness, autosomal dominant, 9 (DFNA9) [MIM:601369]	S7NK92	117	W	R
O43405	LB/B	-	S7NK92	352	T	S
O43405	LB/B	-	S7NK92	532	P	S
O43405	LP/P	Deafness, autosomal dominant, 9 (DFNA9) [MIM:601369]	S7NK92	119	A	T
O43405	LB/B	-	S7NK92	135	G	R
O43405	LB/B	-	S7NK92	281	D	N
O43405	LB/B	-	S7NK92	402	I	V
O43405	LB/B	-	S7NK92	518	E	G
O43405	LP/P	Deafness, autosomal dominant, 9 (DFNA9) [MIM:601369]	S7NK92	162	C	Y
O43405	LP/P	Deafness, autosomal dominant, 9 (DFNA9) [MIM:601369]	S7NK92	87	G	V
O43405	LP/P	Deafness, autosomal dominant, 9 (DFNA9) [MIM:601369]	S7NK92	87	G	W
O43405	LP/P	Deafness, autosomal dominant, 9 (DFNA9) [MIM:601369]	S7NK92	109	I	T
O43405	LP/P	Deafness, autosomal dominant, 9 (DFNA9) [MIM:601369]	S7NK92	512	M	T
O43405	LP/P	Deafness, autosomal dominant, 9 (DFNA9) [MIM:601369]	S7NK92	527	F	C
O43405	LP/P	Deafness, autosomal dominant, 9 (DFNA9) [MIM:601369]	S7NK92	542	C	Y
O43405	LP/P	Deafness, autosomal dominant, 9 (DFNA9) [MIM:601369]	S7NK92	38	G	D
Q9UP83	LB/B	-	W5UCK5	330	F	L
Q9UP83	LB/B	-	W5UCK5	558	S	P
Q9UP83	LB/B	-	W5UCK5	365	I	V
Q9UP83	LB/B	-	W5UCK5	452	H	R
Q9P218	LB/B	-	A0A2Y9G3Q7	134	P	L
Q9BXS0	LP/P	Fibrosis of extraocular muscles, congenital, 5 (CFEOM5) [MIM:616219]	A0A1W5AH66	382	G	R
A6NMZ7	LB/B	-	W5M0P9	345	E	K
A6NMZ7	LB/B	-	W5M0P9	370	A	T
A6NMZ7	LB/B	-	W5M0P9	461	E	A
A6NMZ7	LB/B	-	W5M0P9	1739	R	Q
A6NMZ7	LB/B	-	W5M0P9	1799	H	R
A6NMZ7	LB/B	-	W5M0P9	556	P	S
Q02388	LB/B	-	H0ZBM9	595	P	L
Q02388	LB/B	-	H0ZBM9	1277	P	L
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	1557	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	1782	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	1982	G	W
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2003	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2008	R	G
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2025	G	A
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2034	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, with subcorneal cleavage (EBDSC) [MIM:131750]	H0ZBM9	2034	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2040	G	S
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2043	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2049	G	E
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2055	G	E
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2063	R	W
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2073	G	D
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2076	G	D
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2079	G	E
Q02388	LP/P	Epidermolysis bullosa pruriginosa (EBP) [MIM:604129]	H0ZBM9	2242	G	R
Q02388	LB/B	-	H0ZBM9	2351	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2569	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2575	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, pretibial type (PR-DEB) [MIM:131850]	H0ZBM9	2623	G	C
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2653	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2671	G	V
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2674	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2749	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2798	M	K
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	1347	G	R
Q02388	LP/P	Transient bullous dermolysis of the newborn (TBDN) [MIM:131705]	H0ZBM9	1519	G	D
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	1522	G	E
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	1604	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	1652	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	1703	G	E
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	1772	R	W
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	1776	G	R
Q02388	LP/P	Epidermolysis bullosa pruriginosa (EBP) [MIM:604129]	H0ZBM9	1791	G	E
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	1812	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2006	G	A
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2006	G	D
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2008	R	C
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2009	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2015	G	E
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2028	G	A
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2028	G	R
Q02388	LP/P	Epidermolysis bullosa pruriginosa (EBP) [MIM:604129]	H0ZBM9	2028	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2031	G	S
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2034	G	W
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2037	G	E
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2040	G	D
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2040	G	V
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2043	G	W
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2046	G	V
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2064	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2079	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2132	G	D
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2192	G	S
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2207	G	R
Q02388	LP/P	Transient bullous dermolysis of the newborn (TBDN) [MIM:131705]	H0ZBM9	2251	G	E
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2263	G	V
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2287	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2316	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2366	G	S
Q02388	LP/P	Epidermolysis bullosa pruriginosa (EBP) [MIM:604129]	H0ZBM9	2369	G	S
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2674	G	D
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2713	G	D
Q02388	LP/P	Epidermolysis bullosa pruriginosa (EBP) [MIM:604129]	H0ZBM9	2713	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2740	G	A
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2775	G	S
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2791	R	W
Q02388	LP/P	Nail disorder, non-syndromic congenital, 8 (NDNC8) [MIM:607523]	H0ZBM9	1595	G	R
Q02388	LP/P	Nail disorder, non-syndromic congenital, 8 (NDNC8) [MIM:607523]	H0ZBM9	1815	G	R
Q02388	LB/B	-	H0ZBM9	2429	P	L
Q02388	LB/B	-	H0ZBM9	1120	R	K
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	1845	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	1981	K	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2069	R	C
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal dominant (DDEB) [MIM:131750]	H0ZBM9	2070	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2221	G	A
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2296	G	E
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2557	G	R
Q02388	LP/P	Epidermolysis bullosa dystrophica, autosomal recessive (RDEB) [MIM:226600]	H0ZBM9	2622	R	W
Q5KU26	LB/B	-	L9KM01	91	K	E
Q5KU26	LB/B	-	L9KM01	487	I	V
Q5KU26	LB/B	-	L9KM01	522	S	P
Q5KU26	LB/B	-	L9KM01	606	G	S
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	290	D	N
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	299	G	R
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	328	C	R
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	342	D	Y
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	349	D	V
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	361	D	V
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	361	D	Y
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	371	C	S
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	387	C	G
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	408	D	Y
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	440	G	E
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	440	G	R
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	453	N	S
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	468	C	Y
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	472	D	Y
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	473	D	G
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	482	D	G
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	518	D	N
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	523	N	K
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	585	T	M
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	585	T	R
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	585	T	R
P49747	LB/B	-	A0A060WS70	50	E	D
P49747	LB/B	-	A0A060WS70	51	L	W
P49747	LB/B	-	A0A060WS70	109	A	G
P49747	LB/B	-	A0A060WS70	224	R	G
P49747	LB/B	-	A0A060WS70	285	R	P
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	348	C	R
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	719	G	D
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	276	P	R
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	420	D	A
P49747	LB/B	-	A0A060WS70	381	R	C
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	167	G	E
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	234	P	S
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	290	D	G
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	298	S	L
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	311	A	D
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	317	D	G
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	326	D	G
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	326	D	Y
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	348	C	F
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	371	C	Y
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	374	D	N
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	376	D	N
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	378	D	V
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	385	D	N
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	385	D	Y
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	387	C	R
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	397	D	H
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	404	G	R
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	410	C	Y
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	415	N	K
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	427	G	E
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	446	D	N
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	448	C	S
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	473	D	H
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	475	D	N
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	501	G	D
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	507	D	G
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	511	D	G
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	515	D	G
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	529	T	I
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	718	R	P
P49747	LP/P	Carpal tunnel syndrome 2 (CTS2) [MIM:619161]	A0A060WS70	718	R	W
P49747	LP/P	Multiple epiphyseal dysplasia 1 (EDM1) [MIM:132400]	A0A060WS70	718	R	W
P49747	LP/P	Pseudoachondroplasia (PSACH) [MIM:177170]	A0A060WS70	719	G	S
P49747	LB/B	-	A0A060WS70	756	Q	R
P49747	LP/P	Carpal tunnel syndrome 2 (CTS2) [MIM:619161]	A0A060WS70	66	V	E
P20674	LP/P	Mitochondrial complex IV deficiency, nuclear type 20 (MC4DN20) [MIM:619064]	A0A2I2Y3T0	107	R	C
Q9H799	LB/B	-	H3AN04	1437	I	T
Q9H799	LB/B	-	H3AN04	2033	F	C
Q9H799	LB/B	-	H3AN04	2143	I	V
Q9H799	LB/B	-	H3AN04	2592	P	L
Q9H799	LB/B	-	H3AN04	3062	G	R
Q9H799	LP/P	Joubert syndrome 17 (JBTS17) [MIM:614615]	H3AN04	1336	R	W
Q9H799	LB/B	-	H3AN04	1794	P	L
Q9H799	LB/B	-	H3AN04	2033	F	S
Q9H799	LP/P	Orofaciodigital syndrome 6 (OFD6) [MIM:277170]	H3AN04	2837	V	L
Q9H799	LP/P	Orofaciodigital syndrome 6 (OFD6) [MIM:277170]	H3AN04	1127	S	L
Q9H799	LP/P	Orofaciodigital syndrome 6 (OFD6) [MIM:277170]	H3AN04	1184	R	C
Q9H799	LP/P	Orofaciodigital syndrome 6 (OFD6) [MIM:277170]	H3AN04	1193	R	C
Q9H799	LP/P	Orofaciodigital syndrome 6 (OFD6) [MIM:277170]	H3AN04	1287	D	H
Q9H799	LB/B	-	H3AN04	322	W	G
Q9H799	LB/B	-	H3AN04	875	S	F
Q9H799	LB/B	-	H3AN04	1196	L	R
Q9H799	LP/P	Orofaciodigital syndrome 6 (OFD6) [MIM:277170]	H3AN04	1345	Q	R
Q9H799	LB/B	-	H3AN04	1772	S	G
Q9H799	LB/B	-	H3AN04	2750	P	S
P14384	LB/B	-	F7G5V6	24	R	H
P14384	LB/B	-	F7G5V6	133	V	I
P36551	LP/P	Hereditary coproporphyria (HCP) [MIM:121300]	F6QTP1	189	G	S
P36551	LP/P	Hereditary coproporphyria (HCP) [MIM:121300]	F6QTP1	197	G	W
P36551	LP/P	Hereditary coproporphyria (HCP) [MIM:121300]	F6QTP1	201	E	K
P36551	LP/P	Hereditary coproporphyria (HCP) [MIM:121300]	F6QTP1	249	P	S
P36551	LB/B	-	F6QTP1	272	N	H
P36551	LP/P	Hereditary coproporphyria (HCP) [MIM:121300]	F6QTP1	280	G	R
P36551	LB/B	-	F6QTP1	294	V	I
P36551	LP/P	Hereditary coproporphyria (HCP) [MIM:121300]	F6QTP1	295	H	D
P36551	LP/P	Hereditary coproporphyria (HCP) [MIM:121300]	F6QTP1	331	R	W
P36551	LP/P	Harderoporphyria (HARPO) [MIM:618892]	F6QTP1	404	K	E
P36551	LP/P	Hereditary coproporphyria (HCP) [MIM:121300]	F6QTP1	427	W	R
P36551	LP/P	Hereditary coproporphyria (HCP) [MIM:121300]	F6QTP1	208	S	F
P36551	LP/P	Hereditary coproporphyria (HCP) [MIM:121300]	F6QTP1	328	R	C
P36551	LP/P	Hereditary coproporphyria (HCP) [MIM:121300]	F6QTP1	447	R	C
P36551	LP/P	Hereditary coproporphyria (HCP) [MIM:121300]	F6QTP1	135	V	A
P36551	LP/P	Hereditary coproporphyria (HCP) [MIM:121300]	F6QTP1	214	L	R
P36551	LP/P	Hereditary coproporphyria (HCP) [MIM:121300]	F6QTP1	249	P	R
P36551	LB/B	-	F6QTP1	352	R	C
P36551	LP/P	Hereditary coproporphyria (HCP) [MIM:121300]	F6QTP1	279	G	R
P36551	LP/P	Harderoporphyria (HARPO) [MIM:618892]	F6QTP1	327	H	R
Q6NV74	LB/B	-	L8IQM0	315	S	C
Q8IUR6	LB/B	-	L5L2Z2	483	T	A
Q9P021	LP/P	Short stature with microcephaly and distinctive facies (SSMCF) [MIM:615789]	A0A146MK50	3	C	Y
Q9UKG9	LB/B	-	A0A1S3AAM5	94	R	H
Q9UKG9	LB/B	-	A0A1S3AAM5	474	V	L
O95727	LB/B	-	H2NFM6	321	K	R
O95727	LB/B	-	H2NFM6	368	A	G
O95727	LB/B	-	H2NFM6	16	E	A
O95727	LB/B	-	H2NFM6	78	A	D
O95727	LB/B	-	H2NFM6	173	D	G
P53674	LP/P	-	Q8QFU4	129	S	R
P53674	LP/P	Cataract 17, multiple types (CTRCT17) [MIM:611544]	Q8QFU4	96	V	F
P26998	LB/B	-	A0A1V4JRS7	105	R	Q
P26998	LB/B	-	A0A1V4JRS7	113	H	D
P26998	LB/B	-	A0A1V4JRS7	159	V	I
P26998	LP/P	Cataract 22, multiple types (CTRCT22) [MIM:609741]	A0A1V4JRS7	165	G	R
P26998	LP/P	Cataract 22, multiple types (CTRCT22) [MIM:609741]	A0A1V4JRS7	194	V	E
Q08257	LB/B	-	S7PS02	66	P	S
Q08257	LB/B	-	S7PS02	176	I	V
Q08257	LB/B	-	S7PS02	183	E	K
Q6PB30	LB/B	-	A0A2I2ZBK8	28	Y	F
Q6PB30	LB/B	-	A0A2I2ZBK8	62	R	K
P09603	LB/B	-	G1U8S7	408	L	P
P09603	LB/B	-	G1U8S7	496	S	F
P09603	LB/B	-	G1U8S7	531	A	V
P09603	LB/B	-	G1U8S7	438	G	R
P09603	LB/B	-	G1U8S7	341	S	N
P09603	LB/B	-	G1U8S7	489	F	S
P04141	LB/B	-	E1AK51	117	I	T
P04141	LB/B	-	E1AK51	115	T	I
P07498	LB/B	-	A0A2Y9FZ92	75	Y	C
P07498	LB/B	-	A0A2Y9FZ92	110	R	L
P07498	LB/B	-	A0A2Y9FZ92	145	A	T
P68400	LP/P	Okur-Chung neurodevelopmental syndrome (OCNDS) [MIM:617062]	S7N7R0	47	R	Q
P68400	LP/P	Okur-Chung neurodevelopmental syndrome (OCNDS) [MIM:617062]	S7N7R0	50	Y	S
P68400	LP/P	Okur-Chung neurodevelopmental syndrome (OCNDS) [MIM:617062]	S7N7R0	175	D	G
P68400	LP/P	Okur-Chung neurodevelopmental syndrome (OCNDS) [MIM:617062]	S7N7R0	198	K	R
P67870	LP/P	Poirier-Bienvenu neurodevelopmental syndrome (POBINDS) [MIM:618732]	A0A2U9CXG1	111	R	P
P67870	LP/P	Poirier-Bienvenu neurodevelopmental syndrome (POBINDS) [MIM:618732]	A0A2U9CXG1	137	C	F
P67870	LP/P	Poirier-Bienvenu neurodevelopmental syndrome (POBINDS) [MIM:618732]	A0A2U9CXG1	137	C	G
P67870	LP/P	Poirier-Bienvenu neurodevelopmental syndrome (POBINDS) [MIM:618732]	A0A2U9CXG1	187	L	R
P50461	LP/P	Cardiomyopathy, familial hypertrophic 12 (CMH12) [MIM:612124]	A0A2P4SVZ6	44	L	P
P50461	LP/P	Cardiomyopathy, familial hypertrophic 12 (CMH12) [MIM:612124]	A0A2P4SVZ6	58	C	G
P01037	LB/B	-	A0A1U7Q8B2	4	Y	H
P01037	LB/B	-	A0A1U7Q8B2	31	P	L
P01037	LB/B	-	A0A1U7Q8B2	129	N	D
P01037	LB/B	-	A0A1U7Q8B2	131	R	M
P01037	LB/B	-	A0A1U7Q8B2	135	K	N
P01034	LP/P	Amyloidosis 6 (AMYL6) [MIM:105150]	A0A1U7Q8B2	94	L	Q
P01034	LP/P	Macular degeneration, age-related, 11 (ARMD11) [MIM:611953]	A0A1U7Q8B2	25	A	T
P01036	LB/B	-	A0A1U7Q8B2	36	D	N
P28325	LB/B	-	A0A1U7Q8B2	46	C	R
O60676	LB/B	-	A0A1S3G148	142	A	P
O60676	LB/B	-	A0A1S3G148	52	A	V
Q9UBT7	LB/B	-	A0A1B0CRM1	91	N	T
Q9UBT7	LB/B	-	A0A1B0CRM1	203	E	K
Q9UBT7	LB/B	-	A0A1B0CRM1	527	E	Q
Q9UBT7	LB/B	-	A0A1B0CRM1	593	I	N
Q9UBT7	LB/B	-	A0A1B0CRM1	716	M	R
Q9UBT7	LB/B	-	A0A1B0CRM1	424	T	S
Q9UBT7	LB/B	-	A0A1B0CRM1	555	D	E
P35222	LP/P	Pilomatrixoma (PTR) [MIM:132600]	A0A0P6B6Y1	32	D	G
P35222	LP/P	Pilomatrixoma (PTR) [MIM:132600]	A0A0P6B6Y1	32	D	Y
P35222	LP/P	Medulloblastoma (MDB) [MIM:155255]	A0A0P6B6Y1	33	S	F
P35222	LP/P	Pilomatrixoma (PTR) [MIM:132600]	A0A0P6B6Y1	33	S	F
P35222	LP/P	Colorectal cancer (CRC) [MIM:114500]	A0A0P6B6Y1	33	S	Y
P35222	LP/P	Pilomatrixoma (PTR) [MIM:132600]	A0A0P6B6Y1	33	S	Y
P35222	LP/P	Pilomatrixoma (PTR) [MIM:132600]	A0A0P6B6Y1	34	G	E
P35222	LB/B	-	A0A0P6B6Y1	34	G	V
P35222	LP/P	Medulloblastoma (MDB) [MIM:155255]	A0A0P6B6Y1	37	S	A
P35222	LP/P	Ovarian cancer (OC) [MIM:167000]	A0A0P6B6Y1	37	S	C
P35222	LP/P	Pilomatrixoma (PTR) [MIM:132600]	A0A0P6B6Y1	37	S	C
P35222	LP/P	Pilomatrixoma (PTR) [MIM:132600]	A0A0P6B6Y1	37	S	F
P35222	LP/P	Ovarian cancer (OC) [MIM:167000]	A0A0P6B6Y1	41	T	I
P35222	LP/P	Pilomatrixoma (PTR) [MIM:132600]	A0A0P6B6Y1	41	T	I
P35222	LB/B	-	A0A0P6B6Y1	688	M	V
P35222	LP/P	Neurodevelopmental disorder with spastic diplegia and visual defects (NEDSDV) [MIM:615075]	A0A0P6B6Y1	388	L	P
O60494	LB/B	-	H2MZ70	124	F	I
O60494	LB/B	-	H2MZ70	253	F	S
O60494	LB/B	-	H2MZ70	389	P	T
O60494	LB/B	-	H2MZ70	1032	Y	H
O60494	LP/P	Imerslund-Grasbeck syndrome 1 (IGS1) [MIM:261100]	H2MZ70	1297	P	L
O60494	LB/B	-	H2MZ70	1545	N	Y
O60494	LB/B	-	H2MZ70	1559	P	S
O60494	LB/B	-	H2MZ70	1769	V	I
O60494	LB/B	-	H2MZ70	2153	L	F
O60494	LB/B	-	H2MZ70	2162	C	Y
O60494	LB/B	-	H2MZ70	2575	P	R
O60494	LB/B	-	H2MZ70	2691	G	R
O60494	LB/B	-	H2MZ70	2717	S	W
O60494	LB/B	-	H2MZ70	2879	L	I
O60494	LB/B	-	H2MZ70	2984	I	V
O60494	LB/B	-	H2MZ70	3002	E	G
O60494	LB/B	-	H2MZ70	3422	T	I
O60494	LB/B	-	H2MZ70	3552	N	K
O60494	LB/B	-	H2MZ70	66	G	R
O60494	LB/B	-	H2MZ70	504	I	M
O60494	LB/B	-	H2MZ70	730	H	Y
O60494	LB/B	-	H2MZ70	969	L	V
O60494	LB/B	-	H2MZ70	1775	R	W
O60494	LB/B	-	H2MZ70	1840	G	S
O60494	LB/B	-	H2MZ70	1935	S	G
O60494	LB/B	-	H2MZ70	1971	P	T
O60494	LB/B	-	H2MZ70	2263	F	C
O60494	LB/B	-	H2MZ70	2444	R	Q
O60494	LB/B	-	H2MZ70	2968	E	Q
O60494	LB/B	-	H2MZ70	3432	T	S
O60494	LB/B	-	H2MZ70	335	A	T
O60494	LP/P	Imerslund-Grasbeck syndrome 1 (IGS1) [MIM:261100]	H2MZ70	337	P	L
O60494	LB/B	-	H2MZ70	1690	A	V
O60494	LB/B	-	H2MZ70	2157	N	D
Q86UP6	LB/B	-	A0A1U7QCL9	156	G	S
Q9H2A7	LB/B	-	L9KLM4	123	I	T
Q9H2A7	LB/B	-	L9KLM4	181	A	V
Q8TB03	LB/B	-	A0A2R9CMB2	176	T	A
Q96LI9	LB/B	-	F6UIL6	24	R	C
Q96LI9	LB/B	-	F6UIL6	187	R	H
P49447	LP/P	Orthostatic hypotension 2 (ORTHYP2) [MIM:618182]	A0A2K5NUH1	88	G	R
Q6BCY4	LB/B	-	A0A210PLK3	15	E	A
Q6BCY4	LB/B	-	A0A210PLK3	209	N	D
Q53TN4	LB/B	-	A0A0Q3THJ4	156	M	T
Q53TN4	LB/B	-	A0A0Q3THJ4	226	R	H
Q53TN4	LB/B	-	A0A0Q3THJ4	266	S	N
Q96F07	LB/B	-	F6VDV5	320	K	E
Q96F07	LP/P	Developmental and epileptic encephalopathy 65 (DEE65) [MIM:618008]	F6VDV5	87	R	C
Q96F07	LP/P	Developmental and epileptic encephalopathy 65 (DEE65) [MIM:618008]	F6VDV5	87	R	L
Q96F07	LP/P	Developmental and epileptic encephalopathy 65 (DEE65) [MIM:618008]	F6VDV5	87	R	P
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	42	P	S
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	133	N	H
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	318	T	M
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	319	T	M
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	374	R	Q
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	448	R	H
P15538	LB/B	-	A0A1U7UPA9	494	F	C
P15538	LB/B	-	A0A1U7UPA9	10	C	Y
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	43	R	Q
P15538	LB/B	-	A0A1U7UPA9	160	M	I
P15538	LB/B	-	A0A1U7UPA9	293	L	V
P15538	LB/B	-	A0A1U7UPA9	348	A	T
P15538	LB/B	-	A0A1U7UPA9	386	A	V
P15538	LB/B	-	A0A1U7UPA9	63	D	H
P15538	LB/B	-	A0A1U7UPA9	173	K	R
P15538	LB/B	-	A0A1U7UPA9	257	F	L
P15538	LB/B	-	A0A1U7UPA9	281	S	N
P15538	LB/B	-	A0A1U7UPA9	439	Y	H
P15538	LB/B	-	A0A1U7UPA9	248	T	I
P15538	LB/B	-	A0A1U7UPA9	404	R	H
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	379	G	V
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	454	R	C
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	94	P	L
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	318	T	R
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	42	P	L
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	79	F	I
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	83	L	S
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	88	M	I
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	116	W	C
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	116	W	G
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	125	H	R
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	129	V	M
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	135	P	S
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	139	F	L
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	143	R	W
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	150	S	L
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	158	L	P
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	159	P	L
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	165	A	D
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	196	T	A
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	267	G	D
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	299	L	P
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	306	A	V
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	310	E	K
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	314	G	R
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	318	T	P
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	321	F	V
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	331	A	V
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	332	R	Q
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	341	R	S
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	366	R	C
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	368	A	D
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	371	E	G
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	384	R	G
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	384	R	Q
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	401	T	A
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	427	R	H
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	441	V	G
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	444	G	D
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	448	R	C
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	453	R	Q
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	489	L	S
P15538	LP/P	Adrenal hyperplasia 4 (AH4) [MIM:202010]	A0A1U7UPA9	332	R	G
P19099	LB/B	-	A0A1U7UPA9	173	K	R
P19099	LP/P	Corticosterone methyloxidase 2 deficiency (CMO-2 deficiency) [MIM:610600]	A0A1U7UPA9	181	R	W
P19099	LP/P	Corticosterone methyloxidase 2 deficiency (CMO-2 deficiency) [MIM:610600]	A0A1U7UPA9	198	E	D
P19099	LP/P	Corticosterone methyloxidase 2 deficiency (CMO-2 deficiency) [MIM:610600]	A0A1U7UPA9	386	V	A
P19099	LB/B	-	A0A1U7UPA9	29	A	T
P19099	LB/B	-	A0A1U7UPA9	30	R	Q
P19099	LB/B	-	A0A1U7UPA9	248	I	T
P19099	LB/B	-	A0A1U7UPA9	281	N	S
P19099	LB/B	-	A0A1U7UPA9	339	I	T
P19099	LB/B	-	A0A1U7UPA9	435	G	S
P19099	LB/B	-	A0A1U7UPA9	222	N	T
P19099	LB/B	-	A0A1U7UPA9	383	E	V
P19099	LB/B	-	A0A1U7UPA9	403	V	E
P19099	LB/B	-	A0A1U7UPA9	487	F	V
P19099	LP/P	Corticosterone methyloxidase 2 deficiency (CMO-2 deficiency) [MIM:610600]	A0A1U7UPA9	185	T	I
P19099	LP/P	Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency) [MIM:203400]	A0A1U7UPA9	461	L	P
P19099	LP/P	Corticosterone methyloxidase 2 deficiency (CMO-2 deficiency) [MIM:610600]	A0A1U7UPA9	498	T	A
Q96SQ9	LB/B	-	I3NBB7	466	P	L
Q9H1C7	LB/B	-	A0A1L8GXA9	90	C	S
Q8N465	LB/B	-	A0A059LQE3	15	R	G
Q8N465	LB/B	-	A0A059LQE3	338	V	I
Q8N465	LB/B	-	A0A059LQE3	361	A	V
Q9Y4D2	LB/B	-	A0A2R8Q7R8	889	P	L
Q9Y4D2	LB/B	-	A0A2R8Q7R8	735	G	V
Q9Y4D2	LB/B	-	A0A2R8Q7R8	945	D	E
P59103	LB/B	-	A2T115	30	R	K
P59103	LB/B	-	A2T115	62	K	E
P51398	LB/B	-	A0A218UNR7	240	V	F
Q8N136	LB/B	-	A0A2K6UV01	27	T	I
Q8N136	LB/B	-	A0A2K6UV01	121	T	S
Q8N136	LB/B	-	A0A2K6UV01	259	G	S
Q8N136	LB/B	-	A0A2K6UV01	317	L	F
Q9UK59	LP/P	Encephalitis, acute, infection (viral)-induced, 11 (IIAE11) [MIM:619441]	A0A2K6FA08	13	L	G
Q9UK59	LP/P	Encephalitis, acute, infection (viral)-induced, 11 (IIAE11) [MIM:619441]	A0A2K6FA08	17	Y	H
Q9UK59	LP/P	Encephalitis, acute, infection (viral)-induced, 11 (IIAE11) [MIM:619441]	A0A2K6FA08	120	I	T
Q9NXF7	LB/B	-	A0A2K5R0B6	45	N	S
Q9NXF7	LB/B	-	A0A2K5R0B6	129	T	I
Q8WV16	LB/B	-	G1NGQ2	22	W	C
Q8WV16	LB/B	-	G1NGQ2	193	K	T
Q8WV16	LB/B	-	G1NGQ2	266	N	S
Q8WV16	LB/B	-	G1NGQ2	334	L	F
Q8WV16	LB/B	-	G1NGQ2	345	S	C
Q8WV16	LB/B	-	G1NGQ2	439	R	I
Q8IU60	LB/B	-	F6Z9X4	16	L	F
Q9H295	LB/B	-	G1LGF3	349	D	G
P40126	LP/P	Albinism, oculocutaneous, 8 (OCA8) [MIM:619165]	W0C8I7	40	C	S
P40126	LP/P	Albinism, oculocutaneous, 8 (OCA8) [MIM:619165]	W0C8I7	61	C	W
P20711	LB/B	-	Q7SZR0	17	M	V
P20711	LB/B	-	Q7SZR0	210	P	L
P20711	LB/B	-	Q7SZR0	217	M	V
P20711	LB/B	-	Q7SZR0	61	E	D
P20711	LB/B	-	Q7SZR0	239	M	I
P20711	LB/B	-	Q7SZR0	239	M	L
P20711	LB/B	-	Q7SZR0	462	R	Q
P20711	LP/P	Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643]	Q7SZR0	102	G	S
P20711	LP/P	Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643]	Q7SZR0	47	P	H
P20711	LP/P	Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643]	Q7SZR0	91	A	V
P20711	LP/P	Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643]	Q7SZR0	147	S	R
P20711	LP/P	Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643]	Q7SZR0	250	S	F
P20711	LP/P	Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643]	Q7SZR0	275	A	T
P20711	LP/P	Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643]	Q7SZR0	309	F	L
P20711	LP/P	Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643]	Q7SZR0	347	R	Q
P20711	LP/P	Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643]	Q7SZR0	408	L	I
O94850	LB/B	-	A0A1S3FC68	661	E	G
Q96FC9	LB/B	-	A0A1X0RT49	39	I	S
Q96FC9	LB/B	-	A0A1X0RT49	567	Q	E
Q96FC9	LB/B	-	A0A1X0RT49	575	T	M
Q96FC9	LB/B	-	A0A1X0RT49	856	R	H
Q96FC9	LB/B	-	A0A1X0RT49	864	C	R
Q96FC9	LB/B	-	A0A1X0RT49	951	C	R
Q96FC9	LB/B	-	A0A1X0RT49	966	W	C
Q96FC9	LP/P	Warsaw breakage syndrome (WBRS) [MIM:613398]	A0A1X0RT49	263	R	Q
P17844	LB/B	-	A0A0F8BJR1	480	S	A
Q16698	LB/B	-	M7CC34	333	K	N
Q9H4E7	LB/B	-	A0A2K6E656	287	N	T
Q9H4E7	LB/B	-	A0A2K6E656	578	R	H
Q9H4E7	LP/P	Immunodeficiency 87 and autoimmunity (IMD87) [MIM:619573]	A0A2K6E656	210	Y	D
Q9H4E7	LP/P	Immunodeficiency 87 and autoimmunity (IMD87) [MIM:619573]	A0A2K6E656	331	E	K
Q9H1M4	LB/B	-	A0A0D9RKD2	31	G	R
Q9H1M4	LB/B	-	A0A0D9RKD2	71	R	S
O75140	LB/B	-	A0A023F2J6	491	S	T
O75140	LB/B	-	A0A023F2J6	641	A	V
O75140	LB/B	-	A0A023F2J6	712	S	F
O75140	LP/P	Epilepsy, familial focal, with variable foci 1 (FFEVF1) [MIM:604364]	A0A023F2J6	452	A	V
O75140	LP/P	Epilepsy, familial focal, with variable foci 1 (FFEVF1) [MIM:604364]	A0A023F2J6	485	R	Q
O75140	LP/P	Epilepsy, familial focal, with variable foci 1 (FFEVF1) [MIM:604364]	A0A023F2J6	1073	S	R
O75140	LP/P	Epilepsy, familial focal, with variable foci 1 (FFEVF1) [MIM:604364]	A0A023F2J6	90	V	I
O75140	LP/P	Epilepsy, familial focal, with variable foci 1 (FFEVF1) [MIM:604364]	A0A023F2J6	272	V	L
O75140	LP/P	Epilepsy, familial focal, with variable foci 1 (FFEVF1) [MIM:604364]	A0A023F2J6	864	T	M
O75140	LP/P	Epilepsy, familial focal, with variable foci 1 (FFEVF1) [MIM:604364]	A0A023F2J6	1162	S	G
Q14129	LB/B	-	A0A096MWW0	117	A	V
Q9BY27	LB/B	-	A0A096MWW0	115	V	L
Q9BY27	LB/B	-	A0A096MWW0	195	N	K
P23743	LB/B	-	A0A0A0B1Q0	538	H	Y
Q9Y6T7	LB/B	-	A0A0A0B1Q0	789	G	S
P49619	LB/B	-	A0A0A0B1Q0	142	T	S
P49619	LB/B	-	A0A0A0B1Q0	370	R	W
P49619	LB/B	-	A0A0A0B1Q0	316	R	K
Q7Z3D6	LB/B	-	K7GB88	10	R	C
Q7Z3D6	LB/B	-	K7GB88	502	D	N
Q7Z3D6	LB/B	-	K7GB88	237	S	N
Q7Z3D6	LB/B	-	K7GB88	372	A	T
Q7Z3D6	LB/B	-	K7GB88	507	D	N
Q7Z3D6	LB/B	-	K7GB88	583	G	D
P49366	LB/B	-	A0A1Y2FUP0	174	E	D
P49366	LP/P	Neurodevelopmental disorder with seizures and speech and walking impairment (NEDSSWI) [MIM:618480]	A0A1Y2FUP0	173	N	S
Q6UX07	LB/B	-	G5BVJ0	191	R	Q
Q6UX07	LB/B	-	G5BVJ0	336	L	Q
Q92620	LB/B	-	A0A158QA35	1217	T	A
Q92620	LP/P	Retinitis pigmentosa 84 (RP84) [MIM:618220]	A0A158QA35	324	R	Q
Q08211	LB/B	-	K1QA98	894	I	V
Q9UPY3	LP/P	Pleuropulmonary blastoma (PPB) [MIM:601200]	A0A1S3JIA9	1583	L	R
Q9UPY3	LP/P	Goiter multinodular 1, with or without Sertoli-Leydig cell tumors (MNG1) [MIM:138800]	A0A1S3JIA9	839	S	F
Q9UPY3	LP/P	Global developmental delay, lung cysts, overgrowth, and Wilms tumor (GLOW) [MIM:618272]	A0A1S3JIA9	1709	D	Y
Q9UPY3	LP/P	Global developmental delay, lung cysts, overgrowth, and Wilms tumor (GLOW) [MIM:618272]	A0A1S3JIA9	1713	D	V
P49895	LP/P	Thyroid hormone metabolism, abnormal, 2 (THMA2) [MIM:619855]	D3YX15	94	N	K
P49895	LP/P	Thyroid hormone metabolism, abnormal, 2 (THMA2) [MIM:619855]	D3YX15	201	M	I
Q9NRI5	LB/B	-	H0VN96	264	R	Q
Q9NRI5	LB/B	-	H0VN96	704	S	C
Q9NRI5	LB/B	-	H0VN96	607	L	F
Q9NRI5	LB/B	-	H0VN96	5	G	V
Q9NRI5	LB/B	-	H0VN96	330	L	F
Q9NRI5	LB/B	-	H0VN96	116	A	V
Q9NRI5	LB/B	-	H0VN96	328	T	N
Q9NRI5	LB/B	-	H0VN96	531	G	R
Q15398	LB/B	-	B4DMI9	69	G	E
Q15398	LB/B	-	B4DMI9	324	Q	H
Q15398	LB/B	-	B4DMI9	469	T	I
Q15398	LB/B	-	B4DMI9	753	E	Q
Q6UY11	LB/B	-	F1RRJ7	301	G	R
Q9NR61	LP/P	Adams-Oliver syndrome 6 (AOS6) [MIM:616589]	W5LCV6	121	A	P
Q9NR61	LP/P	Adams-Oliver syndrome 6 (AOS6) [MIM:616589]	W5LCV6	186	R	C
Q9NR61	LP/P	Adams-Oliver syndrome 6 (AOS6) [MIM:616589]	W5LCV6	195	F	L
Q9NR61	LP/P	Adams-Oliver syndrome 6 (AOS6) [MIM:616589]	W5LCV6	267	P	T
Q9NR61	LP/P	Adams-Oliver syndrome 6 (AOS6) [MIM:616589]	W5LCV6	390	C	R
Q9NR61	LP/P	Adams-Oliver syndrome 6 (AOS6) [MIM:616589]	W5LCV6	390	C	Y
Q9NR61	LP/P	Adams-Oliver syndrome 6 (AOS6) [MIM:616589]	W5LCV6	455	C	W
Q14565	LB/B	-	A0A1V4J9B1	200	M	V
Q14565	LB/B	-	A0A1V4J9B1	150	G	D
Q09013	LB/B	-	A0A286XLT9	423	L	V
Q9Y5R5	LB/B	-	G1LJ92	381	A	P
Q9Y5R5	LB/B	-	G1LJ92	458	E	Q
Q9P2D7	LB/B	-	A0A183LAJ4	205	E	D
Q9P2D7	LB/B	-	A0A183LAJ4	441	V	L
Q9P2D7	LB/B	-	A0A183LAJ4	1502	V	M
Q9P2D7	LB/B	-	A0A183LAJ4	1663	R	C
Q9P2D7	LB/B	-	A0A183LAJ4	2384	N	S
Q9P2D7	LB/B	-	A0A183LAJ4	3832	R	H
Q9P2D7	LP/P	Ciliary dyskinesia, primary, 37 (CILD37) [MIM:617577]	A0A183LAJ4	1154	K	Q
Q9P2D7	LP/P	Spermatogenic failure 18 (SPGF18) [MIM:617576]	A0A183LAJ4	1287	V	G
Q9P2D7	LP/P	Spermatogenic failure 18 (SPGF18) [MIM:617576]	A0A183LAJ4	1293	D	N
Q8IVF4	LB/B	-	A0A2S2N784	480	I	V
Q8IVF4	LB/B	-	A0A2S2N784	167	S	P
Q8IVF4	LB/B	-	A0A2S2N784	1724	T	M
Q8IVF4	LB/B	-	A0A2S2N784	1767	D	E
Q8IVF4	LB/B	-	A0A2S2N784	1865	R	K
Q8IVF4	LB/B	-	A0A2S2N784	2403	R	W
Q8IVF4	LB/B	-	A0A2S2N784	2483	N	S
Q8IVF4	LB/B	-	A0A2S2N784	1986	T	M
Q8IVF4	LP/P	Spermatogenic failure 56 (SPGF56) [MIM:619515]	A0A2S2N784	4280	G	R
Q8TE73	LB/B	-	A0A2R2MTI0	12	H	Q
Q8TE73	LB/B	-	A0A2R2MTI0	24	G	E
Q8TE73	LB/B	-	A0A2R2MTI0	558	T	A
Q8TE73	LB/B	-	A0A2R2MTI0	2463	Q	R
Q8TE73	LB/B	-	A0A2R2MTI0	2862	L	F
Q8TE73	LP/P	Ciliary dyskinesia, primary, 3 (CILD3) [MIM:608644]	A0A2R2MTI0	3519	G	R
Q8TE73	LB/B	-	A0A2R2MTI0	4134	A	V
Q8TE73	LB/B	-	A0A2R2MTI0	4220	T	A
Q8TE73	LB/B	-	A0A2R2MTI0	4450	I	V
Q8TE73	LB/B	-	A0A2R2MTI0	766	I	L
Q8TE73	LB/B	-	A0A2R2MTI0	1006	S	G
Q8TE73	LB/B	-	A0A2R2MTI0	1081	M	V
Q8TE73	LB/B	-	A0A2R2MTI0	3791	T	I
Q8TE73	LP/P	Ciliary dyskinesia, primary, 3 (CILD3) [MIM:608644]	A0A2R2MTI0	1716	R	L
Q8TE73	LP/P	Ciliary dyskinesia, primary, 3 (CILD3) [MIM:608644]	A0A2R2MTI0	2264	S	N
Q8TE73	LP/P	Ciliary dyskinesia, primary, 3 (CILD3) [MIM:608644]	A0A2R2MTI0	2347	E	K
Q8TE73	LP/P	Ciliary dyskinesia, primary, 3 (CILD3) [MIM:608644]	A0A2R2MTI0	2501	R	P
Q8TE73	LP/P	Ciliary dyskinesia, primary, 3 (CILD3) [MIM:608644]	A0A2R2MTI0	2843	F	S
Q8TE73	LP/P	Ciliary dyskinesia, primary, 3 (CILD3) [MIM:608644]	A0A2R2MTI0	3409	W	S
Q8TE73	LP/P	Ciliary dyskinesia, primary, 3 (CILD3) [MIM:608644]	A0A2R2MTI0	3843	S	L
Q8TE73	LP/P	Ciliary dyskinesia, primary, 3 (CILD3) [MIM:608644]	A0A2R2MTI0	4205	G	V
Q8TE73	LB/B	-	A0A2R2MTI0	591	L	R
Q8TE73	LB/B	-	A0A2R2MTI0	591	L	V
Q8TE73	LB/B	-	A0A2R2MTI0	620	Q	K
Q8TE73	LB/B	-	A0A2R2MTI0	765	K	N
Q8TE73	LB/B	-	A0A2R2MTI0	2425	R	H
Q8TE73	LP/P	Ciliary dyskinesia, primary, 3 (CILD3) [MIM:608644]	A0A2R2MTI0	1454	R	Q
Q8TE73	LP/P	Ciliary dyskinesia, primary, 3 (CILD3) [MIM:608644]	A0A2R2MTI0	2881	A	G
Q8TE73	LP/P	Ciliary dyskinesia, primary, 3 (CILD3) [MIM:608644]	A0A2R2MTI0	3605	D	N
Q9UI46	LB/B	-	A0A093NRK9	8	A	S
Q9UI46	LP/P	Kartagener syndrome (KTGS) [MIM:244400]	A0A093NRK9	515	G	S
Q9UI46	LB/B	-	A0A093NRK9	60	A	V
Q9UI46	LB/B	-	A0A093NRK9	326	Q	H
Q9UI46	LB/B	-	A0A093NRK9	335	V	I
Q9UI46	LB/B	-	A0A093NRK9	487	V	G
Q9GZS0	LB/B	-	A0A2Y9DGX5	558	A	T
Q9GZS0	LB/B	-	A0A2Y9DGX5	495	V	I
Q8IWG1	LB/B	-	A0A2B4SJU4	674	T	A
Q8IWG1	LB/B	-	A0A2B4SJU4	798	R	H
Q96EY1	LB/B	-	L5M8L6	75	N	Y
Q8WW22	LB/B	-	A0A1U7QCR1	226	H	R
Q8IXB1	LB/B	-	A0A091DYN0	76	D	N
Q8IXB1	LB/B	-	A0A091DYN0	414	Y	C
Q8IXB1	LB/B	-	A0A091DYN0	646	H	Q
Q8IXB1	LB/B	-	A0A091DYN0	347	L	I
O75165	LB/B	-	A0A1W5B0J2	1463	A	S
O75165	LB/B	-	A0A1W5B0J2	1487	F	C
O75165	LB/B	-	A0A1W5B0J2	1995	V	I
O75165	LB/B	-	A0A1W5B0J2	1515	P	S
O75165	LB/B	-	A0A1W5B0J2	264	E	Q
O75165	LB/B	-	A0A1W5B0J2	1082	T	I
O75165	LB/B	-	A0A1W5B0J2	2115	R	L
O75165	LB/B	-	A0A1W5B0J2	556	L	S
O75165	LB/B	-	A0A1W5B0J2	674	D	A
O75165	LB/B	-	A0A1W5B0J2	903	R	K
O75165	LB/B	-	A0A1W5B0J2	997	L	F
O75165	LB/B	-	A0A1W5B0J2	1135	N	S
O75165	LB/B	-	A0A1W5B0J2	1291	E	G
O75165	LB/B	-	A0A1W5B0J2	1516	R	H
O75165	LB/B	-	A0A1W5B0J2	1740	E	Q
O75165	LB/B	-	A0A1W5B0J2	2057	A	S
O75165	LB/B	-	A0A1W5B0J2	2170	L	W
O75061	LB/B	-	A0A1S3FU67	671	S	N
O75061	LB/B	-	A0A1S3FU67	76	M	L
O75061	LB/B	-	A0A1S3FU67	152	L	P
O75061	LB/B	-	A0A1S3FU67	264	I	V
O75061	LB/B	-	A0A1S3FU67	441	C	S
O75061	LB/B	-	A0A1S3FU67	562	R	C
O75061	LP/P	Parkinson disease 19B, early-onset (PARK19B) [MIM:615528]	A0A1S3FU67	870	R	G
Q9UJW3	LB/B	-	G1PNZ5	278	R	G
Q9BU89	LP/P	Neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment (NEDMVIC) [MIM:620066]	A0A146XUK3	249	I	T
O60496	LB/B	-	H3CKK9	152	A	P
O60496	LB/B	-	H3CKK9	394	S	A
O60496	LB/B	-	H3CKK9	274	P	L
Q8N608	LB/B	-	V9KEF2	340	A	P
Q8N608	LB/B	-	V9KEF2	517	S	N
Q8N608	LB/B	-	V9KEF2	401	V	I
P27487	LB/B	-	E2C5M6	266	V	I
P42658	LB/B	-	V9KEF2	854	L	P
P42658	LP/P	Intellectual developmental disorder, autosomal dominant 33 (MRD33) [MIM:616311]	V9KEF2	385	M	L
Q14117	LP/P	Dihydropyrimidinase deficiency (DPYSD) [MIM:222748]	Q18677	68	T	R
Q14117	LP/P	Dihydropyrimidinase deficiency (DPYSD) [MIM:222748]	Q18677	334	Q	R
Q14117	LP/P	Dihydropyrimidinase deficiency (DPYSD) [MIM:222748]	Q18677	360	W	R
Q14117	LP/P	Dihydropyrimidinase deficiency (DPYSD) [MIM:222748]	Q18677	435	G	R
Q14117	LP/P	Dihydropyrimidinase deficiency (DPYSD) [MIM:222748]	Q18677	490	R	T
Q01658	LB/B	-	A0A2U9C4H3	171	E	D
Q8NBI3	LB/B	-	H3BIS3	37	L	F
Q96MC2	LB/B	-	F7CUZ5	357	K	E
Q96MC2	LB/B	-	F7CUZ5	399	W	R
Q96MC2	LB/B	-	F7CUZ5	633	V	F
Q96MC2	LB/B	-	F7CUZ5	702	S	I
Q96MC2	LB/B	-	F7CUZ5	734	V	M
Q8IY82	LB/B	-	V4ARZ7	186	C	S
Q8IY82	LB/B	-	V4ARZ7	433	P	L
Q8IY82	LB/B	-	V4ARZ7	581	N	K
Q8IY82	LB/B	-	V4ARZ7	766	C	R
Q8IY82	LB/B	-	V4ARZ7	120	L	M
Q8IY82	LB/B	-	V4ARZ7	521	P	H
Q8IY82	LB/B	-	V4ARZ7	51	D	N
Q8IY82	LB/B	-	V4ARZ7	241	V	E
P55039	LB/B	-	M7BYA2	194	T	M
P55039	LB/B	-	M7BYA2	224	S	T
Q9NRR4	LB/B	-	A0A1W4Z7L4	67	P	T
Q9NRR4	LB/B	-	A0A1W4Z7L4	321	S	L
Q8TDB6	LB/B	-	A0A1S3ADH2	425	R	K
Q8TDB6	LB/B	-	A0A1S3ADH2	668	K	M
Q9NRD9	LB/B	-	A0A212ES06	1026	C	R
Q9NRD9	LB/B	-	A0A212ES06	1178	L	F
Q9NRD9	LB/B	-	A0A212ES06	962	I	T
Q9NRD8	LP/P	Thyroid dyshormonogenesis 6 (TDH6) [MIM:607200]	A0A212ES06	36	Q	H
Q9NRD8	LB/B	-	A0A212ES06	138	P	L
Q9NRD8	LP/P	Thyroid dyshormonogenesis 6 (TDH6) [MIM:607200]	A0A212ES06	376	R	W
Q9NRD8	LB/B	-	A0A212ES06	1067	S	L
Q9NRD8	LB/B	-	A0A212ES06	678	H	R
Q9NRD8	LP/P	Thyroid dyshormonogenesis 6 (TDH6) [MIM:607200]	A0A212ES06	1518	G	S
P28562	LB/B	-	H3CUA4	56	A	T
P28562	LB/B	-	H3CUA4	187	Y	H
Q9H596	LB/B	-	G3PB35	186	M	T
Q68J44	LB/B	-	A0A2K6F9P4	137	S	R
Q68J44	LB/B	-	A0A2K6F9P4	66	D	N
P33316	LB/B	-	A0A2Y9PHY1	100	P	S
P33316	LP/P	Bone marrow failure and diabetes mellitus syndrome (BMFDMS) [MIM:620044]	A0A2Y9PHY1	142	Y	C
O77932	LB/B	-	F7BXD2	28	S	T
O77932	LB/B	-	F7BXD2	63	D	E
O77932	LB/B	-	F7BXD2	261	H	Q
O77932	LB/B	-	F7BXD2	332	A	V
Q96IM9	LB/B	-	G1NV86	143	G	S
Q7RTS9	LP/P	Smith-McCort dysplasia 1 (SMC1) [MIM:607326]	B4F766	87	E	K
Q7RTS9	LP/P	Dyggve-Melchior-Clausen syndrome (DMC) [MIM:223800]	B4F766	469	N	Y
Q7RTS9	LP/P	Smith-McCort dysplasia 1 (SMC1) [MIM:607326]	B4F766	542	C	R
Q8N1N2	LB/B	-	F6REG5	38	V	A
Q8N1N2	LB/B	-	F6REG5	189	T	P
Q9NP97	LB/B	-	L5K037	13	S	R
Q9NP97	LB/B	-	L5K037	71	I	F
Q8IZS6	LB/B	-	L5KGV8	67	I	V
Q8IZS6	LB/B	-	L5KGV8	88	R	I
Q8IZS6	LB/B	-	L5KGV8	121	V	A
Q8N7M0	LB/B	-	D3Z8A1	49	E	D
Q8N7M0	LB/B	-	D3Z8A1	143	L	I
Q13627	LB/B	-	F1QSN1	415	Y	F
Q13627	LB/B	-	F1QSN1	681	Q	H
Q13627	LB/B	-	F1QSN1	679	A	P
Q9Y463	LB/B	-	G1U355	28	L	P
Q9Y463	LB/B	-	G1U355	102	R	H
Q9Y463	LB/B	-	G1U355	234	S	G
Q9Y463	LP/P	Abdominal obesity-metabolic syndrome 3 (AOMS3) [MIM:615812]	G1U355	90	H	P
Q9Y463	LP/P	Abdominal obesity-metabolic syndrome 3 (AOMS3) [MIM:615812]	G1U355	102	R	C
O43781	LB/B	-	A7RQP1	239	M	L
Q96AV8	LB/B	-	A0A087XBM3	72	F	L
Q96AV8	LB/B	-	A0A087XBM3	626	M	V
Q96AV8	LB/B	-	A0A087XBM3	854	H	Q
Q5JPH6	LB/B	-	G5BV73	457	S	G
Q5JPH6	LP/P	Combined oxidative phosphorylation deficiency 12 (COXPD12) [MIM:614924]	G5BV73	55	R	H
Q5JPH6	LP/P	Combined oxidative phosphorylation deficiency 12 (COXPD12) [MIM:614924]	G5BV73	65	K	E
Q5JPH6	LP/P	Combined oxidative phosphorylation deficiency 12 (COXPD12) [MIM:614924]	G5BV73	96	E	K
Q5JPH6	LP/P	Combined oxidative phosphorylation deficiency 12 (COXPD12) [MIM:614924]	G5BV73	107	R	H
Q5JPH6	LP/P	Combined oxidative phosphorylation deficiency 12 (COXPD12) [MIM:614924]	G5BV73	108	R	W
Q5JPH6	LP/P	Combined oxidative phosphorylation deficiency 12 (COXPD12) [MIM:614924]	G5BV73	110	G	S
Q5JPH6	LP/P	Combined oxidative phosphorylation deficiency 12 (COXPD12) [MIM:614924]	G5BV73	167	C	Y
Q5JPH6	LP/P	Combined oxidative phosphorylation deficiency 12 (COXPD12) [MIM:614924]	G5BV73	168	R	G
Q5JPH6	LP/P	Combined oxidative phosphorylation deficiency 12 (COXPD12) [MIM:614924]	G5BV73	204	G	S
Q5JPH6	LP/P	Combined oxidative phosphorylation deficiency 12 (COXPD12) [MIM:614924]	G5BV73	224	G	S
Q5JPH6	LP/P	Combined oxidative phosphorylation deficiency 12 (COXPD12) [MIM:614924]	G5BV73	317	G	C
Q5JPH6	LP/P	Combined oxidative phosphorylation deficiency 12 (COXPD12) [MIM:614924]	G5BV73	516	R	Q
Q5JPH6	LP/P	Combined oxidative phosphorylation deficiency 12 (COXPD12) [MIM:614924]	G5BV73	107	R	C
Q5JPH6	LP/P	Combined oxidative phosphorylation deficiency 12 (COXPD12) [MIM:614924]	G5BV73	489	R	Q
Q99848	LB/B	-	A0A2K5MV85	223	R	H
O95672	LB/B	-	G1SXE9	10	H	Q
O95672	LB/B	-	G1SXE9	328	H	Y
O95672	LP/P	Arthrogryposis, distal, 5D (DA5D) [MIM:615065]	G1SXE9	418	R	S
O95672	LP/P	Arthrogryposis, distal, 5D (DA5D) [MIM:615065]	G1SXE9	404	R	C
O95672	LP/P	Arthrogryposis, distal, 5D (DA5D) [MIM:615065]	G1SXE9	607	G	S
O95672	LP/P	Arthrogryposis, distal, 5D (DA5D) [MIM:615065]	G1SXE9	760	C	R
Q96DC8	LB/B	-	A0A1W4ZPT2	69	A	T
Q96DC8	LB/B	-	A0A1W4ZPT2	151	A	T
Q96DC8	LB/B	-	A0A1W4ZPT2	162	D	N
Q8WWZ3	LP/P	Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive (ECTD11B) [MIM:614941]	A0A2Y9HJ54	152	E	K
Q8WWZ3	LB/B	-	A0A2Y9HJ54	9	M	I
Q8WWZ3	LB/B	-	A0A2Y9HJ54	103	S	F
Q8WWZ3	LP/P	Ectodermal dysplasia 11A, hypohidrotic/hair/nail type, autosomal dominant (ECTD11A) [MIM:614940]	A0A2Y9HJ54	122	L	R
Q8WWZ3	LP/P	Ectodermal dysplasia 11A, hypohidrotic/hair/nail type, autosomal dominant (ECTD11A) [MIM:614940]	A0A2Y9HJ54	114	D	Y
P25101	LP/P	Mandibulofacial dysostosis with alopecia (MFDA) [MIM:616367]	A0A226NL48	129	Y	F
P25101	LP/P	Mandibulofacial dysostosis with alopecia (MFDA) [MIM:616367]	A0A226NL48	303	E	K
P57772	LB/B	-	F1PQ89	435	A	V
Q6NXP0	LB/B	-	V9GXH0	66	E	G
Q6NXP0	LB/B	-	V9GXH0	215	R	G
Q6NXP0	LB/B	-	V9GXH0	541	P	S
Q6NXP0	LB/B	-	V9GXH0	36	P	L
Q6NXP0	LB/B	-	V9GXH0	280	H	R
Q8IY85	LB/B	-	A0A2K6PHQ4	312	V	I
Q8IY85	LB/B	-	A0A2K6PHQ4	617	M	V
Q8IY85	LB/B	-	A0A2K6PHQ4	279	I	V
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	77	P	T
Q5JVL4	LB/B	-	C3YQF2	159	R	W
Q5JVL4	LB/B	-	C3YQF2	182	R	H
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	210	D	N
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	221	R	H
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	253	D	Y
Q5JVL4	LB/B	-	C3YQF2	619	I	L
Q5JVL4	LB/B	-	C3YQF2	285	R	I
Q5JVL4	LB/B	-	C3YQF2	174	I	V
Q5JVL4	LB/B	-	C3YQF2	259	C	Y
Q5JVL4	LB/B	-	C3YQF2	294	R	H
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	353	R	W
Q5JVL4	LB/B	-	C3YQF2	448	M	T
Q5JVL4	LB/B	-	C3YQF2	357	E	K
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	118	R	C
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	89	H	R
Q5JVL4	LB/B	-	C3YQF2	221	R	C
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	322	E	K
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	355	Y	C
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	372	R	W
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	378	K	E
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	436	R	C
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	485	Y	H
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	519	N	S
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	556	V	L
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	619	I	S
Q5JVL4	LP/P	Juvenile myoclonic epilepsy 1 (EJM1) [MIM:254770]	C3YQF2	631	Y	C
P52797	LB/B	-	G3NKW2	190	V	M
Q15029	LB/B	-	D7KG09	773	G	V
Q15029	LP/P	Mandibulofacial dysostosis with microcephaly (MFDM) [MIM:610536]	D7KG09	262	R	W
Q15029	LP/P	Mandibulofacial dysostosis with microcephaly (MFDM) [MIM:610536]	D7KG09	476	C	R
Q15029	LP/P	Mandibulofacial dysostosis with microcephaly (MFDM) [MIM:610536]	D7KG09	637	L	R
P41567	LB/B	-	G1SDN3	59	L	P
P41567	LB/B	-	G1SDN3	90	R	G
P20042	LB/B	-	C1BGJ1	177	E	D
P38919	LP/P	Richieri-Costa-Pereira syndrome (RCPS) [MIM:268305]	W6MM03	270	D	G
P78545	LB/B	-	A0A226NIB5	317	Q	K
Q99607	LB/B	-	A0A2I3G3K0	95	A	T
Q99607	LB/B	-	A0A2I3G3K0	147	A	V
Q99607	LB/B	-	A0A2I3G3K0	177	R	K
Q99607	LB/B	-	A0A2I3G3K0	187	T	N
Q99607	LP/P	Autoinflammatory syndrome, familial, X-linked, Behcet-like 2 (AIFBL2) [MIM:301074]	A0A2I3G3K0	231	W	R
Q99607	LP/P	Autoinflammatory syndrome, familial, X-linked, Behcet-like 2 (AIFBL2) [MIM:301074]	A0A2I3G3K0	251	W	S
Q99607	LB/B	-	A0A2I3G3K0	345	S	T
Q99607	LB/B	-	A0A2I3G3K0	368	P	L
Q99607	LB/B	-	A0A2I3G3K0	382	V	I
Q99607	LB/B	-	A0A2I3G3K0	408	V	M
Q99607	LB/B	-	A0A2I3G3K0	411	V	M
Q99607	LB/B	-	A0A2I3G3K0	500	A	V
Q99607	LB/B	-	A0A2I3G3K0	512	P	L
Q99607	LB/B	-	A0A2I3G3K0	604	R	C
O95163	LP/P	Neuropathy, hereditary sensory and autonomic, 3 (HSAN3) [MIM:223900]	A0A1U7UFD0	696	R	P
O95163	LB/B	-	A0A1U7UFD0	70	R	C
O95163	LB/B	-	A0A1U7UFD0	182	M	K
O95163	LB/B	-	A0A1U7UFD0	312	E	K
O95163	LB/B	-	A0A1U7UFD0	525	R	Q
O95163	LB/B	-	A0A1U7UFD0	765	G	E
O95163	LB/B	-	A0A1U7UFD0	816	I	L
O95163	LB/B	-	A0A1U7UFD0	830	I	M
O95163	LB/B	-	A0A1U7UFD0	848	T	N
O95163	LB/B	-	A0A1U7UFD0	952	K	I
O95163	LB/B	-	A0A1U7UFD0	1013	G	S
O95163	LB/B	-	A0A1U7UFD0	1072	C	S
O95163	LB/B	-	A0A1U7UFD0	1158	P	L
O95163	LP/P	Neuropathy, hereditary sensory and autonomic, 3 (HSAN3) [MIM:223900]	A0A1U7UFD0	914	P	L
Q9Y6C2	LB/B	-	I3J5A1	149	R	Q
Q9Y6C2	LB/B	-	I3J5A1	536	Q	R
Q9Y6C2	LB/B	-	I3J5A1	903	E	K
Q9Y6C2	LP/P	Neuronopathy, distal hereditary motor, 10 (HMN10) [MIM:620080]	I3J5A1	250	R	C
Q9NT22	LB/B	-	A0A2K5DXD8	532	S	N
P54851	LP/P	Nephrotic syndrome 10 (NPHS10) [MIM:615861]	A0A2K6R4J9	7	F	L
P54851	LP/P	Nephrotic syndrome 10 (NPHS10) [MIM:615861]	A0A2K6R4J9	10	A	T
O14682	LB/B	-	A0A2I0TZH8	256	I	S
Q8TC92	LB/B	-	A0A2I0U3V1	16	E	D
P22413	LB/B	-	A0A1S3G0R2	173	K	Q
P22413	LP/P	Ossification of the posterior longitudinal ligament of the spine (OPLL) [MIM:602475]	A0A1S3G0R2	91	L	P
P22413	LB/B	-	A0A1S3G0R2	268	Y	H
P22413	LP/P	Ossification of the posterior longitudinal ligament of the spine (OPLL) [MIM:602475]	A0A1S3G0R2	287	S	F
P22413	LB/B	-	A0A1S3G0R2	779	T	P
P22413	LB/B	-	A0A1S3G0R2	774	R	C
P22413	LB/B	-	A0A1S3G0R2	179	N	S
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	342	G	V
P22413	LB/B	-	A0A1S3G0R2	886	R	T
P22413	LP/P	Hypophosphatemic rickets, autosomal recessive, 2 (ARHR2) [MIM:613312]	A0A1S3G0R2	266	G	V
P22413	LP/P	Hypophosphatemic rickets, autosomal recessive, 2 (ARHR2) [MIM:613312]	A0A1S3G0R2	901	Y	S
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	305	P	T
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	538	D	H
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	586	G	R
P22413	LP/P	Cole disease (COLED) [MIM:615522]	A0A1S3G0R2	149	C	S
P22413	LP/P	Cole disease (COLED) [MIM:615522]	A0A1S3G0R2	164	C	S
P22413	LP/P	Cole disease (COLED) [MIM:615522]	A0A1S3G0R2	177	C	Y
P22413	LP/P	Hypophosphatemic rickets, autosomal recessive, 2 (ARHR2) [MIM:613312]	A0A1S3G0R2	92	G	D
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	126	C	R
P22413	LP/P	Cole disease (COLED) [MIM:615522]	A0A1S3G0R2	133	C	R
P22413	LP/P	Cole disease (COLED) [MIM:615522]	A0A1S3G0R2	177	C	S
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	195	C	R
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	195	C	S
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	218	D	V
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	301	Y	C
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	456	R	Q
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	471	Y	C
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	500	H	P
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	504	S	R
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	513	Y	C
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	570	Y	C
P22413	LB/B	-	A0A1S3G0R2	611	L	V
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	659	Y	C
P22413	LB/B	-	A0A1S3G0R2	668	E	K
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	726	C	R
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	777	H	R
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	792	N	S
P22413	LP/P	Hypophosphatemic rickets, autosomal recessive, 2 (ARHR2) [MIM:613312]	A0A1S3G0R2	792	N	S
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	804	D	H
P22413	LB/B	-	A0A1S3G0R2	821	R	H
P22413	LP/P	Arterial calcification of infancy, generalized, 1 (GACI1) [MIM:208000]	A0A1S3G0R2	888	R	W
P22413	LP/P	Cole disease (COLED) [MIM:615522]	A0A1S3G0R2	120	C	R
Q9Y6X5	LB/B	-	A0A1U7Q806	144	H	Q
Q9Y6X5	LB/B	-	A0A1U7Q806	255	I	V
Q9Y6X5	LB/B	-	A0A1U7Q806	439	S	A
Q9UJA9	LB/B	-	F6YKL7	6	L	I
Q9UJA9	LB/B	-	F6YKL7	171	I	V
Q9UJA9	LB/B	-	F6YKL7	39	R	P
Q9UJA9	LB/B	-	F6YKL7	69	I	V
Q9UJA9	LB/B	-	F6YKL7	283	Y	C
Q9Y5L3	LB/B	-	A0A2K5IRT6	103	A	V
Q15884	LB/B	-	A0A1S3M6E9	233	T	I
Q15884	LB/B	-	A0A1S3M6E9	261	R	K
P81408	LB/B	-	U3IWE5	549	R	H
P81408	LB/B	-	U3IWE5	646	R	H
Q96L91	LB/B	-	H2NJ62	1308	T	I
Q9HCS5	LB/B	-	G3VEH1	132	V	I
Q6P179	LB/B	-	W5UG66	214	P	L
Q6P179	LB/B	-	W5UG66	392	K	N
Q6P179	LB/B	-	W5UG66	669	L	Q
Q6P179	LB/B	-	W5UG66	411	L	R
Q03468	LB/B	-	G3X3N1	255	K	T
Q03468	LB/B	-	G3X3N1	399	G	D
Q03468	LP/P	Cockayne syndrome B (CSB) [MIM:133540]	G3X3N1	670	R	W
Q03468	LP/P	Cockayne syndrome B (CSB) [MIM:133540]	G3X3N1	851	W	R
Q03468	LP/P	Cockayne syndrome B (CSB) [MIM:133540]	G3X3N1	957	V	G
Q03468	LP/P	Cockayne syndrome B (CSB) [MIM:133540]	G3X3N1	1042	P	L
Q03468	LB/B	-	G3X3N1	1095	P	R
Q03468	LB/B	-	G3X3N1	1097	M	V
Q03468	LB/B	-	G3X3N1	1213	R	G
Q03468	LB/B	-	G3X3N1	1413	Q	R
Q03468	LB/B	-	G3X3N1	425	D	A
Q03468	LB/B	-	G3X3N1	446	G	D
Q03468	LB/B	-	G3X3N1	942	T	M
Q03468	LB/B	-	G3X3N1	1002	Y	C
Q03468	LB/B	-	G3X3N1	1230	R	P
Q03468	LB/B	-	G3X3N1	1308	V	L
Q03468	LB/B	-	G3X3N1	1322	G	V
Q03468	LB/B	-	G3X3N1	1372	G	R
Q03468	LB/B	-	G3X3N1	1382	G	R
Q03468	LB/B	-	G3X3N1	1410	G	R
Q03468	LB/B	-	G3X3N1	1441	T	I
Q03468	LB/B	-	G3X3N1	1220	T	I
Q03468	LB/B	-	G3X3N1	1355	D	E
Q03468	LB/B	-	G3X3N1	134	R	W
Q03468	LP/P	Cockayne syndrome B (CSB) [MIM:133540]	G3X3N1	680	N	D
Q03468	LP/P	Cockayne syndrome B (CSB) [MIM:133540]	G3X3N1	686	W	C
Q03468	LP/P	Cockayne syndrome B (CSB) [MIM:133540]	G3X3N1	687	S	L
Q03468	LP/P	Cerebro-oculo-facio-skeletal syndrome 1 (COFS1) [MIM:214150]	G3X3N1	871	L	P
Q03468	LP/P	Cerebro-oculo-facio-skeletal syndrome 1 (COFS1) [MIM:214150]	G3X3N1	987	L	P
O75460	LB/B	-	R4GFM3	418	V	M
O75460	LB/B	-	R4GFM3	700	N	S
Q56NI9	LP/P	Roberts-SC phocomelia syndrome (RBS) [MIM:268300]	F6UWY7	539	W	G
Q56NI9	LB/B	-	F6UWY7	80	A	V
Q56NI9	LB/B	-	F6UWY7	359	Q	P
Q9H6T0	LB/B	-	L9JIH2	111	S	L
Q9H6T0	LB/B	-	L9JIH2	528	A	V
Q9H6T0	LB/B	-	L9JIH2	627	P	S
Q9NY74	LB/B	-	A0A091QW43	221	M	T
Q9NY74	LB/B	-	A0A091QW43	389	S	N
Q9NY74	LB/B	-	A0A091QW43	715	P	L
Q9NY74	LB/B	-	A0A091QW43	771	P	S
Q9NYK6	LB/B	-	G1SCN2	117	Q	R
Q9NYK6	LB/B	-	G1SCN2	136	D	E
Q9NYK6	LB/B	-	G1SCN2	115	N	K
Q9NYK6	LB/B	-	G1SCN2	195	Q	H
Q9NYK6	LB/B	-	G1SCN2	217	Y	H
Q86UK5	LP/P	Ellis-van Creveld syndrome (EVC) [MIM:225500]	I3L853	283	I	R
Q86UK5	LB/B	-	I3L853	699	T	A
Q86UK5	LP/P	Ellis-van Creveld syndrome (EVC) [MIM:225500]	I3L853	950	R	W
Q86UK5	LB/B	-	I3L853	230	S	G
Q9H790	LB/B	-	D3ZLE0	115	D	N
Q9H790	LB/B	-	D3ZLE0	172	G	V
Q17RC7	LB/B	-	L5JP80	77	R	W
Q17RC7	LB/B	-	L5JP80	93	D	E
Q17RC7	LB/B	-	L5JP80	185	L	H
Q17RC7	LB/B	-	L5JP80	675	Q	R
Q17RC7	LB/B	-	L5JP80	685	Q	E
O00471	LB/B	-	A0A146Z938	10	E	D
Q9Y3B2	LP/P	Pontocerebellar hypoplasia 1F (PCH1F) [MIM:619304]	A0A218V8F8	35	S	L
Q16394	LP/P	Hereditary multiple exostoses 1 (EXT1) [MIM:133700]	A0A091ET56	280	R	G
Q16394	LP/P	Hereditary multiple exostoses 1 (EXT1) [MIM:133700]	A0A091ET56	280	R	S
Q16394	LP/P	Hereditary multiple exostoses 1 (EXT1) [MIM:133700]	A0A091ET56	339	G	D
Q16394	LP/P	Hereditary multiple exostoses 1 (EXT1) [MIM:133700]	A0A091ET56	340	R	C
Q16394	LP/P	Hereditary multiple exostoses 1 (EXT1) [MIM:133700]	A0A091ET56	340	R	H
Q16394	LP/P	Hereditary multiple exostoses 1 (EXT1) [MIM:133700]	A0A091ET56	340	R	L
Q16394	LP/P	Hereditary multiple exostoses 1 (EXT1) [MIM:133700]	A0A091ET56	340	R	S
Q16394	LP/P	Hereditary multiple exostoses 1 (EXT1) [MIM:133700]	A0A091ET56	27	Q	K
Q16394	LP/P	Hereditary multiple exostoses 1 (EXT1) [MIM:133700]	A0A091ET56	164	D	H
Q16394	LP/P	Chondrosarcoma (CHDSA) [MIM:215300]	A0A091ET56	316	N	S
Q16394	LP/P	Hereditary multiple exostoses 1 (EXT1) [MIM:133700]	A0A091ET56	486	A	V
Q16394	LP/P	Hereditary multiple exostoses 1 (EXT1) [MIM:133700]	A0A091ET56	496	P	L
Q92935	LB/B	-	W5P6E5	379	H	N
Q92935	LB/B	-	W5P6E5	163	R	H
O00167	LB/B	-	A0A093F201	83	P	S
O00167	LB/B	-	A0A093F201	238	T	A
P00488	LB/B	-	A0A091DTI3	565	P	L
P00488	LB/B	-	A0A091DTI3	651	V	I
P00488	LB/B	-	A0A091DTI3	652	E	Q
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	682	R	H
P00488	LB/B	-	A0A091DTI3	35	V	L
P00488	LB/B	-	A0A091DTI3	551	T	I
P00488	LB/B	-	A0A091DTI3	589	L	Q
P00488	LB/B	-	A0A091DTI3	40	V	I
P00488	LB/B	-	A0A091DTI3	205	Y	F
P00488	LB/B	-	A0A091DTI3	650	T	I
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	167	P	L
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	172	R	Q
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	274	G	V
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	343	H	Y
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	416	Q	R
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	530	L	P
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	602	Q	K
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	704	R	Q
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	716	R	G
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	38	R	Q
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	168	Y	C
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	290	P	R
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	541	R	Q
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	593	G	S
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	612	R	H
P00488	LP/P	Factor XIII subunit A deficiency (FA13AD) [MIM:613225]	A0A091DTI3	669	D	G
Q7L5A8	LB/B	-	A0A182TQS2	97	P	A
Q7L5A8	LP/P	Spastic paraplegia 35, autosomal recessive, with or without neurodegeneration (SPG35) [MIM:612319]	A0A182TQS2	35	D	Y
Q7L5A8	LP/P	Spastic paraplegia 35, autosomal recessive, with or without neurodegeneration (SPG35) [MIM:612319]	A0A182TQS2	235	R	C
Q7L5A8	LP/P	Spastic paraplegia 35, autosomal recessive, with or without neurodegeneration (SPG35) [MIM:612319]	A0A182TQS2	154	R	C
Q9BTP7	LB/B	-	A0A2K6FS48	158	S	L
Q9BTP7	LB/B	-	A0A2K6FS48	192	I	T
Q9BTP7	LB/B	-	A0A2K6FS48	126	S	F
O60427	LB/B	-	A0A1W4Y1L9	272	P	S
Q9Y5Q0	LB/B	-	M3WWA3	192	K	N
Q9Y5Q0	LB/B	-	M3WWA3	216	N	K
Q9NVQ4	LB/B	-	G1KJ72	117	A	T
Q9NVQ4	LB/B	-	G1KJ72	127	L	S
Q9BQ89	LB/B	-	G1SD20	284	L	I
Q8IWE2	LB/B	-	A0A250YK06	84	G	R
Q8IWE2	LB/B	-	A0A250YK06	116	L	P
Q8IWE2	LB/B	-	A0A250YK06	201	P	L
Q8IWE2	LB/B	-	A0A250YK06	367	R	H
Q8IWE2	LB/B	-	A0A250YK06	443	V	I
Q8IWE2	LB/B	-	A0A250YK06	40	S	L
Q8IWE2	LB/B	-	A0A250YK06	446	S	L
Q9NWS6	LB/B	-	G3TBC4	129	V	L
Q9NWS6	LB/B	-	G3TBC4	239	R	H
Q8WW52	LB/B	-	K7F626	51	D	N
Q8WW52	LB/B	-	K7F626	87	N	D
Q8WW52	LB/B	-	K7F626	119	I	T
Q8WW52	LB/B	-	K7F626	416	A	V
Q8WW52	LB/B	-	K7F626	526	G	A
Q8WW52	LB/B	-	K7F626	546	G	D
Q8IXR5	LB/B	-	Q8IXR5	645	R	C
Q6UWF9	LB/B	-	H2MN30	96	V	I
Q5JX69	LB/B	-	D3ZKD8	129	E	A
Q5JX69	LB/B	-	D3ZKD8	74	Q	K
Q5JX69	LB/B	-	D3ZKD8	84	E	K
Q96KR6	LB/B	-	F6XIR7	126	P	S
Q8IXS0	LB/B	-	A0A2K5ZU09	431	V	I
Q8IXS0	LB/B	-	A0A2K5ZU09	258	A	T
Q8IXS0	LB/B	-	A0A2K5ZU09	309	Q	P
Q8IXS0	LB/B	-	A0A2K5ZU09	360	C	S
Q8IXS0	LB/B	-	A0A2K5ZU09	442	M	V
P58499	LB/B	-	A0A2K5C4H8	14	V	M
Q5T0W9	LB/B	-	M7C6U1	410	N	S
Q5T0W9	LB/B	-	M7C6U1	435	S	R
Q5T0W9	LB/B	-	M7C6U1	640	K	T
Q5T0W9	LB/B	-	M7C6U1	907	T	N
A6ND36	LB/B	-	A0A1V4KSK4	109	I	T
Q86YD7	LB/B	-	G3TZU2	234	A	E
Q86YD7	LB/B	-	G3TZU2	343	R	S
Q86YD7	LB/B	-	G3TZU2	410	T	A
Q86YD7	LB/B	-	G3TZU2	123	R	G
Q86YD7	LB/B	-	G3TZU2	334	P	L
Q86YD7	LB/B	-	G3TZU2	348	T	I
Q9BXW9	LP/P	Fanconi anemia complementation group D2 (FANCD2) [MIM:227646]	A0A2B4RGL0	126	S	G
Q9BXW9	LP/P	Fanconi anemia complementation group D2 (FANCD2) [MIM:227646]	A0A2B4RGL0	302	R	W
Q9BXW9	LB/B	-	A0A2B4RGL0	714	P	L
Q9BXW9	LP/P	Fanconi anemia complementation group D2 (FANCD2) [MIM:227646]	A0A2B4RGL0	1236	R	H
Q9BXW9	LB/B	-	A0A2B4RGL0	33	K	R
Q9BXW9	LB/B	-	A0A2B4RGL0	61	T	M
Q9BXW9	LB/B	-	A0A2B4RGL0	65	Q	H
Q9BXW9	LB/B	-	A0A2B4RGL0	172	I	M
Q9BXW9	LB/B	-	A0A2B4RGL0	193	T	A
Q9BXW9	LB/B	-	A0A2B4RGL0	328	R	Q
Q9BXW9	LB/B	-	A0A2B4RGL0	446	L	V
Q9BXW9	LB/B	-	A0A2B4RGL0	456	L	R
Q9BXW9	LB/B	-	A0A2B4RGL0	623	Q	P
Q9BXW9	LB/B	-	A0A2B4RGL0	865	K	R
Q9BXW9	LB/B	-	A0A2B4RGL0	901	G	V
O95363	LB/B	-	A0A2Y9P5C9	57	S	C
O95363	LB/B	-	A0A2Y9P5C9	280	N	S
O95363	LP/P	Combined oxidative phosphorylation deficiency 14 (COXPD14) [MIM:614946]	A0A2Y9P5C9	144	Y	C
O95363	LP/P	Combined oxidative phosphorylation deficiency 14 (COXPD14) [MIM:614946]	A0A2Y9P5C9	329	I	T
O95363	LP/P	Combined oxidative phosphorylation deficiency 14 (COXPD14) [MIM:614946]	A0A2Y9P5C9	391	D	V
O95363	LP/P	Spastic paraplegia 77, autosomal recessive (SPG77) [MIM:617046]	A0A2Y9P5C9	142	D	Y
Q14296	LB/B	-	A0A1A6HLV6	436	A	V
Q8IX29	LB/B	-	U3J4H6	75	R	Q
Q8IX29	LB/B	-	U3J4H6	254	M	I
Q8IX29	LB/B	-	U3J4H6	255	T	N
O95170	LB/B	-	C3Z5W3	643	F	L
P24071	LB/B	-	A0A2Y9IQ33	113	D	N
P24071	LB/B	-	A0A2Y9IQ33	269	S	G
P06734	LB/B	-	A0A2K6NU86	62	R	W
P06734	LB/B	-	A0A2K6NU86	284	R	Q
P06734	LB/B	-	A0A2K6NU86	316	S	F
P31994	LB/B	-	A0A2K6KH24	258	Y	D
P31994	LB/B	-	A0A2K6KH24	232	I	T
P31994	LB/B	-	A0A2K6KH24	205	Y	F
P31994	LB/B	-	A0A2K6KH24	83	Q	P
Q86WN1	LB/B	-	W5MH16	344	N	K
Q86WN1	LB/B	-	W5MH16	681	P	L
Q9BRP7	LB/B	-	A5PMV5	87	I	N
Q9BRP7	LB/B	-	A5PMV5	475	T	P
Q9BRP7	LB/B	-	A5PMV5	28	T	A
A9Z1Z3	LB/B	-	A0A226PFX7	1179	K	E
A9Z1Z3	LB/B	-	A0A226PFX7	1183	N	S
A9Z1Z3	LB/B	-	A0A226PFX7	1318	V	I
Q5JSP0	LB/B	-	Q9NXY1	275	V	I
Q6ZNL6	LB/B	-	B7ZNX9	403	G	R
Q6ZNL6	LB/B	-	B7ZNX9	828	A	T
Q6ZNL6	LB/B	-	B7ZNX9	941	E	K
Q6ZV73	LB/B	-	U3K876	257	Q	R
Q6ZV73	LB/B	-	U3K876	1393	E	K
Q9NSA1	LB/B	-	A0A212CCN9	174	L	P
Q9NSA1	LB/B	-	A0A212CCN9	141	G	S
P11487	LP/P	Deafness with labyrinthine aplasia, microtia and microdontia (LAMM) [MIM:610706]	G3VM67	156	S	P
P11487	LP/P	Deafness with labyrinthine aplasia, microtia and microdontia (LAMM) [MIM:610706]	G3VM67	6	L	P
P55075	LP/P	Hypogonadotropic hypogonadism 6 with or without anosmia (HH6) [MIM:612702]	P37237	14	H	N
P55075	LP/P	Hypogonadotropic hypogonadism 6 with or without anosmia (HH6) [MIM:612702]	P37237	26	P	L
P55075	LP/P	Hypogonadotropic hypogonadism 6 with or without anosmia (HH6) [MIM:612702]	P37237	40	F	L
P55075	LP/P	Hypogonadotropic hypogonadism 6 with or without anosmia (HH6) [MIM:612702]	P37237	89	K	E
P55075	LP/P	Hypogonadotropic hypogonadism 6 with or without anosmia (HH6) [MIM:612702]	P37237	116	R	G
P55075	LP/P	Hypogonadotropic hypogonadism 6 with or without anosmia (HH6) [MIM:612702]	P37237	218	T	M
P02679	LB/B	-	H3ABI9	301	R	C
P02679	LP/P	Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004]	H3ABI9	301	R	H
P02679	LP/P	Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004]	H3ABI9	318	G	V
P02679	LB/B	-	H3ABI9	334	N	I
P02679	LB/B	-	H3ABI9	336	M	T
P02679	LB/B	-	H3ABI9	355	Q	R
P02679	LB/B	-	H3ABI9	356	D	Y
P02679	LP/P	Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004]	H3ABI9	356	D	V
P02679	LB/B	-	H3ABI9	401	R	G
P02679	LB/B	-	H3ABI9	191	G	R
P02679	LB/B	-	H3ABI9	410	M	V
P02679	LB/B	-	H3ABI9	140	Y	H
P02679	LB/B	-	H3ABI9	77	E	G
P02679	LP/P	Dysfibrinogenemia, congenital (DYSFIBRIN) [MIM:616004]	H3ABI9	404	S	P
P02679	LP/P	Congenital afibrinogenemia (CAFBN) [MIM:202400]	H3ABI9	303	T	P
P02679	LP/P	Congenital afibrinogenemia (CAFBN) [MIM:202400]	H3ABI9	327	D	H
P02679	LP/P	Congenital afibrinogenemia (CAFBN) [MIM:202400]	H3ABI9	345	N	D
P02679	LP/P	Congenital afibrinogenemia (CAFBN) [MIM:202400]	H3ABI9	401	R	W
P09769	LB/B	-	A0A146MRJ9	110	T	I
P09769	LB/B	-	A0A146MRJ9	130	S	R
B1AJZ9	LB/B	-	A0A1U7SAI1	763	E	K
Q02790	LB/B	-	A0A2K6LTR5	436	T	P
Q14318	LB/B	-	A0A091CVJ5	87	A	V
Q75LS8	LB/B	-	A0A2U4AKI8	125	V	G
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	143	R	S
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy congenital with or without impaired intellectual development B5 (MDDGB5) [MIM:606612]	A0A218U984	217	P	T
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy congenital with or without impaired intellectual development B5 (MDDGB5) [MIM:606612]	A0A218U984	221	S	R
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	276	L	I
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy congenital with or without impaired intellectual development B5 (MDDGB5) [MIM:606612]	A0A218U984	309	Y	C
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	312	R	C
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy congenital with or without impaired intellectual development B5 (MDDGB5) [MIM:606612]	A0A218U984	315	P	T
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy congenital with or without impaired intellectual development B5 (MDDGB5) [MIM:606612]	A0A218U984	316	P	R
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	316	P	R
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy congenital with or without impaired intellectual development B5 (MDDGB5) [MIM:606612]	A0A218U984	328	Y	S
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	339	R	L
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy congenital with or without impaired intellectual development B5 (MDDGB5) [MIM:606612]	A0A218U984	339	R	H
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy congenital with or without impaired intellectual development B5 (MDDGB5) [MIM:606612]	A0A218U984	401	D	N
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy congenital with or without impaired intellectual development B5 (MDDGB5) [MIM:606612]	A0A218U984	448	P	L
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy congenital with or without impaired intellectual development B5 (MDDGB5) [MIM:606612]	A0A218U984	465	Y	S
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	54	R	W
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A5 (MDDGA5) [MIM:613153]	A0A218U984	307	Y	N
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	307	Y	N
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	316	P	S
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A5 (MDDGA5) [MIM:613153]	A0A218U984	318	C	Y
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	360	D	N
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy congenital with or without impaired intellectual development B5 (MDDGB5) [MIM:606612]	A0A218U984	405	V	L
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy congenital with or without impaired intellectual development B5 (MDDGB5) [MIM:606612]	A0A218U984	455	A	D
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	462	P	S
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	79	V	M
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	134	R	W
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	160	V	F
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	182	Y	C
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	293	T	I
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	300	V	A
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy congenital with or without impaired intellectual development B5 (MDDGB5) [MIM:606612]	A0A218U984	463	N	D
Q9H9S5	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C5 (MDDGC5) [MIM:607155]	A0A218U984	314	T	M
Q5D862	LB/B	-	G3QZE6	41	L	F
Q5D862	LB/B	-	G3QZE6	107	R	Q
Q5D862	LB/B	-	G3QZE6	137	G	E
Q5D862	LB/B	-	G3QZE6	276	R	Q
Q5D862	LB/B	-	G3QZE6	298	C	S
Q5D862	LB/B	-	G3QZE6	723	E	K
Q5D862	LB/B	-	G3QZE6	881	Y	S
Q5D862	LB/B	-	G3QZE6	1249	H	R
Q5D862	LB/B	-	G3QZE6	1992	E	D
Q5D862	LB/B	-	G3QZE6	2239	Q	H
Q5D862	LB/B	-	G3QZE6	958	S	Y
Q5D862	LB/B	-	G3QZE6	12	I	T
Q5D862	LB/B	-	G3QZE6	1450	A	V
Q96RU3	LB/B	-	A0A146WNQ4	490	S	N
Q9Y2H6	LB/B	-	I3JE84	107	S	G
Q53EP0	LB/B	-	I3JE84	179	T	S
Q53EP0	LB/B	-	I3JE84	1080	M	V
Q5VW36	LB/B	-	A0A091CKZ5	166	L	S
Q5VW36	LB/B	-	A0A091CKZ5	234	V	I
Q5VW36	LB/B	-	A0A091CKZ5	523	I	V
Q5VW36	LB/B	-	A0A091CKZ5	718	S	T
Q5VW36	LB/B	-	A0A091CKZ5	1373	T	P
Q5VW36	LB/B	-	A0A091CKZ5	1668	K	E
Q5VW36	LB/B	-	A0A091CKZ5	721	E	K
Q5VW36	LB/B	-	A0A091CKZ5	1373	T	A
Q5VW36	LB/B	-	A0A091CKZ5	1373	T	S
Q08050	LB/B	-	A0A1W4YAH3	643	S	P
Q08050	LB/B	-	A0A1W4YAH3	402	A	E
Q08050	LB/B	-	A0A1W4YAH3	450	F	L
Q08050	LB/B	-	A0A1W4YAH3	669	P	R
Q08050	LB/B	-	A0A1W4YAH3	673	P	L
O15353	LB/B	-	F7C3S9	283	A	V
O15353	LB/B	-	F7C3S9	69	R	C
O15353	LB/B	-	F7C3S9	599	A	P
O15353	LB/B	-	F7C3S9	411	R	W
O15353	LB/B	-	F7C3S9	242	P	S
O15353	LP/P	T-cell immunodeficiency, congenital alopecia, and nail dystrophy (TIDAND) [MIM:601705]	F7C3S9	320	R	W
O15353	LP/P	T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant (TLIND) [MIM:618806]	F7C3S9	320	R	W
O15353	LB/B	-	F7C3S9	430	P	S
O00409	LB/B	-	E1C4G1	337	Y	H
Q8IWF2	LB/B	-	A0A146WJ91	179	F	L
Q8IWF2	LB/B	-	A0A146WJ91	308	N	S
Q8IWF2	LB/B	-	A0A146WJ91	374	K	R
Q8IWF2	LB/B	-	A0A146WJ91	637	E	D
Q8IWF2	LB/B	-	A0A146WJ91	71	R	C
Q05932	LB/B	-	F7DJU5	437	V	D
Q05932	LB/B	-	F7DJU5	489	A	V
Q05932	LB/B	-	F7DJU5	528	S	T
Q05932	LB/B	-	F7DJU5	22	I	V
Q05932	LB/B	-	F7DJU5	13	F	L
Q05932	LB/B	-	F7DJU5	466	R	C
Q05932	LB/B	-	F7DJU5	499	S	F
C9JXX5	LB/B	-	F6QSK7	80	Q	H
A6NGY1	LB/B	-	A0A2K5XJP0	12	C	R
A6NGY1	LB/B	-	A0A2K5XJP0	210	L	M
Q68DX3	LB/B	-	L5KAF2	20	A	T
Q68DX3	LB/B	-	L5KAF2	534	K	E
Q68DX3	LB/B	-	L5KAF2	239	T	M
Q68DX3	LB/B	-	L5KAF2	1021	T	K
Q68DX3	LB/B	-	L5KAF2	351	G	R
Q8NA03	LB/B	-	F1PBH4	64	N	D
Q8NA03	LB/B	-	F1PBH4	354	R	H
Q8NA03	LB/B	-	F1PBH4	374	E	G
Q8NA03	LB/B	-	F1PBH4	402	C	R
Q8NA03	LB/B	-	F1PBH4	411	L	F
Q8NA03	LB/B	-	F1PBH4	528	G	A
Q8IVP5	LB/B	-	A0A091CKP9	56	M	V
P22083	LB/B	-	G1R651	255	I	V
Q16595	LP/P	Friedreich ataxia (FRDA) [MIM:229300]	O35943	122	D	Y
Q16595	LP/P	Friedreich ataxia (FRDA) [MIM:229300]	O35943	130	G	V
Q16595	LP/P	Friedreich ataxia (FRDA) [MIM:229300]	O35943	182	L	F
Q16595	LP/P	Friedreich ataxia (FRDA) [MIM:229300]	O35943	106	L	S
Q16595	LP/P	Friedreich ataxia (FRDA) [MIM:229300]	O35943	198	L	R
Q16595	LB/B	-	O35943	202	S	C
Q16595	LP/P	Friedreich ataxia (FRDA) [MIM:229300]	O35943	154	I	F
Q16595	LP/P	Friedreich ataxia (FRDA) [MIM:229300]	O35943	155	W	R
Q16595	LP/P	Friedreich ataxia (FRDA) [MIM:229300]	O35943	165	R	C
O15117	LB/B	-	W5N4D9	51	P	L
O15117	LB/B	-	W5N4D9	332	K	R
O15117	LB/B	-	W5N4D9	672	V	F
Q5VWT5	LB/B	-	A0A2K6CWK4	125	I	M
O60353	LB/B	-	A0A1U8DIZ1	33	M	V
O60353	LB/B	-	A0A1U8DIZ1	345	M	L
O60353	LB/B	-	A0A1U8DIZ1	664	A	E
O60353	LP/P	Nail disorder, non-syndromic congenital, 1 (NDNC1) [MIM:161050]	A0A1U8DIZ1	511	R	C
O60353	LB/B	-	A0A1U8DIZ1	140	H	Y
O60353	LB/B	-	A0A1U8DIZ1	152	Q	E
O60353	LB/B	-	A0A1U8DIZ1	388	A	D
O60353	LB/B	-	A0A1U8DIZ1	405	R	Q
O60353	LB/B	-	A0A1U8DIZ1	511	R	H
O60353	LB/B	-	A0A1U8DIZ1	604	G	R
O60353	LB/B	-	A0A1U8DIZ1	620	S	T
Q7L622	LB/B	-	A0A1S3RBB3	232	R	H
P78334	LB/B	-	A0A1A6HDF9	102	S	A
P78334	LB/B	-	A0A1A6HDF9	9	L	F
O95257	LB/B	-	H0VNM2	112	G	S
A6NER3	LB/B	-	A0A158RFV5	9	Y	C
A6NER3	LB/B	-	A0A158RFV5	13	R	S
A6NER3	LB/B	-	A0A158RFV5	16	P	R
A6NER3	LB/B	-	A0A158RFV5	28	R	Q
O14976	LB/B	-	A0A1S3FU67	144	S	L
O14976	LB/B	-	A0A1S3FU67	580	V	M
O14976	LB/B	-	A0A1S3FU67	787	D	Y
O14976	LB/B	-	A0A1S3FU67	877	Q	R
O14976	LB/B	-	A0A1S3FU67	1051	T	M
O14976	LB/B	-	A0A1S3FU67	1120	Q	H
O14976	LB/B	-	A0A1S3FU67	1137	P	L
O14976	LB/B	-	A0A1S3FU67	1168	S	N
O14976	LB/B	-	A0A1S3FU67	1265	K	R
O14976	LB/B	-	A0A1S3FU67	1297	D	N
Q9H3Q3	LB/B	-	W5Q836	4	M	L
Q9NY28	LB/B	-	A0A151P734	53	Y	D
Q9NY28	LB/B	-	A0A151P734	53	Y	N
Q9NY28	LB/B	-	A0A151P734	267	E	G
Q9NY28	LB/B	-	A0A151P734	312	F	S
Q9NY28	LB/B	-	A0A151P734	337	A	V
Q9NY28	LB/B	-	A0A151P734	438	D	G
Q9NY28	LB/B	-	A0A151P734	515	V	F
Q9NY28	LB/B	-	A0A151P734	611	V	M
Q9NY28	LB/B	-	A0A151P734	234	E	K
Q9NY28	LB/B	-	A0A151P734	630	D	G
Q7Z4T8	LB/B	-	A0A2Y9DDX4	124	C	R
Q7Z4T8	LB/B	-	A0A2Y9DDX4	206	G	A
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	28	D	Y
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	32	I	N
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	38	Q	P
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	44	V	L
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	44	V	M
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	51	R	L
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	55	G	C
P07902	LB/B	-	L9L977	62	L	M
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	67	R	C
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	74	L	P
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	81	A	T
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	97	N	S
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	98	D	N
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	113	D	N
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	114	H	L
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	117	F	S
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	118	Q	H
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	123	R	G
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	123	R	Q
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	125	V	A
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	127	K	E
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	130	C	Y
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	132	H	Y
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	135	S	L
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	138	T	M
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	139	L	P
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	142	M	K
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	142	M	V
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	143	S	L
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	148	R	G
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	148	R	Q
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	148	R	W
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	150	V	L
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	151	V	A
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	154	W	G
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	171	F	S
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	179	G	D
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	183	P	T
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	184	H	Q
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	188	Q	R
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	192	S	N
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	194	F	L
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	195	L	P
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	198	I	M
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	198	I	T
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	199	A	T
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	201	R	H
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	203	E	K
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	209	Y	C
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	209	Y	S
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	212	Q	H
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	217	L	P
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	226	L	P
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	231	R	H
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	249	W	R
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	251	Y	C
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	251	Y	S
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	258	R	C
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	259	R	W
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	262	R	P
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	282	L	V
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	285	K	N
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	289	L	R
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	291	E	K
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	308	E	K
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	314	N	D
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	317	Q	H
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	317	Q	R
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	319	H	Q
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	320	A	T
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	323	Y	D
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	323	Y	H
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	324	P	S
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	325	P	L
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	328	R	H
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	329	S	F
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	330	A	V
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	333	R	G
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	333	R	Q
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	333	R	W
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	334	K	R
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	336	M	L
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	344	Q	K
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	350	T	A
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	45	S	L
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	129	M	T
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	167	W	R
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	204	R	P
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	272	R	G
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	294	F	Y
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	51	R	Q
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	135	S	W
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	229	K	N
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	252	Q	H
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	9	Q	H
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	23	T	A
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	28	D	H
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	33	R	H
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	34	Y	N
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	112	S	R
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	132	H	Q
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	168	V	L
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	170	I	T
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	181	S	A
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	185	P	H
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	185	P	S
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	192	S	G
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	201	R	C
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	220	E	K
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	223	R	S
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	227	L	P
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	259	R	Q
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	265	P	A
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	278	I	N
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	289	L	F
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	291	E	V
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	327	L	P
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	342	L	I
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	345	A	D
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	89	Y	H
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	103	Q	R
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	166	P	A
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	181	S	F
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	185	P	L
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	285	K	R
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	333	R	L
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	33	R	P
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	83	G	V
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	142	M	T
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	175	G	D
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	231	R	C
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	244	P	S
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	267	L	R
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	267	L	V
P07902	LP/P	Galactosemia 1 (GALAC1) [MIM:230400]	L9L977	271	E	D
Q14697	LB/B	-	F0ZSI1	173	R	Q
Q14697	LB/B	-	F0ZSI1	154	R	W
Q14697	LB/B	-	F0ZSI1	309	R	C
Q14697	LB/B	-	F0ZSI1	95	Q	R
Q14697	LB/B	-	F0ZSI1	232	T	A
Q14697	LP/P	Polycystic kidney disease 3 with or without polycystic liver disease (PKD3) [MIM:600666]	F0ZSI1	383	T	R
Q14697	LP/P	Polycystic kidney disease 3 with or without polycystic liver disease (PKD3) [MIM:600666]	F0ZSI1	400	R	L
Q14697	LP/P	Polycystic kidney disease 3 with or without polycystic liver disease (PKD3) [MIM:600666]	F0ZSI1	817	R	W
Q14697	LB/B	-	F0ZSI1	850	H	Y
Q9H706	LB/B	-	G3UD67	243	T	N
Q9H706	LB/B	-	G3UD67	291	K	R
Q9H706	LB/B	-	G3UD67	490	A	V
Q9H706	LB/B	-	G3UD67	580	V	I
Q9H706	LB/B	-	G3UD67	720	T	M
Q8NEG0	LB/B	-	A0A2Y9GVI3	30	R	G
Q8NEG0	LB/B	-	A0A2Y9GVI3	71	M	V
Q86XJ1	LB/B	-	H3BED9	461	L	S
Q86XJ1	LB/B	-	H3BED9	500	P	T
Q9UFP1	LB/B	-	A0A2Y9G5U6	227	H	Y
Q9UFP1	LB/B	-	A0A2Y9G5U6	460	Q	R
P43694	LP/P	Atrial septal defect 2 (ASD2) [MIM:607941]	G3R5D7	296	G	S
P43694	LP/P	Atrial septal defect 2 (ASD2) [MIM:607941]	G3R5D7	52	S	F
P43694	LB/B	-	G3R5D7	377	S	G
P43694	LP/P	Ventricular septal defect 1 (VSD1) [MIM:614429]	G3R5D7	6	A	V
P43694	LP/P	Ventricular septal defect 1 (VSD1) [MIM:614429]	G3R5D7	43	R	W
P43694	LP/P	Atrioventricular septal defect 4 (AVSD4) [MIM:614430]	G3R5D7	163	P	S
P43694	LP/P	Atrial septal defect 2 (ASD2) [MIM:607941]	G3R5D7	280	T	M
P43694	LP/P	Atrial septal defect 2 (ASD2) [MIM:607941]	G3R5D7	296	G	C
P43694	LP/P	Ventricular septal defect 1 (VSD1) [MIM:614429]	G3R5D7	296	G	R
P43694	LP/P	Atrial septal defect 2 (ASD2) [MIM:607941]	G3R5D7	310	M	V
P43694	LP/P	Atrioventricular septal defect 4 (AVSD4) [MIM:614430]	G3R5D7	346	A	V
P43694	LP/P	Ventricular septal defect 1 (VSD1) [MIM:614429]	G3R5D7	359	E	K
P43694	LP/P	Atrial septal defect 2 (ASD2) [MIM:607941]	G3R5D7	403	L	M
P43694	LB/B	-	G3R5D7	411	A	V
P43694	LB/B	-	G3R5D7	425	D	N
P43694	LP/P	Ventricular septal defect 1 (VSD1) [MIM:614429]	G3R5D7	429	S	T
P43694	LP/P	Ventricular septal defect 1 (VSD1) [MIM:614429]	G3R5D7	442	A	V
P43694	LP/P	Testicular anomalies with or without congenital heart disease (TACHD) [MIM:615542]	G3R5D7	221	G	R
P43694	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	G3R5D7	9	A	P
P43694	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	G3R5D7	51	L	V
P43694	LP/P	Tetralogy of Fallot (TOF) [MIM:187500]	G3R5D7	285	N	S
P43694	LP/P	-	G3R5D7	39	V	L
P43694	LP/P	-	G3R5D7	226	P	Q
P43694	LP/P	-	G3R5D7	271	C	S
P43694	LP/P	-	G3R5D7	279	T	S
O75879	LB/B	-	A0A131X9C5	30	A	D
P0DPI2	LB/B	-	A0A2K6D479	248	L	V
P0DPI2	LB/B	-	A0A2K6D479	148	V	M
Q9HCG7	LP/P	Spastic paraplegia 46, autosomal recessive (SPG46) [MIM:614409]	J9P6J8	630	R	W
Q9HCG7	LP/P	Spastic paraplegia 46, autosomal recessive (SPG46) [MIM:614409]	J9P6J8	873	R	H
Q9HCG7	LP/P	Spastic paraplegia 46, autosomal recessive (SPG46) [MIM:614409]	J9P6J8	594	D	H
Q8N5D6	LB/B	-	A0A2K6BKQ7	20	L	F
Q8N5D6	LB/B	-	A0A2K6BKQ7	21	S	G
Q8N5D6	LB/B	-	A0A2K6BKQ7	79	L	P
Q8N5D6	LB/B	-	A0A2K6BKQ7	163	R	W
Q8N5D6	LB/B	-	A0A2K6BKQ7	200	D	N
Q8N5D6	LB/B	-	A0A2K6BKQ7	238	Q	P
Q8N5D6	LB/B	-	A0A2K6BKQ7	248	T	I
Q8N5D6	LB/B	-	A0A2K6BKQ7	291	I	F
Q8N5D6	LB/B	-	A0A2K6BKQ7	296	R	Q
O75600	LB/B	-	S9YWH7	39	R	C
O75600	LB/B	-	S9YWH7	100	S	N
Q6ZNI0	LB/B	-	H3BAC4	425	N	H
Q6ZNI0	LB/B	-	H3BAC4	352	D	E
Q8TB36	LP/P	Charcot-Marie-Tooth disease 4A (CMT4A) [MIM:214400]	L9LD39	120	R	Q
Q8TB36	LP/P	Charcot-Marie-Tooth disease 4A (CMT4A) [MIM:214400]	L9LD39	161	R	H
Q8TB36	LP/P	Charcot-Marie-Tooth disease, recessive intermediate A (CMTRIA) [MIM:608340]	L9LD39	282	R	C
Q8TB36	LP/P	Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive (CMT2RV) [MIM:607706]	L9LD39	310	R	Q
Q8TB36	LP/P	Charcot-Marie-Tooth disease, axonal, 2K (CMT2K) [MIM:607831]	L9LD39	256	H	R
Q8TB36	LP/P	Charcot-Marie-Tooth disease, axonal, 2K (CMT2K) [MIM:607831]	L9LD39	282	R	H
Q8TB36	LP/P	Charcot-Marie-Tooth disease, axonal, 2K (CMT2K) [MIM:607831]	L9LD39	120	R	G
Q8TB36	LP/P	Charcot-Marie-Tooth disease, axonal, 2K (CMT2K) [MIM:607831]	L9LD39	120	R	W
Q8TB36	LP/P	Charcot-Marie-Tooth disease, axonal, 2K (CMT2K) [MIM:607831]	L9LD39	123	H	R
Q8TB36	LP/P	Charcot-Marie-Tooth disease, axonal, 2K (CMT2K) [MIM:607831]	L9LD39	156	A	G
Q8TB36	LP/P	Charcot-Marie-Tooth disease, axonal, 2K (CMT2K) [MIM:607831]	L9LD39	310	R	W
Q9NZC3	LB/B	-	A0A2U9BPA6	218	R	Q
Q9NZC3	LB/B	-	A0A2U9BPA6	328	E	K
O95390	LP/P	Vertebral hypersegmentation and orofacial anomalies (VHO) [MIM:619122]	A0A2K6C5A7	298	R	Q
P43026	LP/P	Acromesomelic dysplasia 2A (AMD2A) [MIM:200700]	A0A1L8EKU9	400	C	Y
P43026	LP/P	Acromesomelic dysplasia 2B (AMD2B) [MIM:228900]	A0A1L8EKU9	441	L	P
P43026	LP/P	Brachydactyly A2 (BDA2) [MIM:112600]	A0A1L8EKU9	441	L	P
P43026	LP/P	Multiple synostoses syndrome 2 (SYNS2) [MIM:610017]	A0A1L8EKU9	441	L	P
P43026	LB/B	-	A0A1L8EKU9	276	A	S
P43026	LP/P	Multiple synostoses syndrome 2 (SYNS2) [MIM:610017]	A0A1L8EKU9	438	R	L
P43026	LP/P	Symphalangism, proximal 1B (SYM1B) [MIM:615298]	A0A1L8EKU9	438	R	L
P43026	LB/B	-	A0A1L8EKU9	163	R	G
P43026	LP/P	Brachydactyly C (BDC) [MIM:113100]	A0A1L8EKU9	173	M	V
P43026	LP/P	Acromesomelic dysplasia 2B (AMD2B) [MIM:228900]	A0A1L8EKU9	439	S	T
P43026	LP/P	Acromesomelic dysplasia 2B (AMD2B) [MIM:228900]	A0A1L8EKU9	440	H	L
P43026	LP/P	Multiple synostoses syndrome 2 (SYNS2) [MIM:610017]	A0A1L8EKU9	475	S	N
P43026	LP/P	Symphalangism, proximal 1B (SYM1B) [MIM:615298]	A0A1L8EKU9	491	E	K
P43026	LP/P	Brachydactyly A2 (BDA2) [MIM:112600]	A0A1L8EKU9	380	R	Q
P43026	LP/P	Symphalangism, proximal 1B (SYM1B) [MIM:615298]	A0A1L8EKU9	373	L	R
P43026	LP/P	Acromesomelic dysplasia 2B (AMD2B) [MIM:228900]	A0A1L8EKU9	378	R	Q
P43026	LP/P	Acromesomelic dysplasia 2B (AMD2B) [MIM:228900]	A0A1L8EKU9	436	P	T
P43026	LP/P	Brachydactyly A1, C (BDA1C) [MIM:615072]	A0A1L8EKU9	399	R	C
P43026	LP/P	Brachydactyly C (BDC) [MIM:113100]	A0A1L8EKU9	201	T	P
P43026	LP/P	Brachydactyly C (BDC) [MIM:113100]	A0A1L8EKU9	263	L	P
P43026	LP/P	Brachydactyly A1, C (BDA1C) [MIM:615072]	A0A1L8EKU9	414	W	R
P43026	LP/P	Multiple synostoses syndrome 2 (SYNS2) [MIM:610017]	A0A1L8EKU9	414	W	R
P43026	LP/P	Multiple synostoses syndrome 2 (SYNS2) [MIM:610017]	A0A1L8EKU9	445	N	K
P43026	LP/P	Multiple synostoses syndrome 2 (SYNS2) [MIM:610017]	A0A1L8EKU9	445	N	T
P43026	LP/P	Brachydactyly C (BDC) [MIM:113100]	A0A1L8EKU9	203	T	N
P43026	LP/P	Brachydactyly C (BDC) [MIM:113100]	A0A1L8EKU9	486	V	M
Q9NWZ8	LB/B	-	A1L2Q9	195	E	V
O00258	LB/B	-	L9KZH5	110	V	I
P14136	LB/B	-	A0A2U3ZMP0	47	P	L
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	76	L	F
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	77	N	Y
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	79	R	C
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	79	R	H
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	88	R	C
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	88	R	S
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	239	R	C
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	239	R	H
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	258	R	P
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	362	E	D
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	416	R	W
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	78	D	E
P14136	LB/B	-	A0A2U3ZMP0	223	E	Q
P14136	LB/B	-	A0A2U3ZMP0	295	D	N
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	63	K	Q
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	66	R	Q
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	70	R	Q
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	70	R	W
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	72	E	K
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	73	M	K
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	73	M	R
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	73	M	T
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	74	M	T
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	76	L	V
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	77	N	K
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	77	N	S
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	78	D	N
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	79	R	G
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	79	R	L
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	79	R	P
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	83	Y	H
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	86	K	E
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	90	L	P
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	97	L	P
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	101	L	P
P14136	LB/B	-	A0A2U3ZMP0	115	V	I
P14136	LB/B	-	A0A2U3ZMP0	157	D	N
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	207	E	K
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	207	E	Q
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	210	E	K
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	235	L	P
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	236	K	T
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	239	R	L
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	239	R	P
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	242	Y	D
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	253	A	G
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	257	Y	C
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	267	A	P
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	276	R	L
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	279	K	E
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	330	R	G
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	332	E	K
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	352	L	P
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	359	L	P
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	359	L	V
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	364	A	P
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	366	Y	H
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	371	E	Q
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	371	E	V
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	373	E	D
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	373	E	K
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	373	E	Q
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	374	E	G
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	374	E	Q
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	376	R	G
P14136	LP/P	Alexander disease (ALXDRD) [MIM:203450]	A0A2U3ZMP0	385	S	F
Q9NUV9	LB/B	-	A0A2U3WJH1	128	E	D
Q8TF65	LB/B	-	H9GBJ0	61	S	F
Q8TF65	LB/B	-	H9GBJ0	206	L	P
P57773	LB/B	-	W5NP33	497	V	I
Q86XP6	LB/B	-	U3JBS6	113	S	N
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	32	L	P
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	34	N	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	35	G	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	40	P	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	49	R	L
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	52	C	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	52	C	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	56	C	F
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	56	C	G
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	59	E	K
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	66	E	Q
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	72	M	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	85	G	D
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	89	L	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	100	R	K
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	112	R	C
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	112	R	H
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	128	G	E
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	131	L	P
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	142	C	Y
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	143	A	P
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	144	G	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	146	P	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	156	A	T
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	156	A	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	162	W	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	165	D	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	166	L	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	172	C	Y
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	202	C	W
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	205	P	T
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	215	N	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	219	I	N
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	224	N	D
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	227	R	Q
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	231	D	N
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	244	D	N
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	264	D	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	266	D	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	269	V	A
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	272	N	K
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	279	Q	E
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	284	M	T
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	288	A	D
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	296	M	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	297	S	F
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	298	N	K
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	301	R	Q
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	313	D	Y
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	316	V	E
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	327	Q	K
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	328	G	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	328	G	A
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	342	R	Q
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	356	R	W
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	358	E	K
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	361	G	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	20	A	P
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	31	A	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	40	P	L
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	42	M	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	46	H	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	46	H	Y
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	47	W	G
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	49	R	P
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	49	R	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	56	C	Y
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	86	Y	C
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	89	L	P
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	91	I	T
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	92	D	H
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	92	D	Y
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	93	D	G
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	94	C	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	94	C	Y
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	95	W	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	97	A	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	100	R	T
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	113	F	L
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	113	F	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	134	Y	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	138	G	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	142	C	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	148	S	N
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	148	S	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	162	W	C
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	163	G	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	170	D	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	172	C	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	183	G	D
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	187	M	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	202	C	Y
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	216	Y	D
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	223	C	G
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	224	N	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	226	W	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	230	A	T
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	235	S	C
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	236	W	C
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	236	W	L
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	242	I	N
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	244	D	H
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	258	G	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	259	P	L
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	259	P	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	260	G	A
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	261	G	D
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	263	N	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	265	P	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	266	D	N
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	267	M	I
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	279	Q	H
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	280	Q	H
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	287	W	C
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	287	W	G
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	289	I	F
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	296	M	I
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	298	N	H
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	298	N	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	320	N	K
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	320	N	Y
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	321	Q	E
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	340	W	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	341	E	K
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	363	R	H
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	373	G	D
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	373	G	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	377	A	D
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	378	C	Y
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	409	P	A
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	409	P	T
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	65	S	T
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	266	D	H
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	272	N	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	410	T	A
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	42	M	L
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	43	G	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	46	H	P
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	93	D	N
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	112	R	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	120	L	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	135	A	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	171	G	D
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	201	S	F
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	219	I	T
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	234	D	E
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	264	D	Y
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	276	S	G
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	285	A	P
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	300	L	F
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	328	G	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	338	E	K
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	356	R	Q
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	358	E	A
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	360	G	C
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	414	L	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	47	W	R
P06280	LB/B	-	A0A2I4AUY1	3	L	P
P06280	LB/B	-	A0A2I4AUY1	3	L	V
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	20	A	D
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	21	L	P
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	36	L	W
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	42	M	T
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	45	L	P
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	48	E	D
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	64	I	F
P06280	LB/B	-	A0A2I4AUY1	71	E	G
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	86	Y	H
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	91	I	N
P06280	LB/B	-	A0A2I4AUY1	154	I	T
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	164	V	G
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	167	L	Q
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	187	M	I
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	204	W	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	227	R	P
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	247	S	P
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	262	W	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	269	V	G
P06280	LB/B	-	A0A2I4AUY1	289	I	V
P06280	LB/B	-	A0A2I4AUY1	313	D	N
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	317	I	S
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	327	Q	L
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	327	Q	R
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	342	R	P
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	356	R	P
P06280	LP/P	Fabry disease (FD) [MIM:301500]	A0A2I4AUY1	360	G	S
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	49	R	C
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	49	R	C
P16278	LP/P	GM1-gangliosidosis 3 (GM1G3) [MIM:230650]	B7Z6Q5	51	I	T
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	123	G	R
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	201	R	C
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	201	R	C
P16278	LP/P	Mucopolysaccharidosis 4B (MPS4B) [MIM:253010]	B7Z6Q5	273	W	L
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	316	Y	C
P16278	LP/P	GM1-gangliosidosis 3 (GM1G3) [MIM:230650]	B7Z6Q5	457	R	Q
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	482	R	H
P16278	LP/P	Mucopolysaccharidosis 4B (MPS4B) [MIM:253010]	B7Z6Q5	482	R	H
P16278	LP/P	Mucopolysaccharidosis 4B (MPS4B) [MIM:253010]	B7Z6Q5	509	W	C
P16278	LB/B	-	B7Z6Q5	10	P	L
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	59	R	H
P16278	LP/P	GM1-gangliosidosis 3 (GM1G3) [MIM:230650]	B7Z6Q5	82	T	M
P16278	LP/P	Mucopolysaccharidosis 4B (MPS4B) [MIM:253010]	B7Z6Q5	83	Y	H
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	121	R	S
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	208	R	C
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	240	V	M
P16278	LP/P	Mucopolysaccharidosis 4B (MPS4B) [MIM:253010]	B7Z6Q5	482	R	C
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	491	D	N
P16278	LB/B	-	B7Z6Q5	532	S	G
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	578	K	R
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	590	R	H
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	591	Y	C
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	591	Y	N
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	632	E	G
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	148	R	S
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	201	R	H
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	201	R	H
P16278	LP/P	GM1-gangliosidosis 3 (GM1G3) [MIM:230650]	B7Z6Q5	214	D	Y
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	216	V	A
P16278	LP/P	GM1-gangliosidosis 3 (GM1G3) [MIM:230650]	B7Z6Q5	263	P	S
P16278	LP/P	GM1-gangliosidosis 3 (GM1G3) [MIM:230650]	B7Z6Q5	266	N	S
P16278	LP/P	GM1-gangliosidosis 3 (GM1G3) [MIM:230650]	B7Z6Q5	270	Y	D
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	281	H	Y
P16278	LP/P	GM1-gangliosidosis 3 (GM1G3) [MIM:230650]	B7Z6Q5	281	H	Y
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	332	D	N
P16278	LP/P	Mucopolysaccharidosis 4B (MPS4B) [MIM:253010]	B7Z6Q5	408	Q	P
P16278	LP/P	GM1-gangliosidosis 3 (GM1G3) [MIM:230650]	B7Z6Q5	438	G	E
P16278	LP/P	Mucopolysaccharidosis 4B (MPS4B) [MIM:253010]	B7Z6Q5	438	G	E
P16278	LP/P	Mucopolysaccharidosis 4B (MPS4B) [MIM:253010]	B7Z6Q5	484	N	K
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	494	G	C
P16278	LP/P	Mucopolysaccharidosis 4B (MPS4B) [MIM:253010]	B7Z6Q5	500	T	A
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	579	G	D
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	579	G	D
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	59	R	C
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	68	R	W
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	68	R	W
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	151	D	Y
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	239	T	M
P16278	LB/B	-	B7Z6Q5	436	L	F
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	134	G	V
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	155	L	R
P16278	LP/P	GM1-gangliosidosis 3 (GM1G3) [MIM:230650]	B7Z6Q5	155	L	R
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	162	L	S
P16278	LB/B	-	B7Z6Q5	434	S	L
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	491	D	Y
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	549	P	L
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	590	R	C
P16278	LB/B	-	B7Z6Q5	595	R	W
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	272	G	D
P16278	LB/B	-	B7Z6Q5	109	R	W
P16278	LP/P	GM1-gangliosidosis 3 (GM1G3) [MIM:230650]	B7Z6Q5	49	R	H
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	68	R	Q
P16278	LP/P	GM1-gangliosidosis 3 (GM1G3) [MIM:230650]	B7Z6Q5	73	K	E
P16278	LP/P	Mucopolysaccharidosis 4B (MPS4B) [MIM:253010]	B7Z6Q5	83	Y	C
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	132	M	T
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	136	P	S
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	148	R	C
P16278	LP/P	GM1-gangliosidosis 3 (GM1G3) [MIM:230650]	B7Z6Q5	148	R	C
P16278	LP/P	Mucopolysaccharidosis 4B (MPS4B) [MIM:253010]	B7Z6Q5	149	S	F
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	151	D	V
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	173	L	P
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	184	Q	R
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	190	G	D
P16278	LP/P	Mucopolysaccharidosis 4B (MPS4B) [MIM:253010]	B7Z6Q5	198	D	Y
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	199	Y	C
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	255	Q	H
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	264	L	S
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	329	T	I
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	332	D	E
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	333	Y	H
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	346	K	N
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	347	Y	C
P16278	LP/P	Mucopolysaccharidosis 4B (MPS4B) [MIM:253010]	B7Z6Q5	397	P	A
P16278	LP/P	GM1-gangliosidosis 3 (GM1G3) [MIM:230650]	B7Z6Q5	420	T	K
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	420	T	P
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	422	L	R
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	441	D	N
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	442	R	Q
P16278	LP/P	Mucopolysaccharidosis 4B (MPS4B) [MIM:253010]	B7Z6Q5	444	Y	C
P16278	LP/P	Mucopolysaccharidosis 4B (MPS4B) [MIM:253010]	B7Z6Q5	494	G	S
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	597	P	S
P16278	LB/B	-	B7Z6Q5	129	E	Q
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	236	L	P
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	262	G	E
P16278	LP/P	GM1-gangliosidosis 3 (GM1G3) [MIM:230650]	B7Z6Q5	297	L	F
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	314	F	L
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	337	L	P
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	337	L	P
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	414	G	V
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	493	K	N
P16278	LP/P	GM1-gangliosidosis 1 (GM1G1) [MIM:230500]	B7Z6Q5	514	L	P
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	597	P	L
P16278	LP/P	GM1-gangliosidosis 2 (GM1G2) [MIM:230600]	B7Z6Q5	600	T	I
Q9BZE0	LB/B	-	T1WQU8	492	T	A
Q8NEA6	LB/B	-	W5N5R6	301	P	Q
Q8NEA6	LB/B	-	W5N5R6	269	S	P
Q8NEA6	LB/B	-	W5N5R6	578	P	L
Q04760	LB/B	-	A0A0B7BQJ6	111	E	A
Q04760	LB/B	-	A0A0B7BQJ6	19	C	Y
P43220	LB/B	-	J9JHK2	260	L	F
P43220	LB/B	-	J9JHK2	7	P	L
P43220	LB/B	-	J9JHK2	20	R	K
P43220	LB/B	-	J9JHK2	44	R	H
P43220	LB/B	-	J9JHK2	131	R	Q
P43220	LB/B	-	J9JHK2	168	G	S
P43220	LB/B	-	J9JHK2	316	A	T
P43220	LB/B	-	J9JHK2	333	S	C
P43220	LB/B	-	J9JHK2	421	R	Q
Q9H1C3	LB/B	-	A0A2U9BAS5	37	A	T
Q8WU03	LB/B	-	F7GI24	82	P	S
Q8WU03	LB/B	-	F7GI24	160	E	K
Q8WU03	LB/B	-	F7GI24	168	L	I
Q8IVS8	LB/B	-	A0A1S3LDZ5	170	L	V
Q8IVS8	LB/B	-	A0A1S3LDZ5	394	T	I
Q8IVS8	LB/B	-	A0A1S3LDZ5	27	R	C
Q8IVS8	LP/P	D-glyceric aciduria (D-GA) [MIM:220120]	A0A1S3LDZ5	493	F	C
Q96IJ6	LB/B	-	A0A212D3F9	21	S	F
Q96IJ6	LB/B	-	A0A212D3F9	156	V	A
Q96IJ6	LP/P	Alacrima, achalasia, and impaired intellectual development syndrome (AAMR) [MIM:615510]	A0A212D3F9	182	G	D
Q96IJ6	LP/P	Alacrima, achalasia, and impaired intellectual development syndrome (AAMR) [MIM:615510]	A0A212D3F9	334	T	M
Q96IJ6	LP/P	Alacrima, achalasia, and impaired intellectual development syndrome (AAMR) [MIM:615510]	A0A212D3F9	334	T	P
Q96IJ6	LP/P	Alacrima, achalasia, and impaired intellectual development syndrome (AAMR) [MIM:615510]	A0A212D3F9	390	R	P
Q96IJ6	LP/P	Alacrima, achalasia, and impaired intellectual development syndrome (AAMR) [MIM:615510]	A0A212D3F9	401	N	T
P09471	LP/P	Developmental and epileptic encephalopathy 17 (DEE17) [MIM:615473]	A0A061IFQ9	174	D	G
P09471	LP/P	Developmental and epileptic encephalopathy 17 (DEE17) [MIM:615473]	A0A061IFQ9	203	G	R
P09471	LP/P	Developmental and epileptic encephalopathy 17 (DEE17) [MIM:615473]	A0A061IFQ9	279	I	N
P09471	LP/P	Developmental and epileptic encephalopathy 17 (DEE17) [MIM:615473]	A0A061IFQ9	40	G	R
P09471	LP/P	Neurodevelopmental disorder with involuntary movements (NEDIM) [MIM:617493]	A0A061IFQ9	40	G	R
P09471	LP/P	Developmental and epileptic encephalopathy 17 (DEE17) [MIM:615473]	A0A061IFQ9	209	R	C
P09471	LP/P	Neurodevelopmental disorder with involuntary movements (NEDIM) [MIM:617493]	A0A061IFQ9	209	R	C
P09471	LP/P	Neurodevelopmental disorder with involuntary movements (NEDIM) [MIM:617493]	A0A061IFQ9	227	A	V
P09471	LP/P	Neurodevelopmental disorder with involuntary movements (NEDIM) [MIM:617493]	A0A061IFQ9	246	E	K
P09471	LP/P	Neurodevelopmental disorder with involuntary movements (NEDIM) [MIM:617493]	A0A061IFQ9	47	S	G
P09471	LP/P	Neurodevelopmental disorder with involuntary movements (NEDIM) [MIM:617493]	A0A061IFQ9	56	I	T
P09471	LP/P	Neurodevelopmental disorder with involuntary movements (NEDIM) [MIM:617493]	A0A061IFQ9	209	R	G
P09471	LP/P	Neurodevelopmental disorder with involuntary movements (NEDIM) [MIM:617493]	A0A061IFQ9	209	R	H
P09471	LP/P	Neurodevelopmental disorder with involuntary movements (NEDIM) [MIM:617493]	A0A061IFQ9	209	R	L
P09471	LP/P	Neurodevelopmental disorder with involuntary movements (NEDIM) [MIM:617493]	A0A061IFQ9	246	E	G
P09471	LP/P	-	A0A061IFQ9	40	G	W
P09471	LP/P	-	A0A061IFQ9	52	Q	P
P09471	LP/P	Developmental and epileptic encephalopathy 17 (DEE17) [MIM:615473]	A0A061IFQ9	52	Q	R
Q13439	LB/B	-	A0A093EVL7	1028	Q	K
Q13439	LB/B	-	A0A093EVL7	1552	N	S
Q13439	LB/B	-	A0A093EVL7	2058	R	S
Q8NBJ4	LB/B	-	E1C3N9	217	H	R
P07359	LP/P	Bernard-Soulier syndrome (BSS) [MIM:231200]	G1SER2	81	C	R
P07359	LB/B	-	G1SER2	161	T	M
P07359	LP/P	Bernard-Soulier syndrome (BSS) [MIM:231200]	G1SER2	172	A	V
P07359	LP/P	Bernard-Soulier syndrome A2, autosomal dominant (BSSA2) [MIM:153670]	G1SER2	172	A	V
P07359	LP/P	Bernard-Soulier syndrome (BSS) [MIM:231200]	G1SER2	225	C	S
P07359	LP/P	Pseudo-von Willebrand disease (VWDP) [MIM:177820]	G1SER2	249	G	V
P07359	LP/P	Pseudo-von Willebrand disease (VWDP) [MIM:177820]	G1SER2	255	M	V
P07359	LB/B	-	G1SER2	72	R	H
P07359	LB/B	-	G1SER2	254	A	S
P07359	LB/B	-	G1SER2	86	L	F
P07359	LP/P	Bernard-Soulier syndrome (BSS) [MIM:231200]	G1SER2	73	L	F
P07359	LP/P	Bernard-Soulier syndrome (BSS) [MIM:231200]	G1SER2	145	L	P
P07359	LP/P	Pseudo-von Willebrand disease (VWDP) [MIM:177820]	G1SER2	249	G	S
Q9HCN6	LB/B	-	A0A2Y9IQ33	317	L	Q
Q9HCN6	LB/B	-	A0A2Y9IQ33	322	N	H
Q9HCN6	LB/B	-	A0A2Y9IQ33	219	P	S
Q9HCN6	LB/B	-	A0A2Y9IQ33	237	E	K
Q9HCN6	LB/B	-	A0A2Y9IQ33	249	A	T
Q9HCN6	LB/B	-	A0A2Y9IQ33	335	R	G
Q9HCN6	LP/P	Bleeding disorder, platelet-type, 11 (BDPLT11) [MIM:614201]	A0A2Y9IQ33	58	R	C
Q9HCN6	LP/P	Bleeding disorder, platelet-type, 11 (BDPLT11) [MIM:614201]	A0A2Y9IQ33	175	S	N
O43292	LP/P	Glycosylphosphatidylinositol biosynthesis defect 15 (GPIBD15) [MIM:617810]	E2BWN5	51	S	L
O43292	LP/P	Glycosylphosphatidylinositol biosynthesis defect 15 (GPIBD15) [MIM:617810]	E2BWN5	176	W	S
O43292	LP/P	Glycosylphosphatidylinositol biosynthesis defect 15 (GPIBD15) [MIM:617810]	E2BWN5	290	L	P
O43292	LP/P	Glycosylphosphatidylinositol biosynthesis defect 15 (GPIBD15) [MIM:617810]	E2BWN5	291	L	P
O43292	LP/P	Glycosylphosphatidylinositol biosynthesis defect 15 (GPIBD15) [MIM:617810]	E2BWN5	389	A	P
Q9BRR8	LB/B	-	H2MWV6	476	L	P
Q9BRR8	LB/B	-	H2MWV6	724	H	R
Q9BRR8	LB/B	-	H2MWV6	728	L	S
Q9BRR8	LB/B	-	H2MWV6	909	E	K
Q9BRR8	LB/B	-	H2MWV6	520	L	S
Q9BRR8	LB/B	-	H2MWV6	631	D	E
Q86WP2	LB/B	-	A0A226PJ90	122	R	G
P51654	LP/P	Simpson-Golabi-Behmel syndrome 1 (SGBS1) [MIM:312870]	A0A1D5NTH6	296	W	R
P51654	LB/B	-	A0A1D5NTH6	429	V	M
Q8N335	LB/B	-	A0A1S3G523	178	L	F
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	5	T	I
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	20	H	P
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	75	R	G
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	83	R	W
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	159	G	S
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	101	V	M
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	195	T	I
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	224	T	M
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	273	R	H
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	278	S	L
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	300	A	P
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	339	L	P
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	343	Q	R
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	347	R	C
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	347	R	H
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	375	T	R
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	389	H	R
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	472	R	H
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	487	L	F
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	495	E	K
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	517	L	V
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	525	I	T
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	539	D	N
P06744	LB/B	-	F7EGH4	208	I	T
P06744	LB/B	-	F7EGH4	308	R	H
P06744	LP/P	Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470]	F7EGH4	472	R	C
P80108	LB/B	-	M7BHS6	17	L	V
P80108	LB/B	-	M7BHS6	30	V	I
P80108	LB/B	-	M7BHS6	275	D	E
P80108	LB/B	-	M7BHS6	396	G	S
P80108	LB/B	-	M7BHS6	461	V	M
P80108	LB/B	-	M7BHS6	694	M	V
P80108	LB/B	-	M7BHS6	698	T	I
P80108	LB/B	-	M7BHS6	350	I	V
Q9H9Y4	LB/B	-	A0A164SSF9	227	Q	R
Q9H9Y4	LB/B	-	A0A164SSF9	264	R	G
Q9UHW5	LB/B	-	M7C911	52	A	V
Q9UHW5	LB/B	-	M7C911	244	V	A
Q9NPR9	LB/B	-	A0A2I3N735	79	L	P
Q9NPR9	LB/B	-	A0A2I3N735	36	Q	R
Q6PRD1	LB/B	-	I3MW63	1176	Q	E
Q6PRD1	LB/B	-	I3MW63	1381	C	R
Q6PRD1	LB/B	-	I3MW63	1869	Q	E
Q6PRD1	LB/B	-	I3MW63	1150	K	E
Q6PRD1	LP/P	Night blindness, congenital stationary, 1E (CSNB1E) [MIM:614565]	I3MW63	126	D	H
Q6PRD1	LP/P	Night blindness, congenital stationary, 1E (CSNB1E) [MIM:614565]	I3MW63	220	Y	C
Q6PRD1	LP/P	Night blindness, congenital stationary, 1E (CSNB1E) [MIM:614565]	I3MW63	455	G	D
Q6PRD1	LP/P	Night blindness, congenital stationary, 1E (CSNB1E) [MIM:614565]	I3MW63	603	H	Y
Q15760	LB/B	-	G3WEW5	189	V	I
O75388	LB/B	-	M7AH44	327	F	L
O95800	LB/B	-	A0A093GP26	116	A	T
O95800	LB/B	-	A0A093GP26	160	C	G
O95800	LB/B	-	A0A093GP26	433	L	V
Q5T6X5	LB/B	-	A0A060X8U6	91	P	S
Q5T6X5	LB/B	-	A0A060X8U6	144	I	R
Q5T6X5	LB/B	-	A0A060X8U6	599	I	T
P07203	LB/B	-	A0A2I3GW75	200	P	L
P07203	LB/B	-	A0A2I3GW75	5	R	P
P07203	LB/B	-	A0A2I3GW75	194	A	T
P36969	LB/B	-	G3HF60	2	S	N
P36969	LB/B	-	G3HF60	120	A	T
Q4ZG55	LB/B	-	H3CSS3	77	N	T
Q4ZG55	LB/B	-	H3CSS3	122	V	A
Q4ZG55	LB/B	-	H3CSS3	346	V	M
Q4ZG55	LB/B	-	H3CSS3	973	R	Q
Q4ZG55	LB/B	-	H3CSS3	1463	Y	C
Q4ZG55	LB/B	-	H3CSS3	1687	D	N
Q4ZG55	LB/B	-	H3CSS3	1814	L	V
Q4ZG55	LB/B	-	H3CSS3	359	F	L
Q4ZG55	LB/B	-	H3CSS3	632	A	T
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	128	R	H
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	192	R	L
Q9C091	LB/B	-	H3CSS3	241	R	Q
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	273	G	V
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	328	R	Q
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	497	A	G
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	605	S	R
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	716	L	F
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	751	R	C
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	751	R	H
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	761	E	Q
Q9C091	LB/B	-	H3CSS3	926	A	V
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	1066	R	P
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	1502	M	T
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	1509	D	V
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	1536	H	R
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	1549	V	A
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	1558	R	S
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	1567	L	P
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	1576	A	V
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	1615	V	I
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	1655	I	T
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	1664	Y	C
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	1690	V	M
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	1775	D	N
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	1793	L	R
Q9C091	LP/P	Renal hypodysplasia/aplasia 3 (RHDA3) [MIM:617805]	H3CSS3	1884	R	H
Q9NZI5	LB/B	-	S9WEN8	191	N	S
Q9NZI5	LB/B	-	S9WEN8	397	V	I
Q6ISB3	LB/B	-	S9WEN8	415	V	I
Q6ISB3	LP/P	Ectodermal dysplasia/short stature syndrome (ECTDS) [MIM:616029]	S9WEN8	398	Y	H
Q6ISB3	LP/P	Ectodermal dysplasia/short stature syndrome (ECTDS) [MIM:616029]	S9WEN8	482	I	K
P42261	LB/B	-	A0A146YAN7	487	D	N
P42261	LB/B	-	A0A146YAN7	521	P	T
P42261	LB/B	-	A0A146YAN7	536	A	S
P42261	LB/B	-	A0A146YAN7	548	I	M
P42261	LB/B	-	A0A146YAN7	588	F	L
P42261	LP/P	Intellectual developmental disorder, autosomal dominant 67 (MRD67) [MIM:619927]	A0A146YAN7	636	A	T
P42261	LP/P	Intellectual developmental disorder, autosomal dominant 67 (MRD67) [MIM:619927]	A0A146YAN7	627	I	T
P42261	LP/P	Intellectual developmental disorder, autosomal dominant 67 (MRD67) [MIM:619927]	A0A146YAN7	745	G	D
P42262	LB/B	-	A0A146YAN7	607	Q	R
P42262	LB/B	-	A0A146YAN7	608	Q	R
P42262	LP/P	Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB) [MIM:618917]	A0A146YAN7	302	D	G
P42262	LP/P	Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB) [MIM:618917]	A0A146YAN7	528	P	T
P42262	LP/P	Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB) [MIM:618917]	A0A146YAN7	607	Q	E
P42262	LP/P	Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB) [MIM:618917]	A0A146YAN7	609	G	R
P42262	LP/P	Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB) [MIM:618917]	A0A146YAN7	611	D	N
P42262	LP/P	Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB) [MIM:618917]	A0A146YAN7	639	A	S
P42262	LP/P	Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB) [MIM:618917]	A0A146YAN7	644	F	L
P42262	LP/P	Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB) [MIM:618917]	A0A146YAN7	646	T	N
P42262	LP/P	Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB) [MIM:618917]	A0A146YAN7	647	V	L
P42262	LP/P	Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB) [MIM:618917]	A0A146YAN7	776	E	D
P42262	LP/P	Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB) [MIM:618917]	A0A146YAN7	788	W	L
P42262	LP/P	Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB) [MIM:618917]	A0A146YAN7	792	G	V
P42262	LP/P	Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB) [MIM:618917]	A0A146YAN7	807	A	V
P42262	LP/P	Neurodevelopmental disorder with language impairment and behavioral abnormalities (NEDLIB) [MIM:618917]	A0A146YAN7	812	N	S
P42263	LB/B	-	A0A146YAN7	525	F	L
P42263	LP/P	Intellectual developmental disorder, X-linked, syndromic, Wu type (MRXSW) [MIM:300699]	A0A146YAN7	450	R	Q
P42263	LP/P	Intellectual developmental disorder, X-linked, syndromic, Wu type (MRXSW) [MIM:300699]	A0A146YAN7	631	R	S
P42263	LP/P	Intellectual developmental disorder, X-linked, syndromic, Wu type (MRXSW) [MIM:300699]	A0A146YAN7	706	M	T
P42263	LP/P	Intellectual developmental disorder, X-linked, syndromic, Wu type (MRXSW) [MIM:300699]	A0A146YAN7	833	G	R
P48058	LP/P	Neurodevelopmental disorder with or without seizures and gait abnormalities (NEDSGA) [MIM:617864]	A0A146YAN7	639	T	S
P48058	LP/P	Neurodevelopmental disorder with or without seizures and gait abnormalities (NEDSGA) [MIM:617864]	A0A146YAN7	641	N	D
P48058	LP/P	Neurodevelopmental disorder with or without seizures and gait abnormalities (NEDSGA) [MIM:617864]	A0A146YAN7	643	A	G
P48058	LP/P	Neurodevelopmental disorder with or without seizures and gait abnormalities (NEDSGA) [MIM:617864]	A0A146YAN7	644	A	V
A4D2P6	LB/B	-	H9GSG7	20	R	Q
P43250	LB/B	-	A0A091DSK4	73	T	M
P07492	LB/B	-	A0A2J8W3A1	4	R	S
O15499	LB/B	-	A0A1S2ZKM4	47	R	C
O60443	LB/B	-	A0A093IPB1	142	P	T
O60443	LB/B	-	A0A093IPB1	207	V	M
O60443	LB/B	-	A0A093IPB1	174	M	T
P49840	LB/B	-	H0WA52	461	L	F
P49840	LB/B	-	H0WA52	109	Q	E
P00390	LB/B	-	F7P1G1	314	P	H
P00390	LB/B	-	F7P1G1	153	R	C
P00390	LB/B	-	F7P1G1	232	G	S
P00390	LB/B	-	F7P1G1	261	I	V
P00390	LB/B	-	F7P1G1	297	E	D
P00390	LB/B	-	F7P1G1	232	G	R
P00390	LP/P	Hemolytic anemia due to glutathione reductase deficiency (HAGRD) [MIM:618660]	F7P1G1	374	G	A
P48637	LP/P	Glutathione synthetase deficiency (GSS deficiency) [MIM:266130]	A0A1Y1YAF6	26	A	D
P48637	LP/P	Glutathione synthetase deficiency (GSS deficiency) [MIM:266130]	A0A1Y1YAF6	188	L	P
P48637	LP/P	Glutathione synthetase deficiency (GSS deficiency) [MIM:266130]	A0A1Y1YAF6	219	D	A
P48637	LP/P	Glutathione synthetase deficiency (GSS deficiency) [MIM:266130]	A0A1Y1YAF6	219	D	G
P48637	LP/P	Glutathione synthetase deficiency (GSS deficiency) [MIM:266130]	A0A1Y1YAF6	254	L	R
P48637	LP/P	Glutathione synthetase deficiency (GSS deficiency) [MIM:266130]	A0A1Y1YAF6	267	R	W
P48637	LP/P	Glutathione synthetase deficiency (GSS deficiency) [MIM:266130]	A0A1Y1YAF6	270	Y	C
P48637	LP/P	Glutathione synthetase deficiency (GSS deficiency) [MIM:266130]	A0A1Y1YAF6	270	Y	H
P48637	LP/P	Glutathione synthetase deficiency (GSS deficiency) [MIM:266130]	A0A1Y1YAF6	283	R	C
P48637	LP/P	Glutathione synthetase deficiency (GSS deficiency) [MIM:266130]	A0A1Y1YAF6	286	L	Q
P48637	LP/P	Glutathione synthetase deficiency (GSS deficiency) [MIM:266130]	A0A1Y1YAF6	330	R	C
P48637	LP/P	Glutathione synthetase deficiency (GSS deficiency) [MIM:266130]	A0A1Y1YAF6	464	G	V
P48637	LP/P	Glutathione synthetase deficiency (GSS deficiency) [MIM:266130]	A0A1Y1YAF6	469	D	E
P48637	LB/B	-	A0A1Y1YAF6	236	R	Q
P48637	LB/B	-	A0A1Y1YAF6	437	K	E
P48637	LP/P	Glutathione synthetase deficiency (GSS deficiency) [MIM:266130]	A0A1Y1YAF6	301	L	P
P0CG30	LB/B	-	A0A2I3RRQ3	139	M	I
Q00403	LB/B	-	V8PJC2	19	P	S
P29083	LB/B	-	A0A293N7W2	366	P	S
Q13888	LB/B	-	A0A091D6N8	151	I	M
Q13888	LB/B	-	A0A091D6N8	236	V	L
Q9Y5Q8	LB/B	-	C3YTQ9	445	D	N
Q969Y2	LB/B	-	A0A0L0IW61	250	V	A
Q969Y2	LB/B	-	A0A0L0IW61	368	R	H
Q969Y2	LP/P	Combined oxidative phosphorylation deficiency 23 (COXPD23) [MIM:616198]	A0A0L0IW61	142	E	K
Q969Y2	LP/P	Combined oxidative phosphorylation deficiency 23 (COXPD23) [MIM:616198]	A0A0L0IW61	159	E	V
Q969Y2	LP/P	Combined oxidative phosphorylation deficiency 23 (COXPD23) [MIM:616198]	A0A0L0IW61	162	A	P
Q969Y2	LP/P	Combined oxidative phosphorylation deficiency 23 (COXPD23) [MIM:616198]	A0A0L0IW61	222	A	G
Q969Y2	LB/B	-	A0A0L0IW61	225	E	K
Q969Y2	LP/P	Combined oxidative phosphorylation deficiency 23 (COXPD23) [MIM:616198]	A0A0L0IW61	257	P	H
Q969Y2	LB/B	-	A0A0L0IW61	322	A	P
Q969Y2	LP/P	Combined oxidative phosphorylation deficiency 23 (COXPD23) [MIM:616198]	A0A0L0IW61	337	D	H
Q969Y2	LP/P	Combined oxidative phosphorylation deficiency 23 (COXPD23) [MIM:616198]	A0A0L0IW61	459	E	K
Q8N3Z3	LB/B	-	A0A250XXK8	242	Q	H
Q02846	LP/P	Cone-rod dystrophy 6 (CORD6) [MIM:601777]	A0A1U7UBK3	837	E	D
Q02846	LP/P	Cone-rod dystrophy 6 (CORD6) [MIM:601777]	A0A1U7UBK3	838	R	C
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	362	A	S
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	573	I	V
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	565	F	S
Q02846	LB/B	-	A0A1U7UBK3	701	P	S
Q02846	LB/B	-	A0A1U7UBK3	782	L	H
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	858	P	S
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	954	L	P
Q02846	LP/P	Cone-rod dystrophy 6 (CORD6) [MIM:601777]	A0A1U7UBK3	838	R	H
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	105	C	Y
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	325	L	P
Q02846	LB/B	-	A0A1U7UBK3	328	A	V
Q02846	LB/B	-	A0A1U7UBK3	507	V	M
Q02846	LB/B	-	A0A1U7UBK3	693	A	E
Q02846	LB/B	-	A0A1U7UBK3	331	R	S
Q02846	LB/B	-	A0A1U7UBK3	602	R	W
Q02846	LB/B	-	A0A1U7UBK3	722	R	W
Q02846	LB/B	-	A0A1U7UBK3	21	W	R
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	55	T	M
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	103	E	V
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	312	T	M
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	438	R	C
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	640	W	L
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	660	R	Q
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	728	D	H
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	734	I	A
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	768	R	W
Q02846	LP/P	Night blindness, congenital stationary, 1I (CSNB1I) [MIM:618555]	A0A1U7UBK3	768	R	W
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	784	M	R
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	795	R	Q
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	1007	S	L
Q02846	LP/P	Cone-rod dystrophy 6 (CORD6) [MIM:601777]	A0A1U7UBK3	838	R	G
Q02846	LP/P	Cone-rod dystrophy 6 (CORD6) [MIM:601777]	A0A1U7UBK3	838	R	P
Q02846	LP/P	Cone-rod dystrophy 6 (CORD6) [MIM:601777]	A0A1U7UBK3	849	T	A
Q02846	LP/P	Cone-rod dystrophy 6 (CORD6) [MIM:601777]	A0A1U7UBK3	949	I	T
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	710	A	V
Q02846	LP/P	Cone-rod dystrophy 6 (CORD6) [MIM:601777]	A0A1U7UBK3	841	E	K
Q02846	LP/P	Cone-rod dystrophy 6 (CORD6) [MIM:601777]	A0A1U7UBK3	846	K	N
Q02846	LP/P	Cone-rod dystrophy 6 (CORD6) [MIM:601777]	A0A1U7UBK3	873	P	R
Q02846	LP/P	Leber congenital amaurosis 1 (LCA1) [MIM:204000]	A0A1U7UBK3	902	V	L
P51841	LB/B	-	A0A1U7UBK3	284	L	P
P51841	LB/B	-	A0A1U7UBK3	296	R	Q
P51841	LB/B	-	A0A1U7UBK3	308	Y	C
P51841	LB/B	-	A0A1U7UBK3	380	Q	H
P51841	LB/B	-	A0A1U7UBK3	628	R	Q
P51841	LB/B	-	A0A1U7UBK3	40	S	C
P51841	LB/B	-	A0A1U7UBK3	160	I	N
P51841	LB/B	-	A0A1U7UBK3	230	R	W
P51841	LB/B	-	A0A1U7UBK3	305	R	Q
P51841	LB/B	-	A0A1U7UBK3	434	G	R
P51841	LB/B	-	A0A1U7UBK3	677	V	L
P51841	LB/B	-	A0A1U7UBK3	794	E	K
P51841	LB/B	-	A0A1U7UBK3	1010	A	V
P51841	LB/B	-	A0A1U7UBK3	872	G	D
Q9H116	LB/B	-	A0A218UIH2	275	Q	P
Q9H116	LB/B	-	A0A218UIH2	190	N	S
Q9H116	LB/B	-	A0A218UIH2	318	K	N
Q9H116	LB/B	-	A0A218UIH2	667	D	N
Q9H116	LB/B	-	A0A218UIH2	275	Q	L
Q9H116	LB/B	-	A0A218UIH2	275	Q	R
O75409	LB/B	-	A0A2L0PQR3	68	V	I
B0YJ81	LB/B	-	A0A2R9AN45	64	E	K
B0YJ81	LB/B	-	A0A2R9AN45	64	E	Q
B0YJ81	LB/B	-	A0A2R9AN45	70	V	F
B0YJ81	LB/B	-	A0A2R9AN45	227	H	Y
P55084	LP/P	Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]	A0A2R8MNZ2	61	R	H
P55084	LP/P	Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]	A0A2R8MNZ2	247	R	H
P55084	LP/P	Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]	A0A2R8MNZ2	263	D	G
P55084	LP/P	Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]	A0A2R8MNZ2	444	R	K
P55084	LP/P	Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]	A0A2R8MNZ2	59	G	D
P55084	LP/P	Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]	A0A2R8MNZ2	61	R	C
P55084	LP/P	Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]	A0A2R8MNZ2	117	R	G
P55084	LP/P	Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]	A0A2R8MNZ2	121	L	P
P55084	LP/P	Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]	A0A2R8MNZ2	133	T	P
P55084	LP/P	Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]	A0A2R8MNZ2	242	D	G
P55084	LP/P	Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]	A0A2R8MNZ2	280	G	D
P55084	LP/P	Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]	A0A2R8MNZ2	294	P	L
P55084	LP/P	Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]	A0A2R8MNZ2	294	P	R
P55084	LP/P	Mitochondrial trifunctional protein deficiency (MTPD) [MIM:609015]	A0A2R8MNZ2	301	G	S
P55084	LB/B	-	A0A2R8MNZ2	209	P	S
P55084	LB/B	-	A0A2R8MNZ2	277	K	R
P42357	LB/B	-	A0A2D0T469	439	V	I
P42357	LP/P	Histidinemia (HISTID) [MIM:235800]	A0A2D0T469	206	R	T
P42357	LP/P	Histidinemia (HISTID) [MIM:235800]	A0A2D0T469	208	R	L
P42357	LP/P	Histidinemia (HISTID) [MIM:235800]	A0A2D0T469	259	P	L
P42357	LP/P	Histidinemia (HISTID) [MIM:235800]	A0A2D0T469	322	R	P
Q7Z4H7	LB/B	-	K7FRG3	674	H	Q
Q7Z4H7	LB/B	-	K7FRG3	761	S	I
Q7Z4H7	LB/B	-	K7FRG3	552	S	T
P69905	LB/B	-	A0A1K0FU75	2	V	E
P69905	LB/B	-	A0A1K0FU75	3	L	R
P69905	LB/B	-	A0A1K0FU75	6	A	D
P69905	LB/B	-	A0A1K0FU75	6	A	P
P69905	LB/B	-	A0A1K0FU75	7	D	A
P69905	LB/B	-	A0A1K0FU75	7	D	G
P69905	LB/B	-	A0A1K0FU75	7	D	N
P69905	LB/B	-	A0A1K0FU75	7	D	V
P69905	LB/B	-	A0A1K0FU75	7	D	Y
P69905	LB/B	-	A0A1K0FU75	8	K	E
P69905	LB/B	-	A0A1K0FU75	12	K	E
P69905	LB/B	-	A0A1K0FU75	13	A	D
P69905	LB/B	-	A0A1K0FU75	15	W	R
P69905	LB/B	-	A0A1K0FU75	16	G	R
P69905	LB/B	-	A0A1K0FU75	17	K	M
P69905	LB/B	-	A0A1K0FU75	17	K	N
P69905	LB/B	-	A0A1K0FU75	19	G	D
P69905	LB/B	-	A0A1K0FU75	19	G	R
P69905	LB/B	-	A0A1K0FU75	20	A	E
P69905	LB/B	-	A0A1K0FU75	21	H	Q
P69905	LB/B	-	A0A1K0FU75	21	H	R
P69905	LB/B	-	A0A1K0FU75	22	A	D
P69905	LB/B	-	A0A1K0FU75	22	A	P
P69905	LB/B	-	A0A1K0FU75	23	G	D
P69905	LB/B	-	A0A1K0FU75	24	E	G
P69905	LB/B	-	A0A1K0FU75	24	E	K
P69905	LB/B	-	A0A1K0FU75	25	Y	H
P69905	LB/B	-	A0A1K0FU75	27	A	E
P69905	LB/B	-	A0A1K0FU75	28	E	D
P69905	LB/B	-	A0A1K0FU75	28	E	G
P69905	LB/B	-	A0A1K0FU75	28	E	V
P69905	LB/B	-	A0A1K0FU75	31	E	K
P69905	LB/B	-	A0A1K0FU75	32	R	S
P69905	LB/B	-	A0A1K0FU75	35	L	R
P69905	LB/B	-	A0A1K0FU75	38	P	R
P69905	LB/B	-	A0A1K0FU75	41	K	M
P69905	LB/B	-	A0A1K0FU75	42	T	S
P69905	LB/B	-	A0A1K0FU75	44	F	L
P69905	LB/B	-	A0A1K0FU75	45	P	L
P69905	LB/B	-	A0A1K0FU75	45	P	R
P69905	LB/B	-	A0A1K0FU75	46	H	Q
P69905	LB/B	-	A0A1K0FU75	46	H	R
P69905	LB/B	-	A0A1K0FU75	48	D	A
P69905	LB/B	-	A0A1K0FU75	48	D	G
P69905	LB/B	-	A0A1K0FU75	48	D	H
P69905	LB/B	-	A0A1K0FU75	48	D	Y
P69905	LB/B	-	A0A1K0FU75	49	L	R
P69905	LB/B	-	A0A1K0FU75	50	S	R
P69905	LB/B	-	A0A1K0FU75	51	H	R
P69905	LB/B	-	A0A1K0FU75	52	G	D
P69905	LB/B	-	A0A1K0FU75	52	G	R
P69905	LB/B	-	A0A1K0FU75	54	A	D
P69905	LB/B	-	A0A1K0FU75	55	Q	R
P69905	LB/B	-	A0A1K0FU75	57	K	R
P69905	LB/B	-	A0A1K0FU75	57	K	T
P69905	LB/B	-	A0A1K0FU75	58	G	R
P69905	LB/B	-	A0A1K0FU75	59	H	Y
P69905	LB/B	-	A0A1K0FU75	60	G	D
P69905	LB/B	-	A0A1K0FU75	60	G	V
P69905	LB/B	-	A0A1K0FU75	61	K	N
P69905	LB/B	-	A0A1K0FU75	62	K	N
P69905	LB/B	-	A0A1K0FU75	62	K	T
P69905	LB/B	-	A0A1K0FU75	63	V	M
P69905	LB/B	-	A0A1K0FU75	64	A	D
P69905	LB/B	-	A0A1K0FU75	65	D	Y
P69905	LB/B	-	A0A1K0FU75	69	N	K
P69905	LB/B	-	A0A1K0FU75	72	A	E
P69905	LB/B	-	A0A1K0FU75	72	A	V
P69905	LB/B	-	A0A1K0FU75	73	H	R
P69905	LB/B	-	A0A1K0FU75	75	D	A
P69905	LB/B	-	A0A1K0FU75	75	D	G
P69905	LB/B	-	A0A1K0FU75	75	D	N
P69905	LB/B	-	A0A1K0FU75	76	D	A
P69905	LB/B	-	A0A1K0FU75	76	D	H
P69905	LB/B	-	A0A1K0FU75	77	M	K
P69905	LB/B	-	A0A1K0FU75	77	M	T
P69905	LB/B	-	A0A1K0FU75	78	P	R
P69905	LB/B	-	A0A1K0FU75	79	N	H
P69905	LB/B	-	A0A1K0FU75	79	N	K
P69905	LB/B	-	A0A1K0FU75	81	L	R
P69905	LB/B	-	A0A1K0FU75	82	S	C
P69905	LB/B	-	A0A1K0FU75	83	A	D
P69905	LB/B	-	A0A1K0FU75	85	S	R
P69905	LB/B	-	A0A1K0FU75	86	D	V
P69905	LB/B	-	A0A1K0FU75	86	D	Y
P69905	LB/B	-	A0A1K0FU75	87	L	R
P69905	LB/B	-	A0A1K0FU75	88	H	N
P69905	LB/B	-	A0A1K0FU75	88	H	R
P69905	LB/B	-	A0A1K0FU75	89	A	S
P69905	LB/B	-	A0A1K0FU75	91	K	M
P69905	LB/B	-	A0A1K0FU75	92	L	P
P69905	LB/B	-	A0A1K0FU75	93	R	Q
P69905	LB/B	-	A0A1K0FU75	95	D	Y
P69905	LB/B	-	A0A1K0FU75	96	P	A
P69905	LB/B	-	A0A1K0FU75	96	P	T
P69905	LB/B	-	A0A1K0FU75	98	N	K
P69905	LB/B	-	A0A1K0FU75	100	K	E
P69905	LB/B	-	A0A1K0FU75	103	S	R
P69905	LB/B	-	A0A1K0FU75	104	H	R
P69905	LB/B	-	A0A1K0FU75	110	L	R
P69905	LB/B	-	A0A1K0FU75	111	A	D
P69905	LB/B	-	A0A1K0FU75	113	H	D
P69905	LB/B	-	A0A1K0FU75	114	L	H
P69905	LB/B	-	A0A1K0FU75	115	P	L
P69905	LB/B	-	A0A1K0FU75	115	P	R
P69905	LB/B	-	A0A1K0FU75	115	P	S
P69905	LB/B	-	A0A1K0FU75	116	A	D
P69905	LB/B	-	A0A1K0FU75	117	E	A
P69905	LB/B	-	A0A1K0FU75	121	A	E
P69905	LB/B	-	A0A1K0FU75	122	V	M
P69905	LB/B	-	A0A1K0FU75	123	H	Q
P69905	LB/B	-	A0A1K0FU75	126	L	P
P69905	LB/B	-	A0A1K0FU75	127	D	V
P69905	LB/B	-	A0A1K0FU75	127	D	Y
P69905	LB/B	-	A0A1K0FU75	128	K	N
P69905	LB/B	-	A0A1K0FU75	130	L	P
P69905	LB/B	-	A0A1K0FU75	131	A	P
P69905	LB/B	-	A0A1K0FU75	131	A	D
P69905	LB/B	-	A0A1K0FU75	132	S	P
P69905	LB/B	-	A0A1K0FU75	134	S	R
P69905	LB/B	-	A0A1K0FU75	136	V	E
P69905	LB/B	-	A0A1K0FU75	137	L	M
P69905	LB/B	-	A0A1K0FU75	137	L	P
P69905	LB/B	-	A0A1K0FU75	139	S	P
P69905	LB/B	-	A0A1K0FU75	140	K	E
P69905	LB/B	-	A0A1K0FU75	140	K	T
P69905	LB/B	-	A0A1K0FU75	141	Y	H
P69905	LB/B	-	A0A1K0FU75	142	R	C
P69905	LB/B	-	A0A1K0FU75	142	R	L
P69905	LB/B	-	A0A1K0FU75	142	R	H
P69905	LB/B	-	A0A1K0FU75	142	R	P
P69905	LB/B	-	A0A1K0FU75	80	A	G
P69905	LB/B	-	A0A1K0FU75	93	R	W
P69905	LB/B	-	A0A1K0FU75	32	R	K
P69905	LB/B	-	A0A1K0FU75	27	A	V
P69905	LB/B	-	A0A1K0FU75	59	H	Q
P69905	LB/B	-	A0A1K0FU75	95	D	A
P69905	LB/B	-	A0A1K0FU75	104	H	Y
P69905	LB/B	-	A0A1K0FU75	126	L	R
P69905	LB/B	-	A0A1K0FU75	127	D	G
P69905	LB/B	-	A0A1K0FU75	137	L	R
P69905	LB/B	-	A0A1K0FU75	10	N	T
P69905	LB/B	-	A0A1K0FU75	14	A	P
P69905	LB/B	-	A0A1K0FU75	92	L	F
P14317	LB/B	-	A0A2U9B2K8	235	T	A
P14317	LB/B	-	A0A2U9B2K8	361	E	K
P14317	LB/B	-	A0A2U9B2K8	436	V	L
P56524	LB/B	-	A0A2Y9KWM3	754	V	I
P56524	LP/P	Neurodevelopmental disorder with central hypotonia and dysmorphic facies (NEDCHF) [MIM:619797]	A0A2Y9KWM3	244	T	K
P56524	LP/P	Neurodevelopmental disorder with central hypotonia and dysmorphic facies (NEDCHF) [MIM:619797]	A0A2Y9KWM3	247	E	G
P56524	LP/P	Neurodevelopmental disorder with central hypotonia and dysmorphic facies (NEDCHF) [MIM:619797]	A0A2Y9KWM3	248	P	A
P56524	LP/P	Neurodevelopmental disorder with central hypotonia and dysmorphic facies (NEDCHF) [MIM:619797]	A0A2Y9KWM3	248	P	L
Q9UBN7	LB/B	-	L8XYU0	994	T	I
Q9UBN7	LB/B	-	L8XYU0	1200	N	D
Q9BY41	LP/P	Cornelia de Lange syndrome 5 (CDLS5) [MIM:300882]	A0A0V1F9E9	180	H	R
Q9BY41	LP/P	Cornelia de Lange syndrome 5 (CDLS5) [MIM:300882]	A0A0V1F9E9	311	T	M
Q9BY41	LP/P	Cornelia de Lange syndrome 5 (CDLS5) [MIM:300882]	A0A0V1F9E9	320	G	R
Q9BY41	LP/P	Cornelia de Lange syndrome 5 (CDLS5) [MIM:300882]	A0A0V1F9E9	334	H	R
Q9UKV0	LB/B	-	A0A2Y9KWM3	921	P	T
P19113	LB/B	-	A0A218V865	644	E	D
P19113	LB/B	-	A0A218V865	31	T	M
P19113	LB/B	-	A0A218V865	553	F	L
Q5TGJ6	LB/B	-	G3SPW3	87	T	M
Q7Z353	LB/B	-	A0A2K6CAW9	193	A	T
Q7Z353	LB/B	-	A0A2K6CAW9	397	F	S
A2RTY3	LB/B	-	I3N7C9	480	S	F
Q5U5R9	LB/B	-	A0A2D4JWY8	19	P	A
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	42	E	A
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	60	W	G
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	62	Y	C
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	97	W	G
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	122	A	D
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	153	D	G
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	161	G	R
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	189	S	I
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	216	I	T
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	225	R	H
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	227	F	S
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	230	P	S
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	230	P	T
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	291	D	E
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	300	V	G
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	368	M	V
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	330	R	S
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	371	H	R
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	25	L	P
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	168	E	K
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	270	G	R
Q93099	LB/B	-	G1SWC0	80	Q	H
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	3	E	A
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	13	E	K
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	18	D	N
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	33	Q	R
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	44	L	F
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	53	R	Q
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	61	L	P
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	73	F	L
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	92	P	T
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	97	W	R
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	115	G	R
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	116	L	P
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	120	C	F
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	120	C	W
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	122	A	V
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	123	G	A
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	123	G	R
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	137	L	P
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	152	G	A
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	158	P	L
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	168	E	D
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	169	F	L
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	171	K	N
Q93099	LB/B	-	G1SWC0	172	M	T
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	178	E	G
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	183	Q	R
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	187	R	G
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	197	R	G
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	217	G	W
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	219	N	S
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	225	R	L
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	225	R	P
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	245	V	F
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	258	Q	P
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	269	H	R
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	276	K	N
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	321	R	P
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	329	F	C
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	337	N	D
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	359	P	L
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	360	G	A
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	360	G	R
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	361	G	R
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	362	G	E
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	369	T	N
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	373	P	L
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	374	D	H
Q93099	LP/P	Alkaptonuria (AKU) [MIM:203500]	G1SWC0	401	E	Q
O14964	LB/B	-	A0A1A8RX28	400	E	D
O14964	LB/B	-	A0A1A8RX28	7	T	S
O14964	LB/B	-	A0A1A8RX28	733	A	S
Q14526	LB/B	-	Z4YJP0	725	R	G
O75146	LB/B	-	A0A1S3FQ70	782	V	M
O75146	LB/B	-	A0A1S3FQ70	404	K	Q
O75146	LB/B	-	A0A1S3FQ70	516	K	Q
O75146	LB/B	-	A0A1S3FQ70	943	N	S
O75146	LB/B	-	A0A1S3FQ70	345	N	S
Q8NCD3	LB/B	-	A0A1S3G0B7	4	T	A
Q8NCD3	LB/B	-	A0A1S3G0B7	548	S	T
Q8NCD3	LB/B	-	A0A1S3G0B7	549	S	C
Q8NCD3	LB/B	-	A0A1S3G0B7	568	E	D
Q8NCD3	LB/B	-	A0A1S3G0B7	691	S	F
Q8NCD3	LB/B	-	A0A1S3G0B7	76	E	K
Q8NCD3	LB/B	-	A0A1S3G0B7	199	R	G
Q8NCD3	LB/B	-	A0A1S3G0B7	295	S	C
Q8NCD3	LB/B	-	A0A1S3G0B7	723	E	G
P04439	LB/B	-	C6L2H7	3	V	I
P04439	LB/B	-	C6L2H7	5	A	P
P04439	LB/B	-	C6L2H7	10	L	V
P04439	LB/B	-	C6L2H7	14	S	L
P04439	LB/B	-	C6L2H7	23	W	R
P04439	LB/B	-	C6L2H7	33	F	S
P04439	LB/B	-	C6L2H7	33	F	T
P04439	LB/B	-	C6L2H7	33	F	Y
P04439	LB/B	-	C6L2H7	41	R	S
P04439	LB/B	-	C6L2H7	55	T	S
P04439	LB/B	-	C6L2H7	59	R	Q
P04439	LB/B	-	C6L2H7	67	Q	R
P04439	LB/B	-	C6L2H7	68	R	K
P04439	LB/B	-	C6L2H7	80	G	E
P04439	LB/B	-	C6L2H7	80	G	R
P04439	LB/B	-	C6L2H7	86	Q	E
P04439	LB/B	-	C6L2H7	86	Q	G
P04439	LB/B	-	C6L2H7	86	Q	L
P04439	LB/B	-	C6L2H7	86	Q	R
P04439	LB/B	-	C6L2H7	87	E	N
P04439	LB/B	-	C6L2H7	87	E	Q
P04439	LB/B	-	C6L2H7	89	R	G
P04439	LB/B	-	C6L2H7	90	N	K
P04439	LB/B	-	C6L2H7	91	V	M
P04439	LB/B	-	C6L2H7	94	Q	H
P04439	LB/B	-	C6L2H7	97	T	I
P04439	LB/B	-	C6L2H7	98	D	H
P04439	LB/B	-	C6L2H7	98	D	N
P04439	LB/B	-	C6L2H7	100	V	A
P04439	LB/B	-	C6L2H7	100	V	E
P04439	LB/B	-	C6L2H7	101	D	N
P04439	LB/B	-	C6L2H7	101	D	S
P04439	LB/B	-	C6L2H7	114	A	D
P04439	LB/B	-	C6L2H7	119	I	L
P04439	LB/B	-	C6L2H7	119	I	V
P04439	LB/B	-	C6L2H7	121	I	M
P04439	LB/B	-	C6L2H7	121	I	R
P04439	LB/B	-	C6L2H7	123	Y	F
P04439	LB/B	-	C6L2H7	129	S	P
P04439	LB/B	-	C6L2H7	131	G	W
P04439	LB/B	-	C6L2H7	133	F	L
P04439	LB/B	-	C6L2H7	138	R	E
P04439	LB/B	-	C6L2H7	138	R	H
P04439	LB/B	-	C6L2H7	138	R	Q
P04439	LB/B	-	C6L2H7	140	D	H
P04439	LB/B	-	C6L2H7	140	D	Y
P04439	LB/B	-	C6L2H7	151	N	K
P04439	LB/B	-	C6L2H7	166	I	T
P04439	LB/B	-	C6L2H7	168	K	Q
P04439	LB/B	-	C6L2H7	169	R	H
P04439	LB/B	-	C6L2H7	173	A	T
P04439	LB/B	-	C6L2H7	174	A	V
P04439	LB/B	-	C6L2H7	175	H	R
P04439	LB/B	-	C6L2H7	176	E	A
P04439	LB/B	-	C6L2H7	176	E	R
P04439	LB/B	-	C6L2H7	176	E	V
P04439	LB/B	-	C6L2H7	176	E	W
P04439	LB/B	-	C6L2H7	180	L	Q
P04439	LB/B	-	C6L2H7	180	L	R
P04439	LB/B	-	C6L2H7	180	L	W
P04439	LB/B	-	C6L2H7	182	A	V
P04439	LB/B	-	C6L2H7	185	D	E
P04439	LB/B	-	C6L2H7	187	T	E
P04439	LB/B	-	C6L2H7	187	T	R
P04439	LB/B	-	C6L2H7	190	E	D
P04439	LB/B	-	C6L2H7	191	W	G
P04439	LB/B	-	C6L2H7	195	Y	H
P04439	LB/B	-	C6L2H7	208	P	A
P04439	LB/B	-	C6L2H7	210	K	R
P04439	LB/B	-	C6L2H7	217	P	A
P04439	LB/B	-	C6L2H7	218	I	V
P04439	LB/B	-	C6L2H7	231	G	S
P04439	LB/B	-	C6L2H7	269	A	V
P04439	LB/B	-	C6L2H7	270	A	S
P04439	LB/B	-	C6L2H7	277	E	K
P04439	LB/B	-	C6L2H7	277	E	Q
P04439	LB/B	-	C6L2H7	279	Q	K
P04439	LB/B	-	C6L2H7	292	K	E
P04439	LB/B	-	C6L2H7	300	L	P
P04439	LB/B	-	C6L2H7	306	I	V
P04439	LB/B	-	C6L2H7	307	P	H
P04439	LB/B	-	C6L2H7	312	I	L
P04439	LB/B	-	C6L2H7	318	L	F
P04439	LB/B	-	C6L2H7	321	V	M
P04439	LB/B	-	C6L2H7	322	I	F
P04439	LB/B	-	C6L2H7	323	T	A
P04439	LB/B	-	C6L2H7	331	M	R
P04439	LB/B	-	C6L2H7	334	R	K
P04439	LB/B	-	C6L2H7	335	K	N
P04439	LB/B	-	C6L2H7	338	D	V
P04439	LB/B	-	C6L2H7	345	T	S
P04439	LB/B	-	C6L2H7	358	V	M
P28067	LB/B	-	Q31107	162	H	Q
P28067	LB/B	-	Q31107	163	D	H
P28067	LB/B	-	Q31107	166	V	I
P28067	LB/B	-	Q31107	181	G	A
P28067	LB/B	-	Q31107	210	R	C
P28067	LB/B	-	Q31107	210	R	H
P28067	LB/B	-	Q31107	235	V	M
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	174	F	L
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	54	V	M
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	167	Y	C
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	212	G	R
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	500	R	H
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	112	R	W
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	144	V	L
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	168	G	S
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	169	G	D
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	185	W	R
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	188	R	H
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	232	G	V
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	266	L	S
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	307	M	T
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	360	S	P
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	388	G	R
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	470	F	T
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	503	Y	C
P54868	LP/P	3-hydroxy-3-methylglutaryl-CoA synthase-2 deficiency (HMGCS2D) [MIM:605911]	H2QQU5	505	R	Q
Q86VS8	LB/B	-	A0A091DSE3	670	Y	S
P09629	LB/B	-	W5U710	9	T	A
P35452	LB/B	-	M3ZDX6	186	R	Q
P84074	LB/B	-	G1T5W9	21	E	D
P84074	LP/P	Dystonia 2, torsion, autosomal recessive (DYT2) [MIM:224500]	G1T5W9	71	T	N
P84074	LP/P	Dystonia 2, torsion, autosomal recessive (DYT2) [MIM:224500]	G1T5W9	75	N	K
P84074	LP/P	Dystonia 2, torsion, autosomal recessive (DYT2) [MIM:224500]	G1T5W9	190	A	T
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	7	G	D
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	8	V	G
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	16	G	D
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	16	G	S
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	20	D	V
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	23	C	W
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	41	L	P
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	42	I	F
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	42	I	T
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	45	R	K
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	48	R	H
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	50	A	V
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	50	A	P
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	51	R	G
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	51	R	P
P00492	LB/B	-	L5JYD8	52	D	G
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	53	V	A
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	53	V	M
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	54	M	L
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	57	M	T
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	58	G	R
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	70	G	E
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	71	G	R
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	74	F	L
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	78	L	V
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	80	D	V
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	104	S	R
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	110	S	L
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	130	V	D
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	131	L	S
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	132	I	M
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	132	I	T
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	135	D	G
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	143	M	K
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	161	A	S
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	162	S	R
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	168	T	I
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	176	P	L
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	177	D	V
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	177	D	Y
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	188	V	A
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	188	V	A
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	183	I	T
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	194	D	E
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	194	D	N
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	195	Y	C
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	199	F	V
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	201	D	G
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	201	D	N
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	201	D	Y
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	204	H	D
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	204	H	R
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	206	C	Y
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	23	C	F
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	44	D	Y
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	60	H	R
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	64	A	P
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	65	L	P
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	72	Y	C
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	78	L	Q
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	124	T	P
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	147	L	P
P00492	LP/P	Lesch-Nyhan syndrome (LNS) [MIM:300322]	L5JYD8	159	K	E
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	185	D	G
P00492	LP/P	Hyperuricemia, HPRT-related (HRH) [MIM:300323]	L5JYD8	192	A	V
Q969F9	LP/P	Hermansky-Pudlak syndrome 3 (HPS3) [MIM:614072]	A0A091N8W5	397	R	W
Q969F9	LB/B	-	A0A091N8W5	275	E	K
Q9UPZ3	LB/B	-	A0A1A7WQF2	417	L	M
Q9UPZ3	LP/P	Hermansky-Pudlak syndrome 5 (HPS5) [MIM:614074]	A0A1A7WQF2	624	L	R
Q9UPZ3	LP/P	Hermansky-Pudlak syndrome 5 (HPS5) [MIM:614074]	A0A1A7WQF2	1098	T	I
O43593	LB/B	-	I3MRP4	620	R	Q
O43593	LP/P	Alopecia universalis congenita (ALUNC) [MIM:203655]	I3MRP4	1022	T	A
O43593	LP/P	Alopecia universalis congenita (ALUNC) [MIM:203655]	I3MRP4	1136	V	D
O43593	LP/P	Alopecia universalis congenita (ALUNC) [MIM:203655]	I3MRP4	1012	D	N
O43593	LB/B	-	I3MRP4	337	G	D
O43593	LB/B	-	I3MRP4	924	P	L
O43593	LB/B	-	I3MRP4	526	L	P
Q8N3J3	LB/B	-	A0A0G2K9P1	126	T	P
Q53T59	LB/B	-	A0A0A0AH91	260	V	M
Q53T59	LB/B	-	A0A0A0AH91	273	G	R
Q53T59	LB/B	-	A0A0A0AH91	348	P	R
Q53T59	LB/B	-	A0A0A0AH91	388	A	T
Q8IZP7	LB/B	-	A0A1W4Z2L6	265	K	R
Q53GQ0	LB/B	-	A0A2K6ME15	280	S	L
Q9BPX1	LB/B	-	A0A146NDX8	31	N	D
Q9BPX1	LB/B	-	A0A146NDX8	130	R	W
Q16082	LB/B	-	G3H2H3	111	G	S
P28223	LB/B	-	G1KQ18	25	T	N
P28223	LB/B	-	G1KQ18	452	H	Y
P28223	LB/B	-	G1KQ18	197	I	V
P28223	LB/B	-	G1KQ18	447	A	V
O95264	LB/B	-	F1QMX1	129	Y	S
O95264	LB/B	-	F1QMX1	143	I	T
O95264	LB/B	-	F1QMX1	156	S	R
O95264	LB/B	-	F1QMX1	183	V	I
Q13639	LB/B	-	A0A2U4AHM9	372	C	Y
P34969	LB/B	-	G7PDI9	92	T	K
P34969	LB/B	-	G7PDI9	279	P	L
P34969	LB/B	-	G7PDI9	448	P	Q
O60921	LB/B	-	A0A2Y9KRK0	147	Q	K
O60921	LB/B	-	A0A2Y9KRK0	221	D	E
O60921	LB/B	-	A0A2Y9KRK0	126	S	G
Q8NHY5	LB/B	-	G1TRN1	268	D	Y
Q8NHY5	LB/B	-	G1TRN1	130	H	Q
Q8NHY5	LB/B	-	G1TRN1	201	Q	R
Q9BYI3	LP/P	Leukodystrophy, hypomyelinating, 5 (HLD5) [MIM:610532]	F7E110	53	L	P
Q9BYI3	LP/P	Leukodystrophy, hypomyelinating, 5 (HLD5) [MIM:610532]	F7E110	57	C	R
Q9BYI3	LB/B	-	F7E110	217	R	Q
P41252	LB/B	-	F6X341	769	M	I
P41252	LB/B	-	F6X341	1182	K	E
P41252	LB/B	-	F6X341	684	T	M
P41252	LB/B	-	F6X341	302	N	Y
P41252	LB/B	-	F6X341	1188	M	T
P41252	LP/P	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy (GRIDHH) [MIM:617093]	F6X341	370	V	G
P41252	LP/P	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy (GRIDHH) [MIM:617093]	F6X341	437	P	L
P41252	LP/P	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy (GRIDHH) [MIM:617093]	F6X341	992	N	D
P41252	LP/P	Growth retardation, impaired intellectual development, hypotonia, and hepatopathy (GRIDHH) [MIM:617093]	F6X341	1174	I	N
Q9P2D0	LB/B	-	A0A2K6GZK0	1065	V	I
Q9P2D0	LB/B	-	A0A2K6GZK0	1185	A	V
Q9BYX4	LB/B	-	A0A091GDF2	843	H	R
Q9BYX4	LB/B	-	A0A091GDF2	946	A	T
Q9BYX4	LB/B	-	A0A091GDF2	460	H	R
Q9BYX4	LP/P	Aicardi-Goutieres syndrome 7 (AGS7) [MIM:615846]	A0A091GDF2	337	R	G
Q9BYX4	LP/P	Aicardi-Goutieres syndrome 7 (AGS7) [MIM:615846]	A0A091GDF2	372	L	F
Q9BYX4	LP/P	Aicardi-Goutieres syndrome 7 (AGS7) [MIM:615846]	A0A091GDF2	393	D	V
Q9BYX4	LP/P	Aicardi-Goutieres syndrome 7 (AGS7) [MIM:615846]	A0A091GDF2	452	A	T
Q9BYX4	LP/P	Aicardi-Goutieres syndrome 7 (AGS7) [MIM:615846]	A0A091GDF2	495	G	R
Q9BYX4	LP/P	Aicardi-Goutieres syndrome 7 (AGS7) [MIM:615846]	A0A091GDF2	720	R	Q
Q9BYX4	LP/P	Aicardi-Goutieres syndrome 7 (AGS7) [MIM:615846]	A0A091GDF2	779	R	C
Q9BYX4	LP/P	Aicardi-Goutieres syndrome 7 (AGS7) [MIM:615846]	A0A091GDF2	779	R	H
Q9BYX4	LP/P	Singleton-Merten syndrome 1 (SGMRT1) [MIM:182250]	A0A091GDF2	822	R	Q
Q9BYX4	LP/P	Immunodeficiency 95 (IMD95) [MIM:619773]	A0A091GDF2	365	K	E
Q8IU54	LB/B	-	H0XJU8	188	N	D
Q8IZJ0	LB/B	-	H0XJU8	10	T	M
Q8IZJ0	LB/B	-	H0XJU8	112	T	A
Q8IZI9	LB/B	-	H0XJU8	28	R	H
Q8IZI9	LB/B	-	H0XJU8	70	K	R
Q9UG01	LB/B	-	A0A0L0HV32	953	R	H
Q9UG01	LP/P	Short-rib thoracic dysplasia 10 with or without polydactyly (SRTD10) [MIM:615630]	A0A0L0HV32	296	R	W
Q9UG01	LP/P	Short-rib thoracic dysplasia 10 with or without polydactyly (SRTD10) [MIM:615630]	A0A0L0HV32	411	I	N
Q9UG01	LP/P	Short-rib thoracic dysplasia 10 with or without polydactyly (SRTD10) [MIM:615630]	A0A0L0HV32	1536	L	P
Q9UG01	LP/P	Short-rib thoracic dysplasia 10 with or without polydactyly (SRTD10) [MIM:615630]	A0A0L0HV32	1544	R	C
Q9UG01	LP/P	Short-rib thoracic dysplasia 10 with or without polydactyly (SRTD10) [MIM:615630]	A0A0L0HV32	1727	C	R
Q9UG01	LP/P	Retinitis pigmentosa 71 (RP71) [MIM:616394]	A0A0L0HV32	257	L	P
Q9UG01	LP/P	Bardet-Biedl syndrome 20 (BBS20) [MIM:619471]	A0A0L0HV32	1567	H	Q
Q9UG01	LP/P	Retinitis pigmentosa 71 (RP71) [MIM:616394]	A0A0L0HV32	1605	D	E
Q9P2H3	LP/P	Short-rib thoracic dysplasia 2 with or without polydactyly (SRTD2) [MIM:611263]	T1HYQ8	105	H	Q
Q9P2H3	LB/B	-	T1HYQ8	586	T	S
Q9P2H3	LP/P	Short-rib thoracic dysplasia 2 with or without polydactyly (SRTD2) [MIM:611263]	T1HYQ8	701	A	P
P08069	LB/B	-	Q4S8B8	388	V	M
P08069	LB/B	-	Q4S8B8	605	R	H
P08069	LP/P	Insulin-like growth factor 1 resistance (IGF1RES) [MIM:270450]	Q4S8B8	138	R	Q
P08069	LP/P	Insulin-like growth factor 1 resistance (IGF1RES) [MIM:270450]	Q4S8B8	145	K	N
P08069	LB/B	-	Q4S8B8	437	R	H
P08069	LB/B	-	Q4S8B8	511	R	Q
P08069	LP/P	Insulin-like growth factor 1 resistance (IGF1RES) [MIM:270450]	Q4S8B8	739	R	Q
P08069	LB/B	-	Q4S8B8	808	H	R
P08069	LB/B	-	Q4S8B8	828	A	T
P08069	LB/B	-	Q4S8B8	595	R	H
P08069	LB/B	-	Q4S8B8	857	N	S
P08069	LB/B	-	Q4S8B8	1338	A	T
P08069	LP/P	Insulin-like growth factor 1 resistance (IGF1RES) [MIM:270450]	Q4S8B8	359	N	Y
P08069	LP/P	Insulin-like growth factor 1 resistance (IGF1RES) [MIM:270450]	Q4S8B8	865	Y	C
P08069	LP/P	Insulin-like growth factor 1 resistance (IGF1RES) [MIM:270450]	Q4S8B8	1256	R	S
Q8N6C5	LB/B	-	A0A2U3Z0X7	381	N	H
Q8N6C5	LP/P	Hypothyroidism, central, and testicular enlargement (CHTE) [MIM:300888]	A0A2U3Z0X7	765	S	N
Q8N6C5	LP/P	Hypothyroidism, central, and testicular enlargement (CHTE) [MIM:300888]	A0A2U3Z0X7	858	S	F
Q8N6C5	LP/P	Hypothyroidism, central, and testicular enlargement (CHTE) [MIM:300888]	A0A2U3Z0X7	942	C	R
Q8N6C5	LB/B	-	A0A2U3Z0X7	774	E	G
Q96ID5	LB/B	-	A0A1S3LEV9	245	R	H
Q96ID5	LB/B	-	A0A1S3LEV9	379	T	M
Q14626	LB/B	-	L9L977	65	P	T
Q14626	LB/B	-	L9L977	395	R	W
Q14626	LP/P	Craniosynostosis and dental anomalies (CRSDA) [MIM:614188]	L9L977	221	P	R
Q14626	LP/P	Craniosynostosis and dental anomalies (CRSDA) [MIM:614188]	L9L977	245	S	C
Q14626	LP/P	Craniosynostosis and dental anomalies (CRSDA) [MIM:614188]	L9L977	296	R	W
P29460	LB/B	-	A0A093I4F7	33	V	I
P29460	LB/B	-	A0A093I4F7	298	V	F
P42701	LB/B	-	G3W2F7	365	M	T
P42701	LB/B	-	G3W2F7	378	G	R
P42701	LP/P	Immunodeficiency 30 (IMD30) [MIM:614891]	G3W2F7	213	R	W
P42701	LB/B	-	G3W2F7	3	P	Q
P42701	LB/B	-	G3W2F7	47	P	S
P42701	LB/B	-	G3W2F7	156	R	H
P42701	LB/B	-	G3W2F7	214	Q	R
P42701	LB/B	-	G3W2F7	339	H	Q
Q9NRM6	LB/B	-	F6Q0J4	278	F	L
Q9NRM6	LB/B	-	F6Q0J4	451	I	T
Q9NRM6	LB/B	-	F6Q0J4	458	N	S
Q9NRM6	LB/B	-	F6Q0J4	499	C	R
Q9NRM6	LB/B	-	F6Q0J4	209	A	V
Q9NRM6	LB/B	-	F6Q0J4	232	R	Q
Q9NRM6	LB/B	-	F6Q0J4	177	G	R
Q8NFR9	LB/B	-	H0X4Z5	219	Y	C
Q8NFR9	LB/B	-	H0X4Z5	402	P	S
Q8NFR9	LB/B	-	H0X4Z5	417	S	T
Q8WWZ1	LB/B	-	A0A2Y9QB49	44	I	T
Q8WWZ1	LB/B	-	A0A2Y9QB49	51	A	D
P01589	LB/B	-	A0A2Y9HSN3	272	I	T
P01589	LP/P	Immunodeficiency 41 with lymphoproliferation and autoimmunity (IMD41) [MIM:606367]	A0A2Y9HSN3	41	Y	S
P01589	LP/P	Immunodeficiency 41 with lymphoproliferation and autoimmunity (IMD41) [MIM:606367]	A0A2Y9HSN3	166	S	N
Q9NZH7	LB/B	-	G7NAY6	36	R	C
P08887	LB/B	-	A0A286X8K1	358	D	A
P08887	LB/B	-	A0A286X8K1	385	V	I
P08887	LP/P	Hyper-IgE recurrent infection syndrome 5, autosomal recessive (HIES5) [MIM:618944]	A0A286X8K1	279	I	N
P40189	LB/B	-	Q7TQ89	8	L	V
P40189	LB/B	-	Q7TQ89	148	G	R
P40189	LB/B	-	Q7TQ89	397	L	V
P40189	LB/B	-	Q7TQ89	454	I	T
P40189	LB/B	-	Q7TQ89	499	V	I
P40189	LP/P	Hyper-IgE recurrent infection syndrome 4B, autosomal recessive (HIES4B) [MIM:618523]	Q7TQ89	404	N	Y
P40189	LP/P	Hyper-IgE recurrent infection syndrome 4B, autosomal recessive (HIES4B) [MIM:618523]	Q7TQ89	498	P	L
P40189	LP/P	Hyper-IgE recurrent infection syndrome 4B, autosomal recessive (HIES4B) [MIM:618523]	Q7TQ89	517	A	P
A1L0T0	LB/B	-	A0A0B2V9J5	374	N	D
A1L0T0	LB/B	-	A0A0B2V9J5	510	R	Q
P20839	LP/P	Retinitis pigmentosa 10 (RP10) [MIM:180105]	A0A2K6FEX2	224	R	P
P20839	LP/P	Retinitis pigmentosa 10 (RP10) [MIM:180105]	A0A2K6FEX2	226	D	N
P20839	LP/P	Retinitis pigmentosa 10 (RP10) [MIM:180105]	A0A2K6FEX2	268	V	I
P20839	LP/P	Leber congenital amaurosis 11 (LCA11) [MIM:613837]	A0A2K6FEX2	105	R	W
P20839	LP/P	Retinitis pigmentosa 10 (RP10) [MIM:180105]	A0A2K6FEX2	116	T	M
P20839	LP/P	Leber congenital amaurosis 11 (LCA11) [MIM:613837]	A0A2K6FEX2	198	N	K
P20839	LB/B	-	A0A2K6FEX2	285	A	T
P20839	LP/P	Retinitis pigmentosa 10 (RP10) [MIM:180105]	A0A2K6FEX2	372	H	P
P12268	LB/B	-	A0A2K6FEX2	263	L	F
Q3KP66	LB/B	-	F7GBF7	538	R	C
Q3KP66	LP/P	Inflammatory bowel disease 29 (IBD29) [MIM:618077]	F7GBF7	333	Y	F
Q9NQS7	LB/B	-	A0A2Y9PWM4	2	G	V
Q9NQS7	LB/B	-	A0A2Y9PWM4	100	R	H
Q9NQS7	LB/B	-	A0A2Y9PWM4	137	A	V
Q9NQS7	LB/B	-	A0A2Y9PWM4	506	M	T
Q9NQS7	LB/B	-	A0A2Y9PWM4	644	E	D
Q9UK53	LP/P	Squamous cell carcinoma of the head and neck (HNSCC) [MIM:275355]	D2HQ90	335	A	D
Q9UK53	LP/P	Squamous cell carcinoma of the head and neck (HNSCC) [MIM:275355]	D2HQ90	358	C	S
Q9UK53	LP/P	Squamous cell carcinoma of the head and neck (HNSCC) [MIM:275355]	D2HQ90	359	N	S
Q9UK53	LB/B	-	D2HQ90	125	L	R
Q53TQ3	LB/B	-	W5KLN7	358	A	V
Q1MX18	LB/B	-	S9XLQ5	450	Q	R
Q1MX18	LB/B	-	S9XLQ5	333	D	N
Q9Y581	LB/B	-	Q9WV41	80	F	L
Q6ZSG2	LB/B	-	W5KWS7	147	A	V
Q9NVM9	LB/B	-	A0A195FLJ9	66	M	T
Q9ULD6	LB/B	-	A0A1S3IVF8	452	A	T
O00410	LB/B	-	A0A1S3G1D2	286	L	I
O00410	LB/B	-	A0A1S3G1D2	525	E	K
O00410	LB/B	-	A0A1S3G1D2	549	E	K
O00410	LB/B	-	A0A1S3G1D2	905	Y	C
O00410	LB/B	-	A0A1S3G1D2	969	T	I
O95373	LB/B	-	A0A096M9V2	111	T	N
O15397	LB/B	-	A0A096M9V2	6	I	F
O15397	LB/B	-	A0A096M9V2	640	I	V
O15397	LP/P	VISS syndrome (VISS) [MIM:619472]	A0A096M9V2	88	D	N
O15397	LP/P	VISS syndrome (VISS) [MIM:619472]	A0A096M9V2	749	C	R
O15397	LP/P	VISS syndrome (VISS) [MIM:619472]	A0A096M9V2	834	R	W
Q9H8X2	LB/B	-	H2TJ91	277	R	W
Q9H8X2	LB/B	-	H2TJ91	376	L	F
P10914	LP/P	Gastric cancer (GASC) [MIM:613659]	G3IBC8	8	M	L
P10914	LP/P	Gastric cancer (GASC) [MIM:613659]	G3IBC8	11	W	R
P35568	LB/B	-	A0A1V4K3V1	512	A	P
P35568	LB/B	-	A0A1V4K3V1	971	G	R
P35568	LP/P	Type 2 diabetes mellitus (T2D) [MIM:125853]	A0A1V4K3V1	1043	S	Y
P35568	LP/P	Type 2 diabetes mellitus (T2D) [MIM:125853]	A0A1V4K3V1	1095	C	Y
P35568	LB/B	-	A0A1V4K3V1	158	P	R
P35568	LB/B	-	A0A1V4K3V1	209	M	T
P35568	LB/B	-	A0A1V4K3V1	809	S	F
P35568	LB/B	-	A0A1V4K3V1	892	S	G
P35568	LB/B	-	A0A1V4K3V1	1137	D	N
P35568	LB/B	-	A0A1V4K3V1	608	T	R
P78411	LP/P	Hamamy syndrome (HMMS) [MIM:611174]	A0A2D0T3R9	150	A	P
P78411	LP/P	Hamamy syndrome (HMMS) [MIM:611174]	A0A2D0T3R9	166	N	K
Q9H1K1	LB/B	-	A0A0Q3TZR6	12	A	V
Q2M1V0	LB/B	-	A0A2K5C9N6	28	S	G
Q2M1V0	LB/B	-	A0A2K5C9N6	57	P	S
Q2M1V0	LB/B	-	A0A2K5C9N6	83	R	Q
Q2M1V0	LB/B	-	A0A2K5C9N6	158	A	V
P38570	LB/B	-	L5JW93	360	D	E
P38570	LB/B	-	L5JW93	1041	C	S
P38570	LB/B	-	L5JW93	892	Q	H
P38570	LB/B	-	L5JW93	950	R	W
P38570	LB/B	-	L5JW93	477	I	V
P38570	LB/B	-	L5JW93	482	R	Q
P38570	LB/B	-	L5JW93	1019	V	A
P26012	LB/B	-	M7B3D4	552	S	F
Q96ST2	LB/B	-	K9J2L8	390	A	V
Q96ST2	LB/B	-	K9J2L8	425	V	I
Q9P266	LB/B	-	K7GD11	487	E	D
Q9P266	LB/B	-	K7GD11	494	D	N
Q9P266	LB/B	-	K7GD11	729	E	A
Q9P266	LB/B	-	K7GD11	957	R	G
Q9P266	LB/B	-	K7GD11	1002	S	T
Q9P266	LB/B	-	K7GD11	1095	A	G
Q6NUN7	LB/B	-	F1S9Q5	486	H	R
Q8N9B5	LB/B	-	H3ASN7	364	M	L
Q8N9B5	LB/B	-	H3ASN7	592	A	V
Q8N9B5	LB/B	-	H3ASN7	720	H	R
Q8WXH2	LB/B	-	A0A1S3EUS4	376	I	T
Q8WXH2	LB/B	-	A0A1S3EUS4	472	P	T
Q8WXH2	LB/B	-	A0A1S3EUS4	645	P	L
P05412	LB/B	-	Q08DH1	297	T	M
Q14678	LB/B	-	H2N2T2	464	S	A
Q14678	LB/B	-	H2N2T2	206	N	K
Q14678	LB/B	-	H2N2T2	432	E	Q
Q14678	LB/B	-	H2N2T2	210	H	Q
Q14678	LB/B	-	H2N2T2	321	K	R
Q14678	LB/B	-	H2N2T2	664	A	V
Q14678	LB/B	-	H2N2T2	667	R	H
Q14678	LB/B	-	H2N2T2	901	N	S
Q14678	LB/B	-	H2N2T2	1055	I	T
Q9H9L4	LB/B	-	A0A2K6SLD5	313	N	S
Q9H9L4	LB/B	-	A0A2K6SLD5	445	P	T
Q9H7Z6	LP/P	Li-Ghorbani-Weisz-Hubshman syndrome (LIGOWS) [MIM:618974]	A0A2I3M7X3	90	Y	C
Q9H7Z6	LP/P	Li-Ghorbani-Weisz-Hubshman syndrome (LIGOWS) [MIM:618974]	A0A2I3M7X3	98	R	Q
Q9H7Z6	LP/P	Li-Ghorbani-Weisz-Hubshman syndrome (LIGOWS) [MIM:618974]	A0A2I3M7X3	99	R	Q
Q9H7Z6	LP/P	Li-Ghorbani-Weisz-Hubshman syndrome (LIGOWS) [MIM:618974]	A0A2I3M7X3	175	K	E
Q96I82	LB/B	-	A0A1S3FAS3	76	C	G
Q96I82	LB/B	-	A0A1S3FAS3	236	G	D
Q96I82	LB/B	-	A0A1S3FAS3	255	G	A
Q96I82	LB/B	-	A0A1S3FAS3	256	R	H
Q3ZCT8	LB/B	-	H2LZE6	22	Q	K
Q9NVX7	LB/B	-	V9KDC1	330	D	N
Q09470	LP/P	Episodic ataxia 1 (EA1) [MIM:160120]	H3BG81	174	V	F
Q09470	LP/P	Episodic ataxia 1 (EA1) [MIM:160120]	H3BG81	177	I	R
Q09470	LP/P	Episodic ataxia 1 (EA1) [MIM:160120]	H3BG81	226	T	A
Q09470	LP/P	Episodic ataxia 1 (EA1) [MIM:160120]	H3BG81	239	R	S
Q09470	LP/P	Episodic ataxia 1 (EA1) [MIM:160120]	H3BG81	249	F	I
Q09470	LP/P	Episodic ataxia 1 (EA1) [MIM:160120]	H3BG81	404	V	I
Q09470	LP/P	Episodic ataxia 1 (EA1) [MIM:160120]	H3BG81	408	V	A
Q09470	LB/B	-	H3BG81	204	R	H
Q09470	LP/P	Episodic ataxia 1 (EA1) [MIM:160120]	H3BG81	184	F	C
Q09470	LP/P	Episodic ataxia 1 (EA1) [MIM:160120]	H3BG81	226	T	M
Q09470	LP/P	Episodic ataxia 1 (EA1) [MIM:160120]	H3BG81	325	E	D
Q09470	LP/P	Episodic ataxia 1 (EA1) [MIM:160120]	H3BG81	329	L	I
Q09470	LP/P	Episodic ataxia 1 (EA1) [MIM:160120]	H3BG81	342	S	I
Q09470	LP/P	Myokymia isolated 1 (MK1) [MIM:160120]	H3BG81	226	T	K
Q09470	LP/P	Episodic ataxia 1 (EA1) [MIM:160120]	H3BG81	226	T	R
Q09470	LP/P	Myokymia isolated 1 (MK1) [MIM:160120]	H3BG81	242	A	P
Q09470	LP/P	Myokymia isolated 1 (MK1) [MIM:160120]	H3BG81	244	P	H
Q09470	LP/P	Myokymia isolated 1 (MK1) [MIM:160120]	H3BG81	255	N	D
Q09470	LP/P	-	H3BG81	405	P	L
Q16322	LB/B	-	H3BG81	220	V	M
Q16322	LB/B	-	H3BG81	258	S	N
Q9Y6J6	LB/B	-	W5NMN3	8	T	A
Q9Y6J6	LB/B	-	W5NMN3	9	Q	E
Q9Y6J6	LP/P	Long QT syndrome 6 (LQT6) [MIM:613693]	W5NMN3	54	M	T
Q9Y6J6	LP/P	Long QT syndrome 6 (LQT6) [MIM:613693]	W5NMN3	57	I	T
Q9Y6J6	LP/P	Long QT syndrome 6 (LQT6) [MIM:613693]	W5NMN3	65	V	M
Q9Y6J6	LB/B	-	W5NMN3	66	A	V
Q9Y6J6	LP/P	Long QT syndrome 6 (LQT6) [MIM:613693]	W5NMN3	77	R	W
Q9Y6J6	LB/B	-	W5NMN3	8	T	I
Q9Y6J6	LP/P	Atrial fibrillation, familial, 4 (ATFB4) [MIM:611493]	W5NMN3	27	R	C
Q9UIX4	LB/B	-	H3A5K6	304	I	M
Q8TDN1	LB/B	-	H3A5K6	8	G	W
Q8TDN1	LB/B	-	H3A5K6	206	R	W
Q8TDN1	LB/B	-	H3A5K6	255	C	Y
Q8TDN1	LB/B	-	H3A5K6	321	E	K
Q8TDN1	LB/B	-	H3A5K6	325	G	R
Q8TDN1	LB/B	-	H3A5K6	427	R	H
P63252	LP/P	Long QT syndrome 7 (LQT7) [MIM:170390]	A0A091DU44	67	R	W
P63252	LP/P	Long QT syndrome 7 (LQT7) [MIM:170390]	A0A091DU44	71	D	V
P63252	LP/P	Long QT syndrome 7 (LQT7) [MIM:170390]	A0A091DU44	186	P	L
P63252	LP/P	Long QT syndrome 7 (LQT7) [MIM:170390]	A0A091DU44	216	N	H
P63252	LP/P	Long QT syndrome 7 (LQT7) [MIM:170390]	A0A091DU44	218	R	W
P63252	LP/P	Long QT syndrome 7 (LQT7) [MIM:170390]	A0A091DU44	300	G	V
P63252	LP/P	Long QT syndrome 7 (LQT7) [MIM:170390]	A0A091DU44	302	V	M
P63252	LP/P	Short QT syndrome 3 (SQT3) [MIM:609622]	A0A091DU44	172	D	N
P63252	LP/P	Long QT syndrome 7 (LQT7) [MIM:170390]	A0A091DU44	54	C	F
P63252	LP/P	Long QT syndrome 7 (LQT7) [MIM:170390]	A0A091DU44	75	T	R
P63252	LP/P	Atrial fibrillation, familial, 9 (ATFB9) [MIM:613980]	A0A091DU44	93	V	I
P63252	LP/P	Long QT syndrome 7 (LQT7) [MIM:170390]	A0A091DU44	305	T	P
O14649	LP/P	Pulmonary hypertension, primary, 4 (PPH4) [MIM:615344]	I3LVV6	8	T	K
O14649	LP/P	Pulmonary hypertension, primary, 4 (PPH4) [MIM:615344]	I3LVV6	97	G	R
O14649	LP/P	Pulmonary hypertension, primary, 4 (PPH4) [MIM:615344]	I3LVV6	182	E	K
O14649	LP/P	Pulmonary hypertension, primary, 4 (PPH4) [MIM:615344]	I3LVV6	192	Y	C
O14649	LP/P	Pulmonary hypertension, primary, 4 (PPH4) [MIM:615344]	I3LVV6	203	G	D
O14649	LP/P	Pulmonary hypertension, primary, 4 (PPH4) [MIM:615344]	I3LVV6	221	V	L
Q86W47	LB/B	-	L9KZN3	199	V	I
Q9H2S1	LP/P	Neurodevelopmental disorder with or without variable movement or behavioral abnormalities (NEDMAB) [MIM:619725]	A0A2Y9SQA1	288	I	S
Q9H2S1	LP/P	Neurodevelopmental disorder with or without variable movement or behavioral abnormalities (NEDMAB) [MIM:619725]	A0A2Y9SQA1	359	I	M
Q9H2S1	LP/P	Neurodevelopmental disorder with or without variable movement or behavioral abnormalities (NEDMAB) [MIM:619725]	A0A2Y9SQA1	361	Y	C
Q9H2S1	LP/P	Neurodevelopmental disorder with or without variable movement or behavioral abnormalities (NEDMAB) [MIM:619725]	A0A2Y9SQA1	362	G	S
Q9H2S1	LP/P	Neurodevelopmental disorder with or without variable movement or behavioral abnormalities (NEDMAB) [MIM:619725]	A0A2Y9SQA1	388	L	V
Q9H2S1	LP/P	Neurodevelopmental disorder with or without variable movement or behavioral abnormalities (NEDMAB) [MIM:619725]	A0A2Y9SQA1	432	L	P
O15554	LP/P	Dehydrated hereditary stomatocytosis 2 (DHS2) [MIM:616689]	D3XE74	282	V	E
O15554	LP/P	Dehydrated hereditary stomatocytosis 2 (DHS2) [MIM:616689]	D3XE74	282	V	M
O15554	LP/P	Dehydrated hereditary stomatocytosis 2 (DHS2) [MIM:616689]	D3XE74	352	R	H
Q8TDN2	LP/P	Cone dystrophy retinal 3B (RCD3B) [MIM:610356]	G3VQH1	126	L	Q
Q8TDN2	LP/P	Cone dystrophy retinal 3B (RCD3B) [MIM:610356]	G3VQH1	188	W	C
Q8TDN2	LP/P	Cone dystrophy retinal 3B (RCD3B) [MIM:610356]	G3VQH1	256	S	W
Q8TDN2	LP/P	Cone dystrophy retinal 3B (RCD3B) [MIM:610356]	G3VQH1	259	A	V
Q8TDN2	LP/P	Cone dystrophy retinal 3B (RCD3B) [MIM:610356]	G3VQH1	459	G	D
Q8TDN2	LB/B	-	G3VQH1	533	L	V
Q8TDN2	LP/P	Cone dystrophy retinal 3B (RCD3B) [MIM:610356]	G3VQH1	244	R	P
Q6ZWB6	LB/B	-	A0A091X487	329	P	L
O15550	LB/B	-	A0A091DMJ8	30	A	T
O15550	LB/B	-	A0A091DMJ8	497	Q	H
O15550	LB/B	-	A0A091DMJ8	726	T	K
O15550	LB/B	-	A0A091DMJ8	581	T	A
O15054	LB/B	-	I3LG07	308	S	L
O15054	LB/B	-	I3LG07	203	P	A
O15054	LP/P	Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities (NEDCFSA) [MIM:618505]	I3LG07	1331	N	S
O15054	LP/P	Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities (NEDCFSA) [MIM:618505]	I3LG07	1379	Y	S
Q6ZMT4	LB/B	-	A0A087YEM2	644	R	S
Q9ULL0	LB/B	-	A0A2K5EYG4	103	G	V
Q9ULL0	LB/B	-	A0A2K5EYG4	419	L	F
Q9ULL0	LB/B	-	A0A2K5EYG4	844	P	A
Q9ULL0	LB/B	-	A0A2K5EYG4	852	E	A
Q9ULL0	LB/B	-	A0A2K5EYG4	945	I	F
Q9ULL0	LB/B	-	A0A2K5EYG4	1032	R	W
Q9ULL0	LB/B	-	A0A2K5EYG4	1616	E	G
Q9ULL0	LB/B	-	A0A2K5EYG4	208	V	F
Q9ULL0	LB/B	-	A0A2K5EYG4	1568	Q	E
Q86T90	LB/B	-	A0A0P6JAV8	383	R	C
Q9HCI6	LB/B	-	L5JPW2	75	F	L
Q9HCI6	LB/B	-	L5JPW2	81	V	M
Q96MD2	LB/B	-	A0A1S3HUU0	139	I	M
Q96MD2	LB/B	-	A0A1S3HUU0	443	A	S
P52732	LB/B	-	S7NPY4	1042	L	F
P52732	LP/P	Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development (MCLMR) [MIM:152950]	S7NPY4	144	F	L
P52732	LP/P	Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development (MCLMR) [MIM:152950]	S7NPY4	234	R	C
P52732	LP/P	Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development (MCLMR) [MIM:152950]	S7NPY4	235	S	C
P52732	LP/P	Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development (MCLMR) [MIM:152950]	S7NPY4	944	R	C
O95235	LB/B	-	A0A1A6HT87	63	E	K
O95235	LB/B	-	A0A1A6HT87	839	P	L
O95235	LP/P	Cardiomyopathy, familial restrictive 6 (RCM6) [MIM:619433]	A0A1A6HT87	182	R	W
Q5T7B8	LB/B	-	A0A2I0TSC5	50	D	E
Q5T7B8	LB/B	-	A0A2I0TSC5	140	M	V
Q5T7B8	LB/B	-	A0A2I0TSC5	218	W	L
Q5T7B8	LB/B	-	A0A2I0TSC5	1077	T	K
Q5T7B8	LB/B	-	A0A2I0TSC5	109	R	G
Q5T7B8	LB/B	-	A0A2I0TSC5	837	S	F
Q86VH2	LB/B	-	H2VAX9	213	I	V
Q86VH2	LB/B	-	H2VAX9	300	R	Q
Q86VH2	LB/B	-	H2VAX9	1036	N	D
P43626	LB/B	-	A0A2I3RBP8	5	V	F
P43626	LB/B	-	A0A2I3RBP8	37	P	R
P43626	LB/B	-	A0A2I3RBP8	135	P	L
P43626	LB/B	-	A0A2I3RBP8	175	P	T
P43626	LB/B	-	A0A2I3RBP8	184	D	N
P43626	LB/B	-	A0A2I3RBP8	203	H	R
P43626	LB/B	-	A0A2I3RBP8	237	K	E
P43626	LB/B	-	A0A2I3RBP8	266	R	C
P43626	LB/B	-	A0A2I3RBP8	66	F	Y
P43626	LB/B	-	A0A2I3RBP8	9	A	V
P43626	LB/B	-	A0A2I3RBP8	111	V	L
P43627	LB/B	-	A0A2I3RBP8	37	R	P
P43627	LB/B	-	A0A2I3RBP8	9	A	V
P43627	LB/B	-	A0A2I3RBP8	66	F	Y
P43628	LB/B	-	A0A2I3RBP8	9	V	A
P43628	LB/B	-	A0A2I3RBP8	32	L	R
P43628	LB/B	-	A0A2I3RBP8	56	Q	E
P43628	LB/B	-	A0A2I3RBP8	71	H	R
P43628	LB/B	-	A0A2I3RBP8	318	R	H
P43628	LB/B	-	A0A2I3RBP8	34	H	Q
P43628	LB/B	-	A0A2I3RBP8	229	P	L
P43628	LB/B	-	A0A2I3RBP8	242	R	I
P43628	LB/B	-	A0A2I3RBP8	304	A	T
P43628	LB/B	-	A0A2I3RBP8	37	P	R
P43628	LB/B	-	A0A2I3RBP8	66	F	Y
Q8NHK3	LB/B	-	A0A2I3RBP8	6	V	I
Q8NHK3	LB/B	-	A0A2I3RBP8	141	T	A
Q8NHK3	LB/B	-	A0A2I3RBP8	276	E	G
Q14954	LB/B	-	A0A2I3RBP8	91	K	R
Q14954	LB/B	-	A0A2I3RBP8	111	L	V
P43631	LB/B	-	A0A2I3RBP8	237	K	E
P43631	LB/B	-	A0A2I3RBP8	9	A	V
P43631	LB/B	-	A0A2I3RBP8	66	Y	F
P43631	LB/B	-	A0A2I3RBP8	254	K	N
Q9UEF7	LB/B	-	G1SWI1	15	P	Q
Q9UEF7	LB/B	-	G1SWI1	45	F	V
Q9UEF7	LB/B	-	G1SWI1	352	F	V
Q9UEF7	LB/B	-	G1SWI1	370	C	S
Q9UEF7	LB/B	-	G1SWI1	514	P	S
Q9UEF7	LP/P	Tumoral calcinosis, hyperphosphatemic, familial, 3 (HFTC3) [MIM:617994]	G1SWI1	193	H	R
Q86Z14	LB/B	-	G1SWI1	728	R	Q
Q86Z14	LB/B	-	G1SWI1	747	A	V
Q86Z14	LB/B	-	G1SWI1	1020	Q	K
Q86Z14	LB/B	-	G1SWI1	906	Y	H
Q86Z14	LB/B	-	G1SWI1	65	P	A
Q13351	LB/B	-	I3MZS3	102	S	P
Q13351	LB/B	-	I3MZS3	182	F	L
Q13351	LB/B	-	I3MZS3	299	H	Y
Q13351	LB/B	-	I3MZS3	328	R	H
Q13351	LP/P	Anemia, congenital dyserythropoietic, 4 (CDAN4) [MIM:613673]	I3MZS3	325	E	K
Q13351	LB/B	-	I3MZS3	338	P	S
Q13351	LB/B	-	I3MZS3	5	E	K
Q13351	LB/B	-	I3MZS3	299	H	D
Q13351	LB/B	-	I3MZS3	316	C	W
Q13351	LB/B	-	I3MZS3	334	T	R
Q13351	LB/B	-	I3MZS3	341	C	Y
O14901	LB/B	-	A0A146NQP8	62	Q	R
O14901	LP/P	Maturity-onset diabetes of the young 7 (MODY7) [MIM:610508]	A0A146NQP8	220	T	M
O14901	LP/P	Maturity-onset diabetes of the young 7 (MODY7) [MIM:610508]	A0A146NQP8	347	A	S
O14901	LB/B	-	A0A146NQP8	378	S	F
Q5JT82	LB/B	-	A0A1U7RC11	156	N	S
Q5JT82	LB/B	-	A0A1U7RC11	35	I	N
Q5JT82	LB/B	-	A0A1U7RC11	57	S	T
Q5JT82	LB/B	-	A0A1U7RC11	80	Q	H
Q9H0H3	LB/B	-	A0A2I0TZH8	250	V	I
Q9H0H3	LB/B	-	A0A2I0TZH8	257	M	L
O60662	LB/B	-	A0A2U4ACQ4	271	A	T
O60662	LB/B	-	A0A2U4ACQ4	481	M	V
O60662	LP/P	Nemaline myopathy 9 (NEM9) [MIM:615731]	A0A2U4ACQ4	413	S	L
Q8WZ60	LB/B	-	V9KV51	518	I	V
O43240	LB/B	-	A0A2K5ZAE9	50	S	A
O43240	LB/B	-	A0A2K5ZAE9	149	L	P
P26715	LB/B	-	A4GHC7	29	N	S
P26717	LB/B	-	A4GHC7	2	N	S
P26717	LB/B	-	A4GHC7	102	F	S
Q07444	LB/B	-	A4GHC7	19	W	P
Q07444	LB/B	-	A4GHC7	135	R	S
Q07444	LB/B	-	A4GHC7	2	S	N
Q07444	LB/B	-	A4GHC7	113	H	P
Q07444	LB/B	-	A4GHC7	155	C	S
Q07444	LB/B	-	A4GHC7	19	W	R
Q07444	LB/B	-	A4GHC7	106	A	T
Q8NEZ4	LB/B	-	J9NSP5	823	I	T
Q8NEZ4	LB/B	-	J9NSP5	823	I	N
Q8NEZ4	LB/B	-	J9NSP5	526	R	P
Q8NEZ4	LB/B	-	J9NSP5	1836	S	N
Q8NEZ4	LB/B	-	J9NSP5	2008	T	A
Q8NEZ4	LB/B	-	J9NSP5	2412	P	T
Q8NEZ4	LB/B	-	J9NSP5	2600	P	A
Q8NEZ4	LB/B	-	J9NSP5	291	L	F
Q8NEZ4	LB/B	-	J9NSP5	316	T	S
P01042	LB/B	-	A0A1U8DZM2	163	G	S
P01042	LB/B	-	A0A1U8DZM2	178	M	T
P01042	LB/B	-	A0A1U8DZM2	212	L	P
P01042	LB/B	-	A0A1U8DZM2	197	I	M
P01042	LB/B	-	A0A1U8DZM2	430	D	E
P01042	LB/B	-	A0A1U8DZM2	581	I	T
P01042	LB/B	-	A0A1U8DZM2	642	G	A
P01042	LP/P	Angioedema, hereditary, 6 (HAE6) [MIM:619363]	A0A1U8DZM2	379	M	K
Q6ZNG9	LB/B	-	A0A2K5F8V3	435	T	M
P13646	LP/P	White sponge nevus 2 (WSN2) [MIM:615785]	W5Q6L8	119	L	P
P13646	LP/P	White sponge nevus 2 (WSN2) [MIM:615785]	W5Q6L8	108	M	T
P13646	LP/P	White sponge nevus 2 (WSN2) [MIM:615785]	W5Q6L8	112	N	S
P13646	LP/P	White sponge nevus 2 (WSN2) [MIM:615785]	W5Q6L8	115	L	P
P13646	LP/P	White sponge nevus 2 (WSN2) [MIM:615785]	W5Q6L8	111	L	P
P13646	LB/B	-	W5Q6L8	146	A	G
P13646	LB/B	-	W5Q6L8	81	F	Y
P13646	LB/B	-	W5Q6L8	298	T	A
P13646	LB/B	-	W5Q6L8	187	A	V
P13646	LP/P	White sponge nevus 2 (WSN2) [MIM:615785]	W5Q6L8	118	Y	D
P02533	LP/P	Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760]	W5Q6L8	125	R	C
P02533	LP/P	Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760]	W5Q6L8	125	R	H
P02533	LP/P	Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive (EBS1D) [MIM:601001]	W5Q6L8	144	E	A
P02533	LP/P	Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760]	W5Q6L8	272	M	R
P02533	LP/P	Epidermolysis bullosa simplex 1B, generalized intermediate (EBS1B) [MIM:131900]	W5Q6L8	272	M	R
P02533	LP/P	Epidermolysis bullosa simplex 1B, generalized intermediate (EBS1B) [MIM:131900]	W5Q6L8	384	L	P
P02533	LP/P	Epidermolysis bullosa simplex 1B, generalized intermediate (EBS1B) [MIM:131900]	W5Q6L8	415	Y	H
P02533	LP/P	Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760]	W5Q6L8	419	L	Q
P02533	LB/B	-	W5Q6L8	94	A	T
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	116	K	N
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	119	M	I
P02533	LP/P	Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760]	W5Q6L8	119	M	T
P02533	LP/P	Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760]	W5Q6L8	120	Q	R
P02533	LP/P	Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760]	W5Q6L8	122	L	F
P02533	LP/P	Epidermolysis bullosa simplex 1B, generalized intermediate (EBS1B) [MIM:131900]	W5Q6L8	122	L	F
P02533	LP/P	Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760]	W5Q6L8	123	N	S
P02533	LP/P	Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760]	W5Q6L8	125	R	S
P02533	LP/P	Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760]	W5Q6L8	129	Y	D
P02533	LP/P	Epidermolysis bullosa simplex 1B, generalized intermediate (EBS1B) [MIM:131900]	W5Q6L8	143	L	P
P02533	LP/P	Epidermolysis bullosa simplex 1B, generalized intermediate (EBS1B) [MIM:131900]	W5Q6L8	247	A	D
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	273	D	G
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	274	A	D
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	377	I	N
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	388	R	C
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	422	E	K
P02533	LP/P	Epidermolysis bullosa simplex 1B, generalized intermediate (EBS1B) [MIM:131900]	W5Q6L8	119	M	V
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	119	M	V
P02533	LP/P	Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760]	W5Q6L8	123	N	K
P02533	LP/P	Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760]	W5Q6L8	125	R	G
P02533	LP/P	Epidermolysis bullosa simplex 1B, generalized intermediate (EBS1B) [MIM:131900]	W5Q6L8	133	V	L
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	133	V	L
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	408	L	M
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	211	R	P
P02533	LP/P	Epidermolysis bullosa simplex 1B, generalized intermediate (EBS1B) [MIM:131900]	W5Q6L8	272	M	T
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	272	M	T
P02533	LP/P	Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760]	W5Q6L8	417	R	P
P02533	LP/P	Epidermolysis bullosa simplex 1B, generalized intermediate (EBS1B) [MIM:131900]	W5Q6L8	134	R	P
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	148	R	C
P02533	LP/P	Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive (EBS1D) [MIM:601001]	W5Q6L8	388	R	H
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	415	Y	C
P02533	LP/P	Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760]	W5Q6L8	416	R	P
P02533	LB/B	-	W5Q6L8	133	V	A
P02533	LB/B	-	W5Q6L8	215	E	K
P02533	LB/B	-	W5Q6L8	63	C	Y
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	418	L	Q
P02533	LP/P	-	W5Q6L8	125	R	L
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	133	V	M
P02533	LP/P	Epidermolysis bullosa simplex 1C, localized (EBS1C) [MIM:131800]	W5Q6L8	270	V	A
P02533	LP/P	Epidermolysis bullosa simplex 1A, generalized severe (EBS1A) [MIM:131760]	W5Q6L8	270	V	M
P08779	LP/P	Pachyonychia congenita 1 (PC1) [MIM:167200]	L9JX56	132	L	P
P08779	LP/P	Keratoderma, palmoplantar, non-epidermolytic, focal 1 (FNEPPK1) [MIM:613000]	L9JX56	125	N	S
P08779	LP/P	Pachyonychia congenita 1 (PC1) [MIM:167200]	L9JX56	125	N	S
P08779	LP/P	Keratoderma, palmoplantar, non-epidermolytic, focal 1 (FNEPPK1) [MIM:613000]	L9JX56	127	R	C
P08779	LP/P	Pachyonychia congenita 1 (PC1) [MIM:167200]	L9JX56	127	R	C
P08779	LP/P	Pachyonychia congenita 1 (PC1) [MIM:167200]	L9JX56	122	Q	P
P08779	LP/P	Pachyonychia congenita 1 (PC1) [MIM:167200]	L9JX56	127	R	P
P08779	LP/P	Pachyonychia congenita 1 (PC1) [MIM:167200]	L9JX56	124	L	R
P08779	LP/P	Pachyonychia congenita 1 (PC1) [MIM:167200]	L9JX56	121	M	T
P08779	LP/P	Pachyonychia congenita 1 (PC1) [MIM:167200]	L9JX56	128	L	Q
P08779	LP/P	Pachyonychia congenita 1 (PC1) [MIM:167200]	L9JX56	354	K	N
P08779	LP/P	Pachyonychia congenita 1 (PC1) [MIM:167200]	L9JX56	124	L	H
P08779	LP/P	Pachyonychia congenita 1 (PC1) [MIM:167200]	L9JX56	124	L	P
P08779	LP/P	Pachyonychia congenita 1 (PC1) [MIM:167200]	L9JX56	125	N	D
P08779	LP/P	Pachyonychia congenita 1 (PC1) [MIM:167200]	L9JX56	125	N	G
P08779	LP/P	Pachyonychia congenita 1 (PC1) [MIM:167200]	L9JX56	421	L	P
P35900	LB/B	-	W5Q6L8	129	S	N
Q9C075	LB/B	-	A0A1S3GV49	303	T	A
Q9C075	LB/B	-	A0A1S3GV49	393	S	F
Q52LG2	LB/B	-	A0A1U7TJ38	26	R	C
Q52LG2	LB/B	-	A0A1U7TJ38	74	S	R
Q3LI77	LB/B	-	A0A1U7TJ38	59	A	T
Q3LI77	LB/B	-	A0A1U7TJ38	154	R	H
Q3LHN2	LB/B	-	A0A0D9SBH7	5	Y	H
Q3LHN2	LB/B	-	A0A0D9SBH7	32	G	C
Q3LI61	LB/B	-	A0A0D9SBH7	7	Y	H
Q3LI61	LB/B	-	A0A0D9SBH7	13	Y	C
Q3LI61	LB/B	-	A0A0D9SBH7	17	V	G
Q6L8G9	LB/B	-	Q6L8G9	6	C	F
Q8N6L1	LB/B	-	A0A2Y9E8X1	4	G	V
Q16719	LB/B	-	K1QCQ9	412	K	E
Q16719	LB/B	-	K1QCQ9	188	R	Q
Q16719	LP/P	Hydroxykynureninuria (HYXKY) [MIM:236800]	K1QCQ9	198	T	A
Q6ISS4	LB/B	-	A0A0G2JPH6	78	G	S
Q6ISS4	LB/B	-	A0A0G2JPH6	87	H	R
Q6ISS4	LB/B	-	A0A0G2JPH6	115	F	Y
P24043	LB/B	-	A0A1S3IGN9	545	L	Q
P24043	LB/B	-	A0A1S3IGN9	619	R	H
P24043	LB/B	-	A0A1S3IGN9	919	R	L
P24043	LB/B	-	A0A1S3IGN9	2586	Y	H
P24043	LB/B	-	A0A1S3IGN9	2614	E	K
P24043	LP/P	Merosin-deficient congenital muscular dystrophy 1A (MDC1A) [MIM:607855]	A0A1S3IGN9	527	C	Y
P24043	LP/P	Merosin-deficient congenital muscular dystrophy 1A (MDC1A) [MIM:607855]	A0A1S3IGN9	862	C	R
P24043	LP/P	Merosin-deficient congenital muscular dystrophy 1A (MDC1A) [MIM:607855]	A0A1S3IGN9	2564	L	P
P24043	LB/B	-	A0A1S3IGN9	96	R	S
P24043	LB/B	-	A0A1S3IGN9	240	Y	H
P24043	LB/B	-	A0A1S3IGN9	644	H	D
P24043	LB/B	-	A0A1S3IGN9	1138	V	M
P24043	LB/B	-	A0A1S3IGN9	1205	T	A
P24043	LB/B	-	A0A1S3IGN9	1561	K	Q
P24043	LB/B	-	A0A1S3IGN9	1945	A	T
P24043	LB/B	-	A0A1S3IGN9	2587	A	V
P24043	LB/B	-	A0A1S3IGN9	2636	T	A
P24043	LB/B	-	A0A1S3IGN9	3029	T	A
P24043	LP/P	Merosin-deficient congenital muscular dystrophy 1A (MDC1A) [MIM:607855]	A0A1S3IGN9	2889	G	R
P24043	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 23 (LGMDR23) [MIM:618138]	A0A1S3IGN9	152	W	G
P24043	LB/B	-	A0A1S3IGN9	199	C	S
P24043	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 23 (LGMDR23) [MIM:618138]	A0A1S3IGN9	243	L	P
P24043	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 23 (LGMDR23) [MIM:618138]	A0A1S3IGN9	284	G	R
P24043	LP/P	Merosin-deficient congenital muscular dystrophy 1A (MDC1A) [MIM:607855]	A0A1S3IGN9	1311	W	G
P24043	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 23 (LGMDR23) [MIM:618138]	A0A1S3IGN9	1496	A	V
P24043	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 23 (LGMDR23) [MIM:618138]	A0A1S3IGN9	2477	R	S
P24043	LP/P	Merosin-deficient congenital muscular dystrophy 1A (MDC1A) [MIM:607855]	A0A1S3IGN9	2633	G	A
Q13751	LP/P	Epidermolysis bullosa, junctional 1A, intermediate (JEB1A) [MIM:226650]	L9JBM5	210	E	K
Q13751	LP/P	Epidermolysis bullosa, junctional 1B, severe (JEB1B) [MIM:226700]	L9JBM5	679	P	L
Q13751	LB/B	-	L9JBM5	438	S	T
Q13751	LB/B	-	L9JBM5	690	N	S
Q13751	LB/B	-	L9JBM5	852	M	L
Q13751	LB/B	-	L9JBM5	988	R	W
Q13751	LB/B	-	L9JBM5	181	N	D
Q13751	LP/P	Epidermolysis bullosa, junctional 1A, intermediate (JEB1A) [MIM:226650]	L9JBM5	199	G	A
Q13751	LP/P	Epidermolysis bullosa, junctional 1A, intermediate (JEB1A) [MIM:226650]	L9JBM5	207	K	Q
Q13751	LB/B	-	L9JBM5	292	R	L
Q13751	LB/B	-	L9JBM5	527	V	M
Q13751	LB/B	-	L9JBM5	926	A	D
Q6IAA8	LB/B	-	A0A2R8MV75	73	S	L
Q8IYD9	LB/B	-	F7CLD4	147	R	P
Q8IYD9	LB/B	-	F7CLD4	196	C	F
Q8WX39	LB/B	-	A0A2K5ETM0	65	H	Y
Q8WX39	LB/B	-	A0A2K5ETM0	90	C	F
Q9BYZ2	LB/B	-	W5NE73	14	V	M
Q9BYZ2	LB/B	-	W5NE73	30	P	L
Q9BYZ2	LB/B	-	W5NE73	326	I	T
Q9BYZ2	LB/B	-	W5NE73	259	P	S
P07195	LP/P	Lactate dehydrogenase B deficiency (LDHBD) [MIM:614128]	L5KMJ3	7	K	E
P07195	LP/P	Lactate dehydrogenase B deficiency (LDHBD) [MIM:614128]	L5KMJ3	35	A	E
P07195	LP/P	Lactate dehydrogenase B deficiency (LDHBD) [MIM:614128]	L5KMJ3	129	S	R
P07195	LP/P	Lactate dehydrogenase B deficiency (LDHBD) [MIM:614128]	L5KMJ3	171	F	V
P07195	LP/P	Lactate dehydrogenase B deficiency (LDHBD) [MIM:614128]	L5KMJ3	172	R	H
P07195	LP/P	Lactate dehydrogenase B deficiency (LDHBD) [MIM:614128]	L5KMJ3	175	M	L
P07195	LP/P	Lactate dehydrogenase B deficiency (LDHBD) [MIM:614128]	L5KMJ3	322	D	V
P07195	LP/P	Lactate dehydrogenase B deficiency (LDHBD) [MIM:614128]	L5KMJ3	69	G	E
P07195	LP/P	Lactate dehydrogenase B deficiency (LDHBD) [MIM:614128]	L5KMJ3	107	R	W
P07195	LP/P	Lactate dehydrogenase B deficiency (LDHBD) [MIM:614128]	L5KMJ3	172	R	P
P07195	LP/P	Lactate dehydrogenase B deficiency (LDHBD) [MIM:614128]	L5KMJ3	325	W	R
P07195	LB/B	-	L5KMJ3	175	M	V
P07864	LB/B	-	W5NE73	285	E	Q
Q68G75	LB/B	-	F1S356	25	P	S
Q9BXB1	LB/B	-	A0A060WJW8	215	S	G
Q9BXB1	LB/B	-	A0A060WJW8	233	N	S
Q9BXB1	LB/B	-	A0A060WJW8	480	A	V
Q9BXB1	LB/B	-	A0A060WJW8	684	R	G
Q9BXB1	LB/B	-	A0A060WJW8	709	T	M
P01229	LP/P	Hypogonadotropic hypogonadism 23 with or without anosmia (HH23) [MIM:228300]	H2NZJ7	74	Q	R
P01229	LB/B	-	H2NZJ7	28	W	R
P01229	LB/B	-	H2NZJ7	35	I	T
P01229	LB/B	-	H2NZJ7	18	A	T
P01229	LB/B	-	H2NZJ7	122	G	S
P01229	LB/B	-	H2NZJ7	15	M	I
P55344	LP/P	Cataract, multiple types 19 (CTRCT19) [MIM:615277]	K7FWV0	105	F	V
Q9UGP4	LB/B	-	M7B153	415	G	R
Q9UGP4	LB/B	-	M7B153	36	G	D
Q96GY3	LB/B	-	S9X161	172	P	S
Q96GY3	LB/B	-	S9X161	16	A	V
Q6XXX2	LB/B	-	Q6XXX2	21	S	T
Q6XXX2	LB/B	-	Q6XXX2	39	N	K
Q6XXX2	LB/B	-	Q6XXX2	52	A	S
Q6XXX2	LB/B	-	Q6XXX2	104	M	R
Q96FQ7	LB/B	-	Q96FQ7	16	P	A
Q9H8X3	LB/B	-	Q9H8X3	91	W	R
Q9H8X3	LB/B	-	Q9H8X3	119	K	R
Q9H8X3	LB/B	-	Q9H8X3	27	S	C
Q8NAA6	LB/B	-	Q8NAA6	3	L	V
Q8NAA6	LB/B	-	Q8NAA6	39	A	V
Q15334	LB/B	-	W5MC81	148	S	G
Q15334	LB/B	-	W5MC81	550	Q	H
Q6P1M3	LB/B	-	W5MC81	748	R	H
Q6P1M3	LB/B	-	W5MC81	1001	G	S
Q6P1M3	LB/B	-	W5MC81	45	R	H
Q6P1M3	LB/B	-	W5MC81	479	F	L
Q6P1M3	LB/B	-	W5MC81	488	P	L
Q6P1M3	LB/B	-	W5MC81	490	L	P
Q6P1M3	LB/B	-	W5MC81	759	P	S
Q6P1M3	LB/B	-	W5MC81	790	P	L
Q9UIQ6	LB/B	-	A0A2K5KC40	763	A	T
Q9UIQ6	LB/B	-	A0A2K5KC40	86	S	P
Q9UIQ6	LB/B	-	A0A2K5KC40	963	I	V
Q9UIQ6	LB/B	-	A0A2K5KC40	594	N	I
Q9UIQ6	LB/B	-	A0A2K5KC40	913	S	T
P28300	LB/B	-	L5KLZ9	158	R	Q
P28300	LP/P	Aortic aneurysm, familial thoracic 10 (AAT10) [MIM:617168]	L5KLZ9	267	Q	P
P28300	LP/P	Aortic aneurysm, familial thoracic 10 (AAT10) [MIM:617168]	L5KLZ9	280	S	I
P28300	LP/P	Aortic aneurysm, familial thoracic 10 (AAT10) [MIM:617168]	L5KLZ9	298	M	R
P28300	LP/P	Aortic aneurysm, familial thoracic 10 (AAT10) [MIM:617168]	L5KLZ9	348	S	R
Q14693	LB/B	-	A0A2I0UKU0	610	P	S
Q14693	LB/B	-	A0A2I0UKU0	637	S	T
Q9BQK8	LB/B	-	R0L9I9	679	Q	H
Q96II8	LB/B	-	A0A096M3F1	522	P	L
O75427	LB/B	-	H9G607	642	V	M
Q5T3J3	LB/B	-	F7BX50	599	S	P
Q5T3J3	LB/B	-	F7BX50	641	I	M
Q5T3J3	LB/B	-	F7BX50	438	A	T
A6NDA9	LB/B	-	H2TYY0	28	C	Y
A6NDA9	LB/B	-	H2TYY0	179	K	N
A6NDA9	LB/B	-	H2TYY0	220	L	F
A6NDA9	LB/B	-	H2TYY0	496	V	A
A6NDA9	LB/B	-	H2TYY0	510	T	P
Q86VZ4	LB/B	-	A0A2Y9MBE2	92	P	R
Q86VZ4	LB/B	-	A0A2Y9MBE2	351	R	H
Q86VZ4	LB/B	-	A0A2Y9MBE2	281	T	M
Q86VZ4	LB/B	-	A0A2Y9MBE2	442	G	R
P98164	LB/B	-	C3YYR4	1287	A	P
P98164	LB/B	-	C3YYR4	2872	A	T
P98164	LB/B	-	C3YYR4	4094	K	E
P98164	LB/B	-	C3YYR4	4210	I	L
P98164	LB/B	-	C3YYR4	2065	I	T
P98164	LB/B	-	C3YYR4	3305	R	H
P98164	LB/B	-	C3YYR4	1279	D	A
P98164	LB/B	-	C3YYR4	2012	R	K
P98164	LB/B	-	C3YYR4	2632	N	D
P98164	LB/B	-	C3YYR4	83	N	S
P98164	LB/B	-	C3YYR4	669	G	D
P98164	LB/B	-	C3YYR4	909	H	R
P98164	LB/B	-	C3YYR4	1083	H	Q
P98164	LP/P	Donnai-Barrow syndrome (DBS) [MIM:222448]	C3YYR4	2522	Y	H
P98164	LB/B	-	C3YYR4	3011	R	M
P98164	LB/B	-	C3YYR4	259	G	R
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	173	T	M
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	1168	Y	H
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	1361	C	G
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	570	R	Q
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	752	R	G
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	1367	E	K
O75197	LB/B	-	A0A2Y9JXI4	1525	A	V
O75197	LB/B	-	A0A2Y9JXI4	89	Q	R
O75197	LP/P	Osteopetrosis, autosomal dominant 1 (OPTA1) [MIM:607634]	A0A2Y9JXI4	111	D	Y
O75197	LP/P	Osteopetrosis, autosomal dominant 1 (OPTA1) [MIM:607634]	A0A2Y9JXI4	171	G	R
O75197	LP/P	High bone mass trait (HBM) [MIM:601884]	A0A2Y9JXI4	171	G	V
O75197	LP/P	Endosteal hyperostosis, Worth type (WENHY) [MIM:144750]	A0A2Y9JXI4	214	A	T
O75197	LP/P	Endosteal hyperostosis, Worth type (WENHY) [MIM:144750]	A0A2Y9JXI4	214	A	V
O75197	LP/P	Endosteal hyperostosis, Worth type (WENHY) [MIM:144750]	A0A2Y9JXI4	242	A	T
O75197	LP/P	Osteopetrosis, autosomal dominant 1 (OPTA1) [MIM:607634]	A0A2Y9JXI4	242	A	T
O75197	LP/P	Van Buchem disease 2 (VBCH2) [MIM:607636]	A0A2Y9JXI4	242	A	T
O75197	LP/P	Osteopetrosis, autosomal dominant 1 (OPTA1) [MIM:607634]	A0A2Y9JXI4	253	T	I
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	494	R	Q
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	570	R	W
O75197	LB/B	-	A0A2Y9JXI4	667	V	M
O75197	LB/B	-	A0A2Y9JXI4	1330	A	V
O75197	LB/B	-	A0A2Y9JXI4	1204	V	L
O75197	LB/B	-	A0A2Y9JXI4	97	A	V
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	145	L	F
O75197	LP/P	High bone mass trait (HBM) [MIM:601884]	A0A2Y9JXI4	154	R	M
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	203	D	N
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	244	T	M
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	307	S	F
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	348	R	W
O75197	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A2Y9JXI4	348	R	W
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	353	R	Q
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	356	S	L
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	390	T	K
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	400	A	E
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	404	G	R
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	409	T	A
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	441	E	K
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	444	R	C
O75197	LB/B	-	A0A2Y9JXI4	455	S	L
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	460	E	K
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	478	W	R
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	504	W	C
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	511	D	A
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	520	G	V
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	522	A	T
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	531	N	I
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	535	T	M
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	550	G	R
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	617	F	C
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	683	D	N
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	733	Y	H
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	798	T	A
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	805	R	W
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	1099	D	Y
O75197	LP/P	Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]	A0A2Y9JXI4	1113	R	C
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	1253	C	F
O75197	LB/B	-	A0A2Y9JXI4	1537	A	T
O75197	LB/B	-	A0A2Y9JXI4	1540	T	M
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	422	A	T
O75197	LP/P	Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]	A0A2Y9JXI4	540	L	P
O75197	LB/B	-	A0A2Y9JXI4	816	Q	P
O75197	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A2Y9JXI4	381	D	N
O75197	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A2Y9JXI4	624	R	W
O75197	LP/P	Vitreoretinopathy, exudative 1 (EVR1) [MIM:133780]	A0A2Y9JXI4	1517	Y	C
O75197	LB/B	-	A0A2Y9JXI4	1135	R	C
O75197	LP/P	Polycystic liver disease 4 with or without kidney cysts (PCLD4) [MIM:617875]	A0A2Y9JXI4	1188	R	W
A4QPB2	LB/B	-	G3SCM5	61	T	M
O75581	LB/B	-	V9K7A8	1062	V	I
O75581	LB/B	-	V9K7A8	483	V	I
O75581	LB/B	-	V9K7A8	817	S	C
O75581	LP/P	Coronary artery disease, autosomal dominant, 2 (ADCAD2) [MIM:610947]	V9K7A8	611	R	C
O75581	LB/B	-	V9K7A8	1401	R	H
O75581	LP/P	Tooth agenesis, selective, 7 (STHAG7) [MIM:616724]	V9K7A8	19	A	V
O75581	LP/P	Coronary artery disease, autosomal dominant, 2 (ADCAD2) [MIM:610947]	V9K7A8	360	R	H
O75581	LP/P	Coronary artery disease, autosomal dominant, 2 (ADCAD2) [MIM:610947]	V9K7A8	433	N	S
O75581	LP/P	Coronary artery disease, autosomal dominant, 2 (ADCAD2) [MIM:610947]	V9K7A8	473	R	Q
Q9C0I9	LB/B	-	G3SUW1	195	R	C
Q14392	LB/B	-	V8N5F3	223	L	V
Q14392	LB/B	-	V8N5F3	311	G	A
Q5VT99	LB/B	-	A0A2Y9KG56	276	L	F
Q5VT99	LB/B	-	A0A2Y9KG56	292	K	E
Q8N309	LB/B	-	G7N623	256	Q	K
Q05C16	LB/B	-	J3KQU2	137	M	V
Q05C16	LB/B	-	J3KQU2	206	M	V
Q05C16	LB/B	-	J3KQU2	281	K	R
Q05C16	LB/B	-	J3KQU2	282	T	A
A6NIV6	LB/B	-	M3Z074	159	K	E
Q6UXK5	LB/B	-	A0A087VS79	395	L	V
Q6UXK5	LB/B	-	A0A087VS79	702	T	P
O75325	LB/B	-	A0A087VS79	7	P	L
O75325	LB/B	-	A0A087VS79	518	L	V
O75325	LB/B	-	A0A087VS79	19	A	T
O75325	LB/B	-	A0A087VS79	659	V	A
O75325	LB/B	-	A0A087VS79	692	P	S
Q9H3W5	LB/B	-	A0A087VS79	24	D	G
Q6UWE0	LB/B	-	A0A2K6FH34	318	N	D
Q6UWE0	LP/P	Charcot-Marie-Tooth disease, axonal, 2P (CMT2P) [MIM:614436]	A0A2K6FH34	694	C	R
Q8ND56	LB/B	-	L5JMA4	448	R	Q
Q8ND56	LB/B	-	L5JMA4	238	R	Q
P01374	LB/B	-	A7X5U3	60	T	N
P01374	LB/B	-	A7X5U3	125	T	P
P01374	LB/B	-	A7X5U3	13	C	R
P01374	LB/B	-	A7X5U3	51	H	P
Q8N2S1	LB/B	-	F6SKV7	194	V	I
Q8N2S1	LB/B	-	F6SKV7	635	R	G
Q8N2S1	LB/B	-	F6SKV7	679	P	A
Q8N2S1	LB/B	-	F6SKV7	787	T	A
Q8N2S1	LB/B	-	F6SKV7	820	T	A
Q8N2S1	LB/B	-	F6SKV7	1141	T	M
Q8N2S1	LP/P	Urban-Rifkin-Davis syndrome (URDS) [MIM:613177]	F6SKV7	311	C	G
P36941	LB/B	-	I3MKS6	274	V	I
P02788	LB/B	-	A0A1A6G1K0	29	A	T
P02788	LB/B	-	A0A1A6G1K0	47	K	R
P02788	LB/B	-	A0A1A6G1K0	148	I	T
P02788	LB/B	-	A0A1A6G1K0	422	G	C
P02788	LB/B	-	A0A1A6G1K0	579	E	D
Q6UWN5	LB/B	-	G3TVJ8	47	P	A
Q6UWN5	LB/B	-	G3TVJ8	90	A	P
Q6UWN5	LB/B	-	G3TVJ8	167	N	S
Q8N6I4	LP/P	Dysostosis multiplex, Ain-Naz type (DMAN) [MIM:619345]	A0A2K6TTX2	39	R	W
Q8WZA0	LB/B	-	A0A091DKF1	104	G	D
O75444	LP/P	Cataract 21, multiple types (CTRCT21) [MIM:610202]	H9GW01	288	R	P
O75444	LP/P	Cataract 21, multiple types (CTRCT21) [MIM:610202]	H9GW01	297	K	R
O75444	LP/P	Ayme-Gripp syndrome (AYGRP) [MIM:601088]	H9GW01	54	S	L
O75444	LP/P	Ayme-Gripp syndrome (AYGRP) [MIM:601088]	H9GW01	58	T	A
O75444	LP/P	Ayme-Gripp syndrome (AYGRP) [MIM:601088]	H9GW01	58	T	I
O75444	LP/P	Ayme-Gripp syndrome (AYGRP) [MIM:601088]	H9GW01	59	P	H
O75444	LP/P	Ayme-Gripp syndrome (AYGRP) [MIM:601088]	H9GW01	59	P	L
O75444	LP/P	Ayme-Gripp syndrome (AYGRP) [MIM:601088]	H9GW01	62	T	R
O75444	LP/P	Ayme-Gripp syndrome (AYGRP) [MIM:601088]	H9GW01	69	P	R
O75444	LP/P	Cataract 21, multiple types (CTRCT21) [MIM:610202]	H9GW01	303	Q	L
O75444	LP/P	Cataract 21, multiple types (CTRCT21) [MIM:610202]	H9GW01	320	K	E
Q8NHW3	LP/P	Insulinomatosis and diabetes mellitus (INSDM) [MIM:147630]	H9GW01	64	S	F
P43355	LB/B	-	H0WFN2	32	T	A
P43355	LB/B	-	H0WFN2	72	R	Q
P43355	LB/B	-	H0WFN2	63	A	T
P43365	LB/B	-	H0WFN2	57	E	D
P43359	LB/B	-	A0A2K5TZP1	29	Q	H
P43360	LB/B	-	H0WFN2	152	S	I
P43361	LB/B	-	H0WFN2	121	R	H
P43361	LB/B	-	H0WFN2	306	S	F
P43362	LB/B	-	H0WFN2	31	P	H
O15480	LB/B	-	G5B0V8	107	R	H
O15480	LB/B	-	G5B0V8	112	I	T
Q9Y5V3	LB/B	-	G3UFV7	238	L	M
Q9HAY2	LB/B	-	G1PEM9	93	K	R
Q13495	LB/B	-	K9IPW8	662	N	S
Q13495	LB/B	-	K9IPW8	359	P	S
Q13495	LB/B	-	K9IPW8	580	Q	R
P21397	LB/B	-	F7D3I3	314	F	V
P21397	LB/B	-	F7D3I3	520	K	R
P21397	LB/B	-	F7D3I3	188	E	K
P21397	LP/P	-	F7D3I3	266	C	F
Q13233	LB/B	-	G1PIV9	92	S	N
Q13233	LB/B	-	G1PIV9	443	C	S
Q13233	LB/B	-	G1PIV9	806	D	N
Q13233	LB/B	-	G1PIV9	906	V	I
Q13233	LP/P	46,XY sex reversal 6 (SRXY6) [MIM:613762]	G1PIV9	189	L	P
Q13233	LP/P	46,XY sex reversal 6 (SRXY6) [MIM:613762]	G1PIV9	189	L	R
Q02779	LB/B	-	I3MM95	168	P	Q
Q16584	LB/B	-	G3Q9A0	252	P	H
Q16584	LB/B	-	G3Q9A0	151	D	V
Q16584	LB/B	-	G3Q9A0	282	A	G
Q56UN5	LB/B	-	G3T125	438	T	I
Q56UN5	LB/B	-	G3T125	676	E	Q
Q56UN5	LB/B	-	G3T125	812	E	G
P80192	LB/B	-	I3MM95	497	R	Q
P80192	LB/B	-	I3MM95	646	Y	C
O95819	LB/B	-	A0A2D0Q537	712	S	T
Q14244	LB/B	-	G5C1A8	558	R	W
Q14244	LB/B	-	G5C1A8	361	V	I
Q14244	LB/B	-	G5C1A8	526	R	P
Q3KQU3	LB/B	-	A0A1A6HT50	104	R	W
Q3KQU3	LB/B	-	A0A1A6HT50	531	R	S
P49137	LB/B	-	A0A2K5JYM9	173	A	G
P49137	LB/B	-	A0A2K5JYM9	361	A	S
Q5T0T0	LB/B	-	A0A1S3T278	92	P	S
Q5T0T0	LB/B	-	A0A1S3T278	266	Y	H
P48740	LB/B	-	G3WLP9	21	T	I
P48740	LB/B	-	G3WLP9	568	V	A
P48740	LB/B	-	G3WLP9	679	G	R
O00187	LB/B	-	G3WLP9	99	R	Q
O00187	LB/B	-	G3WLP9	118	R	C
O00187	LP/P	MASP2 deficiency (MASPD) [MIM:613791]	G3WLP9	120	D	G
O00187	LP/P	MASP2 deficiency (MASPD) [MIM:613791]	G3WLP9	126	P	L
O00187	LB/B	-	G3WLP9	155	H	R
O00187	LB/B	-	G3WLP9	371	D	Y
O00187	LB/B	-	G3WLP9	377	V	A
O00187	LB/B	-	G3WLP9	439	R	H
O00187	LB/B	-	G3WLP9	128	T	M
O00187	LB/B	-	G3WLP9	405	V	M
P43243	LP/P	Amyotrophic lateral sclerosis 21 (ALS21) [MIM:606070]	G3W9E4	85	S	C
P43243	LP/P	Amyotrophic lateral sclerosis 21 (ALS21) [MIM:606070]	G3W9E4	115	F	C
P43243	LP/P	Amyotrophic lateral sclerosis 21 (ALS21) [MIM:606070]	G3W9E4	622	T	A
P43243	LB/B	-	G3W9E4	89	I	V
P43243	LB/B	-	G3W9E4	664	E	A
P43243	LB/B	-	G3W9E4	787	N	S
P61244	LP/P	Pheochromocytoma (PCC) [MIM:171300]	V4B4Z8	9	V	L
P61244	LP/P	Pheochromocytoma (PCC) [MIM:171300]	V4B4Z8	25	R	W
P61244	LP/P	Pheochromocytoma (PCC) [MIM:171300]	V4B4Z8	35	R	C
P61244	LP/P	Pheochromocytoma (PCC) [MIM:171300]	V4B4Z8	60	R	W
P61244	LP/P	Pheochromocytoma (PCC) [MIM:171300]	V4B4Z8	71	I	S
P61244	LP/P	Pheochromocytoma (PCC) [MIM:171300]	V4B4Z8	74	M	V
P61244	LP/P	Pheochromocytoma (PCC) [MIM:171300]	V4B4Z8	90	R	P
P61244	LP/P	Pheochromocytoma (PCC) [MIM:171300]	V4B4Z8	94	L	P
P61244	LP/P	Pheochromocytoma (PCC) [MIM:171300]	V4B4Z8	102	L	P
P61244	LB/B	-	V4B4Z8	114	N	T
P61244	LB/B	-	V4B4Z8	142	S	L
Q14703	LB/B	-	A0A146Y1T5	6	I	T
Q14703	LB/B	-	A0A146Y1T5	90	R	G
Q14703	LP/P	Spondyloepiphyseal dysplasia, Kondo-Fu type (SEDKF) [MIM:618392]	A0A146Y1T5	365	D	G
P33032	LB/B	-	A0A1V4J8L8	209	F	L
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	289	A	V
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	325	M	R
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	385	R	S
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	437	L	P
Q96RQ3	LB/B	-	A0A1L8DYM3	464	H	P
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	532	D	H
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	535	S	F
Q96RQ3	LB/B	-	A0A1L8DYM3	560	N	T
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	276	C	R
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	281	R	Q
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	46	G	E
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	56	N	K
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	65	M	L
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	123	Q	H
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	125	I	M
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	134	E	K
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	160	M	R
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	180	G	V
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	187	S	P
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	232	R	W
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	268	A	D
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	288	E	G
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	291	A	V
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	372	Q	P
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	379	G	D
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	379	G	S
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	380	H	P
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	434	I	M
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	439	V	M
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	460	I	M
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	79	Y	C
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	120	S	F
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	130	G	S
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	209	G	V
Q96RQ3	LP/P	3-methylcrotonoyl-CoA carboxylase 1 deficiency (MCC1D) [MIM:210200]	A0A1L8DYM3	444	R	H
Q96RQ3	LB/B	-	A0A1L8DYM3	632	P	S
Q969V1	LB/B	-	W5KNG2	63	R	K
Q969V1	LB/B	-	W5KNG2	152	R	Q
P33991	LB/B	-	A0A1A6HR27	460	E	G
P33991	LB/B	-	A0A1A6HR27	650	L	M
Q9UHV7	LB/B	-	T1IJV1	1370	A	P
Q9UHV7	LB/B	-	T1IJV1	1385	A	P
Q9UHV7	LP/P	Intellectual developmental disorder, autosomal dominant 61 (MRD61) [MIM:618009]	T1IJV1	326	T	I
Q9UHV7	LP/P	Intellectual developmental disorder, autosomal dominant 61 (MRD61) [MIM:618009]	T1IJV1	327	P	Q
Q9UHV7	LP/P	Intellectual developmental disorder, autosomal dominant 61 (MRD61) [MIM:618009]	T1IJV1	327	P	S
Q9NVC6	LB/B	-	A0A1W2PRB8	357	F	L
Q9NVC6	LB/B	-	A0A1W2PRB8	69	E	D
Q9NVC6	LP/P	Microcephaly, postnatal progressive, with seizures and brain atrophy (MCPHSBA) [MIM:613668]	A0A1W2PRB8	371	L	P
Q02078	LB/B	-	V9KPD3	263	N	S
Q02078	LB/B	-	V9KPD3	279	P	L
Q02078	LB/B	-	V9KPD3	283	G	D
Q06413	LP/P	-	V9KPD3	36	S	R
Q06413	LP/P	-	V9KPD3	39	C	R
O15553	LB/B	Familial Mediterranean fever, autosomal dominant (ADFMF) [MIM:134610]	A0A2K5QXG4	148	E	Q
O15553	LB/B	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	148	E	Q
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	167	E	D
O15553	LB/B	-	A0A2K5QXG4	202	R	Q
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	267	T	I
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	408	R	Q
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	479	F	L
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	681	T	I
O15553	LP/P	Familial Mediterranean fever, autosomal dominant (ADFMF) [MIM:134610]	A0A2K5QXG4	694	M	I
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	694	M	I
O15553	LP/P	Familial Mediterranean fever, autosomal dominant (ADFMF) [MIM:134610]	A0A2K5QXG4	694	M	V
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	694	M	V
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	695	K	R
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	726	V	A
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	761	R	H
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	110	L	P
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	230	E	K
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	653	R	H
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	675	S	N
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	680	M	L
O15553	LB/B	-	A0A2K5QXG4	440	Q	E
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	42	R	W
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	108	S	R
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	148	E	V
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	163	E	A
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	177	T	I
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	319	E	K
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	474	E	K
O15553	LP/P	Familial Mediterranean fever, autosomal dominant (ADFMF) [MIM:134610]	A0A2K5QXG4	478	H	Y
O15553	LB/B	-	A0A2K5QXG4	585	F	L
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	632	G	S
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	640	I	M
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	641	I	F
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	646	P	L
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	649	L	P
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	656	E	A
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	661	D	N
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	678	G	E
O15553	LP/P	Familial Mediterranean fever, autosomal dominant (ADFMF) [MIM:134610]	A0A2K5QXG4	680	M	I
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	680	M	I
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	688	Y	C
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	694	M	L
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	695	K	M
O15553	LB/B	-	A0A2K5QXG4	702	S	C
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	704	V	I
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	705	P	S
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	720	I	M
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	743	F	L
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	758	P	S
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	780	P	T
O15553	LB/B	-	A0A2K5QXG4	33	V	L
O15553	LP/P	-	A0A2K5QXG4	577	T	A
O15553	LP/P	-	A0A2K5QXG4	577	T	N
O15553	LP/P	-	A0A2K5QXG4	577	T	S
O15553	LP/P	Familial Mediterranean fever, autosomal recessive (ARFMF) [MIM:249100]	A0A2K5QXG4	694	M	K
O15553	LP/P	Pyrin-associated autoinflammatory disease (PAAND) [MIM:608068]	A0A2K5QXG4	242	S	R
O15553	LP/P	Pyrin-associated autoinflammatory disease (PAAND) [MIM:608068]	A0A2K5QXG4	244	E	K
O75095	LB/B	-	A0A2R8ZSW4	131	S	G
O75095	LB/B	-	A0A2R8ZSW4	916	R	L
O75095	LB/B	-	A0A2R8ZSW4	1137	G	A
O75095	LB/B	-	A0A2R8ZSW4	115	M	T
O75095	LB/B	-	A0A2R8ZSW4	313	A	V
O75095	LB/B	-	A0A2R8ZSW4	688	L	P
O75095	LB/B	-	A0A2R8ZSW4	587	P	L
O75095	LB/B	-	A0A2R8ZSW4	1287	R	H
O75095	LB/B	-	A0A2R8ZSW4	1536	G	S
Q5JSS6	LB/B	-	A0A2Y9FMC4	9	K	T
Q86W50	LB/B	-	L8IW45	479	S	N
Q9GZY8	LB/B	-	S7NLP9	7	S	C
Q9GZY8	LB/B	-	S7NLP9	7	S	I
O00587	LB/B	-	A0A1A6GSX7	302	R	C
Q9BY79	LB/B	-	L5KL69	54	R	G
Q9BY79	LB/B	-	L5KL69	119	I	V
Q9BY79	LB/B	-	L5KL69	136	V	M
Q9BY79	LP/P	Nanophthalmos 2 (NNO2) [MIM:609549]	L5KL69	182	I	T
Q9BY79	LB/B	-	L5KL69	449	G	S
Q9BY79	LB/B	-	L5KL69	514	Q	H
Q8NA29	LP/P	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain imaging abnormalities (NEDMISBA) [MIM:616486]	A0A151MMM4	172	T	M
Q8NA29	LP/P	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain imaging abnormalities (NEDMISBA) [MIM:616486]	A0A151MMM4	179	S	L
Q8NA29	LP/P	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain imaging abnormalities (NEDMISBA) [MIM:616486]	A0A151MMM4	352	S	L
Q8NA29	LP/P	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain imaging abnormalities (NEDMISBA) [MIM:616486]	A0A151MMM4	211	T	M
Q8NA29	LP/P	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain imaging abnormalities (NEDMISBA) [MIM:616486]	A0A151MMM4	263	V	F
Q8NA29	LP/P	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain imaging abnormalities (NEDMISBA) [MIM:616486]	A0A151MMM4	339	R	H
Q8NA29	LP/P	Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain imaging abnormalities (NEDMISBA) [MIM:616486]	A0A151MMM4	506	P	L
O15344	LP/P	Opitz GBBB syndrome (GBBB) [MIM:300000]	A0A1A8QK03	266	C	R
O15344	LP/P	Opitz GBBB syndrome (GBBB) [MIM:300000]	A0A1A8QK03	536	I	T
O15344	LP/P	Opitz GBBB syndrome (GBBB) [MIM:300000]	A0A1A8QK03	626	L	P
O15344	LP/P	Opitz GBBB syndrome (GBBB) [MIM:300000]	A0A1A8QK03	295	L	P
Q9UJV3	LB/B	-	A0A1A8QK03	378	A	D
Q9UJV3	LB/B	-	A0A1A8QK03	343	N	S
Q9UJV3	LP/P	Intellectual developmental disorder, X-linked 101 (XLID101) [MIM:300928]	A0A1A8QK03	347	R	Q
Q6PJG2	LB/B	-	S7PHE3	86	A	V
Q6PJG2	LB/B	-	S7PHE3	554	P	L
Q6PJG2	LB/B	-	S7PHE3	895	D	N
Q7L4E1	LB/B	-	A0A1S3WGQ2	78	E	K
Q7L4E1	LB/B	-	A0A1S3WGQ2	100	V	A
Q7L4E1	LB/B	-	A0A1S3WGQ2	212	G	S
Q8N4C8	LB/B	-	A0A2D0Q537	514	A	T
Q8N4C8	LB/B	-	A0A2D0Q537	1200	I	V
Q8N4C8	LB/B	-	A0A2D0Q537	771	V	A
Q8N4C8	LB/B	-	A0A2D0Q537	775	P	L
Q8N4C8	LB/B	-	A0A2D0Q537	863	V	I
Q99797	LB/B	-	M3XNI2	137	A	V
Q99797	LB/B	-	M3XNI2	340	R	Q
Q99797	LB/B	-	M3XNI2	453	R	H
Q99797	LB/B	-	M3XNI2	488	S	G
Q99797	LP/P	Combined oxidative phosphorylation deficiency 31 (COXPD31) [MIM:617228]	M3XNI2	71	L	Q
Q99797	LP/P	Combined oxidative phosphorylation deficiency 31 (COXPD31) [MIM:617228]	M3XNI2	306	L	F
Q99797	LP/P	Combined oxidative phosphorylation deficiency 31 (COXPD31) [MIM:617228]	M3XNI2	343	K	E
Q9H081	LB/B	-	G5BW77	21	M	V
Q9NXB0	LB/B	-	A0A1S3HGE1	39	L	F
Q9NXB0	LB/B	-	A0A1S3HGE1	123	R	Q
Q9NXB0	LB/B	-	A0A1S3HGE1	286	D	G
Q9NXB0	LB/B	-	A0A1S3HGE1	450	I	T
Q9NXB0	LP/P	Bardet-Biedl syndrome 13 (BBS13) [MIM:615990]	A0A1S3HGE1	492	C	W
Q9NXB0	LP/P	Meckel syndrome 1 (MKS1) [MIM:249000]	A0A1S3HGE1	19	D	Y
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	28	P	L
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	35	M	R
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	44	S	F
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	62	Q	K
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	64	N	S
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	67	G	R
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	68	I	N
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	69	R	K
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	77	C	R
P40692	LB/B	-	F6XE31	93	S	G
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	107	I	R
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	117	T	M
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	117	T	R
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	185	V	G
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	193	S	P
P40692	LB/B	-	F6XE31	219	I	V
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	226	R	L
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	326	V	A
P40692	LB/B	-	F6XE31	384	V	D
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	492	A	T
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	506	V	A
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	542	Q	L
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	574	L	P
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	582	L	V
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	618	K	T
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	659	R	P
P40692	LP/P	Colorectal cancer (CRC) [MIM:114500]	F6XE31	681	A	T
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	681	A	T
P40692	LB/B	-	F6XE31	729	L	V
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	67	G	W
P40692	LP/P	Colorectal cancer (CRC) [MIM:114500]	F6XE31	77	C	Y
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	80	F	V
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	84	K	E
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	128	A	P
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	182	R	G
P40692	LB/B	-	F6XE31	213	V	M
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	244	G	D
P40692	LB/B	-	F6XE31	265	R	H
P40692	LP/P	Colorectal cancer (CRC) [MIM:114500]	F6XE31	268	E	G
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	295	S	T
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	329	H	P
P40692	LB/B	-	F6XE31	406	S	N
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	441	A	T
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	549	L	P
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	551	N	T
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	565	I	F
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	588	L	P
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	622	L	H
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	659	R	L
P40692	LB/B	-	F6XE31	716	V	M
P40692	LB/B	-	F6XE31	755	R	W
P40692	LB/B	-	F6XE31	32	I	V
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	586	A	P
P40692	LB/B	-	F6XE31	217	R	G
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	18	R	C
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	101	G	D
P40692	LP/P	Colorectal cancer (CRC) [MIM:114500]	F6XE31	132	D	H
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	182	R	K
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	379	Y	C
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	559	L	R
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	648	P	S
P40692	LB/B	-	F6XE31	22	G	A
P40692	LP/P	Colorectal cancer (CRC) [MIM:114500]	F6XE31	67	G	E
P40692	LB/B	-	F6XE31	309	P	S
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	21	A	V
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	25	I	F
P40692	LP/P	Mismatch repair cancer syndrome 1 (MMRCS1) [MIM:276300]	F6XE31	35	M	N
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	38	N	H
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	41	D	G
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	63	D	E
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	155	L	R
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	247	S	P
P40692	LP/P	Colorectal cancer (CRC) [MIM:114500]	F6XE31	260	L	R
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	264	H	Y
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	282	A	G
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	304	D	V
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	338	N	S
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	485	D	E
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	542	Q	P
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	550	L	P
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	589	A	D
P40692	LP/P	Colorectal cancer (CRC) [MIM:114500]	F6XE31	618	K	R
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	636	L	P
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	640	P	S
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	646	Y	C
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	654	P	L
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	655	I	V
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	724	L	M
P40692	LP/P	Colorectal cancer (CRC) [MIM:114500]	F6XE31	749	L	P
P40692	LB/B	-	F6XE31	41	D	H
P40692	LB/B	-	F6XE31	98	G	S
P40692	LB/B	-	F6XE31	101	G	S
P40692	LB/B	-	F6XE31	116	T	K
P40692	LB/B	-	F6XE31	126	Y	N
P40692	LB/B	-	F6XE31	215	N	S
P40692	LB/B	-	F6XE31	216	I	S
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	265	R	C
P40692	LB/B	-	F6XE31	320	E	D
P40692	LB/B	-	F6XE31	474	R	W
P40692	LB/B	-	F6XE31	539	A	D
P40692	LB/B	-	F6XE31	585	L	R
P40692	LB/B	-	F6XE31	619	A	P
P40692	LB/B	-	F6XE31	640	P	L
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	656	F	S
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	31	A	C
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	37	E	K
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	38	N	K
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	109	H	P
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	111	A	P
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	265	R	S
P40692	LB/B	-	F6XE31	403	P	S
P40692	LP/P	Lynch syndrome 2 (LYNCH2) [MIM:609310]	F6XE31	582	L	F
P40692	LB/B	-	F6XE31	116	T	R
P40692	LB/B	-	F6XE31	213	V	L
P40692	LB/B	-	F6XE31	264	H	L
P40692	LB/B	-	F6XE31	423	R	T
P40692	LB/B	-	F6XE31	725	R	H
Q96EY8	LB/B	-	I3K762	19	R	Q
Q96EY8	LP/P	Methylmalonic aciduria type cblB (MMAB) [MIM:251110]	I3K762	135	A	T
Q96EY8	LP/P	Methylmalonic aciduria type cblB (MMAB) [MIM:251110]	I3K762	186	R	W
Q96EY8	LP/P	Methylmalonic aciduria type cblB (MMAB) [MIM:251110]	I3K762	191	R	W
Q96EY8	LP/P	Methylmalonic aciduria type cblB (MMAB) [MIM:251110]	I3K762	193	E	K
Q96EY8	LB/B	-	I3K762	239	M	K
Q96EY8	LP/P	Methylmalonic aciduria type cblB (MMAB) [MIM:251110]	I3K762	96	I	T
Q96EY8	LB/B	-	I3K762	19	R	H
Q9H3L0	LP/P	Methylmalonic aciduria and homocystinuria, cblD type (MAHCD) [MIM:277410]	A0A2K5NVV8	182	T	N
Q9H3L0	LP/P	Methylmalonic aciduria and homocystinuria, cblD type (MAHCD) [MIM:277410]	A0A2K5NVV8	249	Y	C
Q9H3L0	LP/P	Methylmalonic aciduria and homocystinuria, cblD type (MAHCD) [MIM:277410]	A0A2K5NVV8	259	L	P
P09238	LB/B	-	D3YV89	4	L	V
P09238	LB/B	-	D3YV89	53	R	K
P09238	LB/B	-	D3YV89	65	G	R
P09238	LB/B	-	D3YV89	226	F	L
P09238	LB/B	-	D3YV89	282	G	E
P09238	LB/B	-	D3YV89	440	L	F
P09238	LB/B	-	D3YV89	475	H	L
P39900	LB/B	-	D3YV89	357	N	S
P39900	LB/B	-	D3YV89	469	G	R
Q9H306	LB/B	-	D3YV89	22	R	W
Q9H306	LB/B	-	D3YV89	24	T	M
Q9H306	LB/B	-	D3YV89	30	M	V
Q9H306	LB/B	-	D3YV89	266	E	V
Q9H306	LB/B	-	D3YV89	304	W	L
Q9H306	LB/B	-	D3YV89	447	D	N
Q9H306	LB/B	-	D3YV89	477	I	V
P08254	LB/B	-	D3YV89	45	K	E
Q13201	LB/B	-	M7CCP8	58	T	A
Q13201	LB/B	-	M7CCP8	805	T	A
Q13201	LB/B	-	M7CCP8	883	G	D
Q13201	LB/B	-	M7CCP8	964	T	R
Q9H8L6	LB/B	-	G3TA55	49	G	S
Q9H8L6	LB/B	-	G3TA55	731	H	D
Q9H8L6	LB/B	-	G3TA55	831	S	R
Q9H8L6	LB/B	-	G3TA55	910	V	L
Q96T76	LB/B	-	A0A151MYY1	68	A	G
Q96T76	LB/B	-	A0A151MYY1	98	R	W
Q96T76	LB/B	-	A0A151MYY1	197	V	I
Q96T76	LB/B	-	A0A151MYY1	306	R	H
Q96T76	LB/B	-	A0A151MYY1	365	M	V
Q96T76	LB/B	-	A0A151MYY1	409	Q	P
Q96T76	LB/B	-	A0A151MYY1	434	Q	E
Q96T76	LB/B	-	A0A151MYY1	526	V	I
Q96T76	LB/B	-	A0A151MYY1	558	A	V
Q96T76	LB/B	-	A0A151MYY1	790	G	D
Q96T76	LB/B	-	A0A151MYY1	983	R	H
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	93	R	H
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	105	W	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	191	A	E
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	228	R	Q
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	231	Y	N
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	312	G	V
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	368	V	D
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	369	R	H
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	377	A	E
P22033	LB/B	-	A0A0V1D2U7	532	R	H
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	623	G	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	626	G	C
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	630	G	E
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	633	V	G
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	648	G	D
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	669	V	E
P22033	LB/B	-	A0A0V1D2U7	671	I	V
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	678	H	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	685	L	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	694	R	W
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	703	G	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	717	G	V
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	94	G	V
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	108	R	H
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	137	A	V
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	148	S	L
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	156	D	N
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	158	G	V
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	174	F	S
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	203	G	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	215	G	S
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	218	Q	H
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	219	N	Y
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	262	S	N
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	293	Q	P
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	328	L	F
P22033	LB/B	-	A0A0V1D2U7	499	A	T
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	535	A	P
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	587	Y	C
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	615	P	T
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	621	K	N
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	624	Q	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	627	H	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	637	G	E
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	638	F	I
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	640	D	Y
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	642	G	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	700	M	K
P22033	LB/B	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	69	I	V
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	109	Q	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	324	A	T
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	328	L	P
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	616	R	C
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	617	L	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	86	P	L
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	87	G	E
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	94	G	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	95	P	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	108	R	C
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	108	R	G
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	145	G	S
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	186	M	V
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	189	N	K
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	197	A	E
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	215	G	C
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	230	T	I
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	265	H	Y
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	281	L	S
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	291	G	E
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	305	L	S
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	306	S	F
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	316	Y	C
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	347	L	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	350	H	Y
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	369	R	C
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	370	T	P
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	383	Q	H
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	383	Q	P
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	386	H	N
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	388	N	H
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	426	G	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	427	G	D
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	518	L	P
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	560	C	Y
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	566	T	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	573	F	S
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	615	P	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	637	G	R
P22033	LB/B	-	A0A0V1D2U7	598	T	A
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	100	Y	C
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	110	Y	C
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	137	A	G
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	143	H	Y
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	288	S	P
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	344	S	F
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	364	Y	S
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	366	N	S
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	387	T	I
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	454	G	E
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	615	P	L
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	625	D	V
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	674	L	F
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	692	L	P
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	694	R	L
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	126	N	K
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	133	G	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	156	D	V
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	161	G	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	187	T	S
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	189	N	I
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	230	T	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	284	G	E
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	284	G	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	325	G	D
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	358	L	P
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	386	H	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	388	N	K
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	424	P	L
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	426	G	E
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	618	L	P
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	625	D	G
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	736	L	F
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	140	L	P
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	141	A	T
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	161	G	V
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	309	W	G
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	505	I	T
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	514	Q	K
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	597	I	R
P22033	LP/P	Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (MMAM) [MIM:251000]	A0A0V1D2U7	723	G	D
Q8NEH6	LB/B	-	G7PBJ4	10	C	Y
Q8NEH6	LB/B	-	G7PBJ4	55	Q	P
Q8NEH6	LB/B	-	G7PBJ4	216	I	T
Q8NEH6	LB/B	-	G7PBJ4	244	Y	H
Q8NEH6	LB/B	-	G7PBJ4	426	E	G
P50219	LP/P	Currarino syndrome (CURRAS) [MIM:176450]	A0A0Q3M437	245	R	G
P50219	LP/P	Currarino syndrome (CURRAS) [MIM:176450]	A0A0Q3M437	245	R	H
P50219	LP/P	Currarino syndrome (CURRAS) [MIM:176450]	A0A0Q3M437	246	T	S
P50219	LP/P	Currarino syndrome (CURRAS) [MIM:176450]	A0A0Q3M437	288	W	G
P50219	LP/P	Currarino syndrome (CURRAS) [MIM:176450]	A0A0Q3M437	288	W	L
P50219	LP/P	Currarino syndrome (CURRAS) [MIM:176450]	A0A0Q3M437	290	Q	P
P50219	LP/P	Currarino syndrome (CURRAS) [MIM:176450]	A0A0Q3M437	292	R	W
P50219	LP/P	Currarino syndrome (CURRAS) [MIM:176450]	A0A0Q3M437	293	R	Q
P50219	LP/P	Currarino syndrome (CURRAS) [MIM:176450]	A0A0Q3M437	293	R	W
P50219	LP/P	Currarino syndrome (CURRAS) [MIM:176450]	A0A0Q3M437	243	R	W
P50219	LP/P	Currarino syndrome (CURRAS) [MIM:176450]	A0A0Q3M437	289	F	S
Q9NZB8	LP/P	Molybdenum cofactor deficiency, complementation group A (MOCODA) [MIM:252150]	A0A0G2FEA1	73	R	W
Q9NZB8	LP/P	Molybdenum cofactor deficiency, complementation group A (MOCODA) [MIM:252150]	A0A0G2FEA1	126	G	D
Q9NZB8	LP/P	Molybdenum cofactor deficiency, complementation group A (MOCODA) [MIM:252150]	A0A0G2FEA1	127	G	D
Q9NZB8	LP/P	Molybdenum cofactor deficiency, complementation group A (MOCODA) [MIM:252150]	A0A0G2FEA1	319	R	Q
Q9NZB8	LP/P	Molybdenum cofactor deficiency, complementation group A (MOCODA) [MIM:252150]	A0A0G2FEA1	324	G	E
Q9NZB8	LP/P	Molybdenum cofactor deficiency, complementation group A (MOCODA) [MIM:252150]	A0A0G2FEA1	67	R	W
Q9NZB8	LP/P	Molybdenum cofactor deficiency, complementation group A (MOCODA) [MIM:252150]	A0A0G2FEA1	80	C	G
Q9NZB8	LP/P	Molybdenum cofactor deficiency, complementation group A (MOCODA) [MIM:252150]	A0A0G2FEA1	84	C	F
Q9NZB8	LP/P	Molybdenum cofactor deficiency, complementation group A (MOCODA) [MIM:252150]	A0A0G2FEA1	123	R	W
Q9NZB8	LP/P	Molybdenum cofactor deficiency, complementation group A (MOCODA) [MIM:252150]	A0A0G2FEA1	324	G	R
Q9NZB8	LB/B	-	A0A0G2FEA1	390	P	H
Q9NZB8	LB/B	-	A0A0G2FEA1	452	R	L
Q3SYC2	LB/B	-	A7SD32	9	M	V
Q3SYC2	LB/B	-	A7SD32	313	C	Y
Q3SYC2	LB/B	-	A7SD32	196	P	H
Q8TE76	LB/B	-	R0LS54	473	T	I
Q8TE76	LB/B	-	R0LS54	653	R	C
O75352	LP/P	Congenital disorder of glycosylation 1F (CDG1F) [MIM:609180]	A0A2G8JPX3	73	G	E
O75352	LP/P	Congenital disorder of glycosylation 1F (CDG1F) [MIM:609180]	A0A2G8JPX3	74	L	S
O75352	LP/P	Congenital disorder of glycosylation 1F (CDG1F) [MIM:609180]	A0A2G8JPX3	119	L	P
O75352	LB/B	-	A0A2G8JPX3	225	G	S
O75352	LB/B	-	A0A2G8JPX3	229	A	T
P29372	LB/B	-	A0A250YE59	64	P	L
P29372	LB/B	-	A0A250YE59	71	Y	H
P29372	LB/B	-	A0A250YE59	120	R	C
P29372	LB/B	-	A0A250YE59	141	R	Q
P29372	LB/B	-	A0A250YE59	258	A	V
P29372	LB/B	-	A0A250YE59	298	A	S
P29372	LB/B	-	A0A250YE59	22	K	Q
P29372	LB/B	-	A0A250YE59	93	Q	R
Q99550	LB/B	-	A0A093ESW9	125	G	S
Q99550	LB/B	-	A0A093ESW9	926	A	D
Q53F39	LB/B	-	A0A2Y9GHY8	138	R	Q
Q53F39	LB/B	-	A0A2Y9GHY8	197	V	M
Q53F39	LB/B	-	A0A2Y9GHY8	268	A	P
Q53F39	LB/B	-	A0A2Y9GHY8	336	M	L
O14807	LP/P	Noonan syndrome 11 (NS11) [MIM:618499]	S7MPB9	23	G	V
O14807	LP/P	Noonan syndrome 11 (NS11) [MIM:618499]	S7MPB9	68	T	I
O14807	LP/P	Noonan syndrome 11 (NS11) [MIM:618499]	S7MPB9	71	Q	R
P49959	LP/P	Ataxia-telangiectasia-like disorder 1 (ATLD1) [MIM:604391]	A0A2D4HYI2	117	N	S
P49959	LB/B	-	A0A2D4HYI2	157	M	V
P49959	LB/B	-	A0A2D4HYI2	468	D	G
P49959	LB/B	-	A0A2D4HYI2	698	M	V
Q9UI43	LP/P	Mitochondrial DNA depletion syndrome 17 (MTDPS17) [MIM:618567]	A0A1A9Y8J1	189	G	R
Q9HC36	LB/B	-	H2RTU7	8	A	S
Q9HC36	LB/B	-	H2RTU7	45	G	E
Q9HC36	LB/B	-	H2RTU7	185	I	V
Q9HC36	LB/B	-	H2RTU7	326	E	Q
A6NES4	LB/B	-	G3WRY0	11	A	D
A6NES4	LB/B	-	G3WRY0	271	Y	H
A6NES4	LB/B	-	G3WRY0	329	E	G
A6NES4	LB/B	-	G3WRY0	489	K	N
A6NES4	LB/B	-	G3WRY0	978	W	R
A6NES4	LB/B	-	G3WRY0	1041	Q	E
A6NES4	LB/B	-	G3WRY0	1075	S	T
A6NES4	LB/B	-	G3WRY0	1107	F	S
A6NES4	LB/B	-	G3WRY0	1141	R	C
A6NES4	LB/B	-	G3WRY0	1184	V	M
A6NES4	LB/B	-	G3WRY0	1410	A	T
A6NES4	LB/B	-	G3WRY0	1454	T	A
A6NES4	LB/B	-	G3WRY0	1537	M	V
A6NES4	LB/B	-	G3WRY0	1546	F	L
A6NES4	LB/B	-	G3WRY0	1562	A	T
A6NES4	LB/B	-	G3WRY0	1569	V	I
A6NES4	LB/B	-	G3WRY0	1643	P	L
Q7Z7H8	LB/B	-	M3WBA1	125	V	I
Q9NWU5	LB/B	-	W5PL71	154	G	S
Q9NZE8	LB/B	-	A0A1S3A612	19	P	S
Q9NZE8	LB/B	-	A0A1S3A612	80	A	P
Q9NZE8	LB/B	-	A0A1S3A612	81	P	L
Q9NZE8	LB/B	-	A0A1S3A612	24	A	T
Q9NZE8	LB/B	-	A0A1S3A612	29	R	H
Q9NZE8	LB/B	-	A0A1S3A612	180	Y	C
Q9BRJ2	LB/B	-	G1QI71	298	G	V
Q9H2W6	LB/B	-	A0A2K6UIP6	106	H	Y
Q13405	LB/B	-	F6U9W9	9	T	A
Q86TS9	LB/B	-	I3MF91	5	G	V
Q86TS9	LB/B	-	I3MF91	19	V	A
Q86TS9	LB/B	-	I3MF91	104	K	R
Q96EL3	LB/B	-	Q9D1H8	4	A	S
Q9Y3D3	LB/B	-	A0A2K6F0K1	12	Y	H
P82921	LB/B	-	K7G7S6	51	R	Q
P82921	LB/B	-	K7G7S6	50	C	R
Q92552	LB/B	-	A0A1D5R0Z4	284	G	D
Q9Y2Q9	LB/B	-	A0A2R8M748	103	R	W
Q9Y2Q9	LP/P	Combined oxidative phosphorylation deficiency 47 (COXPD47) [MIM:618958]	A0A2R8M748	119	K	R
P82673	LB/B	-	A0A2K6K813	6	L	I
Q9Y2R9	LB/B	-	G5B316	2	A	V
Q9Y2R9	LP/P	Combined oxidative phosphorylation deficiency 34 (COXPD34) [MIM:617872]	G5B316	184	M	V
Q9HD23	LB/B	-	G1NW50	35	P	S
Q9HD23	LB/B	-	G1NW50	412	P	S
Q9NXJ0	LB/B	-	A0A2I3FVV7	10	A	D
A6NI15	LB/B	-	F1SCS7	80	E	D
A6NI15	LB/B	-	F1SCS7	104	H	Y
P52701	LB/B	-	H2UBR0	39	G	E
P52701	LB/B	-	H2UBR0	1213	D	V
P52701	LB/B	-	H2UBR0	1260	V	I
P52701	LB/B	-	H2UBR0	220	E	D
P52701	LP/P	Colorectal cancer (CRC) [MIM:114500]	H2UBR0	566	G	R
P52701	LP/P	Lynch syndrome 5 (LYNCH5) [MIM:614350]	H2UBR0	566	G	R
P52701	LB/B	-	H2UBR0	800	V	L
P52701	LB/B	-	H2UBR0	886	I	V
P52701	LB/B	-	H2UBR0	623	P	A
P52701	LB/B	-	H2UBR0	13	K	T
P52701	LB/B	-	H2UBR0	25	A	V
P52701	LB/B	-	H2UBR0	65	S	L
P52701	LB/B	-	H2UBR0	468	R	H
P52701	LB/B	-	H2UBR0	538	Y	S
P52701	LB/B	-	H2UBR0	580	S	L
P52701	LB/B	-	H2UBR0	1232	V	L
P52701	LB/B	-	H2UBR0	1234	E	Q
P52701	LB/B	-	H2UBR0	1321	R	G
P52701	LB/B	-	H2UBR0	221	E	D
P52701	LB/B	-	H2UBR0	295	K	R
P52701	LB/B	-	H2UBR0	509	V	A
P52701	LP/P	Lynch syndrome 5 (LYNCH5) [MIM:614350]	H2UBR0	772	R	W
P52701	LP/P	Colorectal cancer (CRC) [MIM:114500]	H2UBR0	800	V	A
P52701	LP/P	Lynch syndrome 5 (LYNCH5) [MIM:614350]	H2UBR0	1163	E	V
P52701	LP/P	Lynch syndrome 5 (LYNCH5) [MIM:614350]	H2UBR0	1193	E	K
P52701	LB/B	-	H2UBR0	435	L	P
P52701	LB/B	-	H2UBR0	585	L	P
P52701	LB/B	-	H2UBR0	677	S	T
P52701	LB/B	-	H2UBR0	1087	P	R
P03886	LB/B	-	E9KVP5	4	A	T
P03886	LP/P	Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000]	E9KVP5	31	M	T
P03886	LP/P	Alzheimer disease mitochondrial (AD-MT) [MIM:502500]	E9KVP5	31	M	V
P03886	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	E9KVP5	52	A	T
P03886	LB/B	-	E9KVP5	277	Y	C
P03886	LB/B	-	E9KVP5	205	S	P
P03886	LB/B	-	E9KVP5	255	Y	C
P03886	LB/B	-	E9KVP5	288	L	P
P03886	LB/B	-	E9KVP5	87	T	A
P03886	LB/B	-	E9KVP5	168	T	A
P03886	LB/B	-	E9KVP5	30	Y	C
Q5VT66	LB/B	-	V8NYA8	165	T	A
Q5VT66	LB/B	-	V8NYA8	187	M	K
Q5VT66	LB/B	-	V8NYA8	246	C	S
Q5VT66	LB/B	-	V8NYA8	268	M	I
Q5VT66	LB/B	-	V8NYA8	96	V	L
Q5VT66	LB/B	-	V8NYA8	15	L	H
Q5VT66	LB/B	-	V8NYA8	247	D	H
Q969Z3	LB/B	-	V8NYA8	244	G	S
Q969Z3	LB/B	-	V8NYA8	3	A	S
Q969Z3	LB/B	-	V8NYA8	245	C	W
Q86UE4	LB/B	-	G1KRW1	317	T	A
Q9BT17	LB/B	-	A0A2K5U4U6	293	I	V
Q9H2K0	LB/B	-	G3GWI6	68	T	I
Q9H2K0	LB/B	-	G3GWI6	243	F	L
Q9UGC7	LB/B	-	I3IXQ8	38	T	A
Q9UGC7	LB/B	-	I3IXQ8	76	R	Q
Q9UGC7	LB/B	-	I3IXQ8	177	L	F
Q9UGC7	LB/B	-	I3IXQ8	214	V	I
P15941	LB/B	-	A0A087WWM1	1117	V	M
P15941	LB/B	-	A0A087WWM1	1142	S	N
Q9UKN1	LB/B	-	A0A0D9RZI2	4775	T	R
Q8N307	LB/B	-	A0A2J8R0W2	3	C	S
Q8N307	LB/B	-	A0A2J8R0W2	18	V	G
Q8N307	LB/B	-	A0A2J8R0W2	442	T	I
Q8N307	LB/B	-	A0A2J8R0W2	590	P	L
Q8N307	LB/B	-	A0A2J8R0W2	666	R	W
Q8N307	LB/B	-	A0A2J8R0W2	671	S	C
Q8N307	LB/B	-	A0A2J8R0W2	514	G	R
Q3MIW9	LB/B	-	A0A2I3RBF8	337	G	R
Q3MIW9	LB/B	-	A0A2I3RBF8	419	E	K
Q3MIW9	LB/B	-	A0A2I3RBF8	517	R	Q
Q96EY5	LB/B	-	A0A1D5NVM6	106	C	Y
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	20	H	P
Q03426	LP/P	Mevalonic aciduria (MEVA) [MIM:610377]	A0A1A8I8H5	20	H	P
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	167	P	L
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	268	I	T
Q03426	LP/P	Mevalonic aciduria (MEVA) [MIM:610377]	A0A1A8I8H5	268	I	T
Q03426	LP/P	Mevalonic aciduria (MEVA) [MIM:610377]	A0A1A8I8H5	301	N	T
Q03426	LP/P	Mevalonic aciduria (MEVA) [MIM:610377]	A0A1A8I8H5	334	A	T
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	377	V	I
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	310	V	M
Q03426	LP/P	Mevalonic aciduria (MEVA) [MIM:610377]	A0A1A8I8H5	310	V	M
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	20	H	N
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	39	L	P
Q03426	LB/B	-	A0A1A8I8H5	52	S	N
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	135	S	L
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	148	A	T
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	150	S	L
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	202	G	R
Q03426	LP/P	Porokeratosis 3, multiple types (POROK3) [MIM:175900]	A0A1A8I8H5	202	G	R
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	215	R	Q
Q03426	LP/P	Mevalonic aciduria (MEVA) [MIM:610377]	A0A1A8I8H5	243	T	I
Q03426	LP/P	Mevalonic aciduria (MEVA) [MIM:610377]	A0A1A8I8H5	264	L	F
Q03426	LP/P	Mevalonic aciduria (MEVA) [MIM:610377]	A0A1A8I8H5	265	L	P
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	309	G	S
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	326	G	R
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	20	H	Q
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	132	V	I
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	171	G	R
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	211	G	E
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	250	V	I
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	265	L	R
Q03426	LB/B	-	A0A1A8I8H5	335	G	S
Q03426	LB/B	-	A0A1A8I8H5	356	T	M
Q03426	LP/P	Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920]	A0A1A8I8H5	376	G	V
Q03426	LP/P	Porokeratosis 3, multiple types (POROK3) [MIM:175900]	A0A1A8I8H5	12	G	R
Q03426	LP/P	Porokeratosis 3, multiple types (POROK3) [MIM:175900]	A0A1A8I8H5	41	L	P
Q03426	LP/P	Porokeratosis 3, multiple types (POROK3) [MIM:175900]	A0A1A8I8H5	255	L	P
Q03426	LP/P	Porokeratosis 3, multiple types (POROK3) [MIM:175900]	A0A1A8I8H5	279	L	P
Q03426	LP/P	Porokeratosis 3, multiple types (POROK3) [MIM:175900]	A0A1A8I8H5	291	Y	D
Q03426	LP/P	Porokeratosis 3, multiple types (POROK3) [MIM:175900]	A0A1A8I8H5	312	H	R
Q03426	LP/P	Porokeratosis 3, multiple types (POROK3) [MIM:175900]	A0A1A8I8H5	365	F	S
Q03426	LP/P	Porokeratosis 3, multiple types (POROK3) [MIM:175900]	A0A1A8I8H5	376	G	S
P12524	LB/B	-	A0A0Q3P1H6	362	T	S
Q99836	LP/P	Immunodeficiency 68 (IMD68) [MIM:612260]	F1P7V2	93	L	P
Q99836	LP/P	Immunodeficiency 68 (IMD68) [MIM:612260]	F1P7V2	196	R	C
P13349	LP/P	Ophthalmoplegia, external, with rib and vertebral anomalies (EORVA) [MIM:618155]	A0A2U3V0J1	95	R	C
P35580	LP/P	-	A0A1W5AIU0	270	R	C
P35749	LB/B	-	A0A1W5AIU0	1234	A	T
P35749	LB/B	-	A0A1W5AIU0	1289	V	A
P35749	LB/B	-	A0A1W5AIU0	1310	V	M
P35749	LP/P	Aortic aneurysm, familial thoracic 4 (AAT4) [MIM:132900]	A0A1W5AIU0	1758	R	Q
P35749	LB/B	-	A0A1W5AIU0	1104	A	T
P35749	LB/B	-	A0A1W5AIU0	1508	M	V
P35749	LP/P	Megacystis-microcolon-intestinal hypoperistalsis syndrome 2 (MMIHS2) [MIM:619351]	A0A1W5AIU0	677	R	H
P35749	LB/B	-	A0A1W5AIU0	616	A	G
Q9UKX3	LB/B	-	A0A2U9CR75	1071	M	V
Q9UKX3	LB/B	-	A0A2U9CR75	701	G	R
Q9UKX3	LB/B	-	A0A2U9CR75	1076	D	E
Q9UKX3	LB/B	-	A0A2U9CR75	1294	R	Q
Q9UKX3	LB/B	-	A0A2U9CR75	1862	H	R
Q7Z406	LB/B	-	A0A1W5AIU0	266	I	V
Q7Z406	LP/P	Deafness, autosomal dominant, 4A (DFNA4A) [MIM:600652]	A0A1W5AIU0	376	G	C
Q7Z406	LP/P	Deafness, autosomal dominant, 4A (DFNA4A) [MIM:600652]	A0A1W5AIU0	726	R	S
Q7Z406	LP/P	Deafness, autosomal dominant, 4A (DFNA4A) [MIM:600652]	A0A1W5AIU0	976	L	F
Q7Z406	LB/B	-	A0A1W5AIU0	1559	N	S
Q7Z406	LP/P	Deafness, autosomal dominant, 4A (DFNA4A) [MIM:600652]	A0A1W5AIU0	120	S	L
Q7Z406	LB/B	-	A0A1W5AIU0	334	P	A
Q7Z406	LB/B	-	A0A1W5AIU0	1209	A	E
Q7Z406	LB/B	-	A0A1W5AIU0	1540	V	I
Q7Z406	LP/P	Peripheral neuropathy, myopathy, hoarseness, and hearing loss (PNMHH) [MIM:614369]	A0A1W5AIU0	933	R	L
Q7Z406	LB/B	-	A0A1W5AIU0	1154	A	V
P35579	LP/P	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	93	N	K
P35579	LP/P	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	702	R	C
P35579	LP/P	Deafness, autosomal dominant, 17 (DFNA17) [MIM:603622]	A0A1W5AIU0	705	R	H
P35579	LP/P	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	1155	T	I
P35579	LP/P	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	1165	R	C
P35579	LP/P	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	1424	D	H
P35579	LP/P	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	1841	E	K
P35579	LP/P	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	95	A	T
P35579	LP/P	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	96	S	L
P35579	LP/P	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	373	K	N
P35579	LP/P	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	702	R	H
P35579	LP/P	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	1114	S	P
P35579	LP/P	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	1165	R	L
P35579	LB/B	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	1400	R	W
P35579	LP/P	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	1424	D	N
P35579	LP/P	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	1424	D	Y
P35579	LB/B	-	A0A1W5AIU0	1626	I	V
P35579	LP/P	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	1816	I	V
P35579	LP/P	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]	A0A1W5AIU0	910	K	Q
P35579	LB/B	-	A0A1W5AIU0	967	V	E
Q32MK0	LB/B	-	A0A287B960	70	S	T
Q32MK0	LB/B	-	A0A287B960	180	V	L
Q8IUG5	LB/B	-	G3HTB2	661	W	R
Q8IUG5	LB/B	-	G3HTB2	2347	Q	R
Q8IUG5	LB/B	-	G3HTB2	44	G	E
Q8IUG5	LB/B	-	G3HTB2	177	P	L
Q8IUG5	LB/B	-	G3HTB2	547	W	C
Q8IUG5	LB/B	-	G3HTB2	925	S	L
Q8IUG5	LB/B	-	G3HTB2	1037	W	S
Q8IUG5	LB/B	-	G3HTB2	1119	H	Q
Q8IUG5	LB/B	-	G3HTB2	1390	S	F
Q8IUG5	LB/B	-	G3HTB2	1399	I	V
Q8IUG5	LB/B	-	G3HTB2	1444	S	T
Q8IUG5	LB/B	-	G3HTB2	2294	A	D
Q8IUG5	LB/B	-	G3HTB2	2395	G	A
Q8IUG5	LB/B	-	G3HTB2	2513	G	S
Q8IUG5	LB/B	-	G3HTB2	2532	R	Q
Q12965	LP/P	Focal segmental glomerulosclerosis 6 (FSGS6) [MIM:614131]	U3KCZ5	159	A	P
Q12965	LB/B	-	U3KCZ5	185	D	G
Q12965	LB/B	-	U3KCZ5	221	A	V
Q12965	LB/B	-	U3KCZ5	795	G	R
Q12965	LB/B	-	U3KCZ5	1049	P	H
Q12965	LB/B	-	U3KCZ5	469	T	M
Q12965	LP/P	Focal segmental glomerulosclerosis 6 (FSGS6) [MIM:614131]	U3KCZ5	119	T	I
Q12965	LP/P	Focal segmental glomerulosclerosis 6 (FSGS6) [MIM:614131]	U3KCZ5	388	D	H
Q12965	LP/P	-	U3KCZ5	523	R	W
O00160	LB/B	-	U3KCZ5	960	P	L
O00160	LP/P	-	U3KCZ5	502	I	V
Q8NEV4	LB/B	-	I3LVT7	204	D	N
Q8NEV4	LB/B	-	I3LVT7	956	S	N
Q8NEV4	LB/B	-	I3LVT7	1313	R	S
Q8NEV4	LB/B	-	I3LVT7	1284	T	S
Q8NEV4	LB/B	-	I3LVT7	178	T	I
Q8NEV4	LB/B	-	I3LVT7	319	R	H
Q8NEV4	LB/B	-	I3LVT7	348	I	V
Q8NEV4	LB/B	-	I3LVT7	369	V	I
Q8NEV4	LB/B	-	I3LVT7	833	A	S
Q8NEV4	LB/B	-	I3LVT7	1032	A	T
Q8NEV4	LB/B	-	I3LVT7	1045	V	M
Q8NEV4	LB/B	-	I3LVT7	1137	V	M
Q8NEV4	LB/B	-	I3LVT7	1195	V	A
Q8NEV4	LB/B	-	I3LVT7	1287	P	T
Q8NEV4	LB/B	-	I3LVT7	1417	T	I
Q8NEV4	LB/B	-	I3LVT7	1488	K	E
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	246	G	R
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	337	Q	R
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	364	G	V
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	367	G	R
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	370	P	L
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	426	V	F
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	437	Y	H
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	477	I	S
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	480	N	K
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	499	I	F
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	53	V	A
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	433	C	R
Q99972	LB/B	-	B4DVZ2	4	F	S
Q99972	LB/B	-	B4DVZ2	9	C	S
Q99972	LB/B	-	B4DVZ2	12	G	R
Q99972	LB/B	-	B4DVZ2	19	Q	H
Q99972	LB/B	-	B4DVZ2	73	N	S
Q99972	LB/B	-	B4DVZ2	76	R	K
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	82	R	C
Q99972	LB/B	-	B4DVZ2	82	R	H
Q99972	LB/B	-	B4DVZ2	189	R	Q
Q99972	LB/B	-	B4DVZ2	203	S	F
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	286	W	R
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	293	T	K
Q99972	LB/B	-	B4DVZ2	329	V	M
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	361	P	S
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	377	T	M
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	380	D	A
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	380	D	G
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	393	S	R
Q99972	LB/B	-	B4DVZ2	398	K	R
Q99972	LB/B	-	B4DVZ2	402	V	I
Q99972	LB/B	-	B4DVZ2	422	R	C
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	422	R	H
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	423	K	E
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	445	A	V
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	465	I	M
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	470	R	C
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	477	I	N
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	481	P	L
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	481	P	T
Q99972	LB/B	-	B4DVZ2	495	V	I
Q99972	LB/B	-	B4DVZ2	500	K	R
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	502	S	P
Q99972	LB/B	-	B4DVZ2	16	P	L
Q99972	LB/B	-	B4DVZ2	17	A	S
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	25	C	R
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	48	Q	H
Q99972	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	B4DVZ2	48	Q	H
Q99972	LB/B	-	B4DVZ2	57	N	D
Q99972	LB/B	-	B4DVZ2	57	N	S
Q99972	LB/B	-	B4DVZ2	77	D	E
Q99972	LB/B	-	B4DVZ2	95	L	P
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	126	R	W
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	158	R	Q
Q99972	LB/B	-	B4DVZ2	215	L	P
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	245	C	Y
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	251	V	A
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	252	G	R
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	261	E	K
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	274	P	R
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	323	E	K
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	337	Q	E
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	341	S	P
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	342	R	K
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	345	I	M
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	360	I	N
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	363	A	T
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	369	F	L
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	377	T	K
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	380	D	H
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	380	D	N
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	393	S	N
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	399	G	V
Q99972	LB/B	-	B4DVZ2	414	E	K
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	427	A	T
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	434	G	S
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	438	T	I
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	448	T	P
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	450	N	D
Q99972	LB/B	-	B4DVZ2	470	R	H
Q99972	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	B4DVZ2	499	I	S
Q6NSJ0	LB/B	-	I3KAM1	4	N	I
Q6NSJ0	LB/B	-	I3KAM1	53	D	E
Q6NSJ0	LB/B	-	I3KAM1	199	R	S
Q6NSJ0	LB/B	-	I3KAM1	385	F	Y
Q6NSJ0	LP/P	Basal ganglia calcification, idiopathic, 7, autosomal recessive (IBGC7) [MIM:618317]	I3KAM1	35	M	V
Q6NSJ0	LP/P	Basal ganglia calcification, idiopathic, 7, autosomal recessive (IBGC7) [MIM:618317]	I3KAM1	441	R	G
Q96LU7	LB/B	-	G3HZ45	753	A	S
Q96LU7	LB/B	-	G3HZ45	723	S	L
Q96LU7	LB/B	-	G3HZ45	845	L	M
P28698	LB/B	-	A0A0D9S6F3	331	I	V
P28698	LB/B	-	A0A0D9S6F3	51	R	H
P28698	LB/B	-	A0A0D9S6F3	103	R	H
P28698	LB/B	-	A0A0D9S6F3	130	R	Q
P28698	LB/B	-	A0A0D9S6F3	441	R	P
P61599	LP/P	Intellectual developmental disorder, autosomal recessive 73 (MRT73) [MIM:619717]	A0A087XHF9	54	M	V
P61599	LP/P	Intellectual developmental disorder, autosomal recessive 73 (MRT73) [MIM:619717]	A0A087XHF9	80	A	V
Q58DX5	LB/B	-	G1NC35	68	G	S
Q58DX5	LB/B	-	G1NC35	128	I	M
Q58DX5	LB/B	-	G1NC35	194	M	T
Q58DX5	LB/B	-	G1NC35	385	P	S
Q58DX5	LB/B	-	G1NC35	622	P	R
Q58DX5	LB/B	-	G1NC35	677	L	S
Q9UJ70	LB/B	-	A0A1S3J6A0	38	W	R
Q9UJ70	LB/B	-	A0A1S3J6A0	60	A	V
Q99457	LB/B	-	L8XZX2	224	P	A
P49321	LB/B	-	G3T2D1	620	V	G
Q9H0A0	LB/B	-	A0A165DH80	461	Y	H
Q9H0A0	LB/B	-	A0A165DH80	983	A	T
Q8N8M0	LB/B	-	A0A2J8Q8V4	63	F	S
Q8NEY1	LB/B	-	A0A093NWS8	937	Q	H
Q8NEY1	LB/B	-	A0A093NWS8	1273	S	L
Q8NEY1	LB/B	-	A0A093NWS8	1290	H	D
Q8NEY1	LB/B	-	A0A093NWS8	1527	V	I
P0C6P0	LB/B	-	G1MJD2	33	V	A
P0C6P0	LB/B	-	G1MJD2	54	T	I
P0C6P0	LB/B	-	G1MJD2	81	C	R
Q9UBB6	LP/P	Neurodevelopmental disorder with infantile epileptic spasms (NEDIES) [MIM:619373]	A0A091EVA2	478	R	Q
Q9UBB6	LP/P	Neurodevelopmental disorder with infantile epileptic spasms (NEDIES) [MIM:619373]	A0A091EVA2	498	W	R
Q9UBB6	LP/P	Neurodevelopmental disorder with infantile epileptic spasms (NEDIES) [MIM:619373]	A0A091EVA2	652	P	L
P14598	LP/P	Granulomatous disease, chronic, autosomal recessive, 1 (CGD1) [MIM:233700]	F8WH69	42	R	Q
P14598	LB/B	-	F8WH69	160	T	S
P14598	LB/B	-	F8WH69	166	N	D
P14598	LB/B	-	F8WH69	262	G	S
P14598	LB/B	-	F8WH69	308	A	V
P14598	LB/B	-	F8WH69	90	R	H
P14598	LB/B	-	F8WH69	258	K	E
P14598	LB/B	-	F8WH69	99	S	G
Q969V3	LB/B	-	F7DXS5	551	K	R
Q969V3	LB/B	-	F7DXS5	214	E	D
Q15596	LB/B	-	A0A2I0M248	1282	M	I
Q9Y6Q9	LB/B	-	A0A2I0M248	460	G	R
Q9Y6Q9	LB/B	-	A0A2I0M248	559	P	S
Q9Y6Q9	LB/B	-	A0A2I0M248	586	Q	H
Q9Y6Q9	LB/B	-	A0A2I0M248	218	R	C
Q9Y6Q9	LB/B	-	A0A2I0M248	369	L	F
Q9Y6Q9	LB/B	-	A0A2I0M248	777	S	A
Q9Y6Q9	LB/B	-	A0A2I0M248	220	R	I
Q9Y6Q9	LB/B	-	A0A2I0M248	556	I	V
Q9Y6Q9	LB/B	-	A0A2I0M248	1247	M	K
Q9Y6Q9	LB/B	-	A0A2I0M248	1247	M	L
Q9NV92	LB/B	-	M0QWK1	136	A	V
Q9NV92	LB/B	-	M0QWK1	124	P	S
Q8TB73	LP/P	Hypogonadotropic hypogonadism 25 with anosmia (HH25) [MIM:618841]	I3N8G2	201	T	S
O95182	LB/B	-	A0A1D5RL49	66	P	A
Q9Y375	LB/B	-	A0A250YFG0	9	R	H
Q9Y375	LB/B	-	A0A250YFG0	31	R	L
Q9Y375	LB/B	-	A0A250YFG0	176	E	K
Q9Y375	LB/B	-	A0A250YFG0	314	A	G
Q9Y375	LP/P	Mitochondrial complex I deficiency, nuclear type 11 (MC1DN11) [MIM:618234]	A0A250YFG0	207	T	P
Q9Y375	LP/P	Mitochondrial complex I deficiency, nuclear type 11 (MC1DN11) [MIM:618234]	A0A250YFG0	211	R	C
Q9Y375	LP/P	Mitochondrial complex I deficiency, nuclear type 11 (MC1DN11) [MIM:618234]	A0A250YFG0	245	G	R
Q9Y375	LP/P	Mitochondrial complex I deficiency, nuclear type 11 (MC1DN11) [MIM:618234]	A0A250YFG0	253	K	R
Q5TEU4	LB/B	-	H2P124	337	L	F
Q5TEU4	LP/P	Mitochondrial complex I deficiency, nuclear type 16 (MC1DN16) [MIM:618238]	H2P124	229	L	P
Q5TEU4	LP/P	Mitochondrial complex I deficiency, nuclear type 16 (MC1DN16) [MIM:618238]	H2P124	159	L	F
Q5TEU4	LP/P	Mitochondrial complex I deficiency, nuclear type 16 (MC1DN16) [MIM:618238]	H2P124	250	G	V
Q7L592	LB/B	-	S9Y8W4	39	P	A
Q7L592	LP/P	-	S9Y8W4	266	D	E
P49821	LP/P	Mitochondrial complex I deficiency, nuclear type 4 (MC1DN4) [MIM:618225]	A0A0P6ADC6	341	A	V
P49821	LP/P	Mitochondrial complex I deficiency, nuclear type 4 (MC1DN4) [MIM:618225]	A0A0P6ADC6	423	T	M
P49821	LB/B	-	A0A0P6ADC6	76	I	V
P49821	LB/B	-	A0A0P6ADC6	277	N	Y
P49821	LP/P	Mitochondrial complex I deficiency, nuclear type 4 (MC1DN4) [MIM:618225]	A0A0P6ADC6	214	E	K
Q8NBR9	LB/B	-	Q8NBR9	22	P	T
Q96NY8	LB/B	-	A0A2R8M6P4	53	F	L
Q96NY8	LP/P	Ectodermal dysplasia-syndactyly syndrome 1 (EDSS1) [MIM:613573]	A0A2R8M6P4	185	T	M
P07197	LB/B	-	A0A096LWA2	725	P	Q
P07197	LB/B	-	A0A096LWA2	439	P	T
Q8TAT5	LB/B	-	A0A091F4M6	117	P	R
Q8TAT5	LB/B	-	A0A091F4M6	443	P	L
Q8TAT5	LB/B	-	A0A091F4M6	520	G	R
Q8TAT5	LB/B	-	A0A091F4M6	38	R	C
Q8TAT5	LB/B	-	A0A091F4M6	76	V	M
Q8TAT5	LB/B	-	A0A091F4M6	172	Q	H
Q8TAT5	LB/B	-	A0A091F4M6	286	H	R
Q8TAT5	LB/B	-	A0A091F4M6	346	I	V
Q8TAT5	LB/B	-	A0A091F4M6	471	Q	H
Q8TAT5	LB/B	-	A0A091F4M6	547	A	S
Q8TAT5	LB/B	-	A0A091F4M6	556	H	R
Q96PY6	LB/B	-	A0A091E6W6	10	I	F
Q96PY6	LB/B	-	A0A091E6W6	76	L	V
Q96PY6	LB/B	-	A0A091E6W6	355	R	G
Q96PY6	LB/B	-	A0A091E6W6	463	A	V
Q96PY6	LB/B	-	A0A091E6W6	745	K	N
Q96PY6	LB/B	-	A0A091E6W6	598	A	T
Q96PY6	LB/B	-	A0A091E6W6	883	Q	E
Q96PY6	LB/B	-	A0A091E6W6	1180	D	N
Q96PY6	LB/B	-	A0A091E6W6	724	E	G
Q96PY6	LB/B	-	A0A091E6W6	717	N	K
Q96PY6	LP/P	Short-rib thoracic dysplasia 6 with or without polydactyly (SRTD6) [MIM:263520]	A0A091E6W6	145	G	R
Q96PY6	LP/P	Short-rib thoracic dysplasia 6 with or without polydactyly (SRTD6) [MIM:263520]	A0A091E6W6	253	L	S
Q96PY6	LP/P	Amyotrophic lateral sclerosis 24 (ALS24) [MIM:617892]	A0A091E6W6	261	R	H
P51956	LB/B	-	G1TEA9	23	H	L
P51956	LB/B	-	G1TEA9	60	P	R
P51956	LB/B	-	G1TEA9	122	R	H
P51956	LB/B	-	G1TEA9	170	P	L
P51956	LB/B	-	G1TEA9	259	R	G
P51956	LB/B	-	G1TEA9	305	E	D
P51956	LB/B	-	G1TEA9	461	D	N
P51956	LB/B	-	G1TEA9	477	E	K
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	54	V	M
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	68	G	V
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	91	L	R
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	182	S	G
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	217	V	M
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	219	G	A
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	227	G	R
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	231	L	H
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	240	W	R
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	243	G	R
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	260	F	Y
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	270	L	P
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	270	L	F
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	294	R	S
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	298	A	V
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	328	G	S
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	335	P	Q
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	363	L	P
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	370	Y	C
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	80	P	L
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	316	P	S
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	225	R	P
Q99519	LP/P	Sialidosis (SIALIDOSIS) [MIM:256550]	G8F3W3	341	R	G
Q99519	LB/B	-	G8F3W3	88	G	A
Q99519	LB/B	-	G8F3W3	90	L	F
Q99519	LB/B	-	G8F3W3	179	V	A
Q99519	LB/B	-	G8F3W3	208	R	Q
Q99519	LB/B	-	G8F3W3	210	P	A
Q99519	LB/B	-	G8F3W3	217	V	A
Q99519	LB/B	-	G8F3W3	222	T	M
Q99519	LB/B	-	G8F3W3	234	D	N
Q99519	LB/B	-	G8F3W3	248	G	S
Q99519	LB/B	-	G8F3W3	252	G	S
Q99519	LB/B	-	G8F3W3	279	A	T
Q99519	LB/B	-	G8F3W3	351	S	R
Q99519	LB/B	-	G8F3W3	357	R	Q
Q96JN8	LB/B	-	A0A2G9RAF1	1019	Q	H
Q12968	LB/B	-	A0A1A7XST9	75	S	L
Q12968	LB/B	-	A0A1A7XST9	94	E	A
Q12968	LB/B	-	A0A1A7XST9	100	L	S
Q12968	LB/B	-	A0A1A7XST9	136	P	L
Q12968	LB/B	-	A0A1A7XST9	382	P	S
Q14494	LB/B	-	H2U273	63	D	H
Q86UQ8	LB/B	-	A0A2J8IQH2	45	A	D
Q86UQ8	LB/B	-	A0A2J8IQH2	116	Q	R
P25963	LP/P	Ectodermal dysplasia and immunodeficiency 2 (EDAID2) [MIM:612132]	A0A2R9CIZ5	32	S	I
Q8NI38	LB/B	-	G1L1X7	29	V	A
Q9BYH8	LB/B	-	A0A2U3XDS7	307	T	S
Q8N4C6	LB/B	-	S9XGS1	1111	P	A
Q8N4C6	LB/B	-	S9XGS1	1320	G	E
Q8N4C6	LB/B	-	S9XGS1	1837	S	T
Q8N4C6	LB/B	-	S9XGS1	1125	Q	P
Q8N4C6	LB/B	-	S9XGS1	1934	Q	E
Q8N4C6	LP/P	Seckel syndrome 7 (SCKL7) [MIM:614851]	S9XGS1	1222	Q	R
Q8N4C6	LP/P	Seckel syndrome 7 (SCKL7) [MIM:614851]	S9XGS1	1709	N	S
Q8N8D7	LB/B	-	A0A2R9B0V7	140	V	I
Q5M9Q1	LB/B	-	A0A2I0U7Q1	96	Y	C
Q5M9Q1	LB/B	-	A0A2I0U7Q1	152	T	N
Q5M9Q1	LB/B	-	A0A2I0U7Q1	162	H	Y
Q5M9Q1	LB/B	-	A0A2I0U7Q1	398	E	G
O15522	LB/B	-	M7BRH1	16	D	A
Q9UBE8	LB/B	-	A0A2D0SV25	177	V	A
P59046	LB/B	-	A0A1A6FW84	39	G	V
P59046	LB/B	-	A0A1A6FW84	402	F	L
Q96P20	LP/P	Familial cold autoinflammatory syndrome 1 (FCAS1) [MIM:120100]	A0A1A6FW84	200	V	M
Q96P20	LP/P	Muckle-Wells syndrome (MWS) [MIM:191900]	A0A1A6FW84	200	V	M
Q96P20	LP/P	Muckle-Wells syndrome (MWS) [MIM:191900]	A0A1A6FW84	354	A	V
Q96P20	LP/P	Familial cold autoinflammatory syndrome 1 (FCAS1) [MIM:120100]	A0A1A6FW84	441	A	V
Q96P20	LP/P	Familial cold autoinflammatory syndrome 1 (FCAS1) [MIM:120100]	A0A1A6FW84	629	E	G
Q96P20	LP/P	Familial cold autoinflammatory syndrome 1 (FCAS1) [MIM:120100]	A0A1A6FW84	262	R	W
Q96P20	LP/P	Muckle-Wells syndrome (MWS) [MIM:191900]	A0A1A6FW84	262	R	W
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	305	D	N
Q96P20	LP/P	Muckle-Wells syndrome (MWS) [MIM:191900]	A0A1A6FW84	305	D	N
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	311	F	S
Q96P20	LP/P	Muckle-Wells syndrome (MWS) [MIM:191900]	A0A1A6FW84	571	G	R
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	575	F	S
Q96P20	LP/P	Familial cold autoinflammatory syndrome 1 (FCAS1) [MIM:120100]	A0A1A6FW84	307	L	P
Q96P20	LP/P	Muckle-Wells syndrome (MWS) [MIM:191900]	A0A1A6FW84	307	L	P
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	350	T	M
Q96P20	LP/P	Muckle-Wells syndrome (MWS) [MIM:191900]	A0A1A6FW84	350	T	M
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	360	H	R
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	438	T	N
Q96P20	LP/P	Muckle-Wells syndrome (MWS) [MIM:191900]	A0A1A6FW84	441	A	T
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	664	M	T
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	861	Y	C
Q96P20	LP/P	Familial cold autoinflammatory syndrome 1 (FCAS1) [MIM:120100]	A0A1A6FW84	525	F	C
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	174	I	T
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	262	R	L
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	262	R	P
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	266	L	H
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	305	D	G
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	308	Q	K
Q96P20	LP/P	Familial cold autoinflammatory syndrome 1 (FCAS1) [MIM:120100]	A0A1A6FW84	355	L	P
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	356	E	D
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	407	T	P
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	438	T	I
Q96P20	LP/P	Familial cold autoinflammatory syndrome 1 (FCAS1) [MIM:120100]	A0A1A6FW84	490	R	K
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	525	F	L
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	572	Y	C
Q96P20	LP/P	Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]	A0A1A6FW84	634	L	F
Q96P20	LB/B	-	A0A1A6FW84	705	Q	K
Q96P20	LP/P	Keratoendothelitis fugax hereditaria (KEFH) [MIM:148200]	A0A1A6FW84	21	D	H
P28336	LB/B	-	A0A2U4CNF5	390	L	M
Q9ULX3	LB/B	-	A0A0P5R7M9	231	R	Q
Q9ULX3	LB/B	-	A0A0P5R7M9	366	Y	F
Q9Y239	LB/B	-	W5M1G1	266	E	K
Q9Y239	LB/B	-	W5M1G1	372	D	N
Q9Y239	LB/B	-	W5M1G1	447	R	H
Q9Y239	LB/B	-	W5M1G1	605	R	W
Q9Y239	LB/B	-	W5M1G1	610	A	T
Q15155	LB/B	-	V4AJX3	1081	E	K
Q15155	LB/B	-	V4AJX3	404	I	V
Q15155	LB/B	-	V4AJX3	458	K	N
Q15155	LB/B	-	V4AJX3	490	N	D
Q15155	LB/B	-	V4AJX3	1141	I	F
Q15155	LB/B	-	V4AJX3	1195	R	G
Q15155	LB/B	-	V4AJX3	493	M	V
Q15155	LB/B	-	V4AJX3	580	M	V
Q15155	LB/B	-	V4AJX3	583	V	A
Q5JPE7	LB/B	-	V4AJX3	580	V	M
Q5JPE7	LB/B	-	V4AJX3	493	V	M
Q9NZM5	LB/B	-	M3WE30	389	Q	R
Q9NZM5	LB/B	-	M3WE30	16	S	R
P29475	LB/B	-	V9K8S9	228	P	S
P29475	LB/B	-	V9K8S9	394	D	A
P29475	LB/B	-	V9K8S9	725	N	D
P29475	LB/B	-	V9K8S9	864	G	D
P29475	LB/B	-	V9K8S9	1064	Q	R
P46531	LB/B	-	A0A2U3Z4Q4	300	Q	R
P46531	LB/B	-	A0A2U3Z4Q4	1671	V	I
P46531	LB/B	-	A0A2U3Z4Q4	879	R	W
P46531	LP/P	Adams-Oliver syndrome 5 (AOS5) [MIM:616028]	A0A2U3Z4Q4	429	C	R
P46531	LP/P	Adams-Oliver syndrome 5 (AOS5) [MIM:616028]	A0A2U3Z4Q4	1496	C	Y
P46531	LP/P	Adams-Oliver syndrome 5 (AOS5) [MIM:616028]	A0A2U3Z4Q4	1989	D	N
Q9Y5S8	LB/B	-	S7N476	315	R	H
Q9Y5S8	LB/B	-	S7N476	378	R	K
Q96PH1	LB/B	-	A0A2I0MDI9	576	R	H
Q96PH1	LB/B	-	A0A2I0MDI9	759	R	G
Q86UR1	LB/B	-	A0A1S3G9C1	286	P	L
Q99743	LB/B	-	F6S7E7	394	T	A
Q99743	LB/B	-	F6S7E7	471	S	L
Q14207	LB/B	-	H0ZQW8	295	I	L
Q14207	LB/B	-	H0ZQW8	399	L	M
Q14207	LB/B	-	H0ZQW8	447	V	M
Q14207	LB/B	-	H0ZQW8	483	I	L
Q14207	LB/B	-	H0ZQW8	540	L	F
Q14207	LB/B	-	H0ZQW8	575	V	I
Q14207	LB/B	-	H0ZQW8	608	V	A
Q14207	LB/B	-	H0ZQW8	621	V	I
Q14207	LB/B	-	H0ZQW8	967	Q	E
Q14207	LB/B	-	H0ZQW8	973	L	V
Q14207	LB/B	-	H0ZQW8	987	V	A
Q14207	LB/B	-	H0ZQW8	999	N	K
Q14207	LB/B	-	H0ZQW8	1191	Q	R
P61916	LB/B	-	F7HKC6	86	P	L
P61916	LP/P	Niemann-Pick disease C2 (NPC2) [MIM:607625]	F7HKC6	39	V	M
P61916	LP/P	Niemann-Pick disease C2 (NPC2) [MIM:607625]	F7HKC6	67	S	P
P61916	LP/P	Niemann-Pick disease C2 (NPC2) [MIM:607625]	F7HKC6	30	V	M
P61916	LP/P	Niemann-Pick disease C2 (NPC2) [MIM:607625]	F7HKC6	47	C	F
P61916	LP/P	Niemann-Pick disease C2 (NPC2) [MIM:607625]	F7HKC6	93	C	F
P61916	LP/P	Niemann-Pick disease C2 (NPC2) [MIM:607625]	F7HKC6	99	C	R
P61916	LP/P	Niemann-Pick disease C2 (NPC2) [MIM:607625]	F7HKC6	120	P	S
Q8NDH3	LB/B	-	A0A2B4SGL4	303	K	R
Q8NDH3	LB/B	-	A0A2B4SGL4	513	L	V
Q8N729	LB/B	-	H2QAC0	149	D	A
Q14994	LB/B	-	A0A2J8JAS6	133	V	G
Q9Y5X4	LP/P	Enhanced S cone syndrome (ESCS) [MIM:268100]	A0A2K6C6W8	76	R	Q
Q9Y5X4	LP/P	Enhanced S cone syndrome (ESCS) [MIM:268100]	A0A2K6C6W8	76	R	W
Q9Y5X4	LP/P	Enhanced S cone syndrome (ESCS) [MIM:268100]	A0A2K6C6W8	97	R	H
Q9Y5X4	LP/P	Enhanced S cone syndrome (ESCS) [MIM:268100]	A0A2K6C6W8	104	R	W
Q9Y5X4	LP/P	Enhanced S cone syndrome (ESCS) [MIM:268100]	A0A2K6C6W8	121	E	K
Q9Y5X4	LB/B	-	A0A2K6C6W8	140	E	G
Q9Y5X4	LB/B	-	A0A2K6C6W8	163	M	T
Q9Y5X4	LB/B	-	A0A2K6C6W8	232	V	I
Q9Y5X4	LP/P	Enhanced S cone syndrome (ESCS) [MIM:268100]	A0A2K6C6W8	234	W	S
Q9Y5X4	LB/B	-	A0A2K6C6W8	302	V	I
Q9Y5X4	LP/P	Enhanced S cone syndrome (ESCS) [MIM:268100]	A0A2K6C6W8	309	R	G
Q9Y5X4	LP/P	Enhanced S cone syndrome (ESCS) [MIM:268100]	A0A2K6C6W8	311	R	Q
Q9Y5X4	LP/P	Enhanced S cone syndrome (ESCS) [MIM:268100]	A0A2K6C6W8	385	R	P
Q9Y5X4	LP/P	Enhanced S cone syndrome (ESCS) [MIM:268100]	A0A2K6C6W8	407	M	K
Q9Y5X4	LP/P	Enhanced S cone syndrome (ESCS) [MIM:268100]	A0A2K6C6W8	88	G	V
Q9Y5X4	LP/P	Enhanced S cone syndrome (ESCS) [MIM:268100]	A0A2K6C6W8	256	A	E
Q9Y5X4	LP/P	Enhanced S cone syndrome (ESCS) [MIM:268100]	A0A2K6C6W8	263	L	P
Q9Y5X4	LP/P	Enhanced S cone syndrome (ESCS) [MIM:268100]	A0A2K6C6W8	336	L	P
Q9Y5X4	LP/P	Enhanced S cone syndrome (ESCS) [MIM:268100]	A0A2K6C6W8	353	L	V
Q9Y5X4	LP/P	Retinitis pigmentosa 37 (RP37) [MIM:611131]	A0A2K6C6W8	56	G	R
Q9Y5X4	LB/B	-	A0A2K6C6W8	44	S	L
Q9Y5X4	LB/B	-	A0A2K6C6W8	104	R	Q
Q9Y5X4	LB/B	-	A0A2K6C6W8	287	G	S
P04150	LB/B	-	I6Q8X2	363	N	S
P04150	LP/P	Glucocorticoid resistance, generalized (GCCR) [MIM:615962]	I6Q8X2	641	D	V
P04150	LP/P	Glucocorticoid resistance, generalized (GCCR) [MIM:615962]	I6Q8X2	729	V	I
P04150	LB/B	-	I6Q8X2	753	L	F
P04150	LP/P	Glucocorticoid resistance, generalized (GCCR) [MIM:615962]	I6Q8X2	477	R	H
P04150	LP/P	Glucocorticoid resistance, generalized (GCCR) [MIM:615962]	I6Q8X2	679	G	S
P04150	LB/B	-	I6Q8X2	23	R	K
P04150	LB/B	-	I6Q8X2	65	F	V
P04150	LB/B	-	I6Q8X2	29	F	L
P04150	LB/B	-	I6Q8X2	112	L	F
P04150	LB/B	-	I6Q8X2	233	D	N
P04150	LB/B	-	I6Q8X2	421	C	Y
P04150	LP/P	Glucocorticoid resistance, generalized (GCCR) [MIM:615962]	I6Q8X2	559	I	N
P04150	LP/P	Glucocorticoid resistance, generalized (GCCR) [MIM:615962]	I6Q8X2	747	I	M
P04150	LB/B	-	I6Q8X2	571	V	A
P04150	LP/P	Glucocorticoid resistance, generalized (GCCR) [MIM:615962]	I6Q8X2	737	F	L
P04150	LP/P	Glucocorticoid resistance, generalized (GCCR) [MIM:615962]	I6Q8X2	773	L	P
P04150	LP/P	Glucocorticoid resistance, generalized (GCCR) [MIM:615962]	I6Q8X2	556	T	I
P04150	LP/P	Glucocorticoid resistance, generalized (GCCR) [MIM:615962]	I6Q8X2	477	R	S
P04150	LP/P	Glucocorticoid resistance, generalized (GCCR) [MIM:615962]	I6Q8X2	478	Y	C
P04150	LP/P	Glucocorticoid resistance, generalized (GCCR) [MIM:615962]	I6Q8X2	672	L	P
Q86VF7	LB/B	-	A0A1W5AR25	208	V	A
Q86VF7	LB/B	-	A0A1W5AR25	249	Y	C
Q86VF7	LB/B	-	A0A1W5AR25	344	A	T
Q86VF7	LB/B	-	A0A1W5AR25	360	Q	R
Q86VF7	LB/B	-	A0A1W5AR25	1531	L	P
Q86VF7	LB/B	-	A0A1W5AR25	132	A	S
Q86VF7	LB/B	-	A0A1W5AR25	186	Q	E
Q86VF7	LB/B	-	A0A1W5AR25	282	A	T
Q86VF7	LB/B	-	A0A1W5AR25	490	S	L
Q86VF7	LB/B	-	A0A1W5AR25	519	N	I
Q86VF7	LB/B	-	A0A1W5AR25	674	A	V
Q86VF7	LB/B	-	A0A1W5AR25	884	R	C
Q86VF7	LB/B	-	A0A1W5AR25	1112	A	V
Q86VF7	LB/B	-	A0A1W5AR25	484	D	N
Q86VF7	LB/B	-	A0A1W5AR25	647	A	S
Q86VF7	LB/B	-	A0A1W5AR25	1183	I	V
Q86VF7	LB/B	-	A0A1W5AR25	1566	R	C
Q86VF7	LB/B	-	A0A1W5AR25	1569	D	N
Q86VF7	LB/B	-	A0A1W5AR25	1643	A	S
Q86VF7	LB/B	-	A0A1W5AR25	1022	M	V
P01111	LP/P	Melanocytic nevus syndrome, congenital (CMNS) [MIM:137550]	S7MIJ6	13	G	R
P01111	LP/P	Melanocytic nevus syndrome, congenital (CMNS) [MIM:137550]	S7MIJ6	61	Q	K
P01111	LP/P	Melanosis, neurocutaneous (NCMS) [MIM:249400]	S7MIJ6	61	Q	K
P01111	LP/P	Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900]	S7MIJ6	61	Q	R
P01111	LP/P	Melanocytic nevus syndrome, congenital (CMNS) [MIM:137550]	S7MIJ6	61	Q	R
P01111	LP/P	Melanosis, neurocutaneous (NCMS) [MIM:249400]	S7MIJ6	61	Q	R
P01111	LP/P	Thyroid cancer, non-medullary, 2 (NMTC2) [MIM:188470]	S7MIJ6	61	Q	R
P01111	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	S7MIJ6	13	G	D
P01111	LP/P	RAS-associated autoimmune leukoproliferative disorder (RALD) [MIM:614470]	S7MIJ6	13	G	D
P01111	LP/P	Noonan syndrome 6 (NS6) [MIM:613224]	S7MIJ6	50	T	I
P01111	LP/P	Noonan syndrome 6 (NS6) [MIM:613224]	S7MIJ6	60	G	E
P01111	LP/P	Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900]	S7MIJ6	12	G	D
P01111	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	S7MIJ6	12	G	D
P01111	LP/P	Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900]	S7MIJ6	34	P	L
Q9H7Z3	LB/B	-	A0A1S3IRQ6	32	C	F
Q9H7Z3	LB/B	-	A0A1S3IRQ6	1118	N	S
Q9H7Z3	LB/B	-	A0A1S3IRQ6	928	E	K
Q9ULB1	LB/B	-	A0A1W5B2N0	400	Y	N
Q9ULB1	LB/B	-	A0A1W5B2N0	28	G	A
Q9P2S2	LB/B	-	A0A1W5B2N0	81	L	Q
O95478	LB/B	-	A0A1U7T7L9	11	R	C
Q15738	LP/P	Congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD) [MIM:308050]	L5L6W3	105	A	V
Q15738	LP/P	Congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD) [MIM:308050]	L5L6W3	205	G	S
Q15738	LP/P	Congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD) [MIM:308050]	L5L6W3	182	A	P
Q96MG7	LP/P	Lung disease, immunodeficiency, and chromosome breakage syndrome (LICS) [MIM:617241]	I3N673	209	P	L
Q96MG7	LP/P	Lung disease, immunodeficiency, and chromosome breakage syndrome (LICS) [MIM:617241]	I3N673	264	L	F
Q6X4W1	LP/P	Hypogonadotropic hypogonadism 9 with or without anosmia (HH9) [MIM:614838]	H2M474	480	T	A
Q6X4W1	LB/B	-	H2M474	511	L	V
Q6X4W1	LP/P	Hypogonadotropic hypogonadism 9 with or without anosmia (HH9) [MIM:614838]	H2M474	196	R	H
Q9H857	LB/B	-	A0A1U7THG5	91	S	R
P78549	LB/B	-	U3FEL8	21	R	W
P78549	LB/B	-	U3FEL8	33	R	K
P78549	LB/B	-	U3FEL8	176	I	T
P78549	LB/B	-	U3FEL8	239	D	Y
P78549	LB/B	-	U3FEL8	234	S	L
P30989	LB/B	-	A0A2R8MQD9	304	V	I
P30989	LB/B	-	A0A2R8MQD9	275	Q	H
P30989	LB/B	-	A0A2R8MQD9	72	A	V
Q9NV35	LB/B	-	A0A2Y9DKZ5	18	V	I
Q9NV35	LB/B	-	A0A2Y9DKZ5	139	R	C
Q9NV35	LB/B	-	A0A2Y9DKZ5	139	R	H
Q9UKK9	LB/B	-	A0A2U3YS10	123	I	T
P53370	LB/B	-	F7CQR3	209	R	Q
P53370	LB/B	-	F7CQR3	114	C	R
Q14980	LB/B	-	M3YFZ3	242	K	R
Q14980	LB/B	-	M3YFZ3	794	A	G
Q14980	LB/B	-	M3YFZ3	1153	E	D
Q14980	LB/B	-	M3YFZ3	1825	V	M
Q14980	LB/B	-	M3YFZ3	1836	Y	H
Q14980	LB/B	-	M3YFZ3	2049	A	T
Q8WUM0	LB/B	-	L8IKP2	106	T	P
Q8WUM0	LB/B	-	L8IKP2	294	I	V
Q8WUM0	LB/B	-	L8IKP2	406	Q	R
Q8WUM0	LP/P	Nephrotic syndrome 18 (NPHS18) [MIM:618177]	L8IKP2	231	R	G
Q8WUM0	LP/P	Nephrotic syndrome 18 (NPHS18) [MIM:618177]	L8IKP2	974	S	R
Q8WUM0	LP/P	Nephrotic syndrome 18 (NPHS18) [MIM:618177]	L8IKP2	1055	L	S
Q9NY56	LB/B	-	A0A2K6EJL4	61	N	K
Q9NY56	LB/B	-	A0A2K6EJL4	159	M	T
Q9NY56	LB/B	-	A0A2K6EJL4	130	G	A
Q9NY56	LB/B	-	A0A2K6EJL4	133	P	S
Q9NPH6	LB/B	-	A0A2K6EJL4	167	V	I
Q5VST9	LB/B	-	H7BX05	51	A	T
Q5VST9	LB/B	-	H7BX05	4534	R	H
Q5VST9	LB/B	-	H7BX05	502	Q	R
Q5VST9	LB/B	-	H7BX05	1508	V	D
Q5VST9	LB/B	-	H7BX05	3300	A	T
Q5VST9	LB/B	-	H7BX05	4381	H	R
Q5VST9	LB/B	-	H7BX05	4450	C	R
Q5VST9	LB/B	-	H7BX05	804	G	S
Q5VST9	LB/B	-	H7BX05	1027	K	R
Q5VST9	LB/B	-	H7BX05	1086	A	S
Q5VST9	LB/B	-	H7BX05	1090	A	T
Q5VST9	LB/B	-	H7BX05	1091	S	T
Q5VST9	LB/B	-	H7BX05	1101	A	P
Q5VST9	LB/B	-	H7BX05	1121	G	R
Q5VST9	LB/B	-	H7BX05	1133	L	V
Q5VST9	LB/B	-	H7BX05	1156	H	Q
Q5VST9	LB/B	-	H7BX05	1248	Q	H
Q5VST9	LB/B	-	H7BX05	1532	A	V
Q5VST9	LB/B	-	H7BX05	1566	T	M
Q5VST9	LB/B	-	H7BX05	1601	A	T
Q5VST9	LB/B	-	H7BX05	3389	A	V
Q5VST9	LB/B	-	H7BX05	3426	D	E
Q5VST9	LB/B	-	H7BX05	3834	R	G
Q5VST9	LB/B	-	H7BX05	4823	A	S
Q5VST9	LB/B	-	H7BX05	5598	R	Q
Q5VST9	LB/B	-	H7BX05	6473	E	Q
Q5VST9	LB/B	-	H7BX05	908	A	T
Q5VST9	LB/B	-	H7BX05	2106	D	E
Q5VST9	LB/B	-	H7BX05	2116	F	L
Q5VST9	LB/B	-	H7BX05	2529	R	Q
Q5VST9	LB/B	-	H7BX05	2720	V	M
Q5VST9	LB/B	-	H7BX05	2812	R	W
Q5VST9	LB/B	-	H7BX05	3372	E	D
Q5VST9	LB/B	-	H7BX05	3373	S	C
Q5VST9	LB/B	-	H7BX05	4039	G	R
Q5VST9	LB/B	-	H7BX05	4642	S	C
Q5VST9	LB/B	-	H7BX05	4662	R	C
Q5VST9	LB/B	-	H7BX05	4666	G	S
Q5VST9	LB/B	-	H7BX05	4962	D	G
Q5VST9	LB/B	-	H7BX05	5269	L	V
Q5VST9	LB/B	-	H7BX05	5575	R	H
Q5VST9	LB/B	-	H7BX05	5891	Q	E
Q5VST9	LB/B	-	H7BX05	7172	A	V
Q5VST9	LB/B	-	H7BX05	4516	R	W
Q5VST9	LB/B	-	H7BX05	4492	L	R
Q9ULJ1	LB/B	-	A0A099ZSE5	177	R	H
Q9ULJ1	LB/B	-	A0A099ZSE5	350	K	R
Q3SX64	LB/B	-	F7AK71	135	V	A
Q5SWX8	LB/B	-	A0A094KQK3	251	S	C
Q8N543	LB/B	-	A0A2K6UNW3	173	P	S
Q9NZT2	LB/B	-	A0A0A0MRN5	577	S	T
Q9NZT2	LB/B	-	A0A0A0MRN5	545	R	S
Q68BL8	LB/B	-	U3JLK9	10	Y	C
Q68BL8	LB/B	-	U3JLK9	470	W	R
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	290	R	Q
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	300	G	E
O60313	LP/P	Dominant optic atrophy plus syndrome (DOA+) [MIM:125250]	E9FYT2	445	R	H
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	445	R	H
O60313	LB/B	-	E9FYT2	158	S	N
O60313	LB/B	-	E9FYT2	167	P	L
O60313	LB/B	-	E9FYT2	192	A	V
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	396	L	R
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	503	T	K
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	571	R	H
O60313	LP/P	Dominant optic atrophy plus syndrome (DOA+) [MIM:125250]	E9FYT2	545	S	R
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	545	S	R
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	939	L	P
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	80	Y	C
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	95	T	M
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	102	Y	C
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	270	E	K
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	272	L	P
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	273	D	A
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	290	R	W
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	310	Q	R
O60313	LP/P	Dominant optic atrophy plus syndrome (DOA+) [MIM:125250]	E9FYT2	357	A	T
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	357	A	T
O60313	LP/P	Behr syndrome (BEHRS) [MIM:210000]	E9FYT2	382	I	M
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	382	I	M
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	384	L	F
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	396	L	P
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	430	N	D
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	438	D	V
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	449	T	R
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	468	K	E
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	470	D	G
O60313	LP/P	Behr syndrome (BEHRS) [MIM:210000]	E9FYT2	487	E	K
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	487	E	K
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	505	K	N
O60313	LB/B	-	E9FYT2	550	D	N
O60313	LP/P	Dominant optic atrophy plus syndrome (DOA+) [MIM:125250]	E9FYT2	551	C	Y
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	551	C	Y
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	574	L	P
O60313	LP/P	Dominant optic atrophy plus syndrome (DOA+) [MIM:125250]	E9FYT2	582	Y	C
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	590	R	Q
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	590	R	W
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	593	L	P
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	646	S	L
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	728	N	K
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	768	G	D
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	781	R	W
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	785	Q	R
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	823	S	Y
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	841	Y	C
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	882	R	L
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	887	L	P
O60313	LB/B	-	E9FYT2	907	E	G
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	932	R	C
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	949	L	P
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	400	P	A
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	330	T	S
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	377	V	I
O60313	LP/P	Dominant optic atrophy plus syndrome (DOA+) [MIM:125250]	E9FYT2	439	G	V
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	439	G	V
O60313	LP/P	Dominant optic atrophy plus syndrome (DOA+) [MIM:125250]	E9FYT2	449	T	P
O60313	LP/P	Optic atrophy 1 (OPA1) [MIM:165500]	E9FYT2	459	G	E
O60313	LB/B	-	E9FYT2	502	V	G
O60313	LP/P	Dominant optic atrophy plus syndrome (DOA+) [MIM:125250]	E9FYT2	910	V	D
O60313	LP/P	Behr syndrome (BEHRS) [MIM:210000]	E9FYT2	402	V	M
O60313	LP/P	Mitochondrial DNA depletion syndrome 14, cardioencephalomyopathic type (MTDPS14) [MIM:616896]	E9FYT2	534	L	R
Q96CV9	LP/P	Glaucoma 1, open angle, E (GLC1E) [MIM:137760]	I3K179	26	H	D
Q96CV9	LP/P	Glaucoma 1, open angle, E (GLC1E) [MIM:137760]	I3K179	50	E	K
Q96CV9	LB/B	-	I3K179	98	M	K
Q96CV9	LP/P	Glaucoma 1, open angle, E (GLC1E) [MIM:137760]	I3K179	103	E	D
Q96CV9	LB/B	-	I3K179	201	P	S
Q96CV9	LB/B	-	I3K179	216	S	R
Q96CV9	LB/B	-	I3K179	322	E	K
Q96CV9	LB/B	-	I3K179	357	T	P
Q96CV9	LP/P	Glaucoma 1, open angle, E (GLC1E) [MIM:137760]	I3K179	486	H	R
Q96CV9	LB/B	-	I3K179	308	S	P
Q96CV9	LP/P	Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia (ALS12) [MIM:613435]	I3K179	478	E	G
Q96CV9	LP/P	Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia (ALS12) [MIM:613435]	I3K179	295	V	F
Q8NGE5	LB/B	-	G3U4Q1	96	G	S
P30954	LB/B	-	G3U4Q1	62	M	I
P30954	LB/B	-	G3U4Q1	112	M	I
P30954	LB/B	-	G3U4Q1	103	I	M
Q8NGC9	LB/B	-	A0A1U7S9Z7	301	T	S
Q8NGC7	LB/B	-	A0A1U7S9Z7	32	L	V
Q8NGC7	LB/B	-	A0A1U7S9Z7	7	S	Y
Q8NGC7	LB/B	-	A0A1U7S9Z7	107	I	T
Q8NGC7	LB/B	-	A0A1U7S9Z7	146	R	H
Q8NGC7	LB/B	-	A0A1U7S9Z7	195	L	F
Q8NGC7	LB/B	-	A0A1U7S9Z7	236	Y	H
Q8NGC7	LB/B	-	A0A1U7S9Z7	259	C	R
P30953	LB/B	-	P30955	143	A	T
P30953	LB/B	-	P30955	129	P	L
P30953	LB/B	-	P30955	262	S	P
P47887	LB/B	-	P30955	27	C	R
Q8NGS2	LB/B	-	L8IAR9	165	R	Q
Q8NGS2	LB/B	-	L8IAR9	119	A	T
Q8N628	LB/B	-	G5BRI4	20	T	A
Q8N628	LB/B	-	G5BRI4	68	P	S
Q8N628	LB/B	-	G5BRI4	129	R	S
Q8N628	LB/B	-	G5BRI4	289	L	V
Q8NGJ7	LB/B	-	A0A091EKG5	59	G	E
Q8NGJ7	LB/B	-	A0A091EKG5	288	M	T
Q8NGJ7	LB/B	-	A0A091EKG5	289	K	N
Q8NGJ7	LB/B	-	A0A091EKG5	45	G	C
Q8NGJ6	LB/B	-	A0A091EKG5	267	R	G
Q8NGJ6	LB/B	-	A0A091EKG5	288	T	M
Q8NGJ6	LB/B	-	A0A091EKG5	72	D	N
Q8NGJ6	LB/B	-	A0A091EKG5	45	G	C
Q8NGJ6	LB/B	-	A0A091EKG5	311	R	W
Q9Y5P0	LB/B	-	A0A091EKG5	36	V	I
Q9Y5P0	LB/B	-	A0A091EKG5	147	M	T
Q9H343	LB/B	-	A0A061IAE4	252	A	S
Q9H343	LB/B	-	A0A061IAE4	164	V	L
Q9H343	LB/B	-	A0A061IAE4	124	R	H
Q9H344	LB/B	-	A0A061IAE4	263	R	H
Q9H344	LB/B	-	A0A061IAE4	122	R	C
Q9H344	LB/B	-	A0A061IAE4	134	T	A
Q9H344	LB/B	-	A0A061IAE4	151	R	P
Q9H342	LB/B	-	A0A091EKG5	100	C	Y
Q9H2C8	LB/B	-	A0A091EKG5	233	S	L
Q9H2C8	LB/B	-	A0A091EKG5	211	L	V
Q8NGK2	LB/B	-	R4GGX4	139	T	I
Q8NGJ4	LB/B	-	M3VWG6	5	N	S
Q8NGJ4	LB/B	-	M3VWG6	167	R	W
Q8NGJ4	LB/B	-	M3VWG6	264	R	C
Q8NGH9	LB/B	-	M3VWG6	176	V	I
Q8NGH9	LB/B	-	M3VWG6	184	R	M
Q8NGH9	LB/B	-	M3VWG6	49	F	L
Q8NGH9	LB/B	-	M3VWG6	228	R	H
Q8NGH9	LB/B	-	M3VWG6	257	F	L
Q8NGH9	LB/B	-	M3VWG6	227	F	L
Q8NH55	LB/B	-	M3VWG6	165	I	T
Q8NH55	LB/B	-	M3VWG6	209	D	G
Q8NH55	LB/B	-	M3VWG6	234	P	L
Q96RD3	LB/B	-	M3VWG6	39	I	V
Q96RD3	LB/B	-	M3VWG6	48	F	L
Q96RD3	LB/B	-	M3VWG6	64	C	F
Q96RD3	LB/B	-	M3VWG6	95	S	P
Q96RD3	LB/B	-	M3VWG6	133	W	R
Q96RD3	LB/B	-	M3VWG6	159	I	V
Q96RD3	LB/B	-	M3VWG6	170	F	Y
Q96RD3	LB/B	-	M3VWG6	199	M	R
Q8NH60	LB/B	-	M3VWG6	77	T	A
Q8NH60	LB/B	-	M3VWG6	128	V	I
Q8NH60	LB/B	-	M3VWG6	141	Q	L
Q8NH60	LB/B	-	M3VWG6	226	V	I
Q8NH69	LB/B	-	A0A2I0T4Z8	163	A	P
Q8NH69	LB/B	-	A0A2I0T4Z8	189	R	C
Q8NH69	LB/B	-	A0A2I0T4Z8	39	F	L
Q8NH69	LB/B	-	A0A2I0T4Z8	65	H	R
Q8NH69	LB/B	-	A0A2I0T4Z8	160	M	T
Q8NH69	LB/B	-	A0A2I0T4Z8	215	F	L
Q8NH69	LB/B	-	A0A2I0T4Z8	310	F	Y
O95222	LB/B	-	A0A2K6PVM9	22	A	V
Q6IFH4	LB/B	-	A0A2K6PVM9	179	C	R
Q6IFH4	LB/B	-	A0A2K6PVM9	227	R	C
Q8NGW1	LB/B	-	A0A2K6PVM9	234	C	Y
Q8NGZ6	LB/B	-	A0A1U7S9Z7	215	F	L
Q8NGZ6	LB/B	-	A0A1U7S9Z7	159	P	A
Q8NGZ6	LB/B	-	A0A1U7S9Z7	13	L	P
Q8NGC5	LB/B	-	A0A1U7S9Z7	250	S	P
Q8NGY2	LB/B	-	A0A1U7S9Z7	6	R	Q
Q8NGY2	LB/B	-	A0A1U7S9Z7	156	L	V
Q8NGY2	LB/B	-	A0A1U7S9Z7	159	I	F
Q8NGY3	LB/B	-	A0A1U7S9Z7	20	G	R
Q8NGY3	LB/B	-	A0A1U7S9Z7	244	P	S
Q8NGY3	LB/B	-	A0A1U7S9Z7	264	P	L
Q8NGY3	LB/B	-	A0A1U7S9Z7	308	R	K
Q8NGY3	LB/B	-	A0A1U7S9Z7	159	Q	H
Q8NGY3	LB/B	-	A0A1U7S9Z7	279	D	N
Q8NGY3	LB/B	-	A0A1U7S9Z7	216	V	M
Q8NGW6	LB/B	-	A0A1U7S9Z7	39	E	D
Q8NGW6	LB/B	-	A0A1U7S9Z7	49	H	Y
Q8NGW6	LB/B	-	A0A1U7S9Z7	80	G	D
Q8NGW6	LB/B	-	A0A1U7S9Z7	134	S	L
Q8NGW6	LB/B	-	A0A1U7S9Z7	159	R	C
Q8NGW6	LB/B	-	A0A1U7S9Z7	197	C	R
Q8NGW6	LB/B	-	A0A1U7S9Z7	211	P	L
Q8NGW6	LB/B	-	A0A1U7S9Z7	247	R	Q
Q8NGW6	LB/B	-	A0A1U7S9Z7	261	H	R
Q8NGW6	LB/B	-	A0A1U7S9Z7	320	K	R
Q8NGM8	LB/B	-	A0A1U7S9Z7	276	T	K
Q8NGY5	LB/B	-	A0A1U7S9Z7	10	A	T
Q8NGY5	LB/B	-	A0A1U7S9Z7	194	I	T
Q8NGY5	LB/B	-	A0A1U7S9Z7	261	Q	R
Q8NGY5	LB/B	-	A0A1U7S9Z7	293	R	H
Q8NGY5	LB/B	-	A0A1U7S9Z7	245	F	L
Q8NGY6	LB/B	-	A0A1U7S9Z7	204	A	V
Q8NGY6	LB/B	-	A0A1U7S9Z7	250	I	V
Q8NGQ2	LB/B	-	A0A1U7S9Z7	316	G	A
Q8NH40	LB/B	-	A0A1U7S9Z7	42	T	I
Q8NH40	LB/B	-	A0A1U7S9Z7	156	V	I
Q8NH40	LB/B	-	A0A1U7S9Z7	237	R	H
Q8NH40	LB/B	-	A0A1U7S9Z7	296	R	C
Q8NGN1	LB/B	-	A0A1U7S9Z7	23	I	T
Q8NGN1	LB/B	-	A0A1U7S9Z7	64	R	W
Q8NGN1	LB/B	-	A0A1U7S9Z7	251	I	V
Q8N148	LB/B	-	A0A1U7S9Z7	237	S	F
Q8N148	LB/B	-	A0A1U7S9Z7	269	R	K
Q8N148	LB/B	-	A0A1U7S9Z7	295	V	A
Q8NH79	LB/B	-	A0A1U7S9Z7	190	T	N
Q8NGT5	LB/B	-	A0A1U7S9Z7	53	R	H
O43913	LB/B	-	A0A0Q3UQE4	37	G	R
O43913	LB/B	-	A0A0Q3UQE4	52	K	N
O43913	LB/B	-	A0A0Q3UQE4	166	R	C
Q96SU4	LB/B	-	A0A2J7PVR0	266	P	L
Q9Y236	LB/B	-	F7DLQ4	101	Y	H
Q9Y236	LB/B	-	F7DLQ4	319	C	S
Q9HC10	LB/B	-	A0A226PFX7	818	R	W
Q9HC10	LB/B	-	A0A226PFX7	1646	P	S
Q9HC10	LB/B	-	A0A226PFX7	1680	R	H
Q9HC10	LB/B	-	A0A226PFX7	53	A	V
Q9HC10	LB/B	-	A0A226PFX7	82	R	C
Q9HC10	LP/P	Deafness, autosomal recessive, 9 (DFNB9) [MIM:601071]	A0A226PFX7	490	P	Q
Q9HC10	LP/P	Auditory neuropathy, autosomal recessive, 1 (AUNB1) [MIM:601071]	A0A226PFX7	515	I	T
Q9HC10	LP/P	Deafness, autosomal recessive, 9 (DFNB9) [MIM:601071]	A0A226PFX7	515	I	T
Q9HC10	LB/B	-	A0A226PFX7	575	V	M
Q9HC10	LB/B	-	A0A226PFX7	773	R	S
Q9HC10	LP/P	Deafness, autosomal recessive, 9 (DFNB9) [MIM:601071]	A0A226PFX7	794	R	H
Q9HC10	LB/B	-	A0A226PFX7	822	R	W
Q9HC10	LP/P	Auditory neuropathy, autosomal recessive, 1 (AUNB1) [MIM:601071]	A0A226PFX7	1011	L	P
Q9HC10	LP/P	Deafness, autosomal recessive, 9 (DFNB9) [MIM:601071]	A0A226PFX7	1011	L	P
Q9HC10	LB/B	-	A0A226PFX7	1083	A	P
Q9HC10	LP/P	Deafness, autosomal recessive, 9 (DFNB9) [MIM:601071]	A0A226PFX7	1157	R	Q
Q9HC10	LB/B	-	A0A226PFX7	1322	D	E
Q9HC10	LB/B	-	A0A226PFX7	1625	V	M
Q9HC10	LP/P	Deafness, autosomal recessive, 9 (DFNB9) [MIM:601071]	A0A226PFX7	1825	P	A
Q9HC10	LB/B	-	A0A226PFX7	1888	G	D
Q9HC10	LP/P	Auditory neuropathy, autosomal recessive, 1 (AUNB1) [MIM:601071]	A0A226PFX7	1939	R	Q
Q9HC10	LP/P	Auditory neuropathy, autosomal recessive, 1 (AUNB1) [MIM:601071]	A0A226PFX7	1987	P	R
Q9HC10	LP/P	Auditory neuropathy, autosomal recessive, 1 (AUNB1) [MIM:601071]	A0A226PFX7	255	Q	H
Q9HC10	LP/P	Auditory neuropathy, autosomal recessive, 1 (AUNB1) [MIM:601071]	A0A226PFX7	964	A	E
Q9HC10	LP/P	Auditory neuropathy, autosomal recessive, 1 (AUNB1) [MIM:601071]	A0A226PFX7	1138	L	P
Q9HC10	LB/B	-	A0A226PFX7	1236	R	Q
Q9HC10	LB/B	-	A0A226PFX7	1688	T	K
Q9HC10	LP/P	Auditory neuropathy, autosomal recessive, 1 (AUNB1) [MIM:601071]	A0A226PFX7	1795	F	C
Q9HC10	LB/B	-	A0A226PFX7	1886	V	A
Q8NHW6	LB/B	-	W5QB28	7	P	L
Q6IE36	LB/B	-	A0A091P9X7	211	T	M
Q6IE36	LB/B	-	A0A091P9X7	587	L	V
Q6IE36	LB/B	-	A0A091P9X7	789	S	L
Q6IE36	LB/B	-	A0A091P9X7	1329	V	A
P56373	LB/B	-	S7NS14	383	A	V
Q8IVL6	LB/B	-	L5KI33	301	T	A
Q8IVL6	LB/B	-	L5KI33	304	R	C
Q8IVL6	LB/B	-	L5KI33	385	G	E
Q8IVL6	LB/B	-	L5KI33	685	I	T
Q8IVL6	LB/B	-	L5KI33	705	M	T
Q13153	LB/B	-	H9JDI0	515	L	V
Q13153	LP/P	Intellectual developmental disorder with macrocephaly, seizures, and speech delay (IDDMSSD) [MIM:618158]	H9JDI0	131	Y	C
Q13153	LP/P	Intellectual developmental disorder with macrocephaly, seizures, and speech delay (IDDMSSD) [MIM:618158]	H9JDI0	429	Y	C
Q13177	LP/P	Knobloch syndrome 2 (KNO2) [MIM:618458]	H9JDI0	435	E	K
Q8N910	LB/B	-	Q8N910	119	P	S
Q8N910	LB/B	-	Q8N910	151	P	R
Q8N910	LB/B	-	Q8N910	160	I	T
P19021	LB/B	-	L9LDC8	49	V	L
Q9NPB6	LB/B	-	H9G4X6	286	V	I
Q6UWI2	LB/B	-	G3ST63	127	S	L
Q8IXQ6	LB/B	-	M3Y061	21	S	L
Q8IXQ6	LB/B	-	M3Y061	517	I	V
Q8IXQ6	LB/B	-	M3Y061	528	Y	C
Q8IXQ6	LB/B	-	M3Y061	651	T	A
B3GLJ2	LB/B	-	A0A2Y9K622	30	T	K
Q9HBE1	LB/B	-	A0A2K6FPS8	685	E	D
Q06710	LP/P	Hypothyroidism, congenital, non-goitrous, 2 (CHNG2) [MIM:218700]	A0A287CZE8	31	R	H
Q06710	LP/P	Hypothyroidism, congenital, non-goitrous, 2 (CHNG2) [MIM:218700]	A0A287CZE8	40	Q	P
Q06710	LP/P	Hypothyroidism, congenital, non-goitrous, 2 (CHNG2) [MIM:218700]	A0A287CZE8	57	C	Y
Q06710	LP/P	Hypothyroidism, congenital, non-goitrous, 2 (CHNG2) [MIM:218700]	A0A287CZE8	62	L	R
Q06710	LB/B	-	A0A287CZE8	329	F	L
Q9GZY1	LB/B	-	A0A2J8PSK6	73	I	T
Q9BYU1	LB/B	-	A0A091HQH8	169	V	I
Q9BYU1	LB/B	-	A0A091HQH8	177	M	V
Q96AQ6	LB/B	-	G5BDD8	357	G	D
Q96AQ6	LB/B	-	G5BDD8	356	G	D
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	44	R	P
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	106	S	R
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	131	G	R
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	165	R	W
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	168	E	K
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	198	G	D
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	410	R	W
P05166	LB/B	-	A0A1S3WAE2	497	A	V
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	512	R	C
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	519	L	P
P05166	LB/B	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	17	L	M
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	205	V	D
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	228	P	L
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	428	T	I
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	442	M	T
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	536	N	D
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	67	R	S
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	107	V	M
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	112	G	D
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	153	A	P
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	165	R	Q
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	188	G	R
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	246	G	V
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	430	I	L
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	435	Y	C
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	439	Y	C
P05166	LP/P	Propionic acidemia type II (PA-2) [MIM:606054]	A0A1S3WAE2	468	A	T
P05166	LB/B	-	A0A1S3WAE2	287	P	S
Q9BZA7	LB/B	-	A0A146VSE2	1018	R	Q
Q9BZA8	LB/B	-	A0A146VSE2	917	V	F
Q9BZA8	LB/B	-	A0A146VSE2	1012	N	K
Q9BZA8	LB/B	-	A0A146VSE2	1320	A	T
Q9NPG4	LB/B	-	A0A1S3G8E7	385	H	N
Q9NPG4	LB/B	-	A0A1S3G8E7	640	S	N
Q9NPG4	LB/B	-	A0A1S3G8E7	55	R	G
Q9Y5F6	LB/B	-	A0A1L8GVP6	570	D	G
Q9Y5F6	LB/B	-	A0A1L8GVP6	275	G	S
Q15004	LB/B	-	W5QHU2	79	E	K
P12004	LP/P	Ataxia-telangiectasia-like disorder 2 (ATLD2) [MIM:615919]	D2KQP2	228	S	I
Q9H6A9	LB/B	-	L5LDA8	258	Q	R
Q9H6A9	LB/B	-	L5LDA8	458	S	C
Q9H6A9	LB/B	-	L5LDA8	813	K	N
Q9H6A9	LB/B	-	L5LDA8	564	G	S
Q9H6A9	LB/B	-	L5LDA8	1822	H	Q
Q63HM2	LB/B	-	A0A2D4HXC0	770	Q	H
Q63HM2	LB/B	-	A0A2D4HXC0	811	D	Y
Q63HM2	LB/B	-	A0A2D4HXC0	1000	G	S
Q9UHG3	LB/B	-	T1DLT3	149	S	F
Q9UHG3	LB/B	-	T1DLT3	414	T	S
Q9UHG3	LB/B	-	T1DLT3	465	S	G
Q8NBM8	LB/B	-	T1DLT3	5	A	P
Q8NBM8	LB/B	-	T1DLT3	390	E	D
Q8NBM8	LB/B	-	T1DLT3	316	A	T
Q6L8Q7	LB/B	-	C3YEG1	23	R	W
P51160	LB/B	-	A0A1U7S5C8	157	D	E
P51160	LB/B	-	A0A1U7S5C8	822	K	N
P51160	LB/B	-	A0A1U7S5C8	834	E	G
P51160	LB/B	-	A0A1U7S5C8	270	S	T
P51160	LB/B	-	A0A1U7S5C8	699	E	A
P51160	LP/P	Achromatopsia 5 (ACHM5) [MIM:613093]	A0A1U7S5C8	29	R	W
P51160	LP/P	Cone dystrophy 4 (COD4) [MIM:613093]	A0A1U7S5C8	29	R	W
P51160	LP/P	Achromatopsia 5 (ACHM5) [MIM:613093]	A0A1U7S5C8	323	Y	N
P51160	LP/P	Achromatopsia 5 (ACHM5) [MIM:613093]	A0A1U7S5C8	455	M	V
P51160	LP/P	Achromatopsia 5 (ACHM5) [MIM:613093]	A0A1U7S5C8	104	R	W
P51160	LP/P	Achromatopsia 5 (ACHM5) [MIM:613093]	A0A1U7S5C8	391	P	L
P51160	LP/P	Achromatopsia 5 (ACHM5) [MIM:613093]	A0A1U7S5C8	602	H	L
P51160	LP/P	Achromatopsia 5 (ACHM5) [MIM:613093]	A0A1U7S5C8	790	E	K
P18545	LB/B	-	A0A2K6R3C8	27	P	H
P13667	LB/B	-	G3V6T7	173	T	M
Q9NR12	LB/B	-	A0A096N7Y1	326	A	T
Q5EBL8	LB/B	-	F6VM95	81	S	Y
Q9UPQ7	LB/B	-	W5LDU8	783	A	V
Q9BY49	LB/B	-	C3YL38	149	E	K
Q9BY49	LB/B	-	C3YL38	297	F	L
Q96FX8	LB/B	-	A0A2I2Z366	143	P	R
Q96FX8	LB/B	-	A0A2I2Z366	174	P	L
Q96FX8	LP/P	Erythrokeratodermia variabilis et progressiva 7 (EKVP7) [MIM:619209]	A0A2I2Z366	156	G	R
Q9Y5Y5	LB/B	-	F1SI94	254	V	L
Q9Y5Y5	LB/B	-	F1SI94	103	V	M
Q9Y5Y5	LB/B	-	F1SI94	116	V	I
Q9Y5Y5	LP/P	Peroxisome biogenesis disorder 8B (PBD8B) [MIM:614877]	F1SI94	289	P	T
Q9Y5Y5	LP/P	Peroxisome biogenesis disorder 8B (PBD8B) [MIM:614877]	F1SI94	331	Y	C
Q7Z412	LP/P	Peroxisome biogenesis disorder 7B (PBD7B) [MIM:614873]	H0XN11	45	L	P
Q7Z412	LP/P	Peroxisome biogenesis disorder 7A (PBD7A) [MIM:614872]	H0XN11	89	G	R
Q7Z412	LP/P	Peroxisome biogenesis disorder 7B (PBD7B) [MIM:614873]	H0XN11	98	R	W
Q7Z412	LP/P	Peroxisome biogenesis disorder complementation group 8 (PBD-CG8) [MIM:614872]	H0XN11	98	R	W
Q7Z412	LB/B	-	H0XN11	153	L	V
Q7Z412	LP/P	Peroxisome biogenesis disorder complementation group 8 (PBD-CG8) [MIM:614872]	H0XN11	44	L	P
Q7Z412	LP/P	Peroxisome biogenesis disorder 7A (PBD7A) [MIM:614872]	H0XN11	116	L	Q
Q7Z412	LP/P	Peroxisome biogenesis disorder complementation group 8 (PBD-CG8) [MIM:614872]	H0XN11	117	P	L
O00628	LP/P	Rhizomelic chondrodysplasia punctata 1 (RCDP1) [MIM:215100]	A0A2R8MWM7	218	A	V
O00628	LP/P	Peroxisome biogenesis disorder 9B (PBD9B) [MIM:614879]	A0A2R8MWM7	14	T	P
P17858	LB/B	-	A0A0P7X5P2	81	G	A
P17858	LB/B	-	A0A0P7X5P2	151	R	W
P17858	LB/B	-	A0A0P7X5P2	237	D	V
P08237	LP/P	Glycogen storage disease 7 (GSD7) [MIM:232800]	A0A0P7X5P2	39	R	L
P08237	LP/P	Glycogen storage disease 7 (GSD7) [MIM:232800]	A0A0P7X5P2	39	R	P
P08237	LB/B	-	A0A0P7X5P2	100	R	Q
P08237	LP/P	Glycogen storage disease 7 (GSD7) [MIM:232800]	A0A0P7X5P2	209	G	D
P08237	LP/P	Glycogen storage disease 7 (GSD7) [MIM:232800]	A0A0P7X5P2	543	D	A
P08237	LP/P	Glycogen storage disease 7 (GSD7) [MIM:232800]	A0A0P7X5P2	686	W	C
P08237	LB/B	-	A0A0P7X5P2	696	R	H
P08237	LP/P	Glycogen storage disease 7 (GSD7) [MIM:232800]	A0A0P7X5P2	57	G	V
P08237	LP/P	Glycogen storage disease 7 (GSD7) [MIM:232800]	A0A0P7X5P2	180	S	C
P08237	LP/P	Glycogen storage disease 7 (GSD7) [MIM:232800]	A0A0P7X5P2	309	D	G
P08237	LP/P	Glycogen storage disease 7 (GSD7) [MIM:232800]	A0A0P7X5P2	591	D	A
A6NFU8	LB/B	-	A0A1U7T0C5	142	A	V
A6NFU8	LB/B	-	A0A1U7T0C5	169	E	Q
P78364	LB/B	-	A0A1U8BR74	693	T	A
P78364	LP/P	Microcephaly 11, primary, autosomal recessive (MCPH11) [MIM:615414]	A0A1U8BR74	992	L	F
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	77	C	S
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	85	C	Y
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	138	L	P
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	166	R	C
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	252	F	S
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	253	M	I
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	534	P	L
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	579	G	R
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	579	G	V
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	80	F	S
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	85	C	F
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	85	C	R
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	141	S	P
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	142	C	F
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	160	L	R
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	237	D	G
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	317	Y	F
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	530	W	C
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	555	L	P
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	567	R	P
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	573	A	D
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	621	Q	R
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	651	R	P
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	680	N	K
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	693	C	Y
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	720	A	T
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	731	F	Y
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	733	C	S
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	746	C	W
P78562	LP/P	Hypophosphatemic rickets, X-linked dominant (XLHR) [MIM:307800]	L9L2H3	749	W	R
Q96EK2	LB/B	-	A0A0P7U580	127	G	S
Q16816	LB/B	-	T0MFF4	323	R	C
Q6NSJ2	LB/B	-	A0A2K5XLF1	239	Q	R
Q8TCD6	LB/B	-	D8U122	206	K	E
O14813	LP/P	Fibrosis of extraocular muscles, congenital, 2 (CFEOM2) [MIM:602078]	A0A2I3GRP3	72	A	V
O14813	LB/B	-	A0A2I3GRP3	256	P	Q
Q5SRE7	LB/B	-	A0A2K6GG07	222	R	W
Q8IUZ5	LB/B	-	A0A1A6HY70	126	H	R
Q8IUZ5	LP/P	Phosphohydroxylysinuria (PHLU) [MIM:615011]	A0A1A6HY70	240	G	R
Q8IUZ5	LP/P	Phosphohydroxylysinuria (PHLU) [MIM:615011]	A0A1A6HY70	437	E	V
P42356	LB/B	-	A0A091MSH1	380	M	V
P42356	LB/B	-	A0A091MSH1	1851	V	L
P42356	LP/P	Neurodevelopmental disorder with spasticity, hypomyelinating leukodystrophy, and brain abnormalities (NEDSPLB) [MIM:616531]	A0A091MSH1	1854	D	N
P42356	LP/P	Neurodevelopmental disorder with spasticity, hypomyelinating leukodystrophy, and brain abnormalities (NEDSPLB) [MIM:616531]	A0A091MSH1	777	L	P
P42356	LP/P	Gastrointestinal defects and immunodeficiency syndrome 2 (GIDID2) [MIM:619708]	A0A091MSH1	1623	Y	D
P42356	LP/P	Neurodevelopmental disorder with spasticity, hypomyelinating leukodystrophy, and brain abnormalities (NEDSPLB) [MIM:616531]	A0A091MSH1	1664	D	N
P42356	LP/P	Neurodevelopmental disorder with spasticity, hypomyelinating leukodystrophy, and brain abnormalities (NEDSPLB) [MIM:616531]	A0A091MSH1	1808	K	T
P42356	LP/P	Neurodevelopmental disorder with spasticity, hypomyelinating leukodystrophy, and brain abnormalities (NEDSPLB) [MIM:616531]	A0A091MSH1	1925	G	E
P42356	LP/P	Neurodevelopmental disorder with spasticity, hypomyelinating leukodystrophy, and brain abnormalities (NEDSPLB) [MIM:616531]	A0A091MSH1	1937	Y	C
Q9HB75	LB/B	-	A0A2U9BY55	331	Q	R
Q9HB75	LP/P	Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly (MRT75) [MIM:619827]	A0A2U9BY55	815	R	W
Q9HB75	LP/P	Intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly (MRT75) [MIM:619827]	A0A2U9BY55	862	R	W
Q8TCI5	LB/B	-	M3XJZ3	97	K	N
Q8TCI5	LB/B	-	M3XJZ3	105	H	N
Q8TCI5	LB/B	-	M3XJZ3	80	R	K
Q92535	LB/B	-	A0A074YW46	266	P	S
Q92535	LP/P	Glycosylphosphatidylinositol biosynthesis defect 16 (GPIBD16) [MIM:617816]	A0A074YW46	189	L	W
Q92535	LP/P	Glycosylphosphatidylinositol biosynthesis defect 16 (GPIBD16) [MIM:617816]	A0A074YW46	212	L	P
Q14442	LP/P	Glycosylphosphatidylinositol biosynthesis defect 17 (GPIBD17) [MIM:618010]	A0A2Y9MUC6	103	S	P
P57054	LB/B	-	G1U4E9	118	Y	C
P57054	LB/B	-	G1U4E9	136	R	S
P57054	LB/B	-	G1U4E9	9	T	A
P57054	LP/P	Developmental and epileptic encephalopathy 55 (DEE55) [MIM:617599]	G1U4E9	25	M	T
P01833	LB/B	-	G3UTW1	580	A	V
P01833	LB/B	-	G3UTW1	365	G	S
P01833	LB/B	-	G3UTW1	555	T	I
Q96S52	LB/B	-	H3C356	253	R	H
Q96S52	LP/P	Glycosylphosphatidylinositol biosynthesis defect 18 (GPIBD18) [MIM:618143]	H3C356	34	L	P
Q96S52	LP/P	Glycosylphosphatidylinositol biosynthesis defect 18 (GPIBD18) [MIM:618143]	H3C356	308	E	G
O00443	LB/B	-	H0UT05	1415	T	A
Q9P1W9	LB/B	-	A0A2I2UIR4	138	G	D
Q9P1W9	LB/B	-	A0A2I2UIR4	280	I	V
Q9BXM7	LB/B	-	H2T6D8	305	P	L
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	309	G	D
Q9BXM7	LB/B	-	H2T6D8	340	A	T
Q9BXM7	LB/B	-	H2T6D8	521	N	T
Q9BXM7	LB/B	-	H2T6D8	148	L	W
Q9BXM7	LB/B	-	H2T6D8	196	P	S
Q9BXM7	LB/B	-	H2T6D8	209	P	L
Q9BXM7	LB/B	-	H2T6D8	339	A	T
Q9BXM7	LB/B	-	H2T6D8	341	M	I
Q9BXM7	LB/B	-	H2T6D8	377	C	F
Q9BXM7	LB/B	-	H2T6D8	477	S	T
Q9BXM7	LB/B	-	H2T6D8	67	L	F
Q9BXM7	LB/B	-	H2T6D8	68	R	P
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	92	C	F
Q9BXM7	LB/B	-	H2T6D8	98	R	W
Q9BXM7	LB/B	-	H2T6D8	111	I	S
Q9BXM7	LB/B	-	H2T6D8	115	Q	L
Q9BXM7	LB/B	-	H2T6D8	124	A	V
Q9BXM7	LB/B	-	H2T6D8	145	T	M
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	168	A	P
Q9BXM7	LB/B	-	H2T6D8	186	K	N
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	196	P	L
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	217	A	D
Q9BXM7	LB/B	-	H2T6D8	231	E	G
Q9BXM7	LB/B	-	H2T6D8	235	N	I
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	240	E	K
Q9BXM7	LB/B	-	H2T6D8	257	T	I
Q9BXM7	LB/B	-	H2T6D8	263	R	G
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	268	L	V
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	271	H	Q
Q9BXM7	LB/B	-	H2T6D8	276	R	Q
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	279	R	H
Q9BXM7	LB/B	-	H2T6D8	296	P	L
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	313	T	M
Q9BXM7	LB/B	-	H2T6D8	317	V	I
Q9BXM7	LB/B	-	H2T6D8	318	M	L
Q9BXM7	LB/B	-	H2T6D8	322	P	L
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	347	L	P
Q9BXM7	LB/B	-	H2T6D8	362	D	H
Q9BXM7	LB/B	-	H2T6D8	383	A	T
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	388	C	R
Q9BXM7	LB/B	-	H2T6D8	395	G	V
Q9BXM7	LB/B	-	H2T6D8	411	G	S
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	417	E	G
Q9BXM7	LB/B	-	H2T6D8	425	P	S
Q9BXM7	LB/B	-	H2T6D8	431	Y	H
Q9BXM7	LB/B	-	H2T6D8	442	I	T
Q9BXM7	LB/B	-	H2T6D8	451	N	S
Q9BXM7	LB/B	-	H2T6D8	461	L	S
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	464	R	H
Q9BXM7	LB/B	-	H2T6D8	476	E	K
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	489	L	P
Q9BXM7	LB/B	-	H2T6D8	501	R	P
Q9BXM7	LB/B	-	H2T6D8	525	D	N
Q9BXM7	LB/B	-	H2T6D8	537	A	T
Q9BXM7	LB/B	-	H2T6D8	575	C	R
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	125	C	G
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	280	A	T
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	369	L	P
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	386	G	A
Q9BXM7	LP/P	-	H2T6D8	399	P	L
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	407	R	Q
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	409	G	V
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	126	Q	P
Q9BXM7	LP/P	Parkinson disease 6 (PARK6) [MIM:605909]	H2T6D8	170	V	G
Q96BK5	LB/B	-	A0A1S3FTE5	206	Q	H
Q96BK5	LB/B	-	A0A1S3FTE5	215	R	I
Q96BK5	LB/B	-	A0A1S3FTE5	220	T	A
Q96BK5	LB/B	-	A0A1S3FTE5	254	S	C
Q96BK5	LB/B	-	A0A1S3FTE5	315	E	A
Q9UG56	LP/P	Liberfarb syndrome (LIBF) [MIM:618889]	A0A1L8I0B8	277	R	Q
Q9UG56	LP/P	Liberfarb syndrome (LIBF) [MIM:618889]	A0A1L8I0B8	300	C	Y
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	107	M	T
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	134	V	D
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	155	L	P
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	172	E	Q
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	163	R	C
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	275	G	R
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	281	D	N
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	287	F	V
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	314	I	T
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	331	D	E
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	332	G	S
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	336	A	S
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	337	R	P
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	337	R	Q
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	339	D	H
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	341	G	A
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	357	I	T
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	359	R	C
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	359	R	H
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	361	N	D
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	368	V	F
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	384	T	M
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	392	A	T
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	393	N	K
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	393	N	S
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	408	T	I
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	421	Q	K
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	426	R	Q
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	426	R	W
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	431	A	T
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	458	G	D
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	459	A	V
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	460	V	M
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	468	A	V
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	486	R	W
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	490	R	W
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	495	A	V
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	498	R	C
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	498	R	H
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	510	R	Q
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	532	R	Q
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	532	R	W
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	552	V	M
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	559	R	G
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	566	N	K
P30613	LP/P	Pyruvate kinase hyperactivity (PKHYP) [MIM:102900]	A0A158Q4L1	37	G	E
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	80	S	P
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	86	R	P
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	90	I	N
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	95	G	R
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	111	G	R
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	115	A	P
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	120	S	F
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	130	S	Y
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	159	G	V
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	222	G	A
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	293	D	N
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	263	G	R
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	263	G	W
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	288	V	L
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	295	A	V
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	310	I	N
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	315	E	K
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	331	D	N
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	341	G	D
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	342	I	F
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	348	K	N
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	364	G	D
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	376	S	I
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	387	E	G
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	390	D	N
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	394	A	D
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	394	A	V
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	408	T	A
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	427	E	A
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	427	E	D
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	477	T	A
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	485	S	F
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	488	R	Q
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	495	A	T
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	504	R	L
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	511	G	R
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	531	R	C
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	153	I	T
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	219	I	T
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	335	V	M
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	352	A	D
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	385	R	W
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	468	A	G
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	479	R	H
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	557	G	A
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	569	R	Q
P30613	LB/B	-	A0A158Q4L1	506	V	I
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	40	R	W
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	73	L	P
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	154	A	T
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	163	R	L
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	165	G	V
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	272	L	V
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	320	V	L
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	358	G	E
P30613	LP/P	Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200]	A0A158Q4L1	374	L	P
P14618	LB/B	-	A0A158Q4L1	204	G	V
Q99640	LB/B	-	A0A2K6GC18	140	R	C
Q99640	LB/B	-	A0A2K6GC18	417	P	R
Q99640	LB/B	-	A0A2K6GC18	445	V	A
Q99640	LB/B	-	A0A2K6GC18	103	E	Q
Q99640	LB/B	-	A0A2K6GC18	246	R	H
Q99640	LB/B	-	A0A2K6GC18	351	E	K
P14555	LB/B	-	G5C4W0	19	H	Y
Q8NHP8	LB/B	-	K9IM67	524	R	C
Q8NHP8	LB/B	-	K9IM67	54	Q	P
P19174	LB/B	-	A0A1W4YSV3	813	I	T
P19174	LB/B	-	A0A1W4YSV3	279	S	G
P19174	LB/B	-	A0A1W4YSV3	209	T	N
P19174	LB/B	-	A0A1W4YSV3	739	S	T
Q86YW0	LB/B	-	A0A1A8KBL1	500	S	L
Q86YW0	LP/P	Spermatogenic failure 17 (SPGF17) [MIM:617214]	A0A1A8KBL1	489	I	F
Q6IQ23	LB/B	-	V8PJ74	241	L	I
Q6IQ23	LB/B	-	V8PJ74	248	A	V
Q6IQ23	LB/B	-	V8PJ74	279	Q	R
Q6IQ23	LB/B	-	V8PJ74	693	V	I
Q6IQ23	LB/B	-	V8PJ74	689	S	R
Q9ULL1	LB/B	-	M7BHY0	787	Q	R
Q9ULL1	LB/B	-	M7BHY0	1071	V	A
Q9ULL1	LB/B	-	M7BHY0	1321	L	S
Q9ULL1	LB/B	-	M7BHY0	1377	Q	P
Q8IWE5	LB/B	-	G1NTG1	32	I	T
Q494U1	LB/B	-	A0A287A3H3	487	R	P
O94903	LB/B	-	A0A2K5MDP8	24	V	M
O94903	LP/P	Epilepsy, early-onset, vitamin B6-dependent (EPVB6D) [MIM:617290]	A0A2K5MDP8	87	P	L
O94903	LP/P	Epilepsy, early-onset, vitamin B6-dependent (EPVB6D) [MIM:617290]	A0A2K5MDP8	175	L	P
O94903	LP/P	Epilepsy, early-onset, vitamin B6-dependent (EPVB6D) [MIM:617290]	A0A2K5MDP8	241	R	Q
Q8NBV4	LB/B	-	A0A2D0QBS5	174	T	M
Q8NBV4	LB/B	-	A0A2D0QBS5	267	L	V
Q9NRY6	LB/B	-	F6PWF3	293	V	I
Q8TBY8	LB/B	-	A0A1U7TRK0	172	A	T
Q8TBY8	LB/B	-	A0A1U7TRK0	193	E	K
Q8TBY8	LB/B	-	A0A1U7TRK0	381	R	L
Q8TBY8	LB/B	-	A0A1U7TRK0	645	K	T
Q8TBY8	LB/B	-	A0A1U7TRK0	650	T	K
Q8TBY8	LB/B	-	A0A1U7TRK0	913	K	N
P54278	LB/B	-	A0A2K1K8F7	20	R	Q
P54278	LB/B	-	A0A2K1K8F7	485	T	K
P54278	LB/B	-	A0A2K1K8F7	511	T	A
P54278	LB/B	-	A0A2K1K8F7	597	T	S
P54278	LP/P	Lynch syndrome 4 (LYNCH4) [MIM:614337]	A0A2K1K8F7	705	E	K
P54278	LP/P	Mismatch repair cancer syndrome 4 (MMRCS4) [MIM:619101]	A0A2K1K8F7	705	E	K
P54278	LB/B	-	A0A2K1K8F7	277	T	K
P54278	LB/B	-	A0A2K1K8F7	470	P	S
P54278	LB/B	-	A0A2K1K8F7	775	N	S
P54278	LB/B	-	A0A2K1K8F7	541	K	E
P54278	LP/P	Lynch syndrome 4 (LYNCH4) [MIM:614337]	A0A2K1K8F7	46	S	I
P54278	LP/P	Mismatch repair cancer syndrome 4 (MMRCS4) [MIM:619101]	A0A2K1K8F7	46	S	I
P54278	LB/B	-	A0A2K1K8F7	18	I	V
P54278	LP/P	Lynch syndrome 4 (LYNCH4) [MIM:614337]	A0A2K1K8F7	46	S	N
P54278	LB/B	-	A0A2K1K8F7	60	D	E
P54278	LP/P	Mismatch repair cancer syndrome 4 (MMRCS4) [MIM:619101]	A0A2K1K8F7	107	R	W
P54278	LP/P	Mismatch repair cancer syndrome 4 (MMRCS4) [MIM:619101]	A0A2K1K8F7	115	C	G
P54278	LB/B	-	A0A2K1K8F7	563	R	L
P54278	LB/B	-	A0A2K1K8F7	571	L	I
P54278	LP/P	Mismatch repair cancer syndrome 4 (MMRCS4) [MIM:619101]	A0A2K1K8F7	815	S	L
P54278	LP/P	Lynch syndrome 4 (LYNCH4) [MIM:614337]	A0A2K1K8F7	843	C	Y
P54278	LB/B	-	A0A2K1K8F7	857	G	A
P54278	LB/B	-	A0A2K1K8F7	423	A	T
P54278	LB/B	-	A0A2K1K8F7	511	T	M
P54278	LB/B	-	A0A2K1K8F7	511	T	P
P54278	LB/B	-	A0A2K1K8F7	36	S	R
P54278	LB/B	-	A0A2K1K8F7	475	V	E
P54278	LB/B	-	A0A2K1K8F7	699	D	H
P54278	LB/B	-	A0A2K1K8F7	792	D	N
P54278	LB/B	-	A0A2K1K8F7	853	I	M
P54278	LB/B	-	A0A2K1K8F7	232	G	E
P54278	LB/B	-	A0A2K1K8F7	238	S	R
P54278	LB/B	-	A0A2K1K8F7	335	N	S
P54278	LB/B	-	A0A2K1K8F7	779	G	R
P54278	LB/B	-	A0A2K1K8F7	799	R	Q
P54278	LB/B	-	A0A2K1K8F7	816	V	E
Q6P2M8	LB/B	-	A0A1U7T1W2	262	Q	H
P16233	LP/P	Pancreatic lipase deficiency (PNLIPD) [MIM:614338]	A0A1S3F9A3	221	T	M
P54315	LB/B	-	A0A1S3F9A3	461	L	P
P54315	LB/B	-	A0A1S3F9A3	271	A	V
P54315	LB/B	-	A0A1S3F9A3	414	E	D
P54315	LB/B	-	A0A1S3F9A3	61	N	D
P54317	LB/B	-	A0A1S3F9A3	361	I	V
Q17RR3	LB/B	-	A0A1S3F9A3	2	L	F
Q17RR3	LB/B	-	A0A1S3F9A3	332	F	L
Q17RR3	LB/B	-	A0A1S3F9A3	450	F	Y
Q17RR3	LB/B	-	A0A1S3F9A3	381	V	I
Q17RR3	LB/B	-	A0A1S3F9A3	382	R	G
O00592	LB/B	-	M3Y0V5	60	T	R
O00592	LB/B	-	M3Y0V5	194	S	L
O00592	LB/B	-	M3Y0V5	112	G	S
O00592	LB/B	-	M3Y0V5	358	V	I
O00592	LB/B	-	M3Y0V5	298	P	A
O00592	LB/B	-	M3Y0V5	126	T	P
Q9H488	LB/B	-	G1RFC1	322	L	F
Q9H488	LB/B	-	G1RFC1	348	D	N
Q8NBL1	LB/B	-	W5QEP1	75	K	R
Q8NBL1	LB/B	-	W5QEP1	229	P	T
Q8NBL1	LP/P	Dowling-Degos disease 4 (DDD4) [MIM:615696]	W5QEP1	170	G	E
Q8NBL1	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 21 (LGMDR21) [MIM:617232]	W5QEP1	233	D	E
Q8NBL1	LP/P	Dowling-Degos disease 4 (DDD4) [MIM:615696]	W5QEP1	286	C	Y
P06746	LB/B	-	A0A2J8N796	242	P	R
Q07864	LB/B	-	A0A232EX79	252	A	V
Q07864	LB/B	-	A0A232EX79	336	N	S
Q07864	LB/B	-	A0A232EX79	695	F	I
Q07864	LB/B	-	A0A232EX79	1395	Y	C
Q07864	LB/B	-	A0A232EX79	1396	N	S
Q07864	LB/B	-	A0A232EX79	1399	E	Q
Q07864	LB/B	-	A0A232EX79	2040	A	V
Q07864	LB/B	-	A0A232EX79	2165	R	H
Q07864	LB/B	-	A0A232EX79	99	P	L
Q07864	LB/B	-	A0A232EX79	260	R	Q
Q07864	LB/B	-	A0A232EX79	1382	R	C
Q07864	LB/B	-	A0A232EX79	1577	E	A
Q07864	LB/B	-	A0A232EX79	1712	A	V
Q07864	LB/B	-	A0A232EX79	1857	K	R
Q07864	LB/B	-	A0A232EX79	1935	C	Y
Q07864	LB/B	-	A0A232EX79	2140	E	K
Q07864	LB/B	-	A0A232EX79	2159	R	C
Q07864	LB/B	-	A0A232EX79	31	A	S
Q07864	LB/B	-	A0A232EX79	231	R	H
Q07864	LB/B	-	A0A232EX79	286	P	H
Q07864	LP/P	Colorectal cancer 12 (CRCS12) [MIM:615083]	A0A232EX79	411	V	L
Q07864	LP/P	Colorectal cancer 12 (CRCS12) [MIM:615083]	A0A232EX79	424	L	V
Q07864	LB/B	-	A0A232EX79	436	P	R
Q07864	LB/B	-	A0A232EX79	762	R	W
Q07864	LB/B	-	A0A232EX79	1368	V	M
Q07864	LB/B	-	A0A232EX79	1421	P	S
Q07864	LB/B	-	A0A232EX79	1752	D	N
Q07864	LB/B	-	A0A232EX79	2013	D	N
Q07864	LB/B	-	A0A232EX79	2056	A	T
Q07864	LB/B	-	A0A232EX79	286	P	R
Q07864	LP/P	Colorectal cancer 12 (CRCS12) [MIM:615083]	A0A232EX79	458	Y	F
P56282	LB/B	-	A0A1U7UEA1	84	H	P
P56282	LB/B	-	A0A1U7UEA1	456	L	V
P56282	LB/B	-	A0A1U7UEA1	514	P	L
O14802	LB/B	-	A8X1M6	582	R	L
O14802	LB/B	-	A8X1M6	713	K	N
O14802	LP/P	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694]	A8X1M6	372	D	N
O14802	LP/P	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694]	A8X1M6	558	F	L
O14802	LP/P	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694]	A8X1M6	636	S	Y
O14802	LP/P	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694]	A8X1M6	672	G	E
O14802	LP/P	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694]	A8X1M6	724	C	Y
O14802	LP/P	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694]	A8X1M6	775	N	I
O14802	LP/P	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694]	A8X1M6	852	M	V
O14802	LP/P	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694]	A8X1M6	1005	R	C
O14802	LP/P	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694]	A8X1M6	897	I	N
O14802	LP/P	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694]	A8X1M6	91	P	L
O14802	LP/P	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694]	A8X1M6	310	W	C
O14802	LP/P	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694]	A8X1M6	387	A	G
O14802	LP/P	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694]	A8X1M6	602	S	R
O14802	LP/P	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694]	A8X1M6	804	I	T
O14802	LP/P	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694]	A8X1M6	1261	E	K
P01189	LB/B	-	A0A151P1I3	7	S	T
P01189	LB/B	-	A0A151P1I3	9	S	L
P01189	LB/B	-	A0A151P1I3	236	R	G
P01189	LB/B	-	A0A151P1I3	106	D	N
P01189	LB/B	-	A0A151P1I3	214	E	G
P01189	LB/B	-	A0A151P1I3	236	R	Q
P01189	LB/B	-	A0A151P1I3	132	P	A
P01189	LB/B	-	A0A151P1I3	62	P	L
Q8WZA1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A3 (MDDGA3) [MIM:253280]	M7B249	223	E	K
Q8WZA1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A3 (MDDGA3) [MIM:253280]	M7B249	269	C	Y
Q8WZA1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A3 (MDDGA3) [MIM:253280]	M7B249	311	R	Q
Q8WZA1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B3 (MDDGB3) [MIM:613151]	M7B249	311	R	Q
Q8WZA1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A3 (MDDGA3) [MIM:253280]	M7B249	425	W	S
Q8WZA1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A3 (MDDGA3) [MIM:253280]	M7B249	442	R	C
Q8WZA1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A3 (MDDGA3) [MIM:253280]	M7B249	490	C	Y
Q8WZA1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B3 (MDDGB3) [MIM:613151]	M7B249	490	C	Y
Q8WZA1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A3 (MDDGA3) [MIM:253280]	M7B249	493	P	R
Q8WZA1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A3 (MDDGA3) [MIM:253280]	M7B249	550	S	N
Q8WZA1	LB/B	-	M7B249	623	M	V
Q8WZA1	LB/B	-	M7B249	250	E	V
Q8WZA1	LB/B	-	M7B249	504	V	I
Q8WZA1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A3 (MDDGA3) [MIM:253280]	M7B249	176	T	P
Q8WZA1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A3 (MDDGA3) [MIM:253280]	M7B249	198	S	R
Q8WZA1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A3 (MDDGA3) [MIM:253280]	M7B249	367	R	H
Q8WZA1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A3 (MDDGA3) [MIM:253280]	M7B249	427	D	H
Q8WZA1	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C3 (MDDGC3) [MIM:613157]	M7B249	556	D	N
Q8WZA1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B3 (MDDGB3) [MIM:613151]	M7B249	605	R	P
Q8WZA1	LP/P	Retinitis pigmentosa 76 (RP76) [MIM:617123]	M7B249	156	E	K
Q8WZA1	LP/P	Retinitis pigmentosa 76 (RP76) [MIM:617123]	M7B249	287	I	S
Q8WZA1	LP/P	Retinitis pigmentosa 76 (RP76) [MIM:617123]	M7B249	502	G	A
Q8WZA1	LP/P	Retinitis pigmentosa 76 (RP76) [MIM:617123]	M7B249	120	L	R
Q6PJE2	LB/B	-	Q6PJE2	176	R	H
Q9NUX5	LB/B	-	A0A1A8C608	529	V	M
Q9NUX5	LP/P	Melanoma, cutaneous malignant 10 (CMM10) [MIM:615848]	A0A1A8C608	89	Y	C
Q9NUX5	LP/P	Melanoma, cutaneous malignant 10 (CMM10) [MIM:615848]	A0A1A8C608	94	Q	E
Q9NUX5	LP/P	Melanoma, cutaneous malignant 10 (CMM10) [MIM:615848]	A0A1A8C608	137	R	H
Q9NUX5	LP/P	Melanoma, cutaneous malignant 10 (CMM10) [MIM:615848]	A0A1A8C608	224	D	N
Q9NUX5	LP/P	Melanoma, cutaneous malignant 10 (CMM10) [MIM:615848]	A0A1A8C608	270	S	N
Q9NUX5	LP/P	Melanoma, cutaneous malignant 10 (CMM10) [MIM:615848]	A0A1A8C608	273	R	L
Q9NUX5	LP/P	Melanoma, cutaneous malignant 10 (CMM10) [MIM:615848]	A0A1A8C608	532	A	P
Q9NUX5	LP/P	Melanoma, cutaneous malignant 10 (CMM10) [MIM:615848]	A0A1A8C608	623	Q	H
Q9NUX5	LP/P	Glioma 9 (GLM9) [MIM:616568]	A0A1A8C608	95	G	C
Q12837	LB/B	-	A0A2D0QKA9	40	I	T
Q9H2U2	LB/B	-	G1SPZ9	282	K	N
Q9H2U2	LP/P	Sudden cardiac failure, infantile (SCFI) [MIM:617222]	G1SPZ9	61	S	P
Q9H2U2	LP/P	Sudden cardiac failure, infantile (SCFI) [MIM:617222]	G1SPZ9	94	M	V
Q9H2U2	LP/P	Sudden cardiac failure, infantile (SCFI) [MIM:617222]	G1SPZ9	106	M	I
Q9H2U2	LP/P	Sudden cardiac failure, infantile (SCFI) [MIM:617222]	G1SPZ9	127	R	L
Q9H2U2	LP/P	Sudden cardiac failure, infantile (SCFI) [MIM:617222]	G1SPZ9	167	P	L
Q9H2U2	LP/P	Sudden cardiac failure, alcohol-induced (SCFAI) [MIM:617223]	G1SPZ9	172	E	K
Q9H2U2	LP/P	Sudden cardiac failure, infantile (SCFI) [MIM:617222]	G1SPZ9	172	E	K
Q9H2U2	LP/P	Sudden cardiac failure, alcohol-induced (SCFAI) [MIM:617223]	G1SPZ9	228	P	L
Q9H2U2	LP/P	Sudden cardiac failure, infantile (SCFI) [MIM:617222]	G1SPZ9	294	Q	P
P37231	LB/B	-	H2URX2	12	P	A
P37231	LP/P	Obesity (OBESITY) [MIM:601665]	H2URX2	113	P	Q
P37231	LB/B	-	H2URX2	318	V	M
P37231	LB/B	-	H2URX2	495	P	L
P37231	LB/B	-	H2URX2	40	P	A
P37231	LP/P	Lipodystrophy, familial partial, 3 (FPLD3) [MIM:604367]	H2URX2	388	F	L
P37231	LP/P	Lipodystrophy, familial partial, 3 (FPLD3) [MIM:604367]	H2URX2	425	R	C
Q08752	LB/B	-	R7VAP3	49	R	C
Q08752	LB/B	-	R7VAP3	302	L	I
Q08752	LB/B	-	R7VAP3	335	G	E
Q08752	LB/B	-	R7VAP3	196	D	V
O15297	LB/B	-	W5MCR2	322	P	Q
O75807	LB/B	-	A0A2K6G4D3	31	R	H
O75807	LB/B	-	A0A2K6G4D3	32	A	T
O75807	LB/B	-	A0A2K6G4D3	199	V	A
O75807	LB/B	-	A0A2K6G4D3	251	R	P
O75807	LB/B	-	A0A2K6G4D3	277	K	E
O75807	LB/B	-	A0A2K6G4D3	316	A	P
O75807	LB/B	-	A0A2K6G4D3	381	A	V
O75807	LB/B	-	A0A2K6G4D3	476	R	S
O75807	LB/B	-	A0A2K6G4D3	594	R	C
O75807	LB/B	-	A0A2K6G4D3	597	T	A
O75807	LB/B	-	A0A2K6G4D3	312	G	S
O96001	LB/B	-	A0A2U3WZB9	12	L	V
O96001	LB/B	-	A0A2U3WZB9	10	L	R
Q7Z5V6	LB/B	-	A0A1U7Q2L4	238	T	N
Q7Z5V6	LB/B	-	A0A1U7Q2L4	382	S	T
Q96LQ0	LB/B	-	A0A061I2U4	83	T	I
Q96LQ0	LB/B	-	A0A061I2U4	267	F	L
P67775	LB/B	-	A0A1V4L042	52	V	A
P67775	LP/P	Neurodevelopmental disorder and language delay with or without structural brain abnormalities (NEDLBA) [MIM:618354]	A0A1V4L042	88	D	G
P67775	LP/P	Neurodevelopmental disorder and language delay with or without structural brain abnormalities (NEDLBA) [MIM:618354]	A0A1V4L042	122	Q	H
P67775	LP/P	Neurodevelopmental disorder and language delay with or without structural brain abnormalities (NEDLBA) [MIM:618354]	A0A1V4L042	127	Y	C
P67775	LP/P	Neurodevelopmental disorder and language delay with or without structural brain abnormalities (NEDLBA) [MIM:618354]	A0A1V4L042	131	D	H
P67775	LP/P	Neurodevelopmental disorder and language delay with or without structural brain abnormalities (NEDLBA) [MIM:618354]	A0A1V4L042	191	H	R
P67775	LP/P	Neurodevelopmental disorder and language delay with or without structural brain abnormalities (NEDLBA) [MIM:618354]	A0A1V4L042	223	D	H
P67775	LP/P	Neurodevelopmental disorder and language delay with or without structural brain abnormalities (NEDLBA) [MIM:618354]	A0A1V4L042	223	D	V
P67775	LP/P	Neurodevelopmental disorder and language delay with or without structural brain abnormalities (NEDLBA) [MIM:618354]	A0A1V4L042	265	Y	C
Q9UMR5	LB/B	-	C3YTL8	5	C	W
Q9UMR5	LB/B	-	C3YTL8	34	A	E
Q00LT1	LP/P	Retinitis pigmentosa 36 (RP36) [MIM:610599]	A0A1S3GYE7	2	C	Y
Q00LT1	LB/B	-	A0A1S3GYE7	17	R	C
Q00LT1	LP/P	Retinitis pigmentosa 36 (RP36) [MIM:610599]	A0A1S3GYE7	25	P	T
Q9NQX0	LP/P	Patent ductus arteriosus 3 (PDA3) [MIM:617039]	A0A1S3A1U6	462	Q	R
Q9NQX0	LP/P	Patent ductus arteriosus 3 (PDA3) [MIM:617039]	A0A1S3A1U6	549	R	Q
P32119	LB/B	-	A0A0B6Z4Q3	153	D	E
P30048	LB/B	-	F7D6R2	55	S	R
P30048	LB/B	-	F7D6R2	218	A	T
P30048	LB/B	-	F7D6R2	234	T	I
P30048	LB/B	-	F7D6R2	170	R	Q
P30048	LP/P	Corneal dystrophy, punctiform and polychromatic pre-Descemet (PPPCD) [MIM:619871]	F7D6R2	190	D	H
P30048	LP/P	Spinocerebellar ataxia, autosomal recessive, 32 (SCAR32) [MIM:619862]	F7D6R2	202	D	N
P48147	LB/B	-	A0A1S3FPQ5	351	L	V
P48147	LB/B	-	A0A1S3FPQ5	706	V	I
P49643	LB/B	-	A0A2Y9H7H4	265	Q	L
P49643	LB/B	-	A0A2Y9H7H4	181	E	K
P49643	LB/B	-	A0A2Y9H7H4	204	D	G
P49643	LB/B	-	A0A2Y9H7H4	259	G	S
P49643	LB/B	-	A0A2Y9H7H4	287	C	Y
P49643	LB/B	-	A0A2Y9H7H4	446	Q	H
P49643	LB/B	-	A0A2Y9H7H4	465	P	S
Q9UGJ0	LP/P	Cardiomyopathy, familial hypertrophic 6 (CMH6) [MIM:600858]	A0A087XYX9	302	R	Q
Q9UGJ0	LP/P	Wolff-Parkinson-White syndrome (WPW) [MIM:194200]	A0A087XYX9	302	R	Q
Q9UGJ0	LP/P	Cardiomyopathy, familial hypertrophic 6 (CMH6) [MIM:600858]	A0A087XYX9	383	H	R
Q9UGJ0	LP/P	Cardiomyopathy, familial hypertrophic 6 (CMH6) [MIM:600858]	A0A087XYX9	400	T	N
Q9UGJ0	LP/P	Cardiomyopathy, familial hypertrophic 6 (CMH6) [MIM:600858]	A0A087XYX9	488	N	I
Q9UGJ0	LP/P	Glycogen storage disease of heart lethal congenital (GSDH) [MIM:261740]	A0A087XYX9	531	R	Q
Q9UGJ0	LP/P	Wolff-Parkinson-White syndrome (WPW) [MIM:194200]	A0A087XYX9	531	R	G
Q9UGJ0	LB/B	-	A0A087XYX9	6	M	L
P31323	LB/B	-	A0A0Q3T695	335	E	D
Q02156	LB/B	-	G7YNP6	333	A	V
Q02156	LB/B	-	G7YNP6	389	P	R
Q02156	LB/B	-	G7YNP6	563	T	M
Q02156	LB/B	-	G7YNP6	654	A	T
Q15139	LB/B	-	A0A1W4WN85	225	S	P
Q15139	LB/B	-	A0A1W4WN85	478	K	Q
Q15139	LB/B	-	A0A1W4WN85	679	P	L
Q15139	LB/B	-	A0A1W4WN85	891	H	R
Q15139	LB/B	-	A0A1W4WN85	825	R	K
Q15139	LP/P	Congenital heart defects and ectodermal dysplasia (CHDED) [MIM:617364]	A0A1W4WN85	299	L	W
Q15139	LP/P	Congenital heart defects and ectodermal dysplasia (CHDED) [MIM:617364]	A0A1W4WN85	592	G	R
Q13976	LB/B	-	A0A1L8DLB8	249	I	V
Q13976	LB/B	-	A0A1L8DLB8	267	N	S
Q13976	LP/P	Aortic aneurysm, familial thoracic 8 (AAT8) [MIM:615436]	A0A1L8DLB8	177	R	Q
Q13976	LB/B	-	A0A1L8DLB8	474	Y	F
Q13976	LB/B	-	A0A1L8DLB8	666	G	A
O75569	LP/P	Dystonia 16 (DYT16) [MIM:612067]	A0A2D4INH5	222	P	L
P49683	LB/B	-	B1NYI1	283	I	V
P49683	LB/B	-	B1NYI1	302	D	G
Q9UKY0	LB/B	-	A2BDJ3	26	T	P
Q9UKY0	LB/B	-	A2BDJ3	56	P	L
Q9UKY0	LB/B	-	A2BDJ3	174	T	M
Q9UKY0	LB/B	-	A2BDJ3	6	S	I
Q9UKY0	LB/B	-	A2BDJ3	22	S	P
Q9UKY0	LB/B	-	A2BDJ3	31	H	R
Q9UKY0	LB/B	-	A2BDJ3	70	F	L
Q9UKY0	LB/B	-	A2BDJ3	149	L	S
P22891	LB/B	-	G1K1X9	70	E	K
P22891	LB/B	-	G1K1X9	295	R	H
Q8WWY3	LP/P	Retinitis pigmentosa 11 (RP11) [MIM:600138]	G1R345	194	A	E
Q8WWY3	LP/P	Retinitis pigmentosa 11 (RP11) [MIM:600138]	G1R345	216	A	P
Q5THK1	LB/B	-	G5BBV4	455	N	S
Q5THK1	LB/B	-	G5BBV4	740	L	P
Q5THK1	LB/B	-	G5BBV4	876	M	I
Q5THK1	LB/B	-	G5BBV4	961	T	I
Q5THK1	LB/B	-	G5BBV4	963	D	N
Q5THK1	LB/B	-	G5BBV4	1151	S	P
Q5THK1	LB/B	-	G5BBV4	1221	S	L
Q5THK1	LB/B	-	G5BBV4	1395	L	F
Q5THK1	LB/B	-	G5BBV4	1784	V	I
Q5THK1	LB/B	-	G5BBV4	1316	E	K
Q8IV56	LB/B	-	K9IWG2	115	P	S
Q8N4B5	LB/B	-	A0A2D0QR52	136	C	S
Q8IZ63	LB/B	-	A0A2Y9M1F3	118	P	L
P0C7W0	LB/B	-	A0A2K6LMM9	24	T	S
P79522	LB/B	-	A0A2Y9MXI1	61	G	S
Q6MZQ0	LB/B	-	L8YFG6	41	A	T
Q6MZQ0	LB/B	-	L8YFG6	330	P	S
P48634	LB/B	-	S9XAI7	57	P	R
P48634	LB/B	-	S9XAI7	106	P	L
P48634	LB/B	-	S9XAI7	544	T	K
P48634	LB/B	-	S9XAI7	694	Q	K
P48634	LB/B	-	S9XAI7	742	D	E
P48634	LB/B	-	S9XAI7	1285	G	A
P48634	LB/B	-	S9XAI7	1415	G	A
P48634	LB/B	-	S9XAI7	1503	L	P
P48634	LB/B	-	S9XAI7	1740	R	H
P48634	LB/B	-	S9XAI7	1744	G	A
P48634	LB/B	-	S9XAI7	1775	V	M
P48634	LB/B	-	S9XAI7	1895	L	V
P48634	LB/B	-	S9XAI7	2006	P	S
P48634	LB/B	-	S9XAI7	2130	P	L
P48634	LB/B	-	S9XAI7	82	D	V
P48634	LB/B	-	S9XAI7	477	R	C
P48634	LB/B	-	S9XAI7	804	R	C
P48634	LB/B	-	S9XAI7	1407	S	N
P48634	LB/B	-	S9XAI7	1544	G	D
P48634	LB/B	-	S9XAI7	1563	R	Q
P48634	LB/B	-	S9XAI7	1774	V	M
P48634	LB/B	-	S9XAI7	2075	R	W
A1L453	LB/B	-	A0A1S3F313	204	M	V
Q6PEW0	LB/B	-	A0A2I2V345	182	S	G
Q6PEW0	LB/B	-	A0A2I2V345	240	V	I
Q6PEW0	LB/B	-	A0A2I2V345	295	T	A
P24158	LB/B	-	A0A2Y9MHG9	119	V	I
P24158	LB/B	-	A0A2Y9MHG9	135	A	T
P24158	LB/B	-	A0A2Y9MHG9	136	T	S
Q7RTV5	LB/B	-	A0A2I3LG26	83	R	K
Q9Y617	LP/P	Phosphoserine aminotransferase deficiency (PSATD) [MIM:610992]	G1STQ6	100	D	A
Q9Y617	LB/B	-	G1STQ6	87	P	A
Q9Y617	LP/P	Neu-Laxova syndrome 2 (NLS2) [MIM:616038]	G1STQ6	99	A	V
Q9Y617	LP/P	Neu-Laxova syndrome 2 (NLS2) [MIM:616038]	G1STQ6	179	S	L
P20618	LB/B	-	A0A2K3QBC8	11	P	A
P20618	LB/B	-	A0A2K3QBC8	208	I	N
P28072	LB/B	-	A0A2K5EB10	107	P	A
Q99436	LB/B	-	A0A091CPD1	39	V	A
Q9UL46	LB/B	-	F6ZH95	89	H	P
O43586	LB/B	-	A0A151MA49	48	Q	H
O43586	LB/B	-	A0A151MA49	106	E	K
O43586	LB/B	-	A0A151MA49	146	Q	H
O43586	LB/B	-	A0A151MA49	149	R	L
O43586	LB/B	-	A0A151MA49	151	A	S
O43586	LB/B	-	A0A151MA49	155	E	D
O43586	LB/B	-	A0A151MA49	156	Q	H
O43586	LP/P	PAPA syndrome (PAPAS) [MIM:604416]	A0A151MA49	230	A	T
O43586	LP/P	PAPA syndrome (PAPAS) [MIM:604416]	A0A151MA49	250	E	Q
O43586	LP/P	PAPA syndrome (PAPAS) [MIM:604416]	A0A151MA49	250	E	K
Q96BW5	LB/B	-	A0A2A5D829	97	E	G
Q13258	LB/B	-	A0A091E3U0	7	R	C
Q13258	LB/B	-	A0A091E3U0	301	E	A
Q13258	LB/B	-	A0A091E3U0	198	G	E
Q13258	LB/B	-	A0A091E3U0	332	R	Q
P43115	LB/B	-	Q5CZ60	169	M	L
P43115	LB/B	-	Q5CZ60	375	P	L
P43115	LB/B	-	Q5CZ60	366	N	S
P43115	LB/B	-	Q5CZ60	319	T	M
P18031	LB/B	-	S7MTH0	381	G	S
P18031	LB/B	-	S7MTH0	387	P	L
P08575	LB/B	-	F7IKE3	1285	S	R
P08575	LB/B	-	F7IKE3	193	T	A
P08575	LB/B	-	F7IKE3	296	I	L
P08575	LB/B	-	F7IKE3	423	T	I
P08575	LB/B	-	F7IKE3	570	H	Q
P23470	LB/B	-	A0A1S3KNZ0	574	G	S
P23470	LB/B	-	A0A1S3KNZ0	639	Q	R
P23470	LB/B	-	A0A1S3KNZ0	92	Y	H
Q92932	LB/B	-	J9P848	325	S	N
Q92932	LB/B	-	J9P848	343	V	M
Q92932	LB/B	-	J9P848	140	S	T
Q92932	LB/B	-	J9P848	213	R	H
Q92932	LB/B	-	J9P848	208	S	P
Q92932	LB/B	-	J9P848	388	L	H
Q9H0K6	LB/B	-	H2R7C1	92	I	M
Q9H0K6	LB/B	-	H2R7C1	264	K	E
Q9H0K6	LB/B	-	H2R7C1	343	I	V
Q6NUJ5	LB/B	-	V8P6D5	89	R	C
Q6NUJ5	LB/B	-	V8P6D5	98	R	G
Q5TGL8	LB/B	-	H2PHS7	184	Q	H
Q5TGL8	LB/B	-	H2PHS7	189	P	Q
Q92626	LB/B	-	A0A1I8QDU7	1261	Q	R
Q92626	LB/B	-	A0A1I8QDU7	1198	R	Q
Q92626	LP/P	Anterior segment dysgenesis 7 (ASGD7) [MIM:269400]	A0A1I8QDU7	880	R	C
Q9Y6I8	LB/B	-	A0A093F8V2	204	V	I
Q96C36	LP/P	Leukodystrophy, hypomyelinating, 10 (HLD10) [MIM:616420]	G1NUJ1	119	R	C
Q96C36	LP/P	Leukodystrophy, hypomyelinating, 10 (HLD10) [MIM:616420]	G1NUJ1	251	R	C
Q56P42	LB/B	-	H2PCJ7	81	Q	R
P06737	LB/B	-	A0A2J7QIH8	222	V	I
P06737	LP/P	Glycogen storage disease 6 (GSD6) [MIM:232700]	A0A2J7QIH8	339	N	S
P06737	LP/P	Glycogen storage disease 6 (GSD6) [MIM:232700]	A0A2J7QIH8	377	N	K
P06737	LB/B	-	A0A2J7QIH8	231	V	E
P06737	LB/B	-	A0A2J7QIH8	715	R	S
P06737	LB/B	-	A0A2J7QIH8	425	R	P
P06737	LB/B	-	A0A2J7QIH8	698	V	G
P06737	LB/B	-	A0A2J7QIH8	806	I	L
P06737	LB/B	-	A0A2J7QIH8	845	N	S
Q9Y3Y4	LB/B	-	H3AN77	299	P	H
Q8WU10	LP/P	Myopathy, myofibrillar, 8 (MFM8) [MIM:617258]	F1NPI8	155	N	S
Q8WU10	LP/P	Myopathy, myofibrillar, 8 (MFM8) [MIM:617258]	F1NPI8	372	Q	H
Q8N2H3	LB/B	-	S9WY02	428	P	S
Q8N2H3	LB/B	-	S9WY02	461	M	T
Q8N2H3	LB/B	-	S9WY02	533	A	T
Q6WKZ4	LB/B	-	A0A2Y9J9L6	1185	M	T
Q6WKZ4	LB/B	-	A0A2Y9J9L6	768	A	V
Q6WKZ4	LB/B	-	A0A2Y9J9L6	651	A	V
Q6WKZ4	LB/B	-	A0A2Y9J9L6	622	Q	K
O95755	LB/B	-	G1NSZ6	308	N	D
O95755	LB/B	-	G1NSZ6	50	P	L
O95755	LB/B	-	G1NSZ6	320	E	K
Q96AX2	LB/B	-	A0A218UV30	188	A	P
Q15042	LB/B	-	H2SMU1	598	N	S
Q15042	LP/P	Warburg micro syndrome 1 (WARBM1) [MIM:600118]	H2SMU1	18	T	P
Q15042	LP/P	Warburg micro syndrome 1 (WARBM1) [MIM:600118]	H2SMU1	24	E	V
Q9H0N0	LB/B	-	A0A2I3HLC1	159	A	T
P51149	LP/P	Charcot-Marie-Tooth disease, axonal, 2B (CMT2B) [MIM:600882]	A0A147A934	129	L	F
P51149	LP/P	Charcot-Marie-Tooth disease, axonal, 2B (CMT2B) [MIM:600882]	A0A147A934	162	V	M
P51149	LB/B	-	A0A147A934	32	K	E
P51149	LP/P	Charcot-Marie-Tooth disease, axonal, 2B (CMT2B) [MIM:600882]	A0A147A934	157	K	N
P51149	LP/P	Charcot-Marie-Tooth disease, axonal, 2B (CMT2B) [MIM:600882]	A0A147A934	161	N	T
Q7Z6M1	LB/B	-	A0A2U4CH63	60	R	G
Q7Z6M1	LB/B	-	A0A2U4CH63	67	T	P
Q7Z6M1	LB/B	-	A0A2U4CH63	73	H	Y
Q7Z6M1	LB/B	-	A0A2U4CH63	313	D	G
Q7Z6M1	LB/B	-	A0A2U4CH63	333	M	I
Q7Z6M1	LB/B	-	A0A2U4CH63	58	P	A
Q7Z6M1	LB/B	-	A0A2U4CH63	95	S	C
O75943	LB/B	-	U3KEI7	32	V	I
O75943	LB/B	-	U3KEI7	487	R	L
O75943	LB/B	-	U3KEI7	535	K	E
O75943	LB/B	-	U3KEI7	557	L	R
Q9H4I0	LB/B	-	A0A2K5NJA9	90	C	R
Q9H4I0	LB/B	-	A0A2K5NJA9	152	I	L
Q9H4I0	LB/B	-	A0A2K5NJA9	423	H	P
P54725	LB/B	-	M4AI54	131	T	A
P54725	LB/B	-	M4AI54	200	T	M
P54725	LB/B	-	M4AI54	179	R	Q
Q96B01	LB/B	-	Q66IT7	68	K	Q
Q09MP3	LB/B	-	A0A1S3EYM1	876	V	L
Q09MP3	LB/B	-	A0A1S3EYM1	976	R	H
Q09MP3	LB/B	-	A0A1S3EYM1	1037	G	D
P43351	LB/B	-	E2R591	70	R	W
P43351	LB/B	-	E2R591	221	Q	E
P43351	LB/B	-	E2R591	287	S	N
Q92698	LB/B	-	A0A147AJD3	151	K	E
Q92698	LB/B	-	A0A147AJD3	21	D	G
Q92698	LB/B	-	A0A147AJD3	74	I	M
Q92698	LB/B	-	A0A147AJD3	202	R	C
Q92698	LB/B	-	A0A147AJD3	380	R	Q
Q92698	LB/B	-	A0A147AJD3	534	R	C
Q92698	LB/B	-	A0A147AJD3	583	I	T
Q9Y5P3	LB/B	-	I3J519	252	M	V
Q9Y5P3	LB/B	-	I3J519	342	A	P
Q9UKM9	LB/B	-	A0A287CYG4	215	Q	R
Q9UKM9	LB/B	-	A0A287CYG4	251	G	S
Q9UKM9	LB/B	-	A0A287CYG4	139	V	M
P43487	LB/B	-	A0A2I2U3H0	145	A	V
P13631	LB/B	-	S9X676	427	S	L
Q5T160	LB/B	-	A0A2U4AV42	291	K	R
Q5T160	LB/B	-	A0A2U4AV42	331	I	V
Q5T160	LB/B	-	A0A2U4AV42	367	D	G
O14827	LB/B	-	G1NI47	713	L	W
Q5U651	LB/B	-	A0A2K5DUQ8	601	R	C
Q86WH2	LB/B	-	V9KVW6	232	R	H
Q8NC74	LB/B	-	A2ABX0	348	D	N
Q8NC74	LB/B	-	A2ABX0	408	A	T
Q8NC74	LB/B	-	A2ABX0	607	E	K
Q8NC74	LB/B	-	A2ABX0	637	L	R
Q9Y4C8	LB/B	-	A0A2Y9FXR6	609	H	R
Q9Y4C8	LB/B	-	A0A2Y9FXR6	623	I	T
Q9Y4C8	LB/B	-	A0A2Y9FXR6	665	T	A
Q9Y4C8	LB/B	-	A0A2Y9FXR6	921	R	Q
Q9Y4C8	LB/B	-	A0A2Y9FXR6	821	R	G
Q9Y4C8	LB/B	-	A0A2Y9FXR6	602	Q	E
Q86U06	LB/B	-	A0A151N2N4	184	D	N
Q86U06	LB/B	-	A0A151N2N4	428	F	L
Q9NW13	LB/B	-	G1SIU5	253	E	Q
Q9NW13	LP/P	Alopecia, neurologic defects, and endocrinopathy syndrome (ANES) [MIM:612079]	G1SIU5	351	L	P
P10745	LB/B	-	S4RFI3	884	V	M
P10745	LB/B	-	S4RFI3	18	G	V
P10745	LB/B	-	S4RFI3	122	R	H
P10745	LB/B	-	S4RFI3	155	V	M
P10745	LB/B	-	S4RFI3	163	S	P
P10745	LB/B	-	S4RFI3	196	V	M
P10745	LB/B	-	S4RFI3	267	R	Q
P10745	LB/B	-	S4RFI3	282	V	M
P10745	LB/B	-	S4RFI3	321	T	I
P10745	LB/B	-	S4RFI3	325	A	T
P10745	LB/B	-	S4RFI3	346	R	H
P10745	LB/B	-	S4RFI3	379	A	T
P10745	LB/B	-	S4RFI3	433	S	L
P10745	LB/B	-	S4RFI3	443	R	S
P10745	LB/B	-	S4RFI3	505	H	L
P10745	LB/B	-	S4RFI3	518	Q	R
P10745	LB/B	-	S4RFI3	523	H	Q
P10745	LB/B	-	S4RFI3	535	R	C
P10745	LB/B	-	S4RFI3	544	R	H
P10745	LB/B	-	S4RFI3	593	V	A
P10745	LB/B	-	S4RFI3	599	I	V
P10745	LB/B	-	S4RFI3	614	D	N
P10745	LB/B	-	S4RFI3	615	A	V
P10745	LB/B	-	S4RFI3	675	T	I
P10745	LB/B	-	S4RFI3	688	A	V
P10745	LB/B	-	S4RFI3	693	V	M
P10745	LB/B	-	S4RFI3	723	P	L
P10745	LB/B	-	S4RFI3	741	G	S
P10745	LB/B	-	S4RFI3	747	R	C
P10745	LB/B	-	S4RFI3	785	N	K
P10745	LB/B	-	S4RFI3	833	R	C
P10745	LB/B	-	S4RFI3	835	G	S
P10745	LB/B	-	S4RFI3	903	T	R
P10745	LB/B	-	S4RFI3	921	S	R
P10745	LB/B	-	S4RFI3	956	E	K
P10745	LB/B	-	S4RFI3	963	T	I
P10745	LB/B	-	S4RFI3	1021	S	Y
P10745	LB/B	-	S4RFI3	1059	V	I
P10745	LP/P	Retinitis pigmentosa 66 (RP66) [MIM:615233]	S4RFI3	1080	D	N
P10745	LB/B	-	S4RFI3	1194	T	M
Q96I51	LB/B	-	S4RLW5	30	G	R
Q15293	LB/B	-	H0V1C6	73	D	Y
Q96D15	LB/B	-	H0V1C6	250	R	W
Q8NG50	LB/B	-	A0A1U7RDC6	32	H	R
Q8NG50	LB/B	-	A0A1U7RDC6	127	C	W
P46063	LB/B	-	S7N182	487	K	T
P46063	LB/B	-	S7N182	495	D	H
P46063	LB/B	-	S7N182	102	V	I
P46063	LB/B	-	S7N182	372	V	I
P00797	LB/B	-	U3JCG2	33	R	W
P00797	LB/B	-	U3JCG2	217	G	R
P00797	LB/B	-	U3JCG2	160	Q	K
P00797	LP/P	Renal tubular dysgenesis (RTD) [MIM:267430]	U3JCG2	230	R	K
P00797	LP/P	Renal tubular dysgenesis (RTD) [MIM:267430]	U3JCG2	104	D	N
P00797	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 4 (ADTKD4) [MIM:613092]	U3JCG2	16	L	R
Q13127	LB/B	-	H2PDC1	626	V	I
Q13127	LB/B	-	H2PDC1	692	E	D
Q13127	LB/B	-	H2PDC1	762	K	Q
Q13127	LB/B	-	H2PDC1	797	P	L
Q13127	LP/P	Wilms tumor 6 (WT6) [MIM:616806]	H2PDC1	160	R	P
Q13127	LP/P	Wilms tumor 6 (WT6) [MIM:616806]	H2PDC1	290	N	Y
Q13127	LP/P	Wilms tumor 6 (WT6) [MIM:616806]	H2PDC1	322	H	R
Q13127	LP/P	Wilms tumor 6 (WT6) [MIM:616806]	H2PDC1	412	H	Q
P35250	LB/B	-	A0A2K5PEV2	232	A	V
Q14699	LB/B	-	B4E2S3	248	E	K
Q14699	LB/B	-	B4E2S3	421	V	I
Q2KHR2	LB/B	-	A0A1L8H0H2	434	G	V
Q2KHR2	LB/B	-	A0A1L8H0H2	677	V	L
Q2KHR2	LB/B	-	A0A1L8H0H2	1256	L	P
Q8IZJ4	LB/B	-	A0A2K5TY74	24	Q	R
Q8IZJ4	LB/B	-	A0A2K5TY74	241	H	Y
Q8IZJ4	LB/B	-	A0A2K5TY74	342	M	R
Q8IZJ4	LB/B	-	A0A2K5TY74	378	V	A
Q8IZJ4	LB/B	-	A0A2K5TY74	37	R	C
Q8IZJ4	LB/B	-	A0A2K5TY74	216	T	M
Q8IZJ4	LB/B	-	A0A2K5TY74	297	E	K
Q8IZJ4	LB/B	-	A0A2K5TY74	358	D	V
O94810	LB/B	-	G1PG62	427	M	T
O94810	LB/B	-	G1PG62	351	V	M
P49796	LB/B	-	A0A147AWS9	129	R	K
P49796	LB/B	-	A0A147AWS9	809	R	Q
P49802	LB/B	-	A0A1W4XTC6	137	M	L
P49802	LB/B	-	A0A1W4XTC6	409	Q	H
Q6NTF9	LB/B	-	A0A2K6F827	85	R	H
P58872	LB/B	-	A0A2K6LT53	255	V	M
P18577	LB/B	-	A0A2J8SIU8	16	W	C
P18577	LB/B	-	A0A2J8SIU8	36	A	T
P18577	LB/B	-	A0A2J8SIU8	41	Q	R
P18577	LB/B	-	A0A2J8SIU8	60	L	I
P18577	LB/B	-	A0A2J8SIU8	68	N	S
P18577	LB/B	-	A0A2J8SIU8	103	P	S
P18577	LB/B	-	A0A2J8SIU8	226	P	A
P18577	LB/B	-	A0A2J8SIU8	245	L	V
P18577	LB/B	-	A0A2J8SIU8	154	R	T
P18577	LB/B	-	A0A2J8SIU8	233	Q	E
P18577	LB/B	-	A0A2J8SIU8	238	M	V
P18577	LB/B	-	A0A2J8SIU8	127	A	V
P18577	LB/B	-	A0A2J8SIU8	128	G	D
P18577	LB/B	-	A0A2J8SIU8	182	T	S
P18577	LB/B	-	A0A2J8SIU8	198	N	K
P18577	LB/B	-	A0A2J8SIU8	323	H	P
P18577	LB/B	-	A0A2J8SIU8	325	I	S
P18577	LB/B	-	A0A2J8SIU8	329	H	D
P18577	LB/B	-	A0A2J8SIU8	329	H	R
P18577	LB/B	-	A0A2J8SIU8	330	S	Y
P18577	LB/B	-	A0A2J8SIU8	331	I	N
P18577	LB/B	-	A0A2J8SIU8	263	R	G
P18577	LB/B	-	A0A2J8SIU8	267	M	K
P18577	LB/B	-	A0A2J8SIU8	398	V	E
Q02161	LB/B	-	A0A2J8SIU8	110	L	P
Q02161	LB/B	-	A0A2J8SIU8	218	M	I
Q02161	LB/B	-	A0A2J8SIU8	223	F	V
Q02161	LB/B	-	A0A2J8SIU8	233	E	Q
Q02161	LB/B	-	A0A2J8SIU8	238	V	M
Q02161	LB/B	-	A0A2J8SIU8	245	V	L
Q02161	LB/B	-	A0A2J8SIU8	16	W	C
Q02161	LB/B	-	A0A2J8SIU8	193	E	K
Q02161	LB/B	-	A0A2J8SIU8	201	T	R
Q02161	LB/B	-	A0A2J8SIU8	263	G	R
Q02161	LB/B	-	A0A2J8SIU8	306	V	I
Q02161	LB/B	-	A0A2J8SIU8	311	Y	C
Q4ADV7	LP/P	CATIFA syndrome (CATIFA) [MIM:618761]	A0A1S3JAU3	1265	R	P
Q8WYP3	LB/B	-	I3JQY7	197	S	T
Q8WYP3	LB/B	-	I3JQY7	643	A	T
Q8TB24	LB/B	-	G1KIJ2	111	E	K
Q8TB24	LB/B	-	G1KIJ2	215	H	P
Q8TB24	LB/B	-	G1KIJ2	425	T	M
Q8TB24	LB/B	-	G1KIJ2	613	G	A
Q8TB24	LB/B	-	G1KIJ2	425	T	I
Q8TB24	LB/B	-	G1KIJ2	215	H	L
Q8TB24	LB/B	-	G1KIJ2	215	H	R
Q06587	LB/B	-	V9L088	95	R	Q
Q6NUQ1	LB/B	-	L9KWQ5	668	F	S
Q6NUQ1	LB/B	-	L9KWQ5	759	P	L
Q6NUQ1	LB/B	-	L9KWQ5	40	S	C
Q6NUQ1	LP/P	Infantile liver failure syndrome 3 (ILFS3) [MIM:618641]	L9KWQ5	368	A	T
Q6NUQ1	LP/P	Infantile liver failure syndrome 3 (ILFS3) [MIM:618641]	L9KWQ5	370	L	P
Q9BRS2	LB/B	-	C3ZLT4	375	V	I
Q9BVS4	LB/B	-	A0A2I0UDW6	144	H	Y
Q9BVS4	LB/B	-	A0A2I0UDW6	349	G	R
Q9BVS4	LB/B	-	A0A2I0UDW6	397	N	S
Q9BVS4	LB/B	-	A0A2I0UDW6	96	S	C
Q9BVS4	LB/B	-	A0A2I0UDW6	144	H	R
Q9BVS4	LB/B	-	A0A2I0UDW6	155	R	H
Q9BVS4	LB/B	-	A0A2I0UDW6	175	V	I
Q9BVS4	LB/B	-	A0A2I0UDW6	244	M	V
Q9BVS4	LB/B	-	A0A2I0UDW6	409	E	D
Q9BVS4	LB/B	-	A0A2I0UDW6	507	R	H
Q13546	LB/B	-	A0A091SEV0	234	E	K
Q13546	LB/B	-	A0A091SEV0	404	A	S
Q13546	LB/B	-	A0A091SEV0	443	A	V
Q13546	LB/B	-	A0A091SEV0	569	A	V
Q13546	LB/B	-	A0A091SEV0	438	A	V
Q13546	LP/P	Autoinflammation with episodic fever and lymphadenopathy (AIEFL) [MIM:618852]	A0A091SEV0	324	D	H
Q13546	LP/P	Autoinflammation with episodic fever and lymphadenopathy (AIEFL) [MIM:618852]	A0A091SEV0	324	D	N
Q13546	LP/P	Autoinflammation with episodic fever and lymphadenopathy (AIEFL) [MIM:618852]	A0A091SEV0	324	D	Y
Q13546	LP/P	Autoinflammation with episodic fever and lymphadenopathy (AIEFL) [MIM:618852]	A0A091SEV0	324	D	V
Q96K30	LB/B	-	Q9D1H0	220	T	K
Q96K30	LB/B	-	Q9D1H0	113	S	W
P04808	LB/B	-	B1AAP4	28	K	M
P04090	LB/B	-	B1AAP4	28	M	K
P04090	LB/B	-	B1AAP4	12	V	F
Q9NWS8	LB/B	-	A0A2Y9QS42	132	T	M
Q9NWS8	LB/B	-	A0A2Y9QS42	42	S	I
Q9NWS8	LB/B	-	A0A2Y9QS42	47	R	H
Q9NWS8	LP/P	Combined oxidative phosphorylation deficiency 11 (COXPD11) [MIM:614922]	A0A2Y9QS42	417	R	Q
P60153	LB/B	-	A0A091E3H2	204	S	P
P60153	LB/B	-	A0A091E3H2	148	F	S
Q05823	LB/B	-	A0A0P6IYU6	462	R	Q
Q05823	LB/B	-	A0A0P6IYU6	541	D	E
Q05823	LB/B	-	A0A0P6IYU6	59	G	S
Q05823	LB/B	-	A0A0P6IYU6	406	S	F
Q05823	LB/B	-	A0A0P6IYU6	97	I	L
Q05823	LB/B	-	A0A0P6IYU6	289	A	T
Q05823	LB/B	-	A0A0P6IYU6	592	R	H
Q9BV68	LB/B	-	A0A2D0TAJ4	68	V	M
Q8N7C7	LB/B	-	A0A1U7SMM7	221	F	L
Q96PX1	LB/B	-	L5KM10	80	P	H
Q96PX1	LB/B	-	L5KM10	208	G	R
Q96PX1	LB/B	-	L5KM10	596	E	V
Q99496	LP/P	Luo-Schoch-Yamamoto syndrome (LUSYAM) [MIM:619460]	V9L088	70	R	H
Q495C1	LB/B	-	F7GUW4	263	V	I
O75150	LB/B	-	A0A2I0TYU2	463	R	H
O75150	LB/B	-	A0A2I0TYU2	615	R	Q
O76064	LB/B	-	A0A250YIX0	162	A	T
O76064	LB/B	-	A0A250YIX0	473	I	V
Q5VYX0	LB/B	-	A0A0S7KJD0	37	E	D
Q96MS0	LP/P	Gaze palsy, familial horizontal, with progressive scoliosis, 1 (HGPPS1) [MIM:607313]	A0A286ZKM4	319	E	K
Q96MS0	LP/P	Gaze palsy, familial horizontal, with progressive scoliosis, 1 (HGPPS1) [MIM:607313]	A0A286ZKM4	703	R	P
Q96MS0	LP/P	Gaze palsy, familial horizontal, with progressive scoliosis, 1 (HGPPS1) [MIM:607313]	A0A286ZKM4	705	S	P
Q96MS0	LP/P	Gaze palsy, familial horizontal, with progressive scoliosis, 1 (HGPPS1) [MIM:607313]	A0A286ZKM4	5	L	P
Q96MS0	LP/P	Gaze palsy, familial horizontal, with progressive scoliosis, 1 (HGPPS1) [MIM:607313]	A0A286ZKM4	66	I	L
Q96MS0	LP/P	Gaze palsy, familial horizontal, with progressive scoliosis, 1 (HGPPS1) [MIM:607313]	A0A286ZKM4	361	G	E
Q96MS0	LB/B	-	A0A286ZKM4	423	V	M
Q96MS0	LB/B	-	A0A286ZKM4	1369	Q	R
Q96MS0	LB/B	-	A0A286ZKM4	416	R	H
Q96MS0	LB/B	-	A0A286ZKM4	868	P	L
Q01973	LB/B	-	S9X7Z6	518	T	M
Q01973	LB/B	-	S9X7Z6	624	G	R
Q01973	LB/B	-	S9X7Z6	646	Y	C
Q01973	LP/P	Deafness, autosomal recessive, 108 (DFNB108) [MIM:617654]	S9X7Z6	736	R	T
P35398	LP/P	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia (IDDECA) [MIM:618060]	H2MJ30	92	G	A
P35398	LP/P	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia (IDDECA) [MIM:618060]	H2MJ30	94	K	R
P35398	LP/P	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia (IDDECA) [MIM:618060]	H2MJ30	409	S	R
P35398	LP/P	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia (IDDECA) [MIM:618060]	H2MJ30	462	R	Q
P35398	LB/B	-	H2MJ30	476	T	A
Q92753	LP/P	Epilepsy, idiopathic generalized 15 (EIG15) [MIM:618357]	H2MJ30	84	L	P
P51449	LP/P	Immunodeficiency 42 (IMD42) [MIM:616622]	H2N5U0	38	S	L
Q86UA6	LB/B	-	A0A2U3VTI7	103	N	K
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	22	L	P
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	40	G	S
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	44	R	Q
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	68	H	Y
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	91	R	W
Q16518	LP/P	Retinitis pigmentosa 20 (RP20) [MIM:613794]	M7B3D5	91	R	W
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	91	R	Q
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	144	Y	D
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	182	H	Y
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	287	V	F
Q16518	LB/B	-	M7B3D5	321	N	K
Q16518	LP/P	Retinitis pigmentosa 20 (RP20) [MIM:613794]	M7B3D5	341	L	S
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	363	P	T
Q16518	LP/P	Retinitis pigmentosa 20 (RP20) [MIM:613794]	M7B3D5	368	Y	H
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	393	A	G
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	417	E	Q
Q16518	LP/P	Retinitis pigmentosa 20 (RP20) [MIM:613794]	M7B3D5	452	V	G
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	431	Y	C
Q16518	LB/B	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	434	A	V
Q16518	LP/P	Retinitis pigmentosa 20 (RP20) [MIM:613794]	M7B3D5	515	R	W
Q16518	LP/P	Retinitis pigmentosa 20 (RP20) [MIM:613794]	M7B3D5	79	Y	H
Q16518	LP/P	Retinitis pigmentosa 20 (RP20) [MIM:613794]	M7B3D5	95	E	Q
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	102	E	K
Q16518	LP/P	Retinitis pigmentosa 20 (RP20) [MIM:613794]	M7B3D5	102	E	K
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	148	E	D
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	167	D	Y
Q16518	LP/P	Retinitis pigmentosa 20 (RP20) [MIM:613794]	M7B3D5	167	D	Y
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	182	H	N
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	239	Y	D
Q16518	LP/P	Retinitis pigmentosa 20 (RP20) [MIM:613794]	M7B3D5	239	Y	D
Q16518	LB/B	Retinitis pigmentosa 20 (RP20) [MIM:613794]	M7B3D5	294	K	T
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	330	C	Y
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	393	A	E
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	435	Y	C
Q16518	LP/P	Retinitis pigmentosa 20 (RP20) [MIM:613794]	M7B3D5	436	G	V
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	470	P	L
Q16518	LP/P	Retinitis pigmentosa 20 (RP20) [MIM:613794]	M7B3D5	473	V	D
Q16518	LP/P	Retinitis pigmentosa 20 (RP20) [MIM:613794]	M7B3D5	528	G	V
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	70	F	V
Q16518	LP/P	Retinitis pigmentosa 20 (RP20) [MIM:613794]	M7B3D5	70	F	V
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	91	R	P
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	313	H	R
Q16518	LP/P	Retinitis pigmentosa 20 (RP20) [MIM:613794]	M7B3D5	60	L	P
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	40	G	D
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	101	T	I
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	318	Y	N
Q16518	LP/P	Leber congenital amaurosis 2 (LCA2) [MIM:204100]	M7B3D5	408	L	P
Q96L21	LP/P	Spermatogenic failure 63 (SPGF63) [MIM:619689]	A0A0P6IZG8	86	H	P
Q6P5R6	LB/B	-	F6YV34	97	V	F
P62753	LB/B	-	E9E714	221	K	R
P08865	LB/B	-	S7P8J3	117	R	W
P08865	LP/P	Asplenia, isolated congenital (ICAS) [MIM:271400]	S7P8J3	54	T	N
P08865	LP/P	Asplenia, isolated congenital (ICAS) [MIM:271400]	S7P8J3	58	L	F
P08865	LP/P	Asplenia, isolated congenital (ICAS) [MIM:271400]	S7P8J3	180	R	G
P08865	LP/P	Asplenia, isolated congenital (ICAS) [MIM:271400]	S7P8J3	180	R	W
P08865	LB/B	-	S7P8J3	185	M	V
P08865	LP/P	Asplenia, isolated congenital (ICAS) [MIM:271400]	S7P8J3	186	R	C
P08865	LB/B	-	S7P8J3	257	V	G
P08865	LB/B	-	S7P8J3	278	A	T
P55042	LB/B	-	M7BG25	66	Q	P
Q9P2E9	LB/B	-	A0A287D684	1324	R	L
Q5TD94	LB/B	-	M3X9Z3	149	T	S
Q5TD94	LB/B	-	M3X9Z3	556	R	H
Q5TD94	LB/B	-	M3X9Z3	589	L	P
Q5TD94	LB/B	-	M3X9Z3	627	N	H
Q5TD94	LB/B	-	M3X9Z3	700	A	V
Q5TD94	LP/P	Ciliary dyskinesia, primary, 11 (CILD11) [MIM:612649]	M3X9Z3	87	P	S
Q9H1X1	LB/B	-	Q5TYW6	261	V	I
Q7L4I2	LB/B	-	A0A2K6T3S9	88	H	R
Q8N8U3	LB/B	-	D3ZH95	117	P	S
Q5HYW3	LB/B	-	A0A2Y9FY30	420	S	R
Q16799	LB/B	-	A0A1A7WFG3	247	G	E
Q16799	LB/B	-	A0A1A7WFG3	357	I	V
Q9NQC3	LB/B	-	A0A2K5IJL2	357	D	V
Q9NQC3	LB/B	-	A0A2K5IJL2	899	E	Q
Q9NQC3	LB/B	-	A0A2K5IJL2	920	S	C
Q66K80	LB/B	-	A0A1U7TNZ6	231	R	S
Q6NW29	LB/B	-	G1U5C1	124	I	L
P19793	LB/B	-	A0A2K5M5N8	261	P	L
P19793	LB/B	-	A0A2K5M5N8	336	S	I
P19793	LB/B	-	A0A2K5M5N8	327	A	S
P19793	LB/B	-	A0A2K5M5N8	398	A	V
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	35	C	R
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	163	R	C
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	163	R	C
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	341	G	R
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	403	I	M
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	403	I	M
P21817	LB/B	-	M3Z273	471	R	C
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	522	Y	S
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	522	Y	S
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	552	R	W
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	614	R	C
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	614	R	C
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	614	R	L
P21817	LB/B	-	M3Z273	1787	P	L
P21817	LB/B	-	M3Z273	2060	G	C
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2163	R	C
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	2163	R	H
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2163	R	H
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	2168	V	M
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2168	V	M
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2206	T	M
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2434	G	R
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	2435	R	H
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2435	R	H
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	533	R	H
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2163	R	P
P21817	LP/P	King-Denborough syndrome (KDS) [MIM:619542]	M3Z273	2206	T	R
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2206	T	R
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2435	R	L
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2454	R	C
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2454	R	H
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2458	R	C
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2458	R	H
P21817	LP/P	Multiminicore disease with external ophthalmoplegia (MMDO) [MIM:255320]	M3Z273	109	R	W
P21817	LB/B	-	M3Z273	485	M	V
P21817	LB/B	-	M3Z273	1109	R	K
P21817	LB/B	-	M3Z273	1342	S	G
P21817	LB/B	-	M3Z273	1489	S	N
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	2423	M	K
P21817	LP/P	Multiminicore disease with external ophthalmoplegia (MMDO) [MIM:255320]	M3Z273	2423	M	K
P21817	LB/B	-	M3Z273	3756	Q	E
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	13	L	V
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	44	R	C
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	44	R	C
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	160	E	G
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	163	R	L
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	165	G	R
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	166	D	N
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	177	R	C
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	178	Y	C
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	215	G	E
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	227	D	V
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	328	R	W
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	401	R	C
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	401	R	H
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	401	R	S
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	533	R	C
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	1704	G	S
P21817	LB/B	-	M3Z273	1832	G	A
P21817	LB/B	-	M3Z273	2101	M	K
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2117	V	L
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2129	D	E
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2214	V	I
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2280	V	I
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2342	N	S
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2346	V	M
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2348	E	G
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2350	A	T
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2355	R	C
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2367	A	T
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	2421	A	P
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2428	A	T
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2431	D	N
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2437	A	V
P21817	LP/P	King-Denborough syndrome (KDS) [MIM:619542]	M3Z273	2452	R	W
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2452	R	W
P21817	LB/B	-	M3Z273	2676	R	W
P21817	LB/B	-	M3Z273	2787	T	S
P21817	LB/B	-	M3Z273	3118	A	V
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	3527	P	S
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	3539	R	H
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	3772	R	Q
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	3916	I	M
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	4136	R	S
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	4234	V	L
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4558	R	Q
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4637	T	A
P21817	LB/B	-	M3Z273	4637	T	I
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4638	G	D
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4650	L	P
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4651	H	P
P21817	LB/B	-	M3Z273	4668	P	S
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	4684	F	S
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4724	K	Q
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	4737	R	Q
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4793	L	P
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4796	Y	C
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4814	L	F
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	4824	L	P
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4825	R	C
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	4826	T	I
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	4838	L	V
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4842	V	M
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4846	A	V
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4849	V	I
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	4849	V	I
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4861	R	C
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4861	R	H
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	4861	R	H
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4864	Y	C
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	4876	K	R
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4891	G	R
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4893	R	Q
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4893	R	W
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4897	G	V
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4898	I	T
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4899	G	E
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4899	G	R
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4906	A	V
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4914	R	G
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4914	R	T
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4938	I	M
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	4939	D	E
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4940	A	T
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	4942	G	V
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	4973	P	L
P21817	LB/B	-	M3Z273	291	A	T
P21817	LB/B	-	M3Z273	2509	V	I
P21817	LB/B	-	M3Z273	2779	E	K
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	13	L	R
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	226	M	K
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	367	R	L
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	530	R	H
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	544	D	Y
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	1043	R	C
P21817	LB/B	-	M3Z273	1352	A	G
P21817	LB/B	-	M3Z273	2321	I	V
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2336	R	H
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2404	E	K
P21817	LB/B	-	M3Z273	2550	L	V
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2730	D	G
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2880	E	K
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	3217	S	P
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	3290	E	K
P21817	LB/B	-	M3Z273	3583	E	Q
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	3772	R	W
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	3806	G	R
P21817	LB/B	-	M3Z273	4501	P	L
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	4938	I	T
P21817	LP/P	Multiminicore disease with external ophthalmoplegia (MMDO) [MIM:255320]	M3Z273	402	M	T
P21817	LP/P	Multiminicore disease with external ophthalmoplegia (MMDO) [MIM:255320]	M3Z273	2035	H	L
P21817	LP/P	Multiminicore disease with external ophthalmoplegia (MMDO) [MIM:255320]	M3Z273	3326	N	K
P21817	LP/P	Multiminicore disease with external ophthalmoplegia (MMDO) [MIM:255320]	M3Z273	3402	C	G
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	382	H	N
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	1058	E	K
P21817	LP/P	-	M3Z273	1088	Y	C
P21817	LB/B	-	M3Z273	1679	R	H
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	2204	H	Q
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	2508	R	G
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	3366	R	H
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	3933	Y	C
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	3933	Y	C
P21817	LB/B	-	M3Z273	4493	P	A
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4743	G	D
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4882	T	M
P21817	LB/B	-	M3Z273	899	N	K
P21817	LB/B	-	M3Z273	974	V	M
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	1056	D	H
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	1056	D	N
P21817	LB/B	-	M3Z273	1109	R	L
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	1127	R	H
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	1467	K	R
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	1571	I	V
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2013	K	Q
P21817	LB/B	-	M3Z273	2248	R	C
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2400	D	G
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2593	R	G
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2627	V	M
P21817	LB/B	-	M3Z273	2976	H	Y
P21817	LB/B	-	M3Z273	3360	P	Q
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	3410	P	Q
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	3501	D	Y
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4897	G	A
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	2508	R	C
P21817	LP/P	King-Denborough syndrome (KDS) [MIM:619542]	M3Z273	2508	R	C
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2508	R	C
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	2963	L	P
P21817	LP/P	Central core disease of muscle (CCD) [MIM:117000]	M3Z273	4806	N	D
P21817	LB/B	-	M3Z273	2375	G	A
P21817	LP/P	Malignant hyperthermia 1 (MHS1) [MIM:145600]	M3Z273	2508	R	H
P21817	LP/P	-	M3Z273	705	G	R
P21817	LP/P	King-Denborough syndrome (KDS) [MIM:619542]	M3Z273	33	K	E
Q92736	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 2 (ARVD2) [MIM:600996]	M3Z273	433	L	P
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	433	L	P
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	2246	S	L
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	2328	P	S
Q92736	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 2 (ARVD2) [MIM:600996]	M3Z273	2386	N	I
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	2386	N	I
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	2474	R	S
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4104	N	K
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4201	Q	R
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4497	R	C
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4653	V	F
Q92736	LB/B	-	M3Z273	2958	Q	R
Q92736	LB/B	-	M3Z273	1886	G	S
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	2306	V	I
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4902	P	L
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4959	R	Q
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	164	P	S
Q92736	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 2 (ARVD2) [MIM:600996]	M3Z273	176	R	Q
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	176	R	Q
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	414	R	L
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	419	I	F
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	420	R	W
Q92736	LB/B	-	M3Z273	507	V	I
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	2311	E	D
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	2387	A	P
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	2392	Y	C
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	2403	A	T
Q92736	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 2 (ARVD2) [MIM:600996]	M3Z273	2504	T	M
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	2504	T	M
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	3778	L	F
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	3946	G	S
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4097	N	S
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4146	E	K
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4158	T	P
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4499	F	C
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4504	M	I
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4510	A	T
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4607	A	P
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4671	G	R
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4771	V	I
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4848	I	V
Q92736	LP/P	Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome (VACRDS) [MIM:115000]	M3Z273	4860	A	G
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4867	I	M
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4880	V	A
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4895	N	D
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4950	E	K
Q92736	LP/P	-	M3Z273	4955	G	E
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	3800	C	F
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4124	S	T
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4159	Q	P
Q92736	LP/P	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]	M3Z273	4556	A	T
Q92736	LP/P	Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome (VACRDS) [MIM:115000]	M3Z273	3774	Q	L
Q92736	LP/P	Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome (VACRDS) [MIM:115000]	M3Z273	4196	T	I
Q92736	LP/P	Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome (VACRDS) [MIM:115000]	M3Z273	4646	D	A
Q92736	LP/P	Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome (VACRDS) [MIM:115000]	M3Z273	4938	S	F
Q15413	LB/B	-	M3Z273	693	Y	C
Q15413	LB/B	-	M3Z273	731	I	V
Q15413	LB/B	-	M3Z273	1380	E	G
Q15413	LB/B	-	M3Z273	261	R	S
Q15413	LB/B	-	M3Z273	494	V	I
Q15413	LB/B	-	M3Z273	358	I	T
O95136	LP/P	Deafness, autosomal recessive, 68 (DFNB68) [MIM:610419]	A0A2K5KZ64	108	R	P
O95136	LP/P	Deafness, autosomal recessive, 68 (DFNB68) [MIM:610419]	A0A2K5KZ64	140	Y	C
P0DJI8	LB/B	-	A0A2K6MIY0	15	G	S
P0DJI8	LB/B	-	A0A2K6MIY0	70	V	A
P0DJI8	LB/B	-	A0A2K6MIY0	75	A	V
P0DJI8	LB/B	-	A0A2K6MIY0	78	D	N
P0DJI8	LB/B	-	A0A2K6MIY0	90	G	D
P0DJI8	LB/B	-	A0A2K6MIY0	86	F	L
P0DJI9	LB/B	-	A0A2K6MIY0	89	R	H
Q96ER3	LB/B	-	A0A2I3SXC7	315	I	V
Q96ER3	LB/B	-	A0A2I3SXC7	426	S	G
Q9Y512	LB/B	-	G5BKH2	345	I	V
Q9Y512	LB/B	-	G5BKH2	110	D	G
Q5SSQ6	LB/B	-	M3YHT8	30	P	S
Q5SSQ6	LB/B	-	M3YHT8	99	P	L
Q9UL12	LB/B	-	Q28XF9	614	R	H
Q9UL12	LB/B	-	Q28XF9	648	M	V
Q9UL12	LB/B	-	Q28XF9	22	G	C
Q9UL12	LB/B	-	Q28XF9	372	E	D
Q9UL12	LP/P	Sarcosinemia (SARCOS) [MIM:268900]	Q28XF9	71	V	F
Q9UL12	LP/P	Sarcosinemia (SARCOS) [MIM:268900]	Q28XF9	287	P	L
Q8IVN8	LB/B	-	A0A1S3G4X4	186	W	R
Q8IVN8	LB/B	-	A0A1S3G4X4	58	F	L
Q9H7N4	LB/B	-	M3XTQ3	895	T	A
Q9H7N4	LB/B	-	M3XTQ3	1146	M	T
Q9BY12	LB/B	-	F1SJ94	1089	P	T
Q9BY12	LB/B	-	F1SJ94	1140	A	T
Q9BY12	LB/B	-	F1SJ94	1139	A	T
Q6AZY7	LB/B	-	A0A2U3ZS25	130	R	Q
Q6AZY7	LB/B	-	A0A2U3ZS25	325	M	T
Q6AZY7	LB/B	-	A0A2U3ZS25	423	R	Q
Q6AZY7	LB/B	-	A0A2U3ZS25	428	V	I
Q6AZY7	LB/B	-	A0A2U3ZS25	467	F	L
Q6AZY7	LB/B	-	A0A2U3ZS25	551	P	S
Q6ZMJ2	LB/B	-	F6ZYP7	316	D	H
Q6ZMJ2	LB/B	-	F6ZYP7	45	A	T
Q96GP6	LB/B	-	A0A2Y9J0D4	778	E	D
Q96GP6	LB/B	-	A0A2Y9J0D4	779	L	V
Q96GP6	LB/B	-	A0A2Y9J0D4	820	A	G
Q96GP6	LB/B	-	A0A2Y9J0D4	838	A	G
Q96GP6	LB/B	-	A0A2Y9J0D4	425	T	S
Q96GP6	LB/B	-	A0A2Y9J0D4	522	H	L
Q96GP6	LB/B	-	A0A2Y9J0D4	174	P	S
Q96GP6	LP/P	Van den Ende-Gupta syndrome (VDEGS) [MIM:600920]	A0A2Y9J0D4	258	C	Y
O95171	LB/B	-	A0A2K6LYF7	336	V	L
O95171	LB/B	-	A0A2K6LYF7	386	R	K
O95171	LB/B	-	A0A2K6LYF7	480	K	R
P13521	LB/B	-	G3ICK9	61	Y	H
P13521	LB/B	-	G3ICK9	294	D	G
P13521	LB/B	-	G3ICK9	421	R	G
P13521	LB/B	-	G3ICK9	535	D	G
P13521	LB/B	-	G3ICK9	564	P	L
P13521	LB/B	-	G3ICK9	196	A	V
Q96NL6	LB/B	-	A0A1U7R8Z1	441	S	C
O75711	LB/B	-	A0A2U4B3X1	42	P	L
Q8IX30	LB/B	-	H2TMZ0	410	S	L
Q8IX30	LP/P	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 (SSFSC2) [MIM:619184]	H2TMZ0	97	C	W
Q8IX30	LP/P	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 (SSFSC2) [MIM:619184]	H2TMZ0	815	I	T
O75056	LB/B	-	A0A2K5NYH1	208	V	I
O75056	LB/B	-	A0A2K5NYH1	303	D	N
O75056	LB/B	-	A0A2K5NYH1	329	T	I
Q99470	LB/B	-	A0A0L8HRE9	15	A	T
Q92503	LB/B	-	L9KZY3	37	V	M
Q92503	LB/B	-	L9KZY3	97	A	G
Q92503	LB/B	-	L9KZY3	98	Y	H
Q92503	LB/B	-	L9KZY3	188	T	P
Q9UDX4	LB/B	-	A0A2I3NBS5	335	D	E
Q9UDX4	LB/B	-	A0A2I3NBS5	103	I	T
Q9UDX4	LB/B	-	A0A2I3NBS5	214	R	H
Q9UDX4	LB/B	-	A0A2I3NBS5	364	R	C
Q9UDX3	LB/B	-	A0A2I3NBS5	3	S	G
Q9UDX3	LB/B	-	A0A2I3NBS5	124	R	G
Q9UDX3	LB/B	-	A0A2I3NBS5	200	V	M
Q9UDX3	LB/B	-	A0A2I3NBS5	211	E	K
O94979	LB/B	-	A0A1A8NHE0	263	I	V
O94979	LB/B	-	A0A1A8NHE0	841	P	L
O94979	LB/B	-	A0A1A8NHE0	1055	P	T
O94979	LB/B	-	A0A1A8NHE0	456	N	K
Q9NQW1	LB/B	-	A0A1A8NHE0	89	V	A
Q9NQW1	LB/B	-	A0A1A8NHE0	100	Y	C
Q9NQW1	LB/B	-	A0A1A8NHE0	129	L	F
Q9NQW1	LB/B	-	A0A1A8NHE0	332	S	A
Q9NQW1	LB/B	-	A0A1A8NHE0	372	P	S
Q9NQW1	LB/B	-	A0A1A8NHE0	527	S	R
Q9NQW1	LB/B	-	A0A1A8NHE0	1169	A	S
Q9NQW1	LB/B	-	A0A1A8NHE0	433	R	Q
Q9NQW1	LB/B	-	A0A1A8NHE0	478	R	T
Q96T21	LP/P	Thyroid hormone metabolism, abnormal, 1 (THMA1) [MIM:609698]	A0A2Y9RR49	540	R	Q
Q96T21	LB/B	-	A0A2Y9RR49	428	Q	E
Q96EE3	LB/B	-	A0A1D5PSP1	342	T	N
Q68CR1	LB/B	-	A0A1S3W973	401	I	V
Q68CR1	LB/B	-	A0A1S3W973	107	Q	R
Q68CR1	LB/B	-	A0A1S3W973	554	I	V
Q68CR1	LB/B	-	A0A1S3W973	1054	W	C
Q68CR1	LB/B	-	A0A1S3W973	1122	P	S
Q9BVL4	LB/B	-	A0A293LKT3	3	V	A
Q9BVL4	LB/B	-	A0A293LKT3	167	T	N
Q9BVL4	LB/B	-	A0A293LKT3	630	E	K
Q9BVL4	LB/B	-	A0A293LKT3	638	E	K
Q99985	LB/B	-	A0A060XU12	337	V	M
Q99985	LB/B	-	A0A060XU12	302	F	S
Q9H3S1	LP/P	Cone-rod dystrophy 10 (CORD10) [MIM:610283]	U3JIT4	345	D	H
Q9H3S1	LP/P	Retinitis pigmentosa 35 (RP35) [MIM:610282]	U3JIT4	345	D	H
Q9H3S1	LP/P	Cone-rod dystrophy 10 (CORD10) [MIM:610283]	U3JIT4	350	F	C
Q9H3S1	LP/P	Retinitis pigmentosa 35 (RP35) [MIM:610282]	U3JIT4	350	F	C
Q9H3S1	LB/B	-	U3JIT4	510	R	Q
Q9H3S1	LB/B	-	U3JIT4	713	R	Q
Q99611	LB/B	-	A0A1U7TS96	269	P	A
Q9UHD8	LB/B	-	V9KK73	76	R	C
Q9UHD8	LB/B	-	V9KK73	145	P	L
Q9UHD8	LB/B	-	V9KK73	576	M	V
Q9UHD8	LP/P	Hereditary neuralgic amyotrophy (HNA) [MIM:162100]	V9KK73	106	R	W
Q9UHD8	LP/P	Hereditary neuralgic amyotrophy (HNA) [MIM:162100]	V9KK73	111	S	F
Q9NQF3	LB/B	-	A0A2I3LNT5	3	E	K
Q13530	LB/B	-	A0A146VVH4	437	T	A
P08697	LB/B	-	A0A0S3NUB0	27	A	V
P08697	LB/B	-	A0A0S3NUB0	33	R	W
P08697	LP/P	Alpha-2-plasmin inhibitor deficiency (APLID) [MIM:262850]	A0A0S3NUB0	411	V	M
P08697	LB/B	-	A0A0S3NUB0	434	R	K
P08697	LB/B	-	A0A0S3NUB0	2	A	V
P08697	LB/B	-	A0A0S3NUB0	98	A	G
P08697	LB/B	-	A0A0S3NUB0	451	P	S
Q9BYW2	LB/B	-	A0A2U9AYI9	768	V	L
Q9BYW2	LB/B	-	A0A2U9AYI9	1868	A	D
Q9BYW2	LB/B	-	A0A2U9AYI9	1962	P	L
Q9BYW2	LB/B	-	A0A2U9AYI9	902	E	Q
Q9BYW2	LP/P	Renal cell carcinoma (RCC) [MIM:144700]	A0A2U9AYI9	1733	N	D
Q9BYW2	LP/P	Renal cell carcinoma (RCC) [MIM:144700]	A0A2U9AYI9	1769	S	P
Q9BYW2	LP/P	Intellectual developmental disorder, autosomal dominant 70 (MRD70) [MIM:620157]	A0A2U9AYI9	1740	R	Q
Q9BYW2	LP/P	Rabin-Pappas syndrome (RAPAS) [MIM:620155]	A0A2U9AYI9	1740	R	W
Q9NVD3	LB/B	-	A0A091CSE3	387	I	V
Q9BYH1	LB/B	-	G3TWD6	430	M	I
Q9BYH1	LB/B	-	G3TWD6	185	W	L
Q9BYH1	LB/B	-	G3TWD6	52	P	L
Q9BYH1	LB/B	-	G3TWD6	671	Q	H
Q86XK3	LB/B	-	A0A093GWK5	19	D	G
Q96HF1	LB/B	-	A0A2I0LXP9	45	A	V
Q5T4F7	LB/B	-	A0A146ZL20	7	G	A
Q8IWL2	LB/B	-	A0A2K6MA48	9	N	T
Q8IWL2	LB/B	-	A0A2K6MA48	50	L	V
Q8IWL2	LB/B	-	A0A2K6MA48	219	R	W
Q8IWL2	LB/B	-	A0A2K6MA48	223	Q	K
Q8IWL2	LB/B	-	A0A2K6MA48	19	V	A
Q8IWL2	LB/B	-	A0A2K6MA48	5	P	L
Q8IWL2	LP/P	Interstitial lung disease 1 (ILD1) [MIM:619611]	A0A2K6MA48	178	V	M
Q8IWL2	LP/P	Interstitial lung disease 1 (ILD1) [MIM:619611]	A0A2K6MA48	208	Y	H
Q8IWL2	LP/P	Interstitial lung disease 1 (ILD1) [MIM:619611]	A0A2K6MA48	211	W	R
Q8IWL1	LB/B	-	A0A2K6MA48	9	T	N
Q8IWL1	LB/B	-	A0A2K6MA48	50	V	L
Q8IWL1	LB/B	-	A0A2K6MA48	91	A	P
Q8IWL1	LB/B	-	A0A2K6MA48	223	Q	K
Q8IWL1	LB/B	-	A0A2K6MA48	12	L	W
Q8IWL1	LP/P	Interstitial lung disease 2 (ILD2) [MIM:178500]	A0A2K6MA48	198	F	S
Q8IWL1	LP/P	Interstitial lung disease 2 (ILD2) [MIM:178500]	A0A2K6MA48	231	G	V
Q8IWL1	LP/P	Interstitial lung disease 2 (ILD2) [MIM:178500]	A0A2K6MA48	178	V	M
Q8IWL1	LP/P	Interstitial lung disease 2 (ILD2) [MIM:178500]	A0A2K6MA48	233	W	C
Q8IWL1	LP/P	Interstitial lung disease 2 (ILD2) [MIM:178500]	A0A2K6MA48	233	W	L
Q8IWL1	LP/P	Interstitial lung disease 2 (ILD2) [MIM:178500]	A0A2K6MA48	233	W	R
Q8IWL1	LP/P	Interstitial lung disease 2 (ILD2) [MIM:178500]	A0A2K6MA48	238	C	S
Q16585	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 4 (LGMDR4) [MIM:604286]	A0A2U3Y6J1	91	R	L
Q16585	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 4 (LGMDR4) [MIM:604286]	A0A2U3Y6J1	91	R	P
Q16585	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 4 (LGMDR4) [MIM:604286]	A0A2U3Y6J1	100	M	K
Q16585	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 4 (LGMDR4) [MIM:604286]	A0A2U3Y6J1	108	L	R
Q16585	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 4 (LGMDR4) [MIM:604286]	A0A2U3Y6J1	151	T	R
Q16585	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 4 (LGMDR4) [MIM:604286]	A0A2U3Y6J1	11	Q	E
Q16585	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 4 (LGMDR4) [MIM:604286]	A0A2U3Y6J1	91	R	C
Q16585	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 4 (LGMDR4) [MIM:604286]	A0A2U3Y6J1	114	S	F
Q16585	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 4 (LGMDR4) [MIM:604286]	A0A2U3Y6J1	119	I	F
Q16585	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 4 (LGMDR4) [MIM:604286]	A0A2U3Y6J1	139	G	D
Q16585	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 4 (LGMDR4) [MIM:604286]	A0A2U3Y6J1	167	G	S
Q16585	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 4 (LGMDR4) [MIM:604286]	A0A2U3Y6J1	182	T	A
Q16585	LP/P	-	A0A2U3Y6J1	184	Y	C
O43556	LP/P	Dystonia 11, myoclonic (DYT11) [MIM:159900]	G3NTY3	196	L	R
O43556	LB/B	-	G3NTY3	49	N	S
O43556	LB/B	-	G3NTY3	399	P	H
O43556	LP/P	Dystonia 11, myoclonic (DYT11) [MIM:159900]	G3NTY3	36	T	R
O43556	LP/P	Dystonia 11, myoclonic (DYT11) [MIM:159900]	G3NTY3	60	H	P
O43556	LP/P	Dystonia 11, myoclonic (DYT11) [MIM:159900]	G3NTY3	60	H	R
O43556	LP/P	Dystonia 11, myoclonic (DYT11) [MIM:159900]	G3NTY3	92	M	T
O43556	LP/P	Dystonia 11, myoclonic (DYT11) [MIM:159900]	G3NTY3	100	W	G
O43556	LP/P	Dystonia 11, myoclonic (DYT11) [MIM:159900]	G3NTY3	112	G	R
O43556	LP/P	Dystonia 11, myoclonic (DYT11) [MIM:159900]	G3NTY3	115	Y	C
O43556	LP/P	Dystonia 11, myoclonic (DYT11) [MIM:159900]	G3NTY3	175	L	S
O43556	LP/P	Dystonia 11, myoclonic (DYT11) [MIM:159900]	G3NTY3	177	S	C
O43556	LP/P	Dystonia 11, myoclonic (DYT11) [MIM:159900]	G3NTY3	184	L	P
O43556	LP/P	Dystonia 11, myoclonic (DYT11) [MIM:159900]	G3NTY3	270	W	R
O43556	LP/P	Dystonia 11, myoclonic (DYT11) [MIM:159900]	G3NTY3	271	C	Y
O00141	LB/B	-	G5AS59	219	V	I
O00141	LB/B	-	G5AS59	342	A	V
O95470	LB/B	-	M3VW95	21	V	L
O95470	LP/P	Nephrotic syndrome 14 (NPHS14) [MIM:617575]	M3VW95	222	R	Q
O95470	LP/P	Nephrotic syndrome 14 (NPHS14) [MIM:617575]	M3VW95	222	R	W
O95470	LB/B	-	M3VW95	346	S	I
O95470	LP/P	-	M3VW95	184	I	T
Q5SQS7	LB/B	-	A0A2U4AK15	237	H	R
Q5SQS7	LB/B	-	A0A2U4AK15	239	S	L
P29353	LB/B	-	Q4RIB1	205	A	V
P29353	LB/B	-	Q4RIB1	410	M	V
Q8N114	LB/B	-	A0A151PBP4	216	G	R
Q8TBC3	LB/B	-	A0A2Y9HYI6	507	Q	L
P34896	LB/B	-	A7S060	474	L	F
P34896	LB/B	-	A7S060	340	E	Q
Q5VXU9	LB/B	-	A0A151NED9	226	T	S
Q5VXU9	LB/B	-	A0A151NED9	416	H	R
Q5VXU9	LB/B	-	A0A151NED9	649	I	T
Q5VXU9	LB/B	-	A0A151NED9	734	M	L
Q5VXU9	LB/B	-	A0A151NED9	788	R	K
Q5VXU9	LB/B	-	A0A151NED9	809	N	K
Q5VXU9	LB/B	-	A0A151NED9	932	Y	C
Q5VXU9	LB/B	-	A0A151NED9	968	L	P
Q5VXU9	LB/B	-	A0A151NED9	1162	I	T
Q5VXU9	LB/B	-	A0A151NED9	1174	E	G
Q5VXU9	LB/B	-	A0A151NED9	1380	N	K
Q5VXU9	LB/B	-	A0A151NED9	1425	R	C
O15389	LB/B	-	A0A2Y9TFT8	72	V	A
O15389	LB/B	-	A0A2Y9TFT8	215	M	V
O15389	LB/B	-	A0A2Y9TFT8	322	F	S
O15389	LB/B	-	A0A2Y9TFT8	499	P	A
O15389	LB/B	-	A0A2Y9TFT8	358	R	W
P81133	LB/B	-	A0A1W4ZEI4	352	P	T
P81133	LB/B	-	A0A1W4ZEI4	371	A	V
P81133	LB/B	-	A0A1W4ZEI4	175	L	F
Q96ST3	LB/B	-	M3Z0V1	1156	M	L
Q96FS4	LB/B	-	W5Q6V7	80	R	Q
Q96FS4	LB/B	-	W5Q6V7	106	A	S
Q96FS4	LB/B	-	W5Q6V7	174	E	D
Q96FS4	LB/B	-	W5Q6V7	182	S	F
P78324	LB/B	-	A0A091IYF0	20	A	P
P78324	LB/B	-	A0A091IYF0	40	D	E
P78324	LB/B	-	A0A091IYF0	44	L	S
P78324	LB/B	-	A0A091IYF0	50	T	S
P78324	LB/B	-	A0A091IYF0	52	T	I
P78324	LB/B	-	A0A091IYF0	54	R	H
P78324	LB/B	-	A0A091IYF0	57	A	V
P78324	LB/B	-	A0A091IYF0	61	I	N
P78324	LB/B	-	A0A091IYF0	68	W	R
P78324	LB/B	-	A0A091IYF0	75	G	A
P78324	LB/B	-	A0A091IYF0	77	E	K
P78324	LB/B	-	A0A091IYF0	81	N	H
P78324	LB/B	-	A0A091IYF0	95	D	E
P78324	LB/B	-	A0A091IYF0	96	L	S
P78324	LB/B	-	A0A091IYF0	100	N	E
P78324	LB/B	-	A0A091IYF0	107	R	S
P78324	LB/B	-	A0A091IYF0	109	G	S
P78324	LB/B	-	A0A091IYF0	125	R	Q
P78324	LB/B	-	A0A091IYF0	132	V	T
P78324	LB/B	-	A0A091IYF0	134	F	L
P78324	LB/B	-	A0A091IYF0	181	T	S
P78324	LB/B	-	A0A091IYF0	190	E	Q
P78324	LB/B	-	A0A091IYF0	214	K	N
P78324	LB/B	-	A0A091IYF0	220	E	G
P78324	LB/B	-	A0A091IYF0	222	V	I
P78324	LB/B	-	A0A091IYF0	236	Q	R
P78324	LB/B	-	A0A091IYF0	251	R	Q
P78324	LB/B	-	A0A091IYF0	261	Q	L
P78324	LB/B	-	A0A091IYF0	263	V	M
P78324	LB/B	-	A0A091IYF0	271	V	I
P78324	LB/B	-	A0A091IYF0	276	R	T
P78324	LB/B	-	A0A091IYF0	302	V	L
P78324	LB/B	-	A0A091IYF0	339	P	S
P78324	LB/B	-	A0A091IYF0	353	P	L
P78324	LB/B	-	A0A091IYF0	357	G	S
P78324	LB/B	-	A0A091IYF0	367	S	P
P78324	LB/B	-	A0A091IYF0	370	R	Q
P78324	LB/B	-	A0A091IYF0	389	A	E
P78324	LB/B	-	A0A091IYF0	443	Q	R
P78324	LB/B	-	A0A091IYF0	460	P	L
P78324	LB/B	-	A0A091IYF0	491	P	L
O95475	LB/B	-	H0Y0M8	141	H	N
Q8N1H7	LB/B	-	A0A091IUF3	125	Y	C
Q8N1H7	LB/B	-	A0A091IUF3	309	S	L
Q8N1H7	LB/B	-	A0A091IUF3	404	V	I
Q96BD8	LB/B	-	A0A091EG40	91	V	I
Q86WV1	LB/B	-	A0A2K5DAK1	161	G	S
Q86WV1	LB/B	-	A0A2K5DAK1	242	S	G
O75563	LB/B	-	A0A2K5DAK1	202	A	S
O75563	LB/B	-	A0A2K5DAK1	253	S	T
Q6PGP7	LB/B	-	A0A226P862	437	L	V
Q6PGP7	LB/B	-	A0A226P862	1296	R	S
Q6PGP7	LB/B	-	A0A226P862	1270	P	A
Q6PGP7	LP/P	Trichohepatoenteric syndrome 1 (THES1) [MIM:222470]	A0A226P862	251	G	R
Q6PGP7	LP/P	Trichohepatoenteric syndrome 1 (THES1) [MIM:222470]	A0A226P862	1283	D	N
Q6PGP7	LP/P	Trichohepatoenteric syndrome 1 (THES1) [MIM:222470]	A0A226P862	1505	L	S
Q13239	LB/B	-	A0A151P8A7	15	P	T
Q9NQ25	LB/B	-	A0A2Y9M2F0	175	H	Y
Q9NQ25	LB/B	-	A0A2Y9M2F0	302	T	M
Q5PT55	LB/B	-	A0A2U3X6Y8	287	I	T
Q13621	LP/P	Bartter syndrome 1, antenatal (BARTS1) [MIM:601678]	M7B133	272	V	F
Q13621	LP/P	Bartter syndrome 1, antenatal (BARTS1) [MIM:601678]	M7B133	648	D	N
Q13621	LB/B	-	M7B133	958	V	A
Q9H2X9	LB/B	-	A0A0F8AMA1	1100	P	L
Q9H2X9	LB/B	-	A0A0F8AMA1	407	P	A
Q9H2X9	LP/P	Developmental and epileptic encephalopathy 34 (DEE34) [MIM:616645]	A0A0F8AMA1	311	L	H
Q9H2X9	LP/P	Developmental and epileptic encephalopathy 34 (DEE34) [MIM:616645]	A0A0F8AMA1	426	L	P
Q9H2X9	LP/P	Developmental and epileptic encephalopathy 34 (DEE34) [MIM:616645]	A0A0F8AMA1	551	G	D
Q9H2X9	LP/P	Epilepsy, idiopathic generalized 14 (EIG14) [MIM:616685]	A0A0F8AMA1	975	R	H
Q9H2X9	LB/B	-	A0A0F8AMA1	1071	R	W
Q9H2X9	LP/P	Epilepsy, idiopathic generalized 14 (EIG14) [MIM:616685]	A0A0F8AMA1	1072	R	C
Q9UHW9	LB/B	-	A0A0F8AMA1	415	F	S
Q9UHW9	LP/P	Agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) [MIM:218000]	A0A0F8AMA1	207	R	C
Q9UHW9	LP/P	Charcot-Marie-Tooth disease, axonal, 2II (CMT2II) [MIM:620068]	A0A0F8AMA1	207	R	H
Q9UHW9	LP/P	Charcot-Marie-Tooth disease, axonal, 2II (CMT2II) [MIM:620068]	A0A0F8AMA1	289	E	K
Q9UHW9	LP/P	Charcot-Marie-Tooth disease, axonal, 2II (CMT2II) [MIM:620068]	A0A0F8AMA1	679	Y	C
Q9UHW9	LP/P	Charcot-Marie-Tooth disease, axonal, 2II (CMT2II) [MIM:620068]	A0A0F8AMA1	991	T	A
Q9BZW2	LB/B	-	M4A358	174	N	S
Q9BZW2	LB/B	-	M4A358	42	F	L
Q9BZW2	LB/B	-	M4A358	44	V	I
Q9BZW2	LB/B	-	M4A358	157	Q	E
Q9BZW2	LB/B	-	M4A358	205	Y	C
Q9BZW2	LB/B	-	M4A358	277	R	H
Q9BZW2	LB/B	-	M4A358	332	V	A
Q9BZW2	LB/B	-	M4A358	392	I	T
Q9BZW2	LB/B	-	M4A358	240	T	M
Q8WWT9	LP/P	Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate (ARLIAK) [MIM:618384]	Q3UUJ6	254	A	D
Q8WWT9	LP/P	Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate (ARLIAK) [MIM:618384]	Q3UUJ6	548	G	S
Q9UKG4	LB/B	-	M4A358	451	P	S
Q13336	LB/B	-	A0A2Y9M8Y2	280	D	N
Q13336	LB/B	-	A0A2Y9M8Y2	291	S	P
Q13336	LB/B	-	A0A2Y9M8Y2	44	E	K
Q13336	LB/B	-	A0A2Y9M8Y2	167	M	V
Q13336	LB/B	-	A0A2Y9M8Y2	171	W	R
Q13336	LB/B	-	A0A2Y9M8Y2	74	N	K
Q13336	LB/B	-	A0A2Y9M8Y2	299	G	E
Q13336	LB/B	-	A0A2Y9M8Y2	319	T	M
Q15849	LB/B	-	A0A091QJF0	880	A	T
Q15849	LB/B	-	A0A091QJF0	37	T	I
Q15849	LB/B	-	A0A091QJF0	443	G	S
Q15849	LB/B	-	A0A091QJF0	750	V	I
Q15849	LB/B	-	A0A091QJF0	132	I	V
Q15849	LB/B	-	A0A091QJF0	510	R	Q
Q8TF71	LB/B	-	F7AIB3	508	K	Q
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	150	A	V
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	397	L	P
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	438	L	P
P36021	LB/B	-	M3YA43	323	I	L
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	120	S	F
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	161	V	M
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	360	L	W
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	490	G	R
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	494	L	P
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	147	G	R
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	150	A	T
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	197	R	H
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	208	G	C
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	247	P	L
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	371	R	C
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	379	D	V
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	463	P	L
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	484	G	D
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	216	S	F
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	217	L	R
P36021	LP/P	Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523]	M3YA43	490	G	E
O15374	LB/B	-	A0A091QMC5	264	N	H
O15374	LB/B	-	A0A091QMC5	185	A	T
Q14916	LB/B	-	A0A2K5CEU3	76	S	N
Q14916	LB/B	-	A0A2K5CEU3	269	T	I
O00476	LB/B	-	A0A2K5CEU3	100	A	T
O00476	LB/B	-	A0A2K5CEU3	201	G	R
O00476	LB/B	-	A0A2K5CEU3	300	P	L
O00476	LB/B	-	A0A2K5CEU3	68	N	H
O00476	LB/B	-	A0A2K5CEU3	226	F	S
Q9Y2C5	LB/B	-	A0A2K5CEU3	372	A	T
Q9P2U8	LB/B	-	A0A1S3KQG2	551	N	S
Q8NDX2	LB/B	-	A0A1S3KQG2	8	T	I
Q8NDX2	LP/P	Deafness, autosomal dominant, 25 (DFNA25) [MIM:605583]	A0A1S3KQG2	211	A	V
Q8NDX2	LB/B	-	A0A1S3KQG2	220	A	T
Q8NDX2	LB/B	-	A0A1S3KQG2	246	G	E
P43007	LB/B	-	G1LP84	37	G	R
P43007	LB/B	-	G1LP84	399	V	I
P43007	LP/P	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly (SPATCCM) [MIM:616657]	G1LP84	256	E	K
P43007	LP/P	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly (SPATCCM) [MIM:616657]	G1LP84	457	R	W
Q15758	LB/B	-	G1LP84	512	V	L
Q15758	LB/B	-	G1LP84	17	P	A
O00341	LB/B	-	A0A0K8TQB1	537	Q	R
Q96S37	LB/B	-	A0A0H2UHT0	65	G	W
Q96S37	LP/P	Hypouricemia renal 1 (RHUC1) [MIM:220150]	A0A0H2UHT0	90	R	H
Q96S37	LB/B	-	A0A0H2UHT0	92	R	C
Q96S37	LP/P	Hypouricemia renal 1 (RHUC1) [MIM:220150]	A0A0H2UHT0	138	V	M
Q96S37	LP/P	Hypouricemia renal 1 (RHUC1) [MIM:220150]	A0A0H2UHT0	164	G	S
Q96S37	LP/P	Hypouricemia renal 1 (RHUC1) [MIM:220150]	A0A0H2UHT0	217	T	M
Q96S37	LB/B	-	A0A0H2UHT0	226	A	V
Q96S37	LP/P	Hypouricemia renal 1 (RHUC1) [MIM:220150]	A0A0H2UHT0	298	E	D
Q96S37	LB/B	-	A0A0H2UHT0	312	Q	L
Q96S37	LP/P	Hypouricemia renal 1 (RHUC1) [MIM:220150]	A0A0H2UHT0	382	Q	L
Q96S37	LP/P	Hypouricemia renal 1 (RHUC1) [MIM:220150]	A0A0H2UHT0	418	L	R
Q96S37	LP/P	Hypouricemia renal 1 (RHUC1) [MIM:220150]	A0A0H2UHT0	430	M	T
Q96S37	LP/P	Hypouricemia renal 1 (RHUC1) [MIM:220150]	A0A0H2UHT0	477	R	H
Q96S37	LP/P	Hypouricemia renal 1 (RHUC1) [MIM:220150]	A0A0H2UHT0	366	G	R
Q8N1D0	LB/B	-	A0A2K5NLJ8	133	G	R
Q8N1D0	LB/B	-	A0A2K5NLJ8	89	G	D
Q02978	LP/P	Paragangliomas 6 (PGL6) [MIM:618464]	A0A0N5ATW8	141	E	K
Q02978	LP/P	Paragangliomas 6 (PGL6) [MIM:618464]	A0A0N5ATW8	147	M	V
Q02978	LP/P	Paragangliomas 6 (PGL6) [MIM:618464]	A0A0N5ATW8	239	P	T
Q9Y619	LP/P	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHHS) [MIM:238970]	L5MK72	27	G	E
Q9Y619	LP/P	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHHS) [MIM:238970]	L5MK72	27	G	R
Q9Y619	LP/P	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHHS) [MIM:238970]	L5MK72	126	P	R
Q9Y619	LP/P	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHHS) [MIM:238970]	L5MK72	180	E	K
Q9Y619	LP/P	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHHS) [MIM:238970]	L5MK72	190	G	D
Q9Y619	LB/B	-	L5MK72	254	I	L
Q9Y619	LP/P	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHHS) [MIM:238970]	L5MK72	275	R	Q
Q9Y619	LP/P	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHHS) [MIM:238970]	L5MK72	37	M	R
Q9Y619	LP/P	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHHS) [MIM:238970]	L5MK72	71	L	Q
Q9Y619	LP/P	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHHS) [MIM:238970]	L5MK72	113	G	C
Q9Y619	LP/P	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHHS) [MIM:238970]	L5MK72	188	F	L
Q9Y619	LP/P	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHHS) [MIM:238970]	L5MK72	216	G	S
Q9Y619	LP/P	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHHS) [MIM:238970]	L5MK72	272	T	I
Q9Y619	LP/P	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHHS) [MIM:238970]	L5MK72	273	M	K
Q9Y619	LP/P	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHHS) [MIM:238970]	L5MK72	283	L	F
Q9Y619	LP/P	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHHS) [MIM:238970]	L5MK72	15	A	V
Q9H0C2	LB/B	-	L9KIA4	303	K	E
Q96DW6	LB/B	-	W4Y5E3	66	R	G
Q96DW6	LP/P	Anemia, sideroblastic, 2, pyridoxine-refractory (SIDBA2) [MIM:205950]	W4Y5E3	130	G	E
Q96DW6	LP/P	Anemia, sideroblastic, 2, pyridoxine-refractory (SIDBA2) [MIM:205950]	W4Y5E3	134	R	H
Q96DW6	LP/P	Anemia, sideroblastic, 2, pyridoxine-refractory (SIDBA2) [MIM:205950]	W4Y5E3	187	R	P
Q96DW6	LP/P	Anemia, sideroblastic, 2, pyridoxine-refractory (SIDBA2) [MIM:205950]	W4Y5E3	209	D	H
Q9BZJ4	LB/B	-	A0A147AWB3	247	F	L
Q8TBP6	LB/B	-	A0A147AWB3	123	T	I
Q8TBP6	LB/B	-	A0A147AWB3	186	K	Q
Q8TBP6	LB/B	-	A0A147AWB3	105	S	N
Q96AG3	LP/P	Neuropathy, hereditary motor and sensory, 6B, with optic atrophy (HMSN6B) [MIM:616505]	Q6DGU5	333	P	L
Q96AG3	LP/P	Neuropathy, hereditary motor and sensory, 6B, with optic atrophy (HMSN6B) [MIM:616505]	Q6DGU5	340	R	C
Q96AG3	LP/P	Pontocerebellar hypoplasia 1E (PCH1E) [MIM:619303]	Q6DGU5	142	T	I
Q96AG3	LP/P	Pontocerebellar hypoplasia 1E (PCH1E) [MIM:619303]	Q6DGU5	341	L	P
P05141	LB/B	-	F7GUA1	111	L	R
P12236	LB/B	-	F7GUA1	242	S	F
Q9H2B4	LB/B	-	F1SKK5	556	Q	R
Q9H2B4	LP/P	Nephrolithiasis, calcium oxalate (CAON) [MIM:167030]	F1SKK5	185	T	M
Q9H2B4	LP/P	Nephrolithiasis, calcium oxalate (CAON) [MIM:167030]	F1SKK5	358	S	L
Q9Y2P5	LB/B	-	F7DPJ6	50	M	T
Q9Y2P5	LB/B	-	F7DPJ6	53	R	W
O00337	LB/B	-	F1SN44	34	E	G
O00337	LB/B	-	F1SN44	189	V	I
O00337	LB/B	-	F1SN44	409	N	S
O00337	LB/B	-	F1SN44	521	D	N
O00337	LB/B	-	F1SN44	190	A	S
O00337	LB/B	-	F1SN44	237	Q	K
O00337	LP/P	Uridine-cytidineuria (URCTU) [MIM:618477]	F1SN44	510	R	C
O00337	LP/P	Uridine-cytidineuria (URCTU) [MIM:618477]	F1SN44	546	S	P
O00337	LP/P	Uridine-cytidineuria (URCTU) [MIM:618477]	F1SN44	561	R	Q
O43868	LB/B	-	F1SN44	163	L	W
O43868	LB/B	-	F1SN44	22	P	L
O43868	LB/B	-	F1SN44	75	S	R
O43868	LB/B	-	F1SN44	245	S	T
O43868	LB/B	-	F1SN44	355	F	S
O43868	LB/B	-	F1SN44	462	L	F
O43868	LB/B	-	F1SN44	509	G	E
O43868	LB/B	-	F1SN44	12	L	P
O43868	LB/B	-	F1SN44	142	R	H
O43868	LB/B	-	F1SN44	172	E	D
O43868	LB/B	-	F1SN44	385	E	K
O43868	LB/B	-	F1SN44	612	M	T
Q9UGQ3	LB/B	-	A0A2K6QN77	500	T	M
Q6PXP3	LB/B	-	L5LPU9	135	V	I
Q6PXP3	LB/B	-	L5LPU9	261	R	Q
Q99726	LB/B	-	H2P6P4	298	R	C
Q06495	LP/P	Nephrolithiasis/osteoporosis, hypophosphatemic, 1 (NPHLOP1) [MIM:612286]	A0A061IHI1	48	A	F
Q06495	LP/P	Nephrolithiasis/osteoporosis, hypophosphatemic, 1 (NPHLOP1) [MIM:612286]	A0A061IHI1	147	V	M
Q06495	LP/P	Hypercalcemia, infantile, 2 (HCINF2) [MIM:616963]	A0A061IHI1	153	G	A
Q06495	LP/P	Hypercalcemia, infantile, 2 (HCINF2) [MIM:616963]	A0A061IHI1	153	G	V
Q06495	LP/P	Hypercalcemia, infantile, 2 (HCINF2) [MIM:616963]	A0A061IHI1	155	L	P
Q06495	LP/P	Hypercalcemia, infantile, 2 (HCINF2) [MIM:616963]	A0A061IHI1	215	R	W
Q06495	LP/P	Hypercalcemia, infantile, 2 (HCINF2) [MIM:616963]	A0A061IHI1	336	C	G
Q06495	LP/P	Hypercalcemia, infantile, 2 (HCINF2) [MIM:616963]	A0A061IHI1	408	V	E
Q06495	LP/P	Hypercalcemia, infantile, 2 (HCINF2) [MIM:616963]	A0A061IHI1	488	W	R
P78382	LP/P	Congenital disorder of glycosylation 2F (CDG2F) [MIM:603585]	A0A2K5MBT5	101	Q	H
P78382	LP/P	Congenital disorder of glycosylation 2F (CDG2F) [MIM:603585]	A0A2K5MBT5	156	T	R
P78382	LP/P	Congenital disorder of glycosylation 2F (CDG2F) [MIM:603585]	A0A2K5MBT5	196	E	K
P78381	LP/P	Congenital disorder of glycosylation 2M (CDG2M) [MIM:300896]	A0A2Y9JRE3	331	V	I
P78381	LP/P	Congenital disorder of glycosylation 2M (CDG2M) [MIM:300896]	A0A2Y9JRE3	213	S	F
P78381	LP/P	Congenital disorder of glycosylation 2M (CDG2M) [MIM:300896]	A0A2Y9JRE3	266	G	V
P78381	LP/P	Congenital disorder of glycosylation 2M (CDG2M) [MIM:300896]	A0A2Y9JRE3	55	R	P
P78381	LP/P	Congenital disorder of glycosylation 2M (CDG2M) [MIM:300896]	A0A2Y9JRE3	71	V	M
P78381	LP/P	Congenital disorder of glycosylation 2M (CDG2M) [MIM:300896]	A0A2Y9JRE3	82	C	F
P78381	LP/P	Congenital disorder of glycosylation 2M (CDG2M) [MIM:300896]	A0A2Y9JRE3	101	L	P
P78381	LP/P	Congenital disorder of glycosylation 2M (CDG2M) [MIM:300896]	A0A2Y9JRE3	116	A	P
P78381	LP/P	Congenital disorder of glycosylation 2M (CDG2M) [MIM:300896]	A0A2Y9JRE3	118	P	R
P78381	LP/P	Congenital disorder of glycosylation 2M (CDG2M) [MIM:300896]	A0A2Y9JRE3	130	Y	C
P78381	LP/P	Congenital disorder of glycosylation 2M (CDG2M) [MIM:300896]	A0A2Y9JRE3	175	L	F
P78381	LP/P	Congenital disorder of glycosylation 2M (CDG2M) [MIM:300896]	A0A2Y9JRE3	233	L	P
P78381	LP/P	Congenital disorder of glycosylation 2M (CDG2M) [MIM:300896]	A0A2Y9JRE3	273	G	D
P78381	LP/P	Congenital disorder of glycosylation 2M (CDG2M) [MIM:300896]	A0A2Y9JRE3	303	L	P
P78381	LP/P	Congenital disorder of glycosylation 2M (CDG2M) [MIM:300896]	A0A2Y9JRE3	312	S	Y
P78381	LP/P	Congenital disorder of glycosylation 2M (CDG2M) [MIM:300896]	A0A2Y9JRE3	315	L	P
Q76EJ3	LB/B	-	V4A0B0	184	A	S
Q8TBE7	LB/B	-	E6ZIW8	400	K	R
Q8N1S5	LB/B	-	W2TD47	111	T	A
Q15043	LB/B	-	G1SVM9	33	L	P
Q15043	LP/P	Hypermanganesemia with dystonia 2 (HMNDYT2) [MIM:617013]	G1SVM9	98	F	V
Q15043	LP/P	Hypermanganesemia with dystonia 2 (HMNDYT2) [MIM:617013]	G1SVM9	383	G	R
Q15043	LP/P	Hypermanganesemia with dystonia 2 (HMNDYT2) [MIM:617013]	G1SVM9	469	N	K
Q15043	LP/P	Hyperostosis cranialis interna (HCIN) [MIM:144755]	G1SVM9	441	L	R
Q9C0K1	LB/B	-	G3NML9	391	A	T
Q9C0K1	LP/P	Congenital disorder of glycosylation 2N (CDG2N) [MIM:616721]	G3NML9	33	V	M
Q9C0K1	LP/P	Congenital disorder of glycosylation 2N (CDG2N) [MIM:616721]	G3NML9	38	G	R
Q9C0K1	LP/P	Congenital disorder of glycosylation 2N (CDG2N) [MIM:616721]	G3NML9	204	G	C
Q9C0K1	LP/P	Congenital disorder of glycosylation 2N (CDG2N) [MIM:616721]	G3NML9	335	S	T
Q9C0K1	LP/P	Congenital disorder of glycosylation 2N (CDG2N) [MIM:616721]	G3NML9	340	I	N
Q9C0K1	LP/P	-	G3NML9	113	C	S
Q9NUM3	LB/B	-	A0A0P6CGY1	64	E	D
Q9NUM3	LB/B	-	A0A0P6CGY1	221	M	T
Q9NUM3	LB/B	-	A0A0P6CGY1	285	R	C
Q96FL8	LB/B	-	H3A0E8	338	V	I
Q96FL8	LB/B	-	H3A0E8	10	V	L
Q96FL8	LB/B	-	H3A0E8	310	A	V
Q96FL8	LB/B	-	H3A0E8	328	D	A
Q96FL8	LB/B	-	H3A0E8	474	N	S
Q86VL8	LB/B	-	H3A0E8	429	G	R
P02730	LB/B	-	K7GR72	56	K	E
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	327	P	R
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	518	R	C
P02730	LB/B	-	K7GR72	548	P	L
P02730	LB/B	-	K7GR72	552	T	I
P02730	LB/B	-	K7GR72	557	V	M
P02730	LB/B	-	K7GR72	658	E	K
P02730	LB/B	-	K7GR72	854	P	L
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	90	E	K
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	130	G	R
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	147	P	S
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	285	A	D
P02730	LB/B	-	K7GR72	432	R	W
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	455	G	E
P02730	LB/B	-	K7GR72	480	E	K
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	488	V	M
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	490	R	C
P02730	LB/B	-	K7GR72	551	K	N
P02730	LB/B	-	K7GR72	555	Y	H
P02730	LB/B	-	K7GR72	561	P	S
P02730	LB/B	-	K7GR72	565	G	A
P02730	LB/B	-	K7GR72	566	P	A
P02730	LB/B	-	K7GR72	566	P	S
P02730	LB/B	-	K7GR72	569	N	K
P02730	LB/B	-	K7GR72	646	R	Q
P02730	LB/B	-	K7GR72	646	R	W
P02730	LB/B	-	K7GR72	656	R	C
P02730	LB/B	-	K7GR72	656	R	H
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	707	L	P
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	714	G	R
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	760	R	Q
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	760	R	W
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	771	G	D
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	783	I	N
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	808	R	C
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	808	R	H
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	834	H	P
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	837	T	A
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	837	T	M
P02730	LB/B	-	K7GR72	868	P	L
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	870	R	W
P02730	LB/B	-	K7GR72	38	D	A
P02730	LB/B	-	K7GR72	112	R	S
P02730	LB/B	-	K7GR72	442	I	F
P02730	LB/B	-	K7GR72	586	M	L
P02730	LB/B	-	K7GR72	688	I	V
P02730	LB/B	-	K7GR72	690	S	G
P02730	LB/B	-	K7GR72	832	R	H
P02730	LB/B	-	K7GR72	862	V	I
P02730	LP/P	Renal tubular acidosis, distal, 1 (DRTA1) [MIM:179800]	K7GR72	589	R	C
P02730	LP/P	Renal tubular acidosis, distal, 1 (DRTA1) [MIM:179800]	K7GR72	589	R	H
P02730	LP/P	Renal tubular acidosis, distal, 1 (DRTA1) [MIM:179800]	K7GR72	589	R	S
P02730	LP/P	Renal tubular acidosis, distal, 1 (DRTA1) [MIM:179800]	K7GR72	613	S	F
P02730	LP/P	Renal tubular acidosis, distal, 1 (DRTA1) [MIM:179800]	K7GR72	858	A	D
P02730	LP/P	Renal tubular acidosis, distal, 4, with hemolytic anemia (DRTA4) [MIM:611590]	K7GR72	701	G	D
P02730	LP/P	Renal tubular acidosis, distal, with normal red cell morphology (dRTA-NRC) [MIM:611590]	K7GR72	701	G	D
P02730	LB/B	-	K7GR72	508	E	K
P02730	LB/B	-	K7GR72	45	D	E
P02730	LB/B	-	K7GR72	68	E	K
P02730	LB/B	-	K7GR72	73	L	M
P02730	LP/P	Renal tubular acidosis, distal, 4, with hemolytic anemia (DRTA4) [MIM:611590]	K7GR72	602	R	H
P02730	LP/P	Cryohydrocytosis (CHC) [MIM:185020]	K7GR72	687	L	P
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	705	D	Y
P02730	LP/P	Cryohydrocytosis (CHC) [MIM:185020]	K7GR72	731	S	P
P02730	LP/P	Cryohydrocytosis (CHC) [MIM:185020]	K7GR72	734	H	R
P02730	LP/P	Renal tubular acidosis, distal, with normal red cell morphology (dRTA-NRC) [MIM:611590]	K7GR72	773	S	P
P02730	LB/B	-	K7GR72	27	P	H
P02730	LB/B	-	K7GR72	72	E	D
P02730	LB/B	-	K7GR72	429	E	D
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	455	G	R
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	490	R	H
P02730	LB/B	-	K7GR72	561	P	A
P02730	LP/P	Renal tubular acidosis, distal, 1 (DRTA1) [MIM:179800]	K7GR72	609	G	R
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	663	M	K
P02730	LP/P	Spherocytosis 4 (SPH4) [MIM:612653]	K7GR72	837	T	R
P02730	LP/P	Renal tubular acidosis, distal, 4, with hemolytic anemia (DRTA4) [MIM:611590]	K7GR72	444	T	N
Q9Y6R1	LP/P	Renal tubular acidosis, proximal, with ocular abnormalities and impaired intellectual development (pRTA-OA) [MIM:604278]	I3J0V5	342	R	S
Q9Y6R1	LP/P	Renal tubular acidosis, proximal, with ocular abnormalities and impaired intellectual development (pRTA-OA) [MIM:604278]	I3J0V5	471	S	L
Q9Y6R1	LP/P	Renal tubular acidosis, proximal, with ocular abnormalities and impaired intellectual development (pRTA-OA) [MIM:604278]	I3J0V5	529	T	S
Q9Y6R1	LP/P	Renal tubular acidosis, proximal, with ocular abnormalities and impaired intellectual development (pRTA-OA) [MIM:604278]	I3J0V5	554	R	H
Q9Y6R1	LP/P	Renal tubular acidosis, proximal, with ocular abnormalities and impaired intellectual development (pRTA-OA) [MIM:604278]	I3J0V5	843	A	V
Q9Y6R1	LP/P	Renal tubular acidosis, proximal, with ocular abnormalities and impaired intellectual development (pRTA-OA) [MIM:604278]	I3J0V5	925	R	C
Q9Y6R1	LP/P	Renal tubular acidosis, proximal, with ocular abnormalities and impaired intellectual development (pRTA-OA) [MIM:604278]	I3J0V5	530	G	R
Q9Y6R1	LP/P	Renal tubular acidosis, proximal, with ocular abnormalities and impaired intellectual development (pRTA-OA) [MIM:604278]	I3J0V5	566	L	P
Q1EHB4	LB/B	-	A0A2L2Y736	510	V	L
P53794	LB/B	-	W5NP95	50	A	T
P53794	LB/B	-	W5NP95	566	Q	K
Q92911	LP/P	Thyroid dyshormonogenesis 1 (TDH1) [MIM:274400]	W5PXU3	93	G	R
Q92911	LB/B	-	W5PXU3	102	A	P
Q92911	LP/P	Thyroid dyshormonogenesis 1 (TDH1) [MIM:274400]	W5PXU3	267	Q	E
Q92911	LP/P	Thyroid dyshormonogenesis 1 (TDH1) [MIM:274400]	W5PXU3	354	T	P
Q92911	LP/P	Thyroid dyshormonogenesis 1 (TDH1) [MIM:274400]	W5PXU3	395	G	R
Q92911	LP/P	Thyroid dyshormonogenesis 1 (TDH1) [MIM:274400]	W5PXU3	543	G	E
Q92911	LB/B	-	W5PXU3	298	C	G
Q8N695	LB/B	-	W5PXU3	193	V	I
Q8N695	LB/B	-	W5PXU3	251	F	V
Q9H2J7	LB/B	-	W5LMB1	400	A	V
Q9H2J7	LB/B	-	W5LMB1	603	I	M
Q9H1V8	LB/B	-	W5LMB1	57	A	T
Q9H1V8	LP/P	Intellectual developmental disorder, autosomal recessive 48 (MRT48) [MIM:616269]	W5LMB1	162	G	R
Q9H1V8	LP/P	Intellectual developmental disorder, autosomal recessive 48 (MRT48) [MIM:616269]	W5LMB1	633	P	R
P23975	LP/P	Orthostatic intolerance (OI) [MIM:604715]	A0A2Y9LN82	457	A	P
P23975	LB/B	-	A0A2Y9LN82	69	V	I
P23975	LB/B	-	A0A2Y9LN82	99	T	I
P23975	LB/B	-	A0A2Y9LN82	245	V	I
P23975	LB/B	-	A0A2Y9LN82	292	N	T
P23975	LB/B	-	A0A2Y9LN82	356	V	L
P23975	LB/B	-	A0A2Y9LN82	369	A	P
P23975	LB/B	-	A0A2Y9LN82	375	N	S
P23975	LB/B	-	A0A2Y9LN82	463	K	R
P23975	LB/B	-	A0A2Y9LN82	478	G	S
P23975	LB/B	-	A0A2Y9LN82	528	F	C
P23975	LB/B	-	A0A2Y9LN82	548	Y	H
P23975	LB/B	-	A0A2Y9LN82	449	V	I
P23975	LB/B	-	A0A2Y9LN82	283	T	R
P23975	LB/B	-	A0A2Y9LN82	549	I	T
P23975	LB/B	-	A0A2Y9LN82	7	N	K
Q9NP91	LB/B	-	W5LMB1	9	A	G
Q9NP91	LB/B	-	W5LMB1	199	T	M
Q01959	LB/B	-	U5T862	237	R	Q
Q01959	LP/P	Parkinsonism-dystonia 1, infantile-onset (PKDYS1) [MIM:613135]	U5T862	368	L	Q
Q01959	LP/P	Parkinsonism-dystonia 1, infantile-onset (PKDYS1) [MIM:613135]	U5T862	395	P	L
Q01959	LB/B	-	U5T862	471	V	I
P19634	LB/B	-	W5P0Z4	682	N	K
P19634	LP/P	Lichtenstein-Knorr syndrome (LIKNS) [MIM:616291]	W5P0Z4	305	G	R
P48764	LB/B	-	F1MU00	799	C	R
P48764	LP/P	Diarrhea 8, secretory sodium, congenital (DIAR8) [MIM:616868]	F1MU00	269	A	T
P48764	LP/P	Diarrhea 8, secretory sodium, congenital (DIAR8) [MIM:616868]	F1MU00	311	A	V
P48764	LP/P	Diarrhea 8, secretory sodium, congenital (DIAR8) [MIM:616868]	F1MU00	382	R	Q
Q4G0N8	LB/B	-	A0A2U3YBA8	158	I	V
Q4G0N8	LB/B	-	A0A2U3YBA8	286	I	V
Q4G0N8	LB/B	-	A0A2U3YBA8	348	I	M
Q4G0N8	LB/B	-	A0A2U3YBA8	424	T	A
Q4G0N8	LB/B	-	A0A2U3YBA8	705	T	I
Q4G0N8	LB/B	-	A0A2U3YBA8	732	Q	K
Q4G0N8	LB/B	-	A0A2U3YBA8	768	S	I
Q4G0N8	LB/B	-	A0A2U3YBA8	364	I	V
Q4G0N8	LB/B	-	A0A2U3YBA8	826	G	S
Q9H2Y9	LB/B	-	A0A2Y9PW52	33	L	F
O95391	LB/B	-	F1KZK1	111	I	V
O95391	LB/B	-	F1KZK1	229	M	T
Q5VYV7	LB/B	-	F7HEV4	317	R	Q
Q8TAQ2	LP/P	Coffin-Siris syndrome 8 (CSS8) [MIM:618362]	A0A1D5RIN8	134	N	D
Q8TAQ2	LP/P	Coffin-Siris syndrome 8 (CSS8) [MIM:618362]	A0A1D5RIN8	609	L	P
Q8TAQ2	LP/P	Coffin-Siris syndrome 8 (CSS8) [MIM:618362]	A0A1D5RIN8	610	L	P
Q8TAQ2	LP/P	Coffin-Siris syndrome 8 (CSS8) [MIM:618362]	A0A1D5RIN8	613	L	P
Q9H4I9	LB/B	-	S9XK47	46	R	G
Q5SQN1	LB/B	-	G3U4V1	48	R	G
Q5SQN1	LB/B	-	G3U4V1	119	G	R
Q5SQN1	LB/B	-	G3U4V1	154	V	M
Q5SQN1	LB/B	-	G3U4V1	381	R	C
O75643	LP/P	Retinitis pigmentosa 33 (RP33) [MIM:610359]	L1K0L5	1087	S	L
O75643	LP/P	Retinitis pigmentosa 33 (RP33) [MIM:610359]	L1K0L5	1090	R	L
O75643	LP/P	Retinitis pigmentosa 33 (RP33) [MIM:610359]	L1K0L5	681	R	C
O75643	LP/P	Retinitis pigmentosa 33 (RP33) [MIM:610359]	L1K0L5	681	R	H
O75643	LP/P	Retinitis pigmentosa 33 (RP33) [MIM:610359]	L1K0L5	689	Y	C
O75643	LP/P	Retinitis pigmentosa 33 (RP33) [MIM:610359]	L1K0L5	502	C	R
O75643	LP/P	Retinitis pigmentosa 33 (RP33) [MIM:610359]	L1K0L5	542	A	V
O75643	LP/P	Retinitis pigmentosa 33 (RP33) [MIM:610359]	L1K0L5	682	P	S
O75643	LP/P	Retinitis pigmentosa 33 (RP33) [MIM:610359]	L1K0L5	698	I	V
O75643	LP/P	Retinitis pigmentosa 33 (RP33) [MIM:610359]	L1K0L5	885	Q	E
O75643	LP/P	Retinitis pigmentosa 33 (RP33) [MIM:610359]	L1K0L5	1779	R	H
O75643	LB/B	-	L1K0L5	1995	A	T
Q5JUK2	LB/B	-	A0A2Y9J533	37	R	Q
Q5JUK2	LB/B	-	A0A2Y9J533	269	P	S
Q9NX45	LB/B	-	F7CD08	14	S	L
Q9NX45	LB/B	-	F7CD08	339	A	T
Q9BX66	LB/B	-	A0A1U8C5H2	74	R	W
Q9BX66	LB/B	-	A0A1U8C5H2	237	T	A
Q9BX66	LB/B	-	A0A1U8C5H2	61	L	P
Q9BX66	LB/B	-	A0A1U8C5H2	175	G	V
Q9BX66	LB/B	-	A0A1U8C5H2	485	Y	C
P56693	LP/P	Waardenburg syndrome 2E (WS2E) [MIM:611584]	M3YNM2	135	S	T
P56693	LP/P	Waardenburg syndrome 4C (WS4C) [MIM:613266]	M3YNM2	106	R	W
P56693	LP/P	Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136]	M3YNM2	112	M	I
P56693	LP/P	Waardenburg syndrome 2E (WS2E) [MIM:611584]	M3YNM2	112	M	I
P56693	LP/P	Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136]	M3YNM2	131	N	H
P56693	LP/P	Waardenburg syndrome 4C (WS4C) [MIM:613266]	M3YNM2	145	L	P
P56693	LP/P	Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136]	M3YNM2	150	K	N
P56693	LP/P	Waardenburg syndrome 4C (WS4C) [MIM:613266]	M3YNM2	157	A	V
P56693	LP/P	Waardenburg syndrome 2E (WS2E) [MIM:611584]	M3YNM2	161	R	H
P56693	LP/P	Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136]	M3YNM2	174	Q	P
P56693	LP/P	Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136]	M3YNM2	175	P	A
P56693	LP/P	Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136]	M3YNM2	175	P	L
P56693	LP/P	Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136]	M3YNM2	175	P	R
P56693	LP/P	Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136]	M3YNM2	321	G	R
P56693	LB/B	-	M3YNM2	151	R	C
O60271	LB/B	-	A0A147A9G8	1320	N	S
Q8TC71	LB/B	-	L5M8S5	227	S	P
Q8TC71	LB/B	-	L5M8S5	483	K	R
Q8NHS9	LB/B	-	A0A091RN41	112	R	T
Q8NHS9	LB/B	-	A0A091RN41	148	V	M
Q8NHS9	LB/B	-	A0A091RN41	155	Q	R
Q8NHS9	LB/B	-	A0A091RN41	160	I	T
Q96N06	LB/B	-	A0A2K5VFA5	45	S	L
Q0P670	LB/B	-	A0A1U7U5F0	108	S	A
Q0P670	LB/B	-	A0A1U7U5F0	376	Q	R
Q2M3C7	LB/B	-	W5MNT8	425	G	R
Q2M3C7	LB/B	-	W5MNT8	617	K	E
Q2M3C7	LB/B	-	W5MNT8	847	H	Q
Q2M3C7	LB/B	-	W5MNT8	867	Q	R
Q2M3C7	LB/B	-	W5MNT8	1603	S	R
Q01892	LB/B	-	M0R3H8	104	A	P
Q9Y657	LB/B	-	A0A0P7YEC9	221	A	P
Q9BUA3	LB/B	-	E1BD11	58	E	Q
Q6UDR6	LB/B	-	W5P8H3	73	G	S
Q6UDR6	LB/B	-	W5P8H3	30	A	E
Q9H2V7	LB/B	-	A0A2Y9PLF4	230	A	P
Q92563	LB/B	-	V9KM17	353	G	S
Q9BQ16	LB/B	-	A0A2U9BNN9	112	I	V
Q9BUD6	LB/B	-	A0A093F7G9	40	L	P
Q9BUD6	LB/B	-	A0A093F7G9	122	A	E
Q9BUD6	LB/B	-	A0A093F7G9	242	V	L
Q9BUD6	LB/B	-	A0A093F7G9	38	R	G
Q5T280	LB/B	-	H2PTK8	130	T	R
Q5T280	LB/B	-	H2PTK8	369	I	T
Q5T280	LB/B	-	H2PTK8	63	A	V
P10451	LB/B	-	L5M309	301	R	H
P10451	LB/B	-	L5M309	224	S	N
Q8TCT7	LB/B	-	H2NWX3	574	S	P
P35321	LB/B	-	A0A061IKQ2	42	H	Q
P35321	LB/B	-	A0A061IKQ2	61	V	I
P22528	LB/B	-	A0A061IKQ2	23	Q	H
P22528	LB/B	-	A0A061IKQ2	61	V	L
P22528	LB/B	-	A0A061IKQ2	80	A	P
P22528	LB/B	-	A0A061IKQ2	11	T	I
Q13501	LB/B	-	V9KG46	117	A	V
Q13501	LB/B	-	V9KG46	274	E	Q
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	387	P	L
Q13501	LP/P	Paget disease of bone 3 (PDB3) [MIM:167250]	V9KG46	387	P	L
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	392	P	L
Q13501	LP/P	Paget disease of bone 3 (PDB3) [MIM:167250]	V9KG46	392	P	L
Q13501	LP/P	Paget disease of bone 3 (PDB3) [MIM:167250]	V9KG46	399	S	P
Q13501	LP/P	Paget disease of bone 3 (PDB3) [MIM:167250]	V9KG46	404	M	T
Q13501	LP/P	Paget disease of bone 3 (PDB3) [MIM:167250]	V9KG46	404	M	V
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	411	G	S
Q13501	LP/P	Paget disease of bone 3 (PDB3) [MIM:167250]	V9KG46	411	G	S
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	425	G	R
Q13501	LP/P	Paget disease of bone 3 (PDB3) [MIM:167250]	V9KG46	425	G	R
Q13501	LB/B	-	V9KG46	274	E	D
Q13501	LB/B	-	V9KG46	238	K	E
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	16	A	V
Q13501	LB/B	-	V9KG46	17	A	V
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	33	A	V
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	80	D	E
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	90	V	M
Q13501	LB/B	-	V9KG46	103	K	R
Q13501	LB/B	-	V9KG46	107	R	Q
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	107	R	W
Q13501	LB/B	-	V9KG46	108	D	Y
Q13501	LB/B	-	V9KG46	110	R	H
Q13501	LB/B	-	V9KG46	118	P	S
Q13501	LB/B	-	V9KG46	119	R	G
Q13501	LB/B	-	V9KG46	125	N	S
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	129	D	N
Q13501	LB/B	-	V9KG46	139	R	C
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	153	V	I
Q13501	LB/B	-	V9KG46	180	S	L
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	212	R	C
Q13501	LB/B	-	V9KG46	217	R	H
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	219	G	V
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	226	S	P
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	228	P	L
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	232	P	T
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	258	D	N
Q13501	LB/B	-	V9KG46	278	T	I
Q13501	LB/B	-	V9KG46	308	A	V
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	318	S	P
Q13501	LB/B	-	V9KG46	319	E	K
Q13501	LB/B	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	321	R	C
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	329	D	G
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	348	P	L
Q13501	LB/B	-	V9KG46	349	S	T
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	370	S	P
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	381	A	V
Q13501	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 (FTDALS3) [MIM:616437]	V9KG46	430	T	P
Q13501	LB/B	-	V9KG46	439	P	L
Q8N5C6	LB/B	-	H2P6C4	361	T	M
Q8N5C6	LB/B	-	H2P6C4	798	V	F
Q8N5C6	LB/B	-	H2P6C4	811	K	R
P19623	LB/B	-	H2YMD7	149	L	V
Q9Y5M8	LB/B	-	F6V1W9	9	V	L
Q8IYB3	LB/B	-	A0A1A6GBK7	170	R	H
Q14714	LB/B	-	A0A093GWN0	186	S	N
Q14714	LB/B	-	A0A093GWN0	228	V	I
P32745	LB/B	-	A0A1S3FUL5	411	S	T
P32745	LB/B	-	A0A1S3FUL5	251	S	F
P32745	LB/B	-	A0A1S3FUL5	33	A	V
P32745	LB/B	-	A0A1S3FUL5	336	R	C
P32745	LB/B	-	A0A1S3FUL5	414	R	H
P32745	LB/B	-	A0A1S3FUL5	37	P	L
P35346	LB/B	-	F1MV99	335	P	L
P35346	LB/B	-	F1MV99	37	G	R
P35346	LB/B	-	F1MV99	48	L	M
P35346	LB/B	-	F1MV99	52	A	V
P35346	LB/B	-	F1MV99	109	P	S
P35346	LB/B	-	F1MV99	333	T	M
P35346	LB/B	-	F1MV99	105	W	R
P35346	LB/B	-	F1MV99	251	L	S
P35346	LB/B	-	F1MV99	339	R	K
P35346	LB/B	-	F1MV99	234	R	C
P35346	LB/B	-	F1MV99	267	V	I
P35346	LB/B	-	F1MV99	357	G	R
Q8IZP2	LB/B	-	A0A2K6GCV7	71	S	L
Q11201	LB/B	-	Q6KB56	111	N	S
Q92187	LB/B	-	G1PUE1	7	R	K
Q8TBR4	LB/B	-	A0A091VWR3	116	E	Q
Q9Y3M8	LB/B	-	H2SIS9	250	K	R
Q9Y3M8	LB/B	-	H2SIS9	175	T	M
Q9Y3M8	LB/B	-	H2SIS9	383	R	P
Q9Y3M8	LB/B	-	H2SIS9	798	N	S
Q14849	LB/B	-	A0A091P0V4	117	R	Q
Q14849	LB/B	-	A0A091P0V4	216	G	A
Q92502	LB/B	-	H2SIS9	327	R	Q
P40763	LB/B	-	A0A1V4JQS7	143	M	I
P40763	LB/B	-	A0A1V4JQS7	32	Q	K
P40763	LP/P	Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060]	A0A1V4JQS7	382	R	L
P40763	LP/P	Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060]	A0A1V4JQS7	382	R	Q
P40763	LP/P	Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060]	A0A1V4JQS7	382	R	W
P40763	LP/P	Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060]	A0A1V4JQS7	384	F	L
P40763	LP/P	Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060]	A0A1V4JQS7	384	F	S
P40763	LP/P	Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060]	A0A1V4JQS7	389	T	I
P40763	LP/P	Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060]	A0A1V4JQS7	423	R	Q
P40763	LP/P	Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060]	A0A1V4JQS7	437	H	Y
P40763	LB/B	-	A0A1V4JQS7	561	F	Y
P40763	LP/P	Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060]	A0A1V4JQS7	611	S	N
P40763	LP/P	Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060]	A0A1V4JQS7	621	F	V
P40763	LP/P	Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060]	A0A1V4JQS7	622	T	I
P40763	LP/P	Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060]	A0A1V4JQS7	637	V	L
P40763	LP/P	Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060]	A0A1V4JQS7	637	V	M
P40763	LP/P	Hyper-IgE recurrent infection syndrome 1, autosomal dominant (HIES1) [MIM:147060]	A0A1V4JQS7	657	Y	C
P40763	LP/P	Autoimmune disease, multisystem, infantile-onset, 1 (ADMIO1) [MIM:615952]	A0A1V4JQS7	392	K	R
P40763	LP/P	Autoimmune disease, multisystem, infantile-onset, 1 (ADMIO1) [MIM:615952]	A0A1V4JQS7	646	N	K
P40763	LP/P	Autoimmune disease, multisystem, infantile-onset, 1 (ADMIO1) [MIM:615952]	A0A1V4JQS7	658	K	N
P40763	LP/P	Autoimmune disease, multisystem, infantile-onset, 1 (ADMIO1) [MIM:615952]	A0A1V4JQS7	716	T	M
P40763	LP/P	Autoimmune disease, multisystem, infantile-onset, 1 (ADMIO1) [MIM:615952]	A0A1V4JQS7	330	P	S
P51692	LP/P	Growth hormone insensitivity syndrome with immune dysregulation 1, autosomal recessive (GHISID1) [MIM:245590]	L9JWK9	630	A	P
P51692	LB/B	-	L9JWK9	130	A	V
P51692	LP/P	Growth hormone insensitivity syndrome with immune dysregulation 1, autosomal recessive (GHISID1) [MIM:245590]	L9JWK9	646	F	S
P51692	LP/P	Growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant (GHISID2) [MIM:618985]	L9JWK9	177	Q	P
P51692	LP/P	Growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant (GHISID2) [MIM:618985]	L9JWK9	474	Q	R
P51692	LP/P	Growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant (GHISID2) [MIM:618985]	L9JWK9	478	A	V
Q9H668	LB/B	-	A0A2J8XYR9	151	T	A
Q9H668	LB/B	-	A0A2J8XYR9	248	S	C
Q9H668	LP/P	Cerebroretinal microangiopathy with calcifications and cysts 2 (CRMCC2) [MIM:617341]	A0A2J8XYR9	135	R	T
Q9H668	LP/P	Cerebroretinal microangiopathy with calcifications and cysts 2 (CRMCC2) [MIM:617341]	A0A2J8XYR9	157	D	Y
Q9Y6Q2	LB/B	-	G1SS54	127	R	T
Q9Y6Q2	LB/B	-	G1SS54	544	Q	H
Q9Y6Q2	LB/B	-	G1SS54	607	Q	H
Q9Y6Q2	LB/B	-	G1SS54	8	K	N
Q9C0K7	LB/B	-	A0A2D4ME71	386	P	L
P53597	LP/P	Mitochondrial DNA depletion syndrome 9 (MTDPS9) [MIM:245400]	A0A1L8HSG7	14	M	L
P53597	LP/P	Mitochondrial DNA depletion syndrome 9 (MTDPS9) [MIM:245400]	A0A1L8HSG7	170	P	R
P53597	LP/P	Mitochondrial DNA depletion syndrome 9 (MTDPS9) [MIM:245400]	A0A1L8HSG7	85	G	A
P53597	LB/B	-	A0A1L8HSG7	37	G	A
Q8IX01	LB/B	-	A0A2U3YLP6	206	G	S
Q8IX01	LB/B	-	A0A2U3YLP6	552	M	T
Q8IX01	LB/B	-	A0A2U3YLP6	649	Q	R
Q8IX01	LB/B	-	A0A2U3YLP6	722	Q	R
Q8IX01	LB/B	-	A0A2U3YLP6	881	R	Q
Q8IWU5	LB/B	-	F6ZWH0	674	R	H
Q8IWU5	LB/B	-	F6ZWH0	76	A	T
P61956	LB/B	-	A0A061I253	16	D	N
Q8TAQ9	LB/B	-	E2RIK8	127	I	V
Q8TAQ9	LB/B	-	E2RIK8	177	L	V
Q8NEM7	LB/B	-	D2I8E8	154	M	V
Q8NEM7	LB/B	-	D2I8E8	773	T	M
O95425	LB/B	-	D3ZEZ9	189	V	A
O95425	LB/B	-	D3ZEZ9	1235	P	A
O95425	LB/B	-	D3ZEZ9	1688	S	P
O95425	LB/B	-	D3ZEZ9	1041	V	L
O95425	LB/B	-	D3ZEZ9	2005	I	V
O95425	LB/B	-	D3ZEZ9	2041	A	V
O95425	LB/B	-	D3ZEZ9	422	V	I
Q92777	LB/B	-	A0A2U3XYG8	506	T	A
O14994	LB/B	-	A0A2U3XYG8	470	S	N
Q8WXH0	LB/B	-	A0A2U3YDH4	8	P	S
Q8WXH0	LB/B	-	A0A2U3YDH4	574	I	T
Q8WXH0	LB/B	-	A0A2U3YDH4	2358	N	S
Q8WXH0	LB/B	-	A0A2U3YDH4	2394	A	T
Q8WXH0	LB/B	-	A0A2U3YDH4	2801	G	S
Q8WXH0	LB/B	-	A0A2U3YDH4	432	S	R
Q8WXH0	LB/B	-	A0A2U3YDH4	1393	R	W
Q8WXH0	LB/B	-	A0A2U3YDH4	1969	M	T
Q8WXH0	LB/B	-	A0A2U3YDH4	2284	A	V
Q8WXH0	LB/B	-	A0A2U3YDH4	2347	A	E
Q8WXH0	LB/B	-	A0A2U3YDH4	2359	S	G
Q8WXH0	LB/B	-	A0A2U3YDH4	2359	S	N
Q8WXH0	LB/B	-	A0A2U3YDH4	2395	A	T
Q8WXH0	LB/B	-	A0A2U3YDH4	2490	V	G
Q8WXH0	LB/B	-	A0A2U3YDH4	2564	I	V
Q8WXH0	LB/B	-	A0A2U3YDH4	2802	S	G
Q8WXH0	LB/B	-	A0A2U3YDH4	2942	I	V
Q8WXH0	LB/B	-	A0A2U3YDH4	3026	E	D
Q8WXH0	LB/B	-	A0A2U3YDH4	3130	N	S
Q8WXH0	LB/B	-	A0A2U3YDH4	3253	D	H
Q8WXH0	LB/B	-	A0A2U3YDH4	3309	H	R
Q8WXH0	LB/B	-	A0A2U3YDH4	3523	K	Q
Q8WXH0	LB/B	-	A0A2U3YDH4	3982	N	H
Q8WXH0	LB/B	-	A0A2U3YDH4	4041	R	H
Q8WXH0	LB/B	-	A0A2U3YDH4	4912	P	A
Q8WXH0	LB/B	-	A0A2U3YDH4	4913	E	K
Q8WXH0	LB/B	-	A0A2U3YDH4	5086	H	Y
Q8WXH0	LB/B	-	A0A2U3YDH4	5186	L	M
Q8WXH0	LB/B	-	A0A2U3YDH4	5547	D	N
Q8WXH0	LB/B	-	A0A2U3YDH4	6155	A	V
Q8WXH0	LB/B	-	A0A2U3YDH4	6681	K	E
Q8WXH0	LB/B	-	A0A2U3YDH4	6697	R	W
Q8WXH0	LP/P	Emery-Dreifuss muscular dystrophy 5, autosomal dominant (EDMD5) [MIM:612999]	A0A2U3YDH4	6211	T	M
Q6ZMZ3	LB/B	-	F7EJP0	668	T	M
Q6ZMZ3	LB/B	-	F7EJP0	864	R	H
Q6ZMZ3	LB/B	-	F7EJP0	923	A	V
Q6ZMZ3	LB/B	-	F7EJP0	946	I	V
Q8N205	LB/B	-	G7PXB6	224	S	L
Q8N205	LB/B	-	G7PXB6	278	Q	H
Q96PV0	LB/B	-	A0A2D0PSU0	201	D	E
Q96PV0	LB/B	-	A0A2D0PSU0	749	R	Q
Q96PV0	LB/B	-	A0A2D0PSU0	790	T	N
Q96PV0	LB/B	-	A0A2D0PSU0	991	G	R
Q96PV0	LB/B	-	A0A2D0PSU0	1115	I	T
Q96PV0	LB/B	-	A0A2D0PSU0	1283	P	L
Q96PV0	LB/B	-	A0A2D0PSU0	1310	T	M
Q96PV0	LP/P	Intellectual developmental disorder, autosomal dominant 5 (MRD5) [MIM:612621]	A0A2D0PSU0	362	W	R
Q96PV0	LP/P	Intellectual developmental disorder, autosomal dominant 5 (MRD5) [MIM:612621]	A0A2D0PSU0	562	P	L
Q96PV0	LP/P	-	A0A2D0PSU0	170	R	Q
Q96PV0	LP/P	-	A0A2D0PSU0	195	A	P
Q9BT88	LB/B	-	A0A146XQL8	48	Q	H
Q9BT88	LB/B	-	A0A146XQL8	231	G	V
Q58G82	LB/B	-	Q58G82	97	T	M
Q96RJ0	LB/B	-	A0A2U4AHM9	23	R	C
Q96RJ0	LB/B	-	A0A2U4AHM9	252	T	A
Q96RI8	LB/B	-	A0A212C787	37	I	T
Q96RI8	LB/B	-	A0A212C787	165	G	S
Q96RI8	LB/B	-	A0A212C787	173	Y	C
Q96RI8	LB/B	-	A0A212C787	228	A	V
Q96RI8	LB/B	-	A0A212C787	265	V	I
Q96RI8	LB/B	-	A0A212C787	291	C	Y
Q96RI8	LB/B	-	A0A212C787	326	V	I
Q96RI8	LB/B	-	A0A212C787	99	Y	C
Q96RI9	LB/B	-	A0A212C787	278	A	T
Q9BSH4	LB/B	-	A0A2K6SCD5	145	G	S
Q15544	LB/B	-	A0A0A0MXS1	68	T	R
Q15544	LB/B	-	A0A0A0MXS1	155	S	F
Q15572	LB/B	-	F6URP8	304	S	F
Q15572	LB/B	-	F6URP8	357	R	H
Q15572	LB/B	-	F6URP8	387	S	L
Q15572	LB/B	-	F6URP8	518	H	Y
Q15572	LB/B	-	F6URP8	573	P	L
Q15572	LB/B	-	F6URP8	575	L	M
Q15572	LB/B	-	F6URP8	591	A	G
Q15572	LB/B	-	F6URP8	635	G	S
Q15572	LB/B	-	F6URP8	791	T	M
Q15572	LB/B	-	F6URP8	793	P	L
Q15572	LB/B	-	F6URP8	816	R	H
Q15572	LB/B	-	F6URP8	523	G	R
Q15572	LB/B	-	F6URP8	808	P	S
Q15572	LB/B	-	F6URP8	91	C	Y
Q92750	LB/B	-	K7F3R2	249	I	V
Q92750	LB/B	-	K7F3R2	539	N	S
Q03518	LB/B	-	A0A0D9RAM5	333	I	V
Q03518	LB/B	-	A0A0D9RAM5	637	D	G
Q03518	LB/B	-	A0A0D9RAM5	370	A	V
Q03518	LB/B	-	A0A0D9RAM5	458	V	L
Q03518	LB/B	-	A0A0D9RAM5	518	V	I
Q03518	LB/B	-	A0A0D9RAM5	648	R	Q
Q03518	LB/B	-	A0A0D9RAM5	7	P	S
Q03518	LB/B	-	A0A0D9RAM5	17	G	R
Q03518	LB/B	-	A0A0D9RAM5	419	G	C
Q03518	LB/B	-	A0A0D9RAM5	708	Q	R
Q03518	LB/B	-	A0A0D9RAM5	110	L	V
Q03518	LB/B	-	A0A0D9RAM5	286	S	F
Q03518	LB/B	-	A0A0D9RAM5	244	V	L
P59542	LB/B	-	A0A2I3M0D4	126	K	Q
P59542	LB/B	-	A0A2I3M0D4	299	R	C
P59543	LB/B	-	A0A2I3M0D4	79	K	E
P59543	LB/B	-	A0A2I3M0D4	143	H	Q
P59543	LB/B	-	A0A2I3M0D4	148	H	N
P59543	LB/B	-	A0A2I3M0D4	236	I	V
P59543	LB/B	-	A0A2I3M0D4	252	F	S
P59543	LB/B	-	A0A2I3M0D4	255	R	L
P59541	LB/B	-	A0A2I3M0D4	252	F	L
P59538	LB/B	-	A0A2I3M0D4	35	R	W
P59538	LB/B	-	A0A2I3M0D4	162	L	M
P59538	LB/B	-	A0A2I3M0D4	217	Q	E
P59538	LB/B	-	A0A2I3M0D4	227	A	V
P59538	LB/B	-	A0A2I3M0D4	240	V	I
P59538	LB/B	-	A0A2I3M0D4	276	P	R
P59540	LB/B	-	A0A2I3M0D4	228	L	M
P59544	LB/B	-	A0A2I3M0D4	203	C	Y
Q9H6P5	LP/P	Suleiman-El-Hattab syndrome (SULEHS) [MIM:618950]	A0A0Q3MRB5	234	T	M
Q93075	LB/B	-	A0A1S2ZCD3	217	H	R
Q93075	LB/B	-	A0A1S2ZCD3	256	V	I
Q93075	LB/B	-	A0A1S2ZCD3	358	P	L
Q86VP1	LB/B	-	A0A2D4J3I0	307	L	I
Q86VP1	LB/B	-	A0A2D4J3I0	58	S	N
Q9P2M4	LB/B	-	A0A287AG55	446	E	Q
Q9P2M4	LB/B	-	A0A287AG55	41	L	V
Q9HA65	LB/B	-	S4RV69	99	L	P
Q9HA65	LB/B	-	S4RV69	84	G	D
Q96BZ9	LB/B	-	S7N7R0	79	N	S
Q96NH3	LB/B	-	F6TH68	82	R	Q
Q96NH3	LB/B	-	F6TH68	280	I	V
Q96NH3	LB/B	-	F6TH68	375	T	K
Q96NH3	LB/B	-	F6TH68	599	I	V
O60343	LB/B	-	I3M6E8	1147	T	M
O60343	LB/B	-	I3M6E8	1275	V	A
O60343	LB/B	-	I3M6E8	1284	L	I
O60343	LB/B	-	I3M6E8	819	V	I
O60343	LB/B	-	I3M6E8	619	P	L
O60343	LB/B	-	I3M6E8	1119	V	A
Q6ZT07	LB/B	-	A0A2J8K2Y6	7	E	K
Q6ZT07	LB/B	-	A0A2J8K2Y6	779	E	K
Q66K14	LB/B	-	A0A2J8K2Y6	240	L	P
Q66K14	LB/B	-	A0A2J8K2Y6	706	V	I
Q66K14	LB/B	-	A0A2J8K2Y6	1119	K	T
Q96SF7	LB/B	-	A0A2K6L1D0	156	H	N
O95935	LB/B	-	A0A2K6L1D0	48	G	R
O95935	LP/P	Congenital anomalies of kidney and urinary tract 2 (CAKUT2) [MIM:143400]	A0A2K6L1D0	163	K	E
O95935	LB/B	-	A0A2K6L1D0	164	A	T
O95935	LP/P	Congenital anomalies of kidney and urinary tract 2 (CAKUT2) [MIM:143400]	A0A2K6L1D0	524	H	Y
O95935	LB/B	-	A0A2K6L1D0	526	P	S
O95947	LB/B	-	A0A2K6GLS7	178	S	F
O95947	LB/B	-	A0A2K6GLS7	179	P	S
O95947	LB/B	-	A0A2K6GLS7	162	G	S
P24557	LB/B	-	A0A2K6AHL4	160	D	E
P24557	LB/B	-	A0A2K6AHL4	245	N	S
P24557	LB/B	-	A0A2K6AHL4	356	L	V
P24557	LB/B	-	A0A2K6AHL4	416	Q	E
P24557	LB/B	-	A0A2K6AHL4	449	E	K
P24557	LB/B	-	A0A2K6AHL4	450	T	N
P24557	LB/B	-	A0A2K6AHL4	465	R	Q
P24557	LB/B	-	A0A2K6AHL4	60	R	H
P24557	LB/B	-	A0A2K6AHL4	162	L	I
P24557	LB/B	-	A0A2K6AHL4	331	I	T
P24557	LB/B	-	A0A2K6AHL4	424	R	C
P24557	LB/B	-	A0A2K6AHL4	429	A	T
P24557	LB/B	-	A0A2K6AHL4	257	K	E
P24557	LB/B	-	A0A2K6AHL4	260	R	G
P24557	LB/B	-	A0A2K6AHL4	316	Q	K
P24557	LB/B	-	A0A2K6AHL4	389	G	V
P24557	LB/B	-	A0A2K6AHL4	124	V	I
P24557	LB/B	-	A0A2K6AHL4	388	E	K
P24557	LB/B	-	A0A2K6AHL4	501	R	Q
P24557	LP/P	Ghosal hematodiaphyseal dysplasia (GHDD) [MIM:231095]	A0A2K6AHL4	82	L	P
P24557	LB/B	-	A0A2K6AHL4	357	L	V
P24557	LP/P	Ghosal hematodiaphyseal dysplasia (GHDD) [MIM:231095]	A0A2K6AHL4	412	R	Q
P24557	LP/P	Ghosal hematodiaphyseal dysplasia (GHDD) [MIM:231095]	A0A2K6AHL4	481	G	W
P24557	LP/P	Ghosal hematodiaphyseal dysplasia (GHDD) [MIM:231095]	A0A2K6AHL4	487	L	P
P24557	LB/B	-	A0A2K6AHL4	512	L	P
P24557	LB/B	-	A0A2K6AHL4	387	E	K
P24557	LB/B	-	A0A2K6AHL4	511	P	L
P24557	LB/B	-	A0A2K6AHL4	70	L	P
P24557	LB/B	-	A0A2K6AHL4	70	L	V
Q8N3R3	LB/B	-	A0A1A6HQ92	4	H	P
Q15170	LB/B	-	M3YDV2	5	R	C
Q9Y242	LB/B	-	G3NAX4	211	M	V
Q9Y242	LB/B	-	G3NAX4	241	P	L
Q9Y242	LB/B	-	G3NAX4	109	P	S
Q5QJ38	LB/B	-	G1PNV1	193	A	G
P20061	LB/B	-	A0A0B4UD87	35	R	H
P20061	LB/B	-	A0A0B4UD87	301	D	Y
Q8TDR4	LB/B	-	Q68US1	145	H	R
Q8TDR4	LB/B	-	Q68US1	194	R	H
Q8NAT2	LB/B	-	M7B955	104	M	T
Q8NAT2	LB/B	-	M7B955	358	K	E
Q8NAT2	LB/B	-	M7B955	722	E	K
Q8NAT2	LB/B	-	M7B955	239	F	V
O15040	LB/B	-	A0A226MNQ4	320	V	I
O15040	LB/B	-	A0A226MNQ4	386	A	T
O15040	LB/B	-	A0A226MNQ4	439	P	S
O15040	LB/B	-	A0A226MNQ4	683	I	V
Q5XG87	LB/B	-	A0A0G2JDV2	576	N	S
Q5XG87	LB/B	-	A0A0G2JDV2	646	G	S
Q96IP4	LB/B	-	A0A2K5Q8C6	313	T	A
Q6URK8	LB/B	-	A0A2Y9M2C7	260	S	N
A2RU30	LB/B	-	A0A2K5F442	496	E	K
Q8NFU7	LB/B	-	I3LYR2	162	D	G
Q8NFU7	LB/B	-	I3LYR2	193	S	T
Q8NFU7	LB/B	-	I3LYR2	256	A	V
Q8NFU7	LB/B	-	I3LYR2	1018	N	S
Q8NFU7	LB/B	-	I3LYR2	1123	I	M
O43151	LB/B	-	A0A1L8GSA2	712	R	Q
O43151	LP/P	Beck-Fahrner syndrome (BEFAHRS) [MIM:618798]	A0A1L8GSA2	851	T	M
O43151	LP/P	Beck-Fahrner syndrome (BEFAHRS) [MIM:618798]	A0A1L8GSA2	908	V	L
O43151	LP/P	Beck-Fahrner syndrome (BEFAHRS) [MIM:618798]	A0A1L8GSA2	1072	F	C
O43151	LP/P	Beck-Fahrner syndrome (BEFAHRS) [MIM:618798]	A0A1L8GSA2	1076	A	T
O43151	LP/P	Beck-Fahrner syndrome (BEFAHRS) [MIM:618798]	A0A1L8GSA2	1089	V	M
O43151	LP/P	Beck-Fahrner syndrome (BEFAHRS) [MIM:618798]	A0A1L8GSA2	1677	P	L
Q8IYF3	LB/B	-	A0A2U9C5W8	130	K	R
Q8IYF3	LB/B	-	A0A2U9C5W8	451	E	K
Q8IYF3	LP/P	Spermatogenic failure, X-linked, 2 (SPGFX2) [MIM:309120]	A0A2U9C5W8	171	M	V
Q8IYF3	LP/P	Spermatogenic failure, X-linked, 2 (SPGFX2) [MIM:309120]	A0A2U9C5W8	698	A	T
Q9BXT5	LB/B	-	A0A287ASS8	104	C	R
Q9BXT5	LB/B	-	A0A287ASS8	383	P	L
Q9BXT5	LB/B	-	A0A287ASS8	1035	I	V
Q9BXT5	LB/B	-	A0A287ASS8	1311	N	S
Q9BXT5	LB/B	-	A0A287ASS8	1337	L	V
Q9BXT5	LB/B	-	A0A287ASS8	1439	K	R
Q9BXT5	LB/B	-	A0A287ASS8	2138	D	N
Q96LM6	LB/B	-	H0VK41	24	D	N
P02787	LB/B	-	A0A1A6G1K0	296	D	G
P02787	LB/B	-	A0A1A6G1K0	319	H	R
P02787	LB/B	-	A0A1A6G1K0	142	G	S
P02787	LB/B	-	A0A1A6G1K0	277	G	S
P02787	LB/B	-	A0A1A6G1K0	377	W	C
P02787	LB/B	-	A0A1A6G1K0	589	P	S
P02787	LB/B	-	A0A1A6G1K0	645	T	P
P02787	LP/P	Atransferrinemia (ATRAF) [MIM:209300]	A0A1A6G1K0	477	A	P
P02787	LB/B	-	A0A1A6G1K0	646	K	E
P02787	LB/B	-	A0A1A6G1K0	671	G	E
P02787	LB/B	-	A0A1A6G1K0	55	S	R
P02787	LB/B	-	A0A1A6G1K0	42	R	L
P02787	LB/B	-	A0A1A6G1K0	76	A	V
P02787	LB/B	-	A0A1A6G1K0	562	G	V
P02787	LP/P	Atransferrinemia (ATRAF) [MIM:209300]	A0A1A6G1K0	77	D	N
P02787	LB/B	-	A0A1A6G1K0	448	V	I
Q8WVM0	LB/B	-	W8BZL5	120	A	P
Q8WVM0	LB/B	-	W8BZL5	211	T	A
Q8WVM0	LB/B	-	W8BZL5	256	R	Q
O95455	LB/B	-	G3PN12	15	G	S
O95455	LP/P	Catel-Manzke syndrome (CATMANS) [MIM:616145]	G3PN12	90	E	G
O95455	LP/P	Catel-Manzke syndrome (CATMANS) [MIM:616145]	G3PN12	98	F	L
O95455	LP/P	Catel-Manzke syndrome (CATMANS) [MIM:616145]	G3PN12	100	A	S
O95455	LP/P	Catel-Manzke syndrome (CATMANS) [MIM:616145]	G3PN12	234	Y	H
O95455	LP/P	Catel-Manzke syndrome (CATMANS) [MIM:616145]	G3PN12	298	N	D
P61812	LB/B	-	A0A2D4LEH7	91	R	H
P61812	LB/B	-	A0A2D4LEH7	207	V	L
P61812	LP/P	Loeys-Dietz syndrome 4 (LDS4) [MIM:614816]	A0A2D4LEH7	299	R	W
P61812	LP/P	Loeys-Dietz syndrome 4 (LDS4) [MIM:614816]	A0A2D4LEH7	302	R	C
P61812	LP/P	Loeys-Dietz syndrome 4 (LDS4) [MIM:614816]	A0A2D4LEH7	338	P	H
P61812	LP/P	-	A0A2D4LEH7	320	R	C
Q8WY91	LB/B	-	G1T0R8	121	S	G
Q9H5L6	LB/B	-	K7GES0	284	M	I
Q9H5L6	LB/B	-	K7GES0	299	L	F
Q9H5L6	LB/B	-	K7GES0	812	N	D
Q9H5L6	LB/B	-	K7GES0	833	V	I
P35443	LB/B	-	A0A060WS70	55	L	Q
P35443	LB/B	-	A0A060WS70	387	A	P
P35443	LB/B	-	A0A060WS70	420	A	V
P35443	LB/B	-	A0A060WS70	646	V	I
P35443	LB/B	-	A0A060WS70	737	V	I
O60220	LP/P	Mohr-Tranebjaerg syndrome (MTS) [MIM:304700]	H2PW98	66	C	W
Q9GZM7	LB/B	-	A0A067RK97	69	A	S
Q9UDY2	LP/P	Hypercholanemia, familial, 1 (FHCA1) [MIM:607748]	A0A2U3VQW1	48	V	A
Q9UDY2	LB/B	-	A0A2U3VQW1	482	D	E
Q9UDY2	LB/B	-	A0A2U3VQW1	668	M	I
Q9UDY2	LB/B	-	A0A2U3VQW1	711	S	P
Q9UDY2	LB/B	-	A0A2U3VQW1	822	K	N
Q9UDY2	LB/B	-	A0A2U3VQW1	829	N	D
A0PJX2	LB/B	-	L8IIR6	102	G	R
Q9BZW5	LB/B	-	F1MH69	17	I	T
Q9BZW5	LB/B	-	F1MH69	59	P	S
Q8TDI7	LB/B	-	A0A1U7U9G0	123	R	K
Q8TDI7	LB/B	-	A0A1U7U9G0	573	S	C
Q8TDI7	LB/B	-	A0A1U7U9G0	800	E	Q
Q8TDI7	LB/B	-	A0A1U7U9G0	205	Q	R
Q8TDI7	LB/B	-	A0A1U7U9G0	217	W	R
Q8TDI7	LB/B	-	A0A1U7U9G0	589	S	C
Q8TDI7	LB/B	-	A0A1U7U9G0	816	E	Q
Q7Z402	LB/B	-	K7F8K9	59	R	W
Q7Z402	LB/B	-	K7F8K9	254	G	E
Q7Z402	LB/B	-	K7F8K9	635	T	I
Q7Z402	LB/B	-	K7F8K9	355	T	S
Q6UWJ1	LB/B	-	A0A1A8B210	443	A	T
Q6UWJ1	LB/B	-	A0A1A8B210	445	A	T
Q96DC7	LB/B	-	A0A091QUI4	299	T	S
Q8NE00	LB/B	-	A0A2J8Y070	58	V	M
Q8NE00	LB/B	-	A0A2J8Y070	439	A	T
Q9BXJ8	LB/B	-	A0A2R8MIG9	86	Q	R
Q9BXJ8	LB/B	-	A0A2R8MIG9	201	T	A
Q8N131	LB/B	-	A0A2J8XX41	71	V	M
Q8N131	LB/B	-	A0A2J8XX41	86	V	F
Q8N131	LB/B	-	A0A2J8XX41	158	A	T
Q8N3G9	LB/B	-	A0A1V4KS56	407	E	V
Q86UB9	LB/B	-	A0A1S3KBG5	193	P	H
Q86UB9	LB/B	-	A0A1S3KBG5	218	G	R
Q86UB9	LB/B	-	A0A1S3KBG5	430	G	A
Q8N614	LB/B	-	A0A286ZL10	48	Y	C
Q8N614	LB/B	-	A0A286ZL10	212	M	T
Q8N614	LB/B	-	A0A286ZL10	105	S	P
Q8WVE6	LB/B	-	F1S380	23	F	L
Q8WVE6	LB/B	-	F1S380	86	R	G
Q8WVE6	LB/B	-	F1S380	139	N	K
Q53S58	LB/B	-	A0A1S3FIH4	29	G	A
Q53S58	LB/B	-	A0A1S3FIH4	32	I	V
Q53S58	LB/B	-	A0A1S3FIH4	267	D	E
Q8NFB2	LB/B	-	A0A287AL09	179	M	V
Q8NFB2	LB/B	-	A0A287AL09	243	C	S
Q9BSN7	LB/B	-	A0A2D4IHI2	57	G	A
Q9P0N5	LP/P	Joubert syndrome 2 (JBTS2) [MIM:608091]	A0A2Y9JQT0	73	R	L
Q9P0N5	LP/P	Joubert syndrome 2 (JBTS2) [MIM:608091]	A0A2Y9JQT0	73	R	C
Q9P0N5	LP/P	Joubert syndrome 2 (JBTS2) [MIM:608091]	A0A2Y9JQT0	73	R	H
Q9P0N5	LP/P	Meckel syndrome 2 (MKS2) [MIM:603194]	A0A2Y9JQT0	73	R	H
Q9P0N5	LP/P	Meckel syndrome 2 (MKS2) [MIM:603194]	A0A2Y9JQT0	77	G	A
Q9P0N5	LP/P	Meckel syndrome 2 (MKS2) [MIM:603194]	A0A2Y9JQT0	114	L	R
Q9P0N5	LP/P	Joubert syndrome 2 (JBTS2) [MIM:608091]	A0A2Y9JQT0	89	L	F
Q9H0R3	LP/P	Neurodevelopmental disorder with motor and speech delay and behavioral abnormalities (NEDMOSBA) [MIM:619470]	F7ATD8	72	G	S
A0PJW6	LB/B	-	A0A286ZMH2	28	T	A
A0PJW6	LB/B	-	A0A286ZMH2	196	V	G
Q6GV28	LB/B	-	A0A2J8X071	196	C	R
Q6GV28	LB/B	-	A0A2J8X071	134	N	S
Q8NDY8	LB/B	-	A0A1U7UDV7	141	M	T
Q8NDY8	LB/B	-	A0A1U7UDV7	141	M	V
O94886	LB/B	-	A0A087XUL6	622	V	M
O94886	LB/B	-	A0A087XUL6	121	F	I
O94886	LP/P	Leukodystrophy, hypomyelinating, 19, transient infantile (HLD19) [MIM:618688]	A0A087XUL6	168	G	E
O94886	LP/P	Leukodystrophy, hypomyelinating, 19, transient infantile (HLD19) [MIM:618688]	A0A087XUL6	462	I	N
O94886	LP/P	Leukodystrophy, hypomyelinating, 19, transient infantile (HLD19) [MIM:618688]	A0A087XUL6	567	G	S
A2RUT3	LB/B	-	Q9DA04	61	P	T
Q6UXU6	LB/B	-	Q3TE29	90	S	T
Q6UXU6	LB/B	-	Q3TE29	90	S	N
Q6UXU6	LB/B	-	Q3TE29	4	A	T
Q86WS5	LB/B	-	G3T748	19	Y	H
Q86WS5	LB/B	-	G3T748	62	E	K
Q86WS5	LB/B	-	G3T748	127	A	T
P24821	LB/B	-	U3J4N9	2008	E	Q
P24821	LB/B	-	U3J4N9	1781	A	T
P24821	LB/B	-	U3J4N9	539	Q	R
P24821	LB/B	-	U3J4N9	605	V	I
P24821	LB/B	-	U3J4N9	680	Q	R
P24821	LB/B	-	U3J4N9	213	G	S
P24821	LB/B	-	U3J4N9	850	D	H
P24821	LB/B	-	U3J4N9	1677	I	L
P24821	LP/P	Deafness, autosomal dominant, 56 (DFNA56) [MIM:615629]	U3J4N9	1773	V	M
P24821	LP/P	Deafness, autosomal dominant, 56 (DFNA56) [MIM:615629]	U3J4N9	1796	T	S
P01375	LB/B	-	A0A061IFV4	94	A	T
P01375	LB/B	-	A0A061IFV4	84	P	L
Q03169	LB/B	-	A0A2U3VL39	282	Q	E
Q03169	LB/B	-	A0A2U3VL39	565	T	I
Q03169	LB/B	-	A0A2U3VL39	580	T	M
O14836	LP/P	Immunodeficiency, common variable, 2 (CVID2) [MIM:240500]	A0A2J8J315	104	C	R
O14836	LP/P	Immunoglobulin A deficiency 2 (IGAD2) [MIM:609529]	A0A2J8J315	104	C	R
O14836	LP/P	Immunodeficiency, common variable, 2 (CVID2) [MIM:240500]	A0A2J8J315	181	A	G
O14836	LP/P	Immunodeficiency, common variable, 2 (CVID2) [MIM:240500]	A0A2J8J315	202	R	H
O14836	LB/B	-	A0A2J8J315	251	P	L
Q02223	LB/B	-	J9NXG8	153	A	T
Q02223	LB/B	-	J9NXG8	54	A	V
Q02223	LB/B	-	J9NXG8	65	I	V
Q02223	LB/B	-	J9NXG8	75	F	V
Q02223	LB/B	-	J9NXG8	81	N	S
Q02223	LB/B	-	J9NXG8	165	C	S
Q02223	LB/B	-	J9NXG8	176	E	D
Q07011	LB/B	-	A0A287DAR0	56	A	T
Q07011	LB/B	-	A0A287DAR0	115	K	N
Q07011	LB/B	-	A0A287DAR0	176	A	D
Q9UKE5	LB/B	-	F7E1Y7	778	K	E
Q9UKE5	LB/B	-	F7E1Y7	910	G	E
Q9UKE5	LB/B	-	F7E1Y7	999	A	T
Q15025	LB/B	-	A0A091SBL8	103	P	S
Q15025	LB/B	-	A0A091SBL8	146	A	V
Q15025	LB/B	-	A0A091SBL8	151	P	A
Q15025	LB/B	-	A0A091SBL8	233	R	Q
Q15025	LB/B	-	A0A091SBL8	260	A	V
Q15388	LB/B	-	A0A218VB09	117	P	L
Q15388	LB/B	-	A0A218VB09	134	V	L
Q9HCN2	LB/B	-	A0A2K5CPH3	7	A	V
Q9Y2B4	LB/B	-	W5P5R2	57	R	H
Q9Y2B4	LB/B	-	W5P5R2	172	V	A
Q9Y2B4	LB/B	-	W5P5R2	191	R	H
Q9Y2B4	LB/B	-	W5P5R2	219	H	Q
Q9Y2B4	LB/B	-	W5P5R2	221	P	L
Q9Y2B4	LB/B	-	W5P5R2	257	V	A
Q9Y2B4	LB/B	-	W5P5R2	275	H	N
Q15661	LB/B	-	H0XUS1	18	A	V
Q15661	LB/B	-	H0XUS1	23	G	V
Q15661	LB/B	-	H0XUS1	85	A	T
Q15661	LB/B	-	H0XUS1	141	T	A
Q15661	LB/B	-	H0XUS1	162	D	N
Q15661	LB/B	-	H0XUS1	170	P	S
Q15661	LB/B	-	H0XUS1	215	T	S
Q15661	LB/B	-	H0XUS1	216	R	Q
Q15661	LB/B	-	H0XUS1	132	N	K
Q15661	LB/B	-	H0XUS1	136	H	R
Q15661	LB/B	-	H0XUS1	3	N	S
Q15661	LB/B	-	H0XUS1	15	R	P
Q15661	LB/B	-	H0XUS1	28	R	Q
Q15661	LB/B	-	H0XUS1	29	V	A
Q15661	LB/B	-	H0XUS1	51	H	R
Q15661	LB/B	-	H0XUS1	52	G	D
Q15661	LB/B	-	H0XUS1	53	P	R
Q15661	LB/B	-	H0XUS1	76	V	L
Q15661	LB/B	-	H0XUS1	115	T	I
Q15661	LB/B	-	H0XUS1	116	A	I
Q15661	LB/B	-	H0XUS1	118	I	T
Q15661	LB/B	-	H0XUS1	133	V	I
Q15661	LB/B	-	H0XUS1	141	T	M
Q15661	LB/B	-	H0XUS1	168	R	P
Q15661	LB/B	-	H0XUS1	205	V	I
Q15661	LB/B	-	H0XUS1	221	Q	K
Q15661	LB/B	-	H0XUS1	245	G	D
Q15661	LB/B	-	H0XUS1	263	Y	N
Q9BZJ3	LB/B	-	H0XUS1	22	P	R
Q9BZJ3	LB/B	-	H0XUS1	25	V	A
Q9BZJ3	LB/B	-	H0XUS1	83	V	M
P56180	LB/B	-	A0A2I3HL79	470	L	P
P56180	LB/B	-	A0A2I3HL79	195	R	Q
P56180	LB/B	-	A0A2I3HL79	549	G	E
P56180	LB/B	-	A0A2I3HL79	482	Y	S
P56180	LB/B	-	A0A2I3HL79	386	K	E
Q13077	LB/B	-	Q4VA12	139	M	T
O43734	LB/B	-	H0VMA6	332	H	Q
O43734	LB/B	-	H0VMA6	83	R	W
O43734	LP/P	Psoriasis 13 (PSORS13) [MIM:614070]	H0VMA6	19	D	N
O43734	LP/P	Candidiasis, familial, 8 (CANDF8) [MIM:615527]	H0VMA6	536	T	I
Q9Y228	LB/B	-	A0A093IGY5	373	Q	E
Q6Q0C0	LP/P	Cardiac, facial, and digital anomalies with developmental delay (CAFDADD) [MIM:618164]	A0A2I3RJ08	346	K	E
Q6Q0C0	LP/P	Cardiac, facial, and digital anomalies with developmental delay (CAFDADD) [MIM:618164]	A0A2I3RJ08	371	R	G
Q6Q0C0	LP/P	Cardiac, facial, and digital anomalies with developmental delay (CAFDADD) [MIM:618164]	A0A2I3RJ08	601	T	A
Q6Q0C0	LP/P	Cardiac, facial, and digital anomalies with developmental delay (CAFDADD) [MIM:618164]	A0A2I3RJ08	655	R	Q
Q8IXB3	LB/B	-	G3QUW3	3	H	Y
Q8IXB3	LB/B	-	G3QUW3	15	P	S
Q8IXB3	LB/B	-	G3QUW3	18	A	T
Q8IXB3	LB/B	-	G3QUW3	20	F	S
Q8IXB3	LB/B	-	G3QUW3	34	E	D
Q8IXB3	LB/B	-	G3QUW3	57	S	G
Q86YW5	LB/B	-	A0A096NI19	231	H	P
Q9BQ50	LB/B	-	F6UKI1	137	R	C
Q9C019	LB/B	-	A0A2U3X692	29	I	V
Q9C019	LB/B	-	A0A2U3X692	42	A	T
Q9C019	LB/B	-	A0A2U3X692	84	E	Q
Q9C019	LB/B	-	A0A2U3X692	235	L	V
Q9C019	LB/B	-	A0A2U3X692	324	S	N
Q96LD4	LB/B	-	A0A2K5EDK7	500	E	A
Q9BYV6	LB/B	-	A0A151MNA4	343	K	R
Q9BYV6	LB/B	-	A0A151MNA4	54	I	V
Q9BYV6	LB/B	-	A0A151MNA4	252	S	F
Q9BYV6	LB/B	-	A0A151MNA4	257	N	K
Q9BYV6	LB/B	-	A0A151MNA4	258	V	I
Q9BYV6	LB/B	-	A0A151MNA4	336	E	Q
Q9BYV6	LB/B	-	A0A151MNA4	418	T	I
Q9BYV6	LB/B	-	A0A151MNA4	458	P	L
Q9BYV6	LB/B	-	A0A151MNA4	488	A	T
Q6PF06	LB/B	-	Q9D075	234	V	G
Q6PF06	LB/B	-	Q9D075	242	V	A
Q8IYL2	LB/B	-	A0A091D686	352	R	G
Q8IYL2	LB/B	-	A0A091D686	300	M	L
Q8IYL2	LB/B	-	A0A091D686	455	I	V
Q8IYL2	LB/B	-	A0A091D686	641	G	A
Q96Q11	LB/B	-	A0A212C9Z6	23	P	L
Q96Q11	LP/P	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD) [MIM:616084]	A0A212C9Z6	154	T	I
Q96Q11	LP/P	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD) [MIM:616084]	A0A212C9Z6	158	M	V
Q96Q11	LP/P	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD) [MIM:616084]	A0A212C9Z6	166	L	S
Q96Q11	LP/P	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD) [MIM:616084]	A0A212C9Z6	190	R	I
Q96Q11	LP/P	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD) [MIM:616084]	A0A212C9Z6	223	I	T
Q96Q11	LP/P	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD) [MIM:616084]	A0A212C9Z6	326	I	T
Q96Q11	LP/P	Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD) [MIM:616084]	A0A212C9Z6	416	K	E
Q86TN4	LB/B	-	I3MMM2	3	F	L
Q86TN4	LB/B	-	I3MMM2	172	H	R
Q86TN4	LB/B	-	I3MMM2	221	R	C
Q8NET8	LB/B	-	H2NS93	25	I	V
Q8NET8	LB/B	-	H2NS93	117	R	G
Q8NET8	LB/B	-	H2NS93	774	T	I
Q8NET8	LP/P	Olmsted syndrome 1 (OLMS1) [MIM:614594]	H2NS93	573	G	C
Q8NET8	LP/P	Olmsted syndrome 1 (OLMS1) [MIM:614594]	H2NS93	573	G	S
Q8NET8	LP/P	Olmsted syndrome 1 (OLMS1) [MIM:614594]	H2NS93	692	W	G
Q8NET8	LP/P	Palmoplantar keratoderma, non-epidermolytic, focal 2 (FNEPPK2) [MIM:616400]	H2NS93	580	Q	P
O75157	LB/B	-	I3JX80	419	A	T
Q99816	LB/B	-	A0A1U7S061	167	M	I
P01222	LB/B	-	Q9I996	14	T	A
P01222	LP/P	Hypothyroidism, congenital, non-goitrous, 4 (CHNG4) [MIM:275100]	Q9I996	73	T	P
O43657	LB/B	-	G3UJQ3	108	A	T
P41732	LP/P	Intellectual developmental disorder, X-linked 58 (XLID58) [MIM:300210]	A0A151NTT8	172	P	H
P41732	LB/B	-	A0A151NTT8	53	E	K
P41732	LB/B	-	A0A151NTT8	127	A	T
P19075	LB/B	-	A0A287B7T0	213	S	A
P19075	LB/B	-	A0A287B7T0	73	G	A
P19075	LB/B	-	A0A287B7T0	35	V	I
Q969E8	LP/P	Diamond-Blackfan anemia 14, with mandibulofacial dysostosis (DBA14) [MIM:300946]	H2PVR5	64	E	G
Q96PF2	LB/B	-	H0W1X3	27	K	R
Q96PF2	LB/B	-	H0W1X3	61	M	V
Q96PF2	LB/B	-	H0W1X3	197	Y	C
Q96PF2	LB/B	-	H0W1X3	280	T	M
Q96PF2	LB/B	-	H0W1X3	244	E	K
Q96PF2	LB/B	-	H0W1X3	245	C	S
Q99614	LB/B	-	A0A1D5PW73	290	N	S
A2A3L6	LB/B	-	A0A1U7SYJ3	231	E	G
A2A3L6	LB/B	-	A0A1U7SYJ3	532	P	A
A2A3L6	LB/B	-	A0A1U7SYJ3	550	N	S
Q6P3X3	LB/B	-	A0A226NXW0	476	Y	C
Q6P3X3	LB/B	-	A0A226NXW0	525	R	H
Q6P3X3	LB/B	-	A0A226NXW0	586	R	H
Q6P3X3	LB/B	-	A0A226NXW0	498	T	M
Q8N0Z6	LB/B	-	L8YE84	14	Q	H
Q8N0Z6	LB/B	-	L8YE84	47	Q	R
Q8N6N2	LB/B	-	W5P959	223	L	P
Q9UJT1	LB/B	-	A0A2I4BKJ2	76	M	T
Q96CW5	LB/B	-	A0A2U4A6K1	208	T	S
Q9NNX1	LB/B	-	A0A226MES5	296	K	R
Q9NNX1	LB/B	-	A0A226MES5	18	Q	R
Q16881	LB/B	-	A0A2U3Y989	365	D	G
Q8TAI1	LB/B	-	Q8TAI1	62	R	G
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	19	H	Q
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	21	P	S
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	42	D	G
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	47	G	D
P14679	LB/B	-	W0C8I7	52	R	I
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	55	C	Y
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	77	R	Q
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	77	R	W
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	80	W	R
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	81	P	L
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	89	C	R
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	97	G	R
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	176	F	I
P14679	LB/B	-	W0C8I7	192	S	Y
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	206	A	T
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	216	L	M
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	217	R	G
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	217	R	W
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	217	R	Q
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	253	G	R
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	275	V	F
P14679	LP/P	Albinism, oculocutaneous, 1B (OCA1B) [MIM:606952]	W0C8I7	275	V	F
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	289	C	R
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	299	R	H
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	299	R	S
P14679	LB/B	-	W0C8I7	312	L	V
P14679	LB/B	-	W0C8I7	313	P	R
P14679	LP/P	Albinism, oculocutaneous, 1B (OCA1B) [MIM:606952]	W0C8I7	325	T	A
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	339	S	G
P14679	LB/B	-	W0C8I7	340	F	L
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	355	A	P
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	371	N	T
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	373	T	K
P14679	LP/P	Albinism, oculocutaneous, 1B (OCA1B) [MIM:606952]	W0C8I7	380	S	P
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	382	N	K
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	383	D	N
P14679	LP/P	Albinism, oculocutaneous, 1B (OCA1B) [MIM:606952]	W0C8I7	390	H	D
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	395	S	N
P14679	LB/B	-	W0C8I7	402	R	Q
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	403	R	S
P14679	LP/P	Albinism, oculocutaneous, 1B (OCA1B) [MIM:606952]	W0C8I7	403	R	S
P14679	LB/B	-	W0C8I7	404	H	P
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	406	P	L
P14679	LP/P	Albinism, oculocutaneous, 1B (OCA1B) [MIM:606952]	W0C8I7	406	P	L
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	419	G	R
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	422	R	Q
P14679	LP/P	Albinism, oculocutaneous, 1B (OCA1B) [MIM:606952]	W0C8I7	422	R	Q
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	446	G	S
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	448	D	N
P14679	LP/P	Albinism, oculocutaneous, 1B (OCA1B) [MIM:606952]	W0C8I7	152	P	S
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	288	L	S
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	294	E	K
P14679	LP/P	Albinism, oculocutaneous, 1B (OCA1B) [MIM:606952]	W0C8I7	294	E	K
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	328	E	Q
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	346	G	E
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	355	A	E
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	361	S	R
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	367	H	Y
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	370	M	T
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	371	N	Y
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	393	V	F
P14679	LP/P	Albinism, oculocutaneous, 1B (OCA1B) [MIM:606952]	W0C8I7	402	R	G
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	431	P	L
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	289	C	G
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	400	W	L
P14679	LB/B	-	W0C8I7	308	R	T
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	36	C	Y
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	44	S	G
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	44	S	R
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	47	G	V
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	68	Q	H
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	79	S	L
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	109	G	R
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	155	T	S
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	177	V	F
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	179	M	L
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	180	H	N
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	199	D	N
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	201	A	S
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	205	P	T
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	217	R	S
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	236	W	L
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	236	W	S
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	239	R	W
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	240	D	V
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	243	K	T
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	256	H	Y
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	272	W	C
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	294	E	G
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	318	V	E
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	329	S	P
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	332	M	T
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	345	E	G
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	378	Q	K
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	395	S	R
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	398	E	A
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	398	E	V
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	402	R	L
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	404	H	N
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	405	R	L
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	408	Q	H
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	409	E	D
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	416	A	S
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	417	P	H
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	424	S	F
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	426	M	K
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	427	V	G
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	434	R	I
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	435	N	D
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	439	F	V
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	444	D	G
P14679	LB/B	-	W0C8I7	134	F	C
P14679	LB/B	-	W0C8I7	142	K	N
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	198	I	T
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	50	S	L
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	91	C	Y
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	298	R	W
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	355	A	V
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	364	N	H
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	384	P	A
P14679	LP/P	Albinism, oculocutaneous, 1A (OCA1A) [MIM:203100]	W0C8I7	490	A	D
Q01081	LP/P	Myelodysplastic syndrome (MDS) [MIM:614286]	A0A2T7P276	34	S	F
Q01081	LP/P	Myelodysplastic syndrome (MDS) [MIM:614286]	A0A2T7P276	34	S	Y
Q01081	LP/P	Myelodysplastic syndrome (MDS) [MIM:614286]	A0A2T7P276	157	Q	R
Q9GZZ9	LP/P	Developmental and epileptic encephalopathy 44 (DEE44) [MIM:617132]	A0A293MZ07	55	R	H
Q9GZZ9	LP/P	Developmental and epileptic encephalopathy 44 (DEE44) [MIM:617132]	A0A293MZ07	57	M	V
Q9GZZ9	LP/P	Developmental and epileptic encephalopathy 44 (DEE44) [MIM:617132]	A0A293MZ07	168	G	E
Q9GZZ9	LP/P	Developmental and epileptic encephalopathy 44 (DEE44) [MIM:617132]	A0A293MZ07	260	V	M
Q9GZZ9	LP/P	Spinocerebellar ataxia, autosomal recessive, 24 (SCAR24) [MIM:617133]	A0A293MZ07	310	K	E
Q9GZZ9	LP/P	Developmental and epileptic encephalopathy 44 (DEE44) [MIM:617132]	A0A293MZ07	371	A	T
Q9GZZ9	LP/P	Developmental and epileptic encephalopathy 44 (DEE44) [MIM:617132]	A0A293MZ07	389	D	Y
Q9BSL1	LB/B	-	A0A2J7R702	374	E	D
Q8IYU4	LB/B	-	A0A2K5VB56	92	D	V
Q8IYU4	LB/B	-	A0A2K5VB56	143	Q	K
Q8IYU4	LB/B	-	A0A2K5VB56	171	C	R
Q8IYU4	LB/B	-	A0A2K5VB56	259	G	D
Q8IYU4	LB/B	-	A0A2K5VB56	274	Y	H
Q8IYU4	LB/B	-	A0A2K5VB56	275	A	V
Q8IYU4	LB/B	-	A0A2K5VB56	379	W	G
Q8IYU4	LB/B	-	A0A2K5VB56	455	Q	E
O95071	LB/B	-	I3KHU7	2150	S	R
Q9BZV1	LB/B	-	F6U781	425	P	L
Q9BZV1	LB/B	-	F6U781	31	A	T
O00124	LB/B	-	G5C9Y6	18	V	M
O00124	LB/B	-	G5C9Y6	51	I	T
Q9Y5K5	LB/B	-	G1TCB7	197	I	F
O94874	LB/B	-	A0A2R2MJ50	137	V	F
O60701	LP/P	Developmental and epileptic encephalopathy 84 (DEE84) [MIM:618792]	S7PUQ9	14	Y	C
O60701	LP/P	Developmental and epileptic encephalopathy 84 (DEE84) [MIM:618792]	S7PUQ9	44	A	V
O60701	LP/P	Developmental and epileptic encephalopathy 84 (DEE84) [MIM:618792]	S7PUQ9	72	S	A
O60701	LP/P	Developmental and epileptic encephalopathy 84 (DEE84) [MIM:618792]	S7PUQ9	82	A	T
O60701	LP/P	Developmental and epileptic encephalopathy 84 (DEE84) [MIM:618792]	S7PUQ9	367	Y	C
Q16851	LB/B	-	E4X9E6	268	M	I
Q16851	LP/P	Developmental and epileptic encephalopathy 83 (DEE83) [MIM:618744]	E4X9E6	12	M	V
Q16880	LB/B	-	H3B4I3	226	P	L
Q16880	LB/B	-	H3B4I3	368	I	M
Q96C45	LB/B	-	F6YIH9	542	A	T
Q96C45	LB/B	-	F6YIH9	569	K	R
Q96C45	LB/B	-	F6YIH9	603	L	S
Q96C45	LB/B	-	F6YIH9	640	S	A
Q96C45	LB/B	-	F6YIH9	715	A	T
Q96C45	LB/B	-	F6YIH9	18	V	A
Q96C45	LB/B	-	F6YIH9	39	K	R
Q96C45	LB/B	-	F6YIH9	139	N	K
Q96C45	LB/B	-	F6YIH9	223	S	N
Q96C45	LB/B	-	F6YIH9	348	S	G
Q96C45	LB/B	-	F6YIH9	415	T	M
Q96C45	LB/B	-	F6YIH9	417	S	P
Q96C45	LB/B	-	F6YIH9	224	I	V
Q96C45	LB/B	-	F6YIH9	1261	A	V
Q96C45	LB/B	-	F6YIH9	1260	S	N
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	103	G	C
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	148	C	Y
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	217	C	R
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	77	C	Y
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	126	C	R
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	128	N	S
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	148	C	W
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	150	C	S
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	223	C	Y
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	225	T	K
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	248	C	W
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	255	C	Y
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	300	C	G
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	315	C	R
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	317	C	Y
P07911	LB/B	-	B3KTU0	458	V	L
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	109	V	E
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	230	W	R
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	236	P	Q
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	461	A	E
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	52	C	W
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	59	D	A
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	112	C	R
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	135	C	S
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	170	C	Y
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	185	R	S
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	195	C	F
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	202	W	S
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	204	R	G
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	217	C	G
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	222	R	P
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	225	T	M
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	236	P	L
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	236	P	R
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	282	C	R
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	316	Q	P
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	347	C	G
P07911	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 1 (ADTKD1) [MIM:162000]	B3KTU0	120	C	G
Q9UPW8	LB/B	-	W5MG77	359	A	T
O14795	LB/B	-	W5MG77	238	D	E
O14795	LB/B	-	W5MG77	1232	E	D
P13051	LP/P	Immunodeficiency with hyper-IgM 5 (HIGM5) [MIM:608106]	A0A2U3ZIS2	251	F	S
P13051	LB/B	-	A0A2U3ZIS2	4	Q	R
Q9UBR1	LP/P	Beta-ureidopropionase deficiency (UPB1D) [MIM:613161]	K1PD48	85	A	E
Q9UBR1	LB/B	-	K1PD48	340	A	D
Q9UBR1	LP/P	Beta-ureidopropionase deficiency (UPB1D) [MIM:613161]	K1PD48	13	L	S
Q9UBR1	LP/P	Beta-ureidopropionase deficiency (UPB1D) [MIM:613161]	K1PD48	235	G	R
Q9UBR1	LP/P	Beta-ureidopropionase deficiency (UPB1D) [MIM:613161]	K1PD48	236	R	W
Q9UBR1	LP/P	Beta-ureidopropionase deficiency (UPB1D) [MIM:613161]	K1PD48	264	S	R
Q9UBR1	LP/P	Beta-ureidopropionase deficiency (UPB1D) [MIM:613161]	K1PD48	271	E	K
Q9UBR1	LP/P	Beta-ureidopropionase deficiency (UPB1D) [MIM:613161]	K1PD48	326	R	Q
Q9UBR1	LP/P	Beta-ureidopropionase deficiency (UPB1D) [MIM:613161]	K1PD48	359	T	M
Q9BT76	LB/B	-	A0A2K6K403	293	Q	R
Q9BT76	LB/B	-	A0A2K6K403	319	W	R
O95045	LB/B	-	A0A060XU81	10	R	S
O95045	LB/B	-	A0A060XU81	78	M	L
P47985	LB/B	-	A0A287D8D2	6	S	A
P47985	LP/P	Mitochondrial complex III deficiency, nuclear type 10 (MC3DN10) [MIM:618775]	A0A287D8D2	14	V	D
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	167	E	K
P06132	LP/P	Hepatoerythropoietic porphyria (HEP) [MIM:176100]	A0A2H5XHW2	167	E	K
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	281	G	E
P06132	LP/P	Hepatoerythropoietic porphyria (HEP) [MIM:176100]	A0A2H5XHW2	281	G	E
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	281	G	V
P06132	LP/P	Hepatoerythropoietic porphyria (HEP) [MIM:176100]	A0A2H5XHW2	292	R	G
P06132	LP/P	Hepatoerythropoietic porphyria (HEP) [MIM:176100]	A0A2H5XHW2	80	A	G
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	165	M	R
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	195	L	F
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	253	L	Q
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	304	N	K
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	318	G	R
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	332	R	H
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	334	I	T
P06132	LP/P	Hepatoerythropoietic porphyria (HEP) [MIM:176100]	A0A2H5XHW2	62	P	L
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	134	V	Q
P06132	LP/P	Hepatoerythropoietic porphyria (HEP) [MIM:176100]	A0A2H5XHW2	134	V	Q
P06132	LP/P	Hepatoerythropoietic porphyria (HEP) [MIM:176100]	A0A2H5XHW2	220	H	P
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	229	F	L
P06132	LP/P	Hepatoerythropoietic porphyria (HEP) [MIM:176100]	A0A2H5XHW2	311	Y	C
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	324	M	T
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	142	R	Q
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	161	L	Q
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	219	S	F
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	235	P	S
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	25	G	E
P06132	LP/P	Hepatoerythropoietic porphyria (HEP) [MIM:176100]	A0A2H5XHW2	46	F	L
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	80	A	S
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	144	R	P
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	156	G	D
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	193	R	P
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	216	L	Q
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	218	E	K
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	232	F	L
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	260	I	T
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	282	L	R
P06132	LP/P	Familial porphyria cutanea tarda (FPCT) [MIM:176100]	A0A2H5XHW2	303	G	S
P06132	LB/B	-	A0A2H5XHW2	15	K	E
P06132	LB/B	-	A0A2H5XHW2	106	P	L
P06132	LB/B	-	A0A2H5XHW2	113	R	T
P06132	LB/B	-	A0A2H5XHW2	303	G	V
P06132	LP/P	Hepatoerythropoietic porphyria (HEP) [MIM:176100]	A0A2H5XHW2	168	G	R
P06132	LP/P	Hepatoerythropoietic porphyria (HEP) [MIM:176100]	A0A2H5XHW2	170	G	D
P06132	LB/B	-	A0A2H5XHW2	77	P	L
Q9Y6N9	LB/B	-	A0A1S3PDH9	519	E	D
Q495M9	LP/P	Usher syndrome 1G (USH1G) [MIM:606943]	T0NI60	48	L	P
Q495M9	LP/P	Usher syndrome 1G (USH1G) [MIM:606943]	T0NI60	458	D	V
Q495M9	LP/P	-	T0NI60	104	M	V
Q14694	LB/B	-	H0VLL0	200	M	V
Q14694	LB/B	-	H0VLL0	203	S	P
Q14694	LB/B	-	H0VLL0	204	V	L
O94966	LB/B	-	F6ZR76	36	D	H
Q8NFA0	LB/B	-	H3BBL5	76	H	Y
Q8NFA0	LB/B	-	H3BBL5	1469	A	G
Q8NFA0	LB/B	-	H3BBL5	1568	G	R
Q8NFA0	LB/B	-	H3BBL5	1578	T	I
Q86UV5	LB/B	-	A0A2R5LJ95	125	S	C
Q86UV5	LB/B	-	A0A2R5LJ95	135	E	K
Q70EK8	LB/B	-	L5LXR6	962	S	R
Q70EK8	LP/P	Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss (PFIC7) [MIM:619658]	L5LXR6	99	R	S
Q70EK8	LP/P	Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss (PFIC7) [MIM:619658]	L5LXR6	132	H	R
Q70EK8	LP/P	Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss (PFIC7) [MIM:619658]	L5LXR6	293	G	V
Q93008	LP/P	Intellectual developmental disorder, X-linked 99, syndromic, female-restricted (MRXS99F) [MIM:300968]	R7VLC1	1693	L	W
O00507	LB/B	-	R7VLC1	1060	A	T
O00507	LB/B	-	R7VLC1	1035	P	S
O00507	LB/B	-	R7VLC1	65	E	D
O00507	LB/B	-	R7VLC1	211	R	C
O00507	LB/B	-	R7VLC1	1705	A	S
Q5W0Q7	LB/B	-	T0MK27	173	E	G
Q5W0Q7	LB/B	-	T0MK27	384	P	S
Q5W0Q7	LB/B	-	T0MK27	522	A	P
Q5W0Q7	LB/B	-	T0MK27	531	L	S
Q5W0Q7	LB/B	-	T0MK27	739	S	C
Q5W0Q7	LB/B	-	T0MK27	950	S	N
Q5W0Q7	LB/B	-	T0MK27	1043	T	S
Q5W0Q7	LB/B	-	T0MK27	583	I	V
Q5W0Q7	LB/B	-	T0MK27	786	L	I
Q8TAA9	LB/B	-	A0A0F6N0Q3	116	A	T
Q8TAA9	LP/P	Sacral defect with anterior meningocele (SDAM) [MIM:600145]	A0A0F6N0Q3	239	V	I
Q8TAA9	LP/P	Neural tube defects (NTD) [MIM:182940]	A0A0F6N0Q3	274	R	Q
Q8TAA9	LP/P	Neural tube defects (NTD) [MIM:182940]	A0A0F6N0Q3	328	M	T
Q8TAA9	LB/B	-	A0A0F6N0Q3	347	E	A
Q8TAA9	LB/B	-	A0A0F6N0Q3	25	E	K
Q8TAA9	LB/B	-	A0A0F6N0Q3	175	R	Q
Q8TAA9	LB/B	-	A0A0F6N0Q3	251	T	M
Q8TAA9	LB/B	-	A0A0F6N0Q3	290	Y	H
Q8TAA9	LB/B	-	A0A0F6N0Q3	468	D	E
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	29	V	L
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	45	V	A
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	58	R	G
Q9BQB6	LP/P	Combined deficiency of vitamin K-dependent clotting factors 2 (VKCFD2) [MIM:607473]	A0A2F0BCZ7	98	R	W
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	128	L	R
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	26	A	T
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	36	D	G
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	36	D	Y
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	52	S	W
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	56	S	F
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	59	W	C
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	59	W	L
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	66	V	G
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	66	V	M
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	71	G	A
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	77	N	S
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	77	N	Y
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	123	I	N
Q9BQB6	LP/P	Coumarin resistance (CMRES) [MIM:122700]	A0A2F0BCZ7	139	Y	H
Q7Z5H4	LB/B	-	F1PE98	350	R	C
Q9H270	LB/B	-	A0A1Y1Z9A9	770	V	I
Q9H270	LP/P	Leukodystrophy, hypomyelinating, 12 (HLD12) [MIM:616683]	A0A1Y1Z9A9	846	C	G
Q96RL7	LP/P	Choreoacanthocytosis (CHAC) [MIM:200150]	A0A1A8G9Y1	1452	S	P
Q96RL7	LP/P	Choreoacanthocytosis (CHAC) [MIM:200150]	A0A1A8G9Y1	90	I	K
Q96RL7	LP/P	Choreoacanthocytosis (CHAC) [MIM:200150]	A0A1A8G9Y1	2721	Y	C
Q96RL7	LB/B	-	A0A1A8G9Y1	565	F	L
Q96RL7	LB/B	-	A0A1A8G9Y1	898	V	A
Q96RL7	LP/P	Choreoacanthocytosis (CHAC) [MIM:200150]	A0A1A8G9Y1	1095	A	P
Q96RL7	LB/B	-	A0A1A8G9Y1	1490	R	K
Q96RL7	LB/B	-	A0A1A8G9Y1	1587	Y	C
Q96RL7	LB/B	-	A0A1A8G9Y1	1973	V	I
Q96RL7	LP/P	Choreoacanthocytosis (CHAC) [MIM:200150]	A0A1A8G9Y1	2460	W	R
Q96RL7	LB/B	-	A0A1A8G9Y1	2486	I	T
Q96RL7	LB/B	-	A0A1A8G9Y1	3172	P	L
Q96RL7	LP/P	Choreoacanthocytosis (CHAC) [MIM:200150]	A0A1A8G9Y1	67	L	P
Q709C8	LB/B	-	V8PET1	153	R	H
Q709C8	LB/B	-	V8PET1	974	R	K
Q709C8	LB/B	-	V8PET1	1132	I	V
Q709C8	LB/B	-	V8PET1	1302	Y	C
Q709C8	LB/B	-	V8PET1	1485	T	A
Q709C8	LB/B	-	V8PET1	1495	I	V
Q709C8	LB/B	-	V8PET1	1592	S	Y
Q709C8	LB/B	-	V8PET1	2322	V	M
Q709C8	LB/B	-	V8PET1	2913	S	N
Q709C8	LB/B	-	V8PET1	2808	K	R
Q709C8	LB/B	-	V8PET1	2872	C	F
Q709C8	LP/P	Parkinson disease 23, autosomal recessive, early onset (PARK23) [MIM:616840]	V8PET1	1389	G	R
O75351	LB/B	-	M4ANX1	58	I	M
Q86Y07	LB/B	-	G1NX01	167	I	V
Q86Y07	LB/B	-	G1NX01	50	N	D
Q86Y07	LB/B	-	G1NX01	157	I	M
Q86Y07	LB/B	-	G1NX01	211	N	S
O00534	LB/B	-	A0A1A8U6S6	499	S	I
O00534	LB/B	-	A0A1A8U6S6	506	R	K
O00534	LB/B	-	A0A1A8U6S6	757	R	C
O00534	LB/B	-	A0A1A8U6S6	759	H	R
O00534	LB/B	-	A0A1A8U6S6	202	S	G
O00534	LB/B	-	A0A1A8U6S6	205	E	K
Q9Y334	LB/B	-	L5LBZ0	139	R	H
Q9Y334	LB/B	-	L5LBZ0	488	R	Q
Q9Y334	LB/B	-	L5LBZ0	680	R	Q
Q9Y334	LB/B	-	L5LBZ0	704	G	V
Q9Y334	LB/B	-	L5LBZ0	711	R	C
Q9Y334	LB/B	-	L5LBZ0	861	T	A
P42768	LP/P	Thrombocytopenia 1 (THC1) [MIM:313900]	W5UEQ2	27	L	F
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	31	E	K
P42768	LP/P	Thrombocytopenia 1 (THC1) [MIM:313900]	W5UEQ2	48	T	I
P42768	LP/P	Thrombocytopenia 1 (THC1) [MIM:313900]	W5UEQ2	56	A	V
P42768	LP/P	Thrombocytopenia 1 (THC1) [MIM:313900]	W5UEQ2	75	V	M
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	82	S	P
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	86	R	H
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	86	R	L
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	86	R	C
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	97	W	C
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	131	E	K
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	133	E	K
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	187	G	C
P42768	LP/P	Thrombocytopenia 1 (THC1) [MIM:313900]	W5UEQ2	236	A	E
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	476	K	E
P42768	LP/P	Thrombocytopenia 1 (THC1) [MIM:313900]	W5UEQ2	477	R	K
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	43	C	W
P42768	LP/P	Thrombocytopenia 1 (THC1) [MIM:313900]	W5UEQ2	45	T	M
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	45	T	M
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	73	C	R
P42768	LP/P	Thrombocytopenia 1 (THC1) [MIM:313900]	W5UEQ2	83	Y	C
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	84	F	L
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	89	G	D
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	52	Q	H
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	70	G	W
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	58	P	L
P42768	LP/P	Wiskott-Aldrich syndrome (WAS) [MIM:301000]	W5UEQ2	134	A	T
P42768	LP/P	Thrombocytopenia 1 (THC1) [MIM:313900]	W5UEQ2	58	P	R
P42768	LP/P	Neutropenia, severe congenital, X-linked (XLN) [MIM:300299]	W5UEQ2	270	L	P
P42768	LP/P	Thrombocytopenia 1 (THC1) [MIM:313900]	W5UEQ2	481	I	N
Q9UPY6	LB/B	-	H2ZWI6	415	S	L
Q12768	LP/P	Spastic paraplegia 8, autosomal dominant (SPG8) [MIM:603563]	A0A087T0S0	471	N	D
Q12768	LP/P	Spastic paraplegia 8, autosomal dominant (SPG8) [MIM:603563]	A0A087T0S0	619	L	F
Q12768	LP/P	Spastic paraplegia 8, autosomal dominant (SPG8) [MIM:603563]	A0A087T0S0	626	V	F
Q12768	LP/P	Spastic paraplegia 8, autosomal dominant (SPG8) [MIM:603563]	A0A087T0S0	226	I	T
Q12768	LP/P	Spastic paraplegia 8, autosomal dominant (SPG8) [MIM:603563]	A0A087T0S0	696	G	A
Q12768	LP/P	Spastic paraplegia 8, autosomal dominant (SPG8) [MIM:603563]	A0A087T0S0	620	V	A
Q969T9	LP/P	Deafness, autosomal recessive, 107 (DFNB107) [MIM:617639]	A0A2R8Z7M8	160	A	T
Q8NI36	LB/B	-	C3YZV9	264	I	V
Q8NI36	LB/B	-	C3YZV9	25	L	P
Q8NI36	LB/B	-	C3YZV9	163	A	V
Q8NI36	LP/P	Glaucoma 1, open angle, G (GLC1G) [MIM:609887]	C3YZV9	355	N	S
Q8NI36	LB/B	-	C3YZV9	449	A	T
Q8NI36	LP/P	Glaucoma 1, open angle, G (GLC1G) [MIM:609887]	C3YZV9	529	R	Q
Q8NI36	LB/B	-	C3YZV9	658	D	G
Q8NI36	LB/B	-	C3YZV9	671	M	V
Q8NI36	LB/B	-	C3YZV9	454	E	Q
Q8NI36	LB/B	-	C3YZV9	31	P	T
Q8NI36	LB/B	-	C3YZV9	33	D	E
Q8NI36	LB/B	-	C3YZV9	212	H	P
B1ANS9	LB/B	-	A0A2K5CMC1	647	R	Q
B1ANS9	LB/B	-	A0A2K5CMC1	952	R	W
A4D1P6	LB/B	-	A0A2U3XCR2	257	P	L
Q6P2C0	LB/B	-	F1MLQ2	66	L	H
Q6P2C0	LB/B	-	F1MLQ2	254	S	T
Q6P2C0	LB/B	-	F1MLQ2	352	T	M
P30291	LB/B	-	A0A2K5R4H6	210	G	C
P30291	LB/B	-	A0A2K5R4H6	472	S	I
Q9P202	LB/B	-	G3NG69	440	A	T
Q9P202	LB/B	-	G3NG69	783	V	A
Q9P202	LB/B	-	G3NG69	796	N	K
Q9P202	LB/B	-	G3NG69	813	T	M
Q9P202	LB/B	-	G3NG69	364	H	R
Q9P202	LB/B	-	G3NG69	423	R	P
Q9P202	LB/B	-	G3NG69	562	P	A
Q9P202	LB/B	-	G3NG69	613	M	T
Q9P202	LB/B	-	G3NG69	752	Q	H
Q9P202	LB/B	-	G3NG69	443	A	S
Q5MNZ9	LB/B	-	K1QZR2	31	T	I
Q5MNZ9	LB/B	-	K1QZR2	308	R	H
Q9Y4P8	LP/P	Intellectual developmental disorder with short stature and variable skeletal anomalies (IDDSSA) [MIM:618453]	K1QZR2	249	V	M
Q9BYP7	LB/B	-	A0A061HZG0	704	Q	H
Q9BYP7	LB/B	-	A0A061HZG0	998	A	T
Q9BYP7	LB/B	-	A0A061HZG0	1169	K	E
Q9BYP7	LB/B	-	A0A061HZG0	1375	T	I
O00755	LP/P	Fuhrmann syndrome (FUHRS) [MIM:228930]	A0A0Q3X0I9	109	A	T
O00755	LP/P	Limb pelvis hypoplasia aplasia syndrome (LPHAS) [MIM:276820]	A0A0Q3X0I9	292	R	C
O00755	LP/P	Limb pelvis hypoplasia aplasia syndrome (LPHAS) [MIM:276820]	A0A0Q3X0I9	222	R	W
O00755	LP/P	Limb pelvis hypoplasia aplasia syndrome (LPHAS) [MIM:276820]	A0A0Q3X0I9	72	E	K
Q2TBF2	LB/B	-	A0A1S3F1T7	266	T	I
Q9UBD3	LB/B	-	F6Q0G4	28	H	D
Q9UBD3	LB/B	-	F6Q0G4	29	R	K
P18887	LB/B	-	F1QXI2	399	Q	R
P18887	LB/B	-	F1QXI2	194	R	W
P18887	LB/B	-	F1QXI2	280	R	H
P18887	LB/B	-	F1QXI2	7	R	L
P18887	LB/B	-	F1QXI2	10	V	M
P18887	LB/B	-	F1QXI2	157	E	K
P18887	LB/B	-	F1QXI2	161	P	L
P18887	LB/B	-	F1QXI2	298	K	N
P18887	LB/B	-	F1QXI2	309	P	S
P18887	LB/B	-	F1QXI2	485	S	Y
P18887	LB/B	-	F1QXI2	559	R	Q
P18887	LB/B	-	F1QXI2	560	R	W
P18887	LB/B	-	F1QXI2	576	Y	S
P18887	LB/B	-	F1QXI2	72	V	A
P18887	LB/B	-	F1QXI2	514	P	L
P18887	LB/B	-	F1QXI2	304	T	A
P18887	LB/B	-	F1QXI2	107	R	H
P18887	LB/B	-	F1QXI2	576	Y	N
P18887	LP/P	Spinocerebellar ataxia, autosomal recessive, 26 (SCAR26) [MIM:617633]	F1QXI2	431	K	N
Q13426	LB/B	-	Q5XI44	240	Q	P
Q13426	LB/B	-	Q5XI44	247	A	S
Q13426	LB/B	-	Q5XI44	12	S	C
Q13426	LB/B	-	Q5XI44	56	A	T
Q13426	LB/B	-	Q5XI44	134	I	T
Q13426	LB/B	-	Q5XI44	142	E	Q
Q13426	LP/P	Short stature, microcephaly, and endocrine dysfunction (SSMED) [MIM:616541]	Q5XI44	43	W	R
Q13426	LP/P	Short stature, microcephaly, and endocrine dysfunction (SSMED) [MIM:616541]	Q5XI44	161	R	Q
Q13426	LP/P	Short stature, microcephaly, and endocrine dysfunction (SSMED) [MIM:616541]	Q5XI44	82	D	E
Q9H0D6	LB/B	-	A0A091DDA0	743	R	M
Q9H0D6	LB/B	-	A0A091DDA0	925	R	C
Q9Y2T7	LB/B	-	A0A2K6U318	9	G	V
Q9Y2T7	LB/B	-	A0A2K6U318	63	S	P
Q96MU7	LB/B	-	Q5U3V6	183	H	R
O75132	LB/B	-	A0A2K5XJP3	420	I	V
O43167	LB/B	-	R0K0W4	518	A	T
O43167	LP/P	Immunodeficiency-centromeric instability-facial anomalies syndrome 2 (ICF2) [MIM:614069]	R0K0W4	408	C	G
Q9NQZ6	LP/P	Wieacker-Wolf syndrome (WRWF) [MIM:314580]	A0A2J8UB68	63	V	L
Q9NQZ6	LP/P	Wieacker-Wolf syndrome (WRWF) [MIM:314580]	A0A2J8UB68	198	R	Q
Q9NQZ6	LP/P	Wieacker-Wolf syndrome (WRWF) [MIM:314580]	A0A2J8UB68	201	P	S
Q9NQZ6	LP/P	Wieacker-Wolf syndrome (WRWF) [MIM:314580]	A0A2J8UB68	213	R	W
Q9NQZ6	LP/P	Wieacker-Wolf syndrome (WRWF) [MIM:314580]	A0A2J8UB68	18	R	K
Q9NQZ6	LP/P	Wieacker-Wolf syndrome (WRWF) [MIM:314580]	A0A2J8UB68	66	L	H
Q9NQZ6	LP/P	Wieacker-Wolf syndrome (WRWF) [MIM:314580]	A0A2J8UB68	70	H	Q
Q9NQZ6	LP/P	Wieacker-Wolf syndrome (WRWF) [MIM:314580]	A0A2J8UB68	200	A	T
Q9NQZ6	LP/P	Wieacker-Wolf syndrome (WRWF) [MIM:314580]	A0A2J8UB68	200	A	V
Q9NQZ6	LP/P	Wieacker-Wolf syndrome (WRWF) [MIM:314580]	A0A2J8UB68	201	P	H
Q9NQZ6	LP/P	Wieacker-Wolff syndrome, female-restricted (WRWFFR) [MIM:301041]	A0A2J8UB68	203	C	S
Q9NQZ6	LP/P	Wieacker-Wolff syndrome, female-restricted (WRWFFR) [MIM:301041]	A0A2J8UB68	206	C	F
Q9NQZ6	LP/P	Wieacker-Wolf syndrome (WRWF) [MIM:314580]	A0A2J8UB68	217	K	R
Q6NZY4	LB/B	-	A0A091HKR7	672	P	A
Q6NZY4	LP/P	Pulmonary fibrosis, and/or bone marrow failure, telomere-related, 5 (PFBMFT5) [MIM:618674]	A0A091HKR7	186	P	L
Q8IYP9	LB/B	-	A0A091E6M5	132	H	N
Q8IYP9	LB/B	-	A0A091E6M5	221	T	A
Q8IYP9	LB/B	-	A0A091E6M5	247	K	R
Q8IYP9	LB/B	-	A0A091E6M5	274	H	R
Q9NXF8	LB/B	-	L9KJL6	201	V	I
P37275	LB/B	-	K6ZDQ8	553	K	R
P37275	LB/B	-	K6ZDQ8	90	G	R
P37275	LP/P	Corneal dystrophy, Fuchs endothelial, 6 (FECD6) [MIM:613270]	K6ZDQ8	78	N	T
P37275	LP/P	Corneal dystrophy, Fuchs endothelial, 6 (FECD6) [MIM:613270]	K6ZDQ8	649	P	A
P37275	LP/P	Corneal dystrophy, Fuchs endothelial, 6 (FECD6) [MIM:613270]	K6ZDQ8	810	Q	P
P37275	LP/P	Corneal dystrophy, Fuchs endothelial, 6 (FECD6) [MIM:613270]	K6ZDQ8	840	Q	P
P37275	LP/P	Corneal dystrophy, Fuchs endothelial, 6 (FECD6) [MIM:613270]	K6ZDQ8	905	A	T
P37275	LP/P	Corneal dystrophy, Fuchs endothelial, 6 (FECD6) [MIM:613270]	K6ZDQ8	640	Q	H
P37275	LP/P	Corneal dystrophy, Fuchs endothelial, 6 (FECD6) [MIM:613270]	K6ZDQ8	696	N	S
P37275	LP/P	Corneal dystrophy, Fuchs endothelial, 6 (FECD6) [MIM:613270]	K6ZDQ8	905	A	G
Q8N6M9	LB/B	-	A0A0B8RYL1	53	H	L
P26651	LB/B	-	G5BJD9	37	P	S
P26651	LB/B	-	G5BJD9	259	I	F
P26651	LB/B	-	G5BJD9	324	V	F
P26651	LB/B	-	G5BJD9	55	P	S
Q86YA3	LB/B	-	G3S9F9	410	N	S
Q86YA3	LB/B	-	G3S9F9	451	G	E
Q86YA3	LB/B	-	G3S9F9	978	T	I
Q86YA3	LB/B	-	G3S9F9	1410	I	T
Q86YA3	LB/B	-	G3S9F9	1568	S	L
Q86YA3	LB/B	-	G3S9F9	1696	S	C
Q63HK3	LB/B	-	I3LVD4	253	L	F
Q63HK3	LB/B	-	I3LVD4	615	E	D
Q63HK3	LB/B	-	I3LVD4	947	P	S
Q9H091	LB/B	-	G5BWA8	401	R	H
Q8NC26	LB/B	-	L5L6C2	99	H	N
Q8NC26	LB/B	-	L5L6C2	207	V	A
P52742	LB/B	-	A0A287B3J4	22	G	D
P52742	LB/B	-	A0A287B3J4	507	S	L
P52742	LB/B	-	A0A287B3J4	517	T	A
P52742	LB/B	-	A0A287B3J4	579	G	R
P52742	LB/B	-	A0A287B3J4	592	S	L
P52746	LB/B	-	G3NDC1	751	S	G
P52746	LB/B	-	G3NDC1	956	L	H
P52746	LB/B	-	G3NDC1	1313	A	T
P52746	LP/P	Neurodevelopmental disorder with impaired speech and hyperkinetic movements (NEDISHM) [MIM:618425]	G3NDC1	1233	C	F
P52746	LP/P	Neurodevelopmental disorder with impaired speech and hyperkinetic movements (NEDISHM) [MIM:618425]	G3NDC1	1500	R	T
Q15072	LB/B	-	A0A1L8FUD4	8	R	K
P17020	LB/B	-	H0XM87	105	E	K
P17020	LB/B	-	H0XM87	227	R	H
Q9UK13	LB/B	-	A0A2K6EUV1	337	P	A
Q9UK13	LB/B	-	A0A2K6EUV1	519	S	T
Q9UK13	LB/B	-	A0A2K6EUV1	557	G	R
Q9UK13	LB/B	-	A0A2K6EUV1	165	V	M
Q9UK13	LB/B	-	A0A2K6EUV1	179	F	I
Q9UK13	LB/B	-	A0A2K6EUV1	256	C	R
P17027	LB/B	-	A0A286XF72	28	S	G
Q9UIE0	LB/B	-	A0A2K6EUV1	441	D	E
Q9UIE0	LB/B	-	A0A2K6EUV1	310	S	C
Q9UIE0	LB/B	-	A0A2K6EUV1	434	F	Y
Q14587	LB/B	-	A0A2Y9Q4D2	175	T	M
Q2VY69	LB/B	-	A0A2K6EUV1	546	K	E
Q2VY69	LB/B	-	A0A2K6EUV1	577	E	K
Q96PQ6	LB/B	-	G1TG53	19	Q	H
Q9NW07	LB/B	-	A0A2F0B3M9	32	N	S
Q569K4	LB/B	-	A0A096M5S5	242	S	G
Q569K4	LB/B	-	A0A096M5S5	416	F	Y
Q09FC8	LB/B	-	A0A2Y9THY5	196	H	P
Q09FC8	LB/B	-	A0A2Y9THY5	229	I	L
Q09FC8	LB/B	-	A0A2Y9THY5	233	I	V
Q09FC8	LB/B	-	A0A2Y9THY5	241	Y	C
Q09FC8	LB/B	-	A0A2Y9THY5	463	N	D
Q8NDP4	LB/B	-	A0A2K5XPP7	427	L	S
Q8NDP4	LB/B	-	A0A2K5XPP7	6	P	S
Q96MX3	LB/B	-	F1N0K1	65	A	V
Q96MX3	LB/B	-	F1N0K1	224	I	V
Q96MX3	LB/B	-	F1N0K1	21	Q	R
Q6AHZ1	LB/B	-	G3VF73	946	N	H
Q6AHZ1	LB/B	-	G3VF73	1328	R	Q
Q6NX49	LB/B	-	H0WSI1	203	H	D
Q6NX49	LB/B	-	H0WSI1	700	Q	R
Q7Z398	LB/B	-	A0A286ZXR3	359	I	T
Q96ND8	LB/B	-	A0A1U7QYR4	324	F	I
Q86UK7	LB/B	-	A0A212CZ08	453	S	Y
Q86UK7	LB/B	-	A0A212CZ08	725	C	S
Q86UK7	LB/B	-	A0A212CZ08	637	T	M
Q86UK7	LB/B	-	A0A212CZ08	608	A	T
Q8N883	LB/B	-	A0A2U3YU84	68	T	I
Q8N883	LB/B	-	A0A2U3YU84	223	H	R
Q8N883	LB/B	-	A0A2U3YU84	415	V	I
Q8N883	LB/B	-	A0A2U3YU84	160	G	E
O75123	LB/B	-	A0A287AR64	126	D	N
Q14966	LB/B	-	K7FXB7	110	I	V
Q14966	LB/B	-	K7FXB7	980	N	S
Q14966	LB/B	-	K7FXB7	1726	V	M
Q14966	LB/B	-	K7FXB7	1912	A	V
Q14966	LB/B	-	K7FXB7	1462	S	N
Q5TYW1	LB/B	-	A0A1U7UK72	68	S	Y
Q96K58	LB/B	-	A0A1U7Q566	25	L	V
Q96K58	LB/B	-	A0A1U7Q566	304	G	E
Q96K58	LB/B	-	A0A1U7Q566	447	A	V
Q96BR6	LB/B	-	A0A2K5WCI9	76	E	D
Q96BR6	LB/B	-	A0A2K5WCI9	460	G	S
Q2M3X9	LB/B	-	H0XHB8	343	T	M
Q2M3X9	LB/B	-	H0XHB8	182	L	F
Q5TEC3	LB/B	-	L8Y600	158	P	T
P17097	LB/B	-	A0A2Y9H5J6	188	G	R
P17097	LB/B	-	A0A2Y9H5J6	347	S	L
P17097	LB/B	-	A0A2Y9H5J6	596	L	F
Q7L3S4	LB/B	-	L5KHB7	207	D	N
Q6NX45	LB/B	-	L9KIS4	65	P	L
Q6NX45	LB/B	-	L9KIS4	83	N	S
Q6NX45	LB/B	-	L9KIS4	147	V	I
Q6DD87	LB/B	-	A0A2Y9IGY7	379	G	A
P51504	LB/B	-	A0A2Y9JD11	253	D	A
P51504	LB/B	-	A0A2Y9JD11	201	R	H
P16415	LB/B	-	A0A2K5XPP7	566	R	H
P51522	LB/B	-	A0A2Y9THY5	70	T	I
P51522	LB/B	-	A0A2Y9THY5	96	S	N
P51522	LB/B	-	A0A2Y9THY5	119	T	M
P51522	LB/B	-	A0A2Y9THY5	392	H	R
Q5JPB2	LB/B	-	K7FEK0	845	G	R
Q5JPB2	LB/B	-	K7FEK0	1513	S	P
Q5JPB2	LB/B	-	K7FEK0	1615	R	H
Q96EG3	LB/B	-	A0A2K5PRP7	153	Q	R
Q96EG3	LB/B	-	A0A2K5PRP7	242	A	T
Q15649	LP/P	PEHO syndrome (PEHO) [MIM:260565]	A0A0B6ZUS4	31	S	L
P60852	LB/B	-	A0A2Y9H857	158	T	I
Q05996	LB/B	-	A0A091EDQ4	36	G	V
P17040	LB/B	-	F6WPG6	248	D	N
P17040	LB/B	-	F6WPG6	432	Y	D
Q8IWY8	LB/B	-	I3LVD4	199	G	S
Q8IWY8	LB/B	-	I3LVD4	104	R	G
O95229	LB/B	-	A0A2I3MH88	4	A	S
O95229	LB/B	-	A0A2I3MH88	187	R	G
Q9N2K0	LB/B	-	Q5G5C9	81	V	L
Q9N2K0	LB/B	-	Q5G5C9	150	F	L
